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Abstract
Reverse Vaccinology of Bovine Trichomoniasis
Tritrichomonas foetus is an anaerobic flagellated protist and the causative agent of the venereal
disease, bovine trichomoniasis. It is responsible for significant economic losses to farmers in several
countries where the disease is endemic, and currently there is no vaccine available that can prevent
infection.
The aim of this thesis was to identify putative vaccine candidates from the T. foetus genome using
a reverse vaccinology approach. This is achieved by assembling and annotating a parasite genome
sequence and evaluating putative cell-surface antigen genes for their immunogenic potential.
In Chapter 2 the T. foetus genome is assembled using various methods and annotated using mul-
tiple computational tools. Multiple transcriptomes are produced to identify protein-coding gene
sequences. After manual curation of the genome sequence there is a repertoire of 84,706 protein
–coding genes.
In Chapter 3, multiple proteomics approaches, including biotin labelling, are used in order to iden-
tify cell surface proteins and to identify differences between the two T. foetus life stages, trophozoites
and pseudocysts. A peptide array is also used to examine the immunogenicity of selected proteins
when exposed to sera from naturally infected and experimentally infected cattle. Immunogenic
epitopes are identified in many of the proteins and those with the greatest number of epitopes are
selected for further study.
In Chapter 4, multiple strains of T. foetus, along with T. mobilensis are grown in co-culture with
an MDCK monolayer in order to identify genes preferentially expressed in the presence of host cells.
Cytotoxicity and cell binding assays are also performed, which shows clear differences between the
different T. foetus strains. These genes are crosschecked with the peptide array and original tran-
scriptomic results to produce a shortlist of potential vaccine candidates.
In Chapter 5, the structural invariance of the gene shortlist is examined. Single Nucleotide Poly-
morphisms are identified between all the T. foetus and T. mobilensis strains and the reference T.
foetus genome, with some genes appearing to be invariant. These were again cross referenced to
produce a list of eight potential vaccine candidates.
In conclusion, this thesis identifies eight candidate antigens, each predicted to be localised to the
cell surface. These antigens are consistently immunogenic, they are preferentially expressed in the
ii
presence of a host, and they are not genetically polymorphic across parasite strains. This work
provides a basis for the development of recombinant T. foetus vaccine and pipeline permanent
solution to endemic trichomoniasis in livestock herds.
iii
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Chapter 1
Introduction
Bovine trichomoniasis is a parasitic disease of cattle and is directly transmitted during coitus.
Although bovine trichomoniasis has been eradicated in the UK, it is still endemic to many areas
of the world, including the US, Australia and South Africa. This parasite poses a large economic
and welfare problem to farmers, particularly in countries where beef and dairy are main exports
or consumed in high quantities. The eradication of this disease globally would have far reaching
consequences, particularly as the economic cost of this disease is predicted to be over $500 million
in the US alone [1] and is likely to be much higher due to the disease going mostly undiagnosed..
1.1 Tritrichomonas foetus
1.1.1 Morphology
Tritrichomonas foetus is a unicellular trichomonad that causes the venereal disease bovine tri-
chomoniasis. It is a pear-shaped organism approximately 16.5µm long and 6.7µm wide [2] [3],
although this can vary slightly by strain, where strain refers to a genetic subtype of the species.
It possesses a large single nucleus, three anterior flagella [4] and one posterior attached flagellum
which attaches to an undulating membrane along one side [5] (Figure 1.1). Other organelles of
interest include the axostyle and costa [2] [3].
The axostyle is an intercellular projection formed by microtubule arrangements [2] [6] in a ribbon-
like structure. It originates near the basal bodies, runs the length of the cell from anterior to
posterior and is associated with structures such as the smooth endoplasmic reticulum and hy-
drogenosomes [7] (Figure 1.2) and protrudes through the posterior end. The axostyle may have a
1
role in the nuclear division as, during mitosis, two axostyles are present and become associated with
the nuclear membrane [7]. It may also have a structural role, providing support for the flagella canal
[2]. However, when T. foetus cells are treated with drugs that affect microtubule function, such as
colchicine, the axostyle does not seem to be affected [2] [8], this may suggest that it is comprised of
a different form of microtubules than the flagella and cell membrane as their morphology is altered
by the addition of these drugs [9] [8]. It is thought that the axostyle is made of stable microtubules
rather than labile microtubules as appears to be the case with the flagella [8]. At present, there
are very few conclusive studies on the T. foetus axostyle and its functions.
The costa is a structure only found in trichomonads [2] and is made of striated fibres [2]. It is
found in the cytoplasm [10] and runs parallel and beneath the undulating membrane [11]. It has
an association with the flagella and it is thought this may be necessary for motility. It may have a
role in energy production or as an energy reserve [11] as there is biochemical evidence of ATPase
[10] and it is thought it is involved in cell motility.
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Figure 1.1: Representations of Tritrichomonas foetus trophozoites, showing:
(A) Scanning electron microscope image reproduced from Rosa (2013) [12] showing two anterior
flagella (AF), undulating membrane (UM), axostyle (Ax) and posterior flagellum (PF
(B) T. foetus line drawing showing key morphological features: the flagella, axostyle, costa, nucleus
and undulating membrane reproduced from K-state.edu [13] (Original line drawings by Jarrod
Wood)
(C) Light microscopy of T. foetus, reproduced from [14] blogs.cornell.edu
(D) Transmission electron microscopy of T. foetus from Rosa 2013 [12] showing hydrogenosomes
(1), costa (2), nucleus (3) and undulating membrane (4).
Trichomonads do not possess mitochondria [2]. Instead, T. foetus and other trichomonads such as
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T. vaginalis have hydrogenosomes. These are hydrogen producing derivatives of mitochondria [15]
that regulate the cellular metabolism [16]. In particular, they are known to function in glycogen
metabolism along with the axostyle and costa [2]. Whereas mitochondria use oxidative phospho-
rylation to produce ATP [17], hydrogenosomes use substrate level phosphorylation and have no
electron transport chain [18] but do possess an iron-sulphur biosynthesis pathway (ISC) (Figure
1.2). Reflecting its common ancestry with eukaryotic mitochondria, the hydrogenosome possesses
a double membrane [3] and and can produce hydrogen and ATP from imported pyruvate produced
by glycolysis in the cellular cytosol [17] [19]. They can also uptake calcium and have areas for cal-
cium deposits on their periphery [3]. The hydrogenosomal enzymes of T. vaginalis are homologous
with adhesin proteins [2]. The T. vaginalis cell surface proteome has identified enzymes that are
known to localise in hydrogenosomes , as well as the cell-surface, and adhesins. The cell can secrete
these hydrogenosomal enzymes and also transcription initiation factor like proteins [20], both can
cause cytotoxic effects and it is likely that some similar enzymes and and secreted proteins are also
produced in T. foetus [20].
Figure 1.2: Comparison of the structures of the aerobic mitochondria and the hydrogenosome using
a simplified view showing the major distinguishing features of each. The hydrogenosome does not
possess a mitochondrial genome or the necessary machinery for oxidative phosphorylation. However,
both the mitochondria and hydrogenosomes are double membrane bound. The hydrogenosome can
use pyruvate imported from the cytosol to produce hydrogen and ATP. Adapted from Burki (2016)
[18].
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1.1.2 Life Cycle and Host Range
T. foetus is directly transmitted between organisms without a vector and, in cattle, is sexually
transmitted from cows to bulls and vice versa during coitus leading to spontaneous abortion, foetal
maceration and infertility in cows. Parsonson et al. (1976) [21] found that a single mating service
with an infected bull infected 95% of females that had not previously borne calves. Although
both bulls and cows harbour the infection, bulls are considered to be the maintenance host since
once they are infected they become asymptomatic carriers for life [22]. In contrast females, when
infected, are more likely to exhibit a range of clinical signs: vaginitis, endometriosis, early abortions
and in some cases either transient or long-term infertility [5]. Although the infection can often be
resolved in cows they can still become infected in subsequent seasons [23]. Due to the asymptomatic
nature of the infection, a further difficulty is identifying and separating infected animals from the
herd [24].
The age of the bull is an important factor in transmission of the parasite; older bulls (over the age of
4 years) are more likely to be infected and retain infection than younger bulls. This is thought to be
due to the development of deeper crypts (microscopic invaginations in the epithelium of the penis
and prepuce) in the older animals, which provide a more conducive environment for the trichomonad
[25]. Susceptibility to infection has also been found to depend on cattle breed. For example, Bos
taurus has been found to be up to 6 times more likely to retain a T. foetus infection than Bos
indicus [26], and within Bos taurus the breeds Angus, Simmental and Charolais are more likely to
have and retain the infection. It was also found that owners with a good knowledge of the disease
were 70% less likely to have incidence of T. foetus in the herd [27]. In addition to transmission by
direct contact between the bull and heifer, the disease may be spread via contaminated artificial
insemination equipment [28].
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Figure 1.3: The life cycle and transmission of T. foetus in cattle. The parasite reproduces within
the urogential tract of the cattle and is directly transmitted by coitus and has no intermediate host.
1.1.3 Life Stages
T. foetus may adopt two distinct developmental forms. Actively growing cells typically adopt a
trophozoite (amoeba-like) form but can internalise its flagella and form a pseudocyst, which is
more spherical in shape rather than pear shaped (Figure 1.4). This pseudocyst usually occurs
under stressful environmental conditions [29]. It was previously postulated that pseudocysts are
a degradative form of the parasite however, this does not now appear to be the case [16]. It is
currently unknown what the true purpose of pseudocysts are, though it has been suggested that
they protect against adverse envrionments, or function as an infective stage [9]. The fact that
pseudocysts have been shown to survive for 48 hours in environments such as water bowls [30]
provides further evidence that it has a protective function [31].
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Figure 1.4: Comparison of the two T. foetus life stages, the pear-shaped trophozoite and the more
spherical pseudocyst. Although the true reason for pseudocyst formation is unknown, it is thought
that it is either an infective or protective form. The pseudocyst form can be induced by environ-
mental or chemical stresses, such as a decrease in temperature or addition of microtubule affecting
drugs such as colchicine. However, this use of colchicine is likely mimicking the morphological effect
rather than inducing a true change as it is non-reversible.
1.1.4 Taxonomy
T. foetus belongs to the Phylum Sarcomastigophora, Order Trichomonadorida and the Family Tri-
chomonadidae. Currently, the closest well-studied relative of T. foetus is the human pathogen
Trichomonas vaginalis [32]. T. vaginalis is a sexually-transmitted infection associated with nu-
merous health problems in humans, including: male and female infertility, vaginosis and preterm
births [33]. Other related trichomonad parasites include T. gallinae, Pentatrichomonas hominis
and Dientmoeba fragilis. Generally, trichomonads are not extensively studied and their taxonomy
is not well advanced. Debate continues with respect to what is a true species, as opposed to a
strain or subspecies. The taxonomic similarity between organisms, particularly when they repro-
duce asexually, can be used to define whether it is a species or a strain, although the deciding
threshold often has to be arbitrary. New trichomonad species are often discovered, for example, in
2015 T. gypaetinii, previously thought to be T. gallinae was found to be a distinct species based
on DNA sequencing [34]. Due to these new discoveries and the fact that sequencing and molecular
methods are always improving, the taxonomy of trichomonads is liable to change in the future.
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Figure 1.5: Maximum likelihood phylogenetic tree of RNA polymerase II genes from diverse tri-
chomonads based on Maritz (2014) [32]. 20 amino acid sequences were obtained from Genbank
[35] and their accession numbers are shown at the tips. The sequences were aligned using Clustal
Omega. A phylogeny was estimated using Mega X [36] with a Le-Gascuel amino acid substitution
model [37]. Bootstap values were inferred from 100 replicate data sets [38]. A discrete Gamma
distribution was used to model evolutionary rate differences among sites. The tree is drawn to
scale, with branch lengths measured in the number of substitutions per site.
1.1.5 Tritrichomonas foetus in other species
Besides cattle, T.foetus infection is commonly found in cats and pigs and uncommonly (in three
known cases), humans. Although the parasite is sexually transmitted in cattle this is not the case
in other hosts. In cats, where it is an important cause of diarrhoea and colitis [39], it is transmitted
by the faecal-oral route [4]. Infection is mainly found in young cats particularly in colonies and
multi cat households where it is believed to be spread by contact with faecal matter.
The organism is viable in cat faeces for days and also for short periods in urine, wet cat food and
water [40]. Studies have shown that 10% - 15% of cats in the UK and USA are infected. When
infected, many cats are infected for life and the only treatment available is ronidazol [41]. However,
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there is evidence that this drug is losing its potency due to the development of resistant strains.
These drugs cannot be used in pregnant animals due to their teratogenic nature [41]. Although
isolates from the feline gastrointestinal tract and the bovine reproductive tract are morphologically
identical, consistent differences in their DNA have been found [4] [42]. Morin-Adeline et al. (2014)
[42] suggest that the prominent genetic similarities between the two strains is evidence of recent
adaptations to the mucosal environment of their respective hosts. However, both the feline and
bovine strains appear to occupy distinct niches in the UK and there does not appear to be any
evidence of sporadic cases in cattle from contaminated cat faeces. This provides some evidence that
the two strains could be separate species. The name T. blagburni had been proposed as a possible
name for the feline strain due to the differences in host specificity and pathogenicity [43].
More recently, in 2020, the rRNA genes of several American bovine T. foetus strains have been
sequenced [44], as have suspected T. foetus samples from other mammalian hosts. There was
over 99% similarity between the newly isolated American strains and previous bovine isolates.
When they were compared, two clear clades of Tritrichomonads were seen: one containing the
bovine, swine and and human isolates and one containing feline, avian, squirrel monkey and canine
isolates. All Tritrichomonas species sequenced were more similar to each other than to any other
Trichomonads sequenced, such as Pentatrichomonas hominis or T. vaginalis. This study concluded
that all of the mammalian Tritrichomonas species that were sequenced belonged to T. foetus,
however, they also agree that further study is needed to fully support this [44].
Tritrichmonas suis is a commensal in the intestinal tract of pigs. T. suis and T. foetus were
originally considered to be separate species, but recent evidence from genetic studies, along with
microscopy [3], has led to the conclusion that they are in fact the same species [45] [46]. Tachezy
et al. (2002) [45] analysing 16S rRNA sequences , found no species specific differences and showed
that they had the same cell morphology and structure. Experiments involving infecting cattle
with T. suis and pigs with bovine T. foetus and seeing if there are clinical symptoms of disease
could provide evidence whether the strains are the same species and can occupy the same niches.
The prevalence of T. suis in pigs is commonly high [47]. T. suis was found in the nasal cavity
of 55% of pigs tested and it was found in 64.5% of Australian pigs even though there were T.
foetus negative cows nearby [48]. Additionally, there have been three isolated reports of T. foetus
infections in immunocompromised humans [49]. There has also been a case of T. foetus associated
with periodontitis in a 52-year-old man, again, he was immunocompromised [50].
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1.2 Other Trichomonads
Trichomonads are found in essentially all species of vertebrates [51] [52] and were even thought to
infect the dinosaurs [53]. Many trichomonads are simply commensals, for example, Tritrichomonas
suis in pigs [45] and some can be ectosymbiotic, such as Mixotricha paradoxa [54]. However, most
known species are pathogenic and can cause a range of serious diseases. There are four species that
are considered to be human parasites: Trichomonas vaginalis, Trichomonas tenax, Dientamoeba
fragilis and Pentatrichomonas hominis, the latter two species are also parasites of non-human
animals [32], which may indicate zoonotic potential between the species. Other trichomonads, such
as T. foetus, T. gallinae and T. mobilensis are known animal parasites and are not known to infect
non-immunocompromised humans. Trichomonads are not limited to one area of the body; with
Trichomonas vaginalis found in the urogenital tract, Trichomonas tenax found in the oral cavity
and Dientamoeba fragilis and Pentatrichomonas hominis both found in the gastrointestinal tract
[32]. As previously stated, Tritrichomonas foetus can be found in the urogential tract of cattle but
the gastrointestinal tract of pigs and cats and T. gallinae is found in the oral cavity and crop of
birds. There are different modes of transmission depending on the species, including faecal-oral and
sexual. However, there is no known intermediate host in the life cycle of any of the trichomonads.
There has been much debate on whether certain species of trichomonads, for example T. suis and
T. tenax are merely variants of other trichomonads [55] [56] due to their high similarities in their
rRNA and class II fumarase gene sequences [56] [57] [58]. This could mean that the taxonomy of
the trichomonads could be revised in the future.
1.2.1 Trichomonas vaginalis
T. vaginalis is the most common non-viral human sexually transmitted pathogen [20] [59] and the
causative agent of trichomonaisis. Regarding incidence: T. vaginalis has an incidence of 177.7 per
thousand in women in the Americas and 180.6 per thousand in men. In south east Asia it is 40.3 in
females and 50.1 in males [60]. It is found globally and has, in some areas, reached an prevalence
of 25% or higher [61] and is associated with several other diseases and complications, such as HIV
and pelvic inflammatory disease [62]. It is also seen concurrently with a range of other diseases,
such as gonorrhoea and bacterial vaginosis. T. vaginalis has also been thought to be associated
with various cancers, as have many trichomonads [63] [64] [65]. It may also be zoonotic from birds
in a similar way to T. tenax [60]. One reason why human trichomoniasis is so prevalent is due
to the fact that most men and up to 50% of woman may be asymptomatic [66] [61]. Due to this
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asymptomatic nature, estimating the true prevalence of the parasite is very difficult [67]. The fact
that T. vaginalis infects humans means that it has been studied in much greater detail compared to
its bovine counterpart and the similarity between the two means that knowledge about T. vaginalis
could be applied to T. foetus, such as virulence factors.
T. vaginalis has only one anterior flagellum rather than the three found in T. foetus. Apart from
this, morphologically speaking, T. foetus and T. vaginalis are very similar [61]. T. vaginalis also
forms stress induced pseudocysts [68] like T. foetus and, also like T. foetus, these are viable and
their formation can be reversible. These these pseudocysts were found to have a reduced glycolytic
metabolic pathway but the lactate dehydrogenase pathway was greatly increased. There may be
similar metabolic differences between T. foetus trophozoites and pseudocysts. The environmental
conditions in which both species interact to the host are constantly changing, for example the
shedding of the epithelial lining or changes to pH of the genital tract [67] and so both would need
adaptations to these environmental pressures.
Many of the relevant antigens for T. vaginalis that confer pathogenicity are known, such as adhesion
proteins: AP120, AP65 and AP51, in addition to cysteine proteases and various lectins [67] and
infection is known to produce IgG and IgA responses in vaginal fluids. Proteomics approaches have
looked into T. vaginalis cell surface proteins along with secreted proteins that could be involved in
the host-parasite interactions. In terms of host-parasite interactions; lipophosphoglycan is known
to be a likely involved in the adhesion of T. foetus. Additionally, metabolic and membrane proteins
have also been postulated as adhesin proteins.
1.2.2 Trichomonas tenax
Trichomonas tenax is a commensal of the human oral cavity [69] and feeds on the epithelial micro-
biota. It is usually found around diseased teeth and gums [70] and it is thought that infection is
related to poor oral hygiene. Not a great deal is known about the organism, which older literature
refers to as T. buccalis or T. elongata. It has previously been thought that it may be related to the
incidence of pulmonary trichomoniasis [70], a rare infection, reported only 39 times between 1945
and 1985 [70] and thought to self-cure or was treated with antibiotics. It may be that the presence
of T. tenax was incidental and was an opportunistic infection. The fact that most infections re-
ported recently, were in patients with underlying conditions, such as cancers [71] further suggests
that it could be an opportunistic co-infection. It is easily spread between people via saliva and
droplets and the prevalence of T. tenax can be highly varied, ranging from 4-53% [72]. A study in
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Iraq [73] showed that the incidence of the parasite was affected by many factors, such as existing
oral disease, such as periodontal disease; 12.6% of patients with oral disease were positive for T.
tenax but this dropped to 5.3% in people with no oral disease [73]. Smoking was also identified as
a risk factor; the infection rate in smokers was 15.7% compared to 4.5% in non-smokers. When T.
tenax cells were added to MDCKs (canine kidney cells), HeLa cells and 3D spheroids [69] they were
found to cause cell damage and death in a similar way to T. vaginalis suggesting it has potential to
be pathogenic or cytotoxic. It has also been suggested that T. tenax is a genetic variant of either
T. vaginalis [56] or T gallinae [74] in a similar way that Trichomonas suis was found to be the
conspecific with T. foetus. [45] [55].
1.2.3 Dientamoeba fragilis
Dientamoeba fragilis is another parasite of the human gastrointestinal system. It was originally
classed as an amoeba but was later placed in the class Tritrichomonadea with Histomonas [75] [76].
When it was first discovered it was considered a harmless commensal, comparable to the views held
for Trichomonas tenax [77]. Yet, as with T. tenax, there is increasing evidence that D. fragilis may
be pathogenic [77] [78] [79], implicated perhaps in irritable bowel syndrome and diarrhoea [79]. In
a study by Stark et al. (2010) [80], D. fragilis was found to be more common in the patient stool
samples than Giardia and 83.3% of patients with D. fragilis experienced diarrhoea. The worldwide
prevalence ranges from 0.4-32% [81] [82] and the true infection rates are likely under-reported due
to a lack of accurate diagnostics and the short survival time of the parasite outside the host [81]
[80] . D. fragilis has also been found to be related to T. musculis which has associations with
cancer. The similarity between the organisms may mean that D. fragilis could possibly have the
same associations with cancer [63] [83]. D. fragilis parasites that have similar genotypes to a human
strain of D. fragilis have also been found in pigs, providing more evidence for the potential that is is
zoonotic [84]. Little is known about parasite ransmission or life-cycle and it was long thought that
there was no cyst form [84] [85]. However, Munasinghe et al. [86] identified a cyst form and showed
that these are shed from rats, therefore providing the likely mechanism for faecal-oral transmission.
Currently this is the accepted mode of transmission [75]. Stark et al. [87] showed that D. fragilis
cysts could be found in human clinical samples, however the numbers and proportions of these were
very low (0.01% of the sample) [87].
When the D. fragilis transcriptome was produced, it was found to be similar to that of T. vaginalis
despite their morphological differences [76]. The trophozoites of both species were considered to
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metabolically similar and D. fragilis was found to have a very large BspA expansion in the same
way T. vaginalis does, suggesting the BspA family is very important amongst the trichomonads.
Transcripts that were homologous to cytotoxic cysteines were also identified in D. fragilis [78].
These genes may provide crucial evidence in identifying the diversity between different D. fragilis
strains [76] in a similar way to how bovine and feline isolates of T. foetus can be differentiated [88].
1.2.4 Pentatrichomonas hominis
Pentatrichomonas hominis is known to inhabit the gastrointestinal system of humans [63], in ad-
dition to many other mammalian species, including rabbits, foxes, sheep, goats and cats [89] [90]
[91] [92]. As with T. vaginalis and some other protistan parasites may be associated with certain
cancers [63] [93] [94] [64] [65], P. hominis may be associated with some gastrointestinal cancers
[63]. In 2019, Zhang et al. [63] found that infection with P. hominis increased the risk of colorec-
tal, oesophageal, stomach, small intestine and liver cancers. Infections with P. hominis increased
the risk of these gastrointestinal cancers by 6.75 fold. It was previously thought that P. hominis
was a commensal, however, as well as cancers, it has since been linked to several conditions, such
as irritable bowel syndrome and rheumatoid arthritis [63] [95] [96] and may be a causative agent
of diarrhoea [63]. In one case where a T. foetus infection was suspected in two cats presenting
with diarrhoea, molecular analysis showed that the infection was due to P. hominis instead [92],
showing that it is not likely to be merely a commensal organism. In fact, P. hominis may be often
misidentified as T. foetus in clinical animal cases, such as gastrointestinal issues in cats. In a few
sporadic cases, P. hominis has been identified in the human respiratory tract [97] suggesting it can
colonise other areas. This may be similar to how T. foetus can occupy different niches in different
mammalian hosts.
1.2.5 Trichomonas gallinae
Trichomonas gallinae is an emerging pathogen of birds [98]. It is found globally and has been found
in a range of avian species. While it has been associated with a decline in finches in Europe, however
its natural hosts are thought to be pigeons and doves (Columbidae) [98] [99]. It has been suggested
that a T. gallinae-like parasite infected the dinosaurs [53]. The domestic pigeon (Columba livia)
that is often credited with the wide spread of T. gallinae infections [100].
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Prevalence of the parasite in columbiforms varies widely depending on the study, ranging from 15%
[101] to 34% [102] for the same species of wood pigeon on different parts of the same peninsula.
This makes determining a typical prevalence of the parasite globally very challenging. T. gallinae
infects the crop and oesophagus of birds [103] and can cause cankers and lesions to form, leading to
the death of the animal by starvation [104]. It has caused large decreases in the greenfinch popula-
tion across the UK [105]. The most likely mode of transmission is direct between birds, likely via
crop milk from infected parent birds to their offspring [99] [106], from raptors consuming infected
animals or from courtship. Contamination of water by an infected animal has also been shown
to cause spread of infection, for example, in species of chickens [99]. T. gallinae is also known to
form pseudocysts, similar to those of T. foetus, which are thought to enhance infectivity or prolong
longevity outside of the host [99] [107].
Several genotypes of T. gallinae have been described [104] [108] suggesting the possibility of mul-
tiple genotypes of the species [74]. The ITS1-5.8S-ITS2 regions of parasites isolated from racing
pigeons in Poland contained two different sequence types [108]. Sansano-Maestre et. al [109] also
investigated the ITS1-5.8S-ITS2 regions of T. gallinae isolates from columbiforms and raptors; they
identified two genotypes, called A and B. They also showed that genotype A was more prevalent
in columbiforms, whilst genotype B was more prevalent in raptors. Moreover, the genotype B was
present in all isolates that were found to have lesions, suggesting that this form may have a higher
virulence or pathogenicity [109]. Grabensteiner [110] discovered a further four genotypes when
comparing samples from 16 birds, including pigeons, vultures and doves. The strains had high se-
quence identity, ranging from 84.7-97.6%. This study also demonstrated that the sequence identity
between different T. gallinae strains and T. vaginalis ranged between 87.2-99%, and between T.
gallinae and T. tenax of 86.6-97.3%; [110]. One strain did not appear to group closely to any of the
others. Grabsteiner [110] postulated that this could be an early step in the establishment of a new
strain. Due to the poor taxonomy in trichomonads, it is possible that species diversity is massively
underestimated when it is based on morphological similarity. In many cases it may be that two
organisms with low sequence identify are two separate species rather than separate strains.
1.2.6 Trichomonas mobilensis
Trichomonas mobilensis infects the gut lumen of squirrel monkeys [103]. It is known to be highly
invasive and can infect up to 100% of colony members in large monkey colonies. When T. mobilen-
sis cells were incubated with RK-12 cells (rabbit kidney) to investigate their virulence, they were
14
found to damage the monolayer. They also adhered to the flask and produced a haemagglutinin
which was found to have similar properties to sialic acid-specific lectins [103] [111]. This haemag-
glutinin appeared to be inhibited by the presence of sialic acid. The same result occurred when
the experiment was repeated using T. foetus parasites. Similarly, Demes et al. (1989) [112] added
T. mobilensis parasites to a CHO cell monolayer, the parasites adhered within 5-15 minutes. Cell
adherence was time and parasite concentration dependant and could be inhibited by sialic acid
and sialyllactose. The parasites infected the luminal crypts, in a manner reminiscent of T. foetus
infecting the crypts of the bovine prepuce. There was also evidence of mucosal invasion, this is
commonly seen in T. vaginalis and T.foetus infections [103]. These results show that both T. foetus
and T. mobilensis use sialic-specific lectins in some way for host-cell attachment.
When Midlej [113] compared the binding of T. mobilensis and T. foetus the binding capacity of T.
mobilensis was lower. Feilessen [55] suggested that both T. mobilensis and T. foetus could be the
same species, with T. mobilensis being a variant or subtype of T. foetus.
1.2.7 Genetics and Omics of Trichomonads
Trichomonad genetics
The number of chromosomes in the trichomonads varies with species [114], T. vaginalis for instance
has 6 chromosomes [115]. The same karyotype was found across various different isolates, showing
that it is broadly conserved. Other trichomonads, such as, T. foetus and T. augusta have 5
predicted chromosomes [114], T. tenax and P. hominis also have 6 chromosomes each. There
is little known about the regulation of trichomonad genomes. In T. vaginalis, two thirds of genes
encode transposable elements and there is evidence of a large genome expansion. Very few genes
have introns. There is no evidence of TATA box elements though there is an Inr promoter element.
This appears to have evolved early so likely to be a feature of all trichomonads [116]. Iron is thought
to play a crucial role in gene expression as well as other key functions within the cells. This will be
further discussed later in the chapter. Isoenzyme electrophoresis showed different levels of enzyme
polymorphisms between trichomonad species[117]: T. gallinae had 5 polymorphic loci out of 11
tested whereas T. vaginalis had 2. Additionally, the T. foetus KV1 strain had malate dehydrogenase
differences compared to all other T. foetus strains examined. Regarding trichomonad reproduction
[118], it was initially assumed to be sexual due to diploidy. Xu (1998) [119] stained T. foetus
and T. suis chromosomes and identified five pairs, however, segregation and recombination were
found to be absent in natural populations [118]. Therefore, trichomonads appear to reproduce by
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clonal reproduction. Zubacova (2008) [114] stated that all trichomonads were haploid and that
T. foetus had five chromosomes. Even in 2020 [120], it has not been fully determined whether T.
foetus is haploid or diploid. In Giardia, zymodermes sampled in many geographical areas and from
different hosts, including humans and cats, were found to be almost identical [121][122] and T.
foetus populations are similarly thought to have clonal structures.
Omics
Trichomonads have a smaller repertoire of genomic, transcriptomic and proteomic resources avail-
able compared to other protists, such as Plasmodium [123]. In part this is because trichomonads
have large and repetitive genomes that have been difficult to reolve until recently. The advent of
long-read sequencing platforms such as PacBio and Nanopore has made sequencing trichomonad
genomes practical. T. vaginalis has a 160Mb genome and other trichomonads may be similar if
they too contain a large proportion of repetitive regions. However, the range of genome sizes pre-
dicted for the parabasalids is large, with T. tenax having a predicted size of 133 Mb (+/- 4) and
Pentatrichomonad hominis having a predicted genome size of 94Mb (+/-8) [114].
RNA-Seq analysis of gene expression has been used in several protists, including T. vaginalis. This
exposed a large family of BspA proteins and also genes that were differentially expressed in the
presence of iron [123]. RNA-Seq in Pentatrichomonad hominis identified 442 hydrogenosomal pro-
teins [124] including multiple homologues of T. vaginalis hydrogenosomal proteins. Proteomics
and metabolomics have also been used to study T. vaginalis and has been used to validate and
improve in silico predictions [123]. In silico analysis of the T. vaginalis genome predicted 138
hydrogenosomal proteins [125] but mass spectrometry of hydrogenosomes predicted 569 proteins
[126]. Additional proteomic studies could help to identify further proteins that are localised to the
T. vaginalis organelles. In a similar way, proteomic studies in conjunction with in silico predictions
could produce a full repertoire of T. foetus proteins.
1.3 The Reproductive System of the Cow
T. foetus can adapt to a range of mucosal environments. The urogenital tract of the cow is one such
environment and poses several challenges to the parasite, including pH changes and an abundance
of micobiotic flora and fauna. The reproductive system of a cow consists (briefly) of two ovaries,
two oviducts, cervix, vagina, vulva, two uterine horns and a uterine body. Cows typically have a
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21-day oestrus cycle [127], meaning that every 21 days cows are able to ovulate and conceive. For
most cows their gestation period is 283 days [128] however, this can vary depending on the breed of
the cow or the sex of the calf and can range from 279 to 287 days. Cows are usually able to become
pregnant again 50-60 days after calving. Non-pregnant cows are known as open cows [129]. These
open cows are 7.5 times more likely to be culled than pregnant ones [130] [131]. One of the most
obvious signs that a herd is infected by T. foetus is an increase in the number of open cows and a
reduced gestational period. The female bovine vaginal tract is home to a host of bacterial species
[132] in comparison to the human reproductive tract which is 90% lactobacili, keeping the pH low
(3-4.5) [133] [134]. One study [132] in cows found 792 different genera of bacteria between the
uterus and the vagina and the abundance of species changed depending on the pregnancy status of
the cows. The pH of the urogenital tract also changed, becoming lower when the cow was pregnant.
In order to infect cows, T. foetus would have to be able to cope with these changes in environment.
The bovine uterus also undergoes large changes after birth [132] [135] such as re-growing the uterine
endometrium and shedding some of the uterine mucosa, which can put them at higher risk of disease
caused by colonising bacteria. 80-100% of cattle were found to have contaminating bacteria in the
lumen two weeks after giving birth, dropping to 40% after another week [135] due to clearance by
the immune system. In order to infect the cow, T. foetus has to overcome the immune response
and the vaginal mucus barrier [2].
1.4 Bovine Trichomoniasis
1.4.1 Clinical Signs of T. foetus Infections
The clinical signs of T. foetus infections differ depending on the animal host. In cats it causes
diarrhoea, colitis, vomiting, weight loss and dehydration [16] [30]. The presence of the parasites
also leads to histological features including a crypt epithelial cell hypertrophy and a loss of goblet
cells [136].
In female cattle the clinical signs can be much more severe, causing vaginitis, infertility, endometrio-
sis and in some cases pyometra (roughly in 2-8% of cases [137]) [138] [45] [139]. A T. foetus infection
can also cause early embryonic death and abortion and the inflammation due to the T. foetus in-
fection can cause placental oedema. Foetal pneumonia also occurs in roughly half of cases [140]
and the abortion of the foetus can lead to longer breeding seasons. In bulls, T. foetus infections
are largely asymptomatic, however, there can be small amounts of discharge present [139] [137].
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In pigs T. foetus is primarily a commensal although it has been known in some cases to cause
respiratory problems [141].
1.4.2 Prevalence and Economic Impact
Bovine trichomoniasis is a world-wide problem with cases of the disease being reported in the
USA, Australia, Italy, Spain and Argentina amongst many others [142] [143]. The prevalence varies
globally across a wide range of geographical locations. In Australia, for instance, bull infection
rates in 1984 were 3.25%-34.6% [144] and infection rates in herds 11.5%-76.2%. This incidence
led to a decrease in calf production of 3.6%-28.6%. In 1988 the estimated number of calves lost
each year was 25,500 in the Victoria River district of Northern Australia [28], resulting in financial
losses due to reduced milk and calf production estimated to be US $665 per infected cow. There
is an estimated average financial reduction of 5% return per cow when the incidence of T. foetus
infection reaches 20% among bulls in the herd. When the incidence of infection doubles then the
financial reduction in turn increases to 35%. In the United States, infection has been detected in
over 12 states [27], including Nevada where it is estimated that 5.8%-7.8% of bulls are infected;
herd infections as high as 10.7% and it is thought that 40% of ranches have an infected bull [145].
In Floridian herds tested for T. foetus, the incidence was 6% overall (with a range of 0-27% within
each herd). In Oklahoma, where calf production was found to be reduced by 18%, the projected
financial loss due to T. foetus was US $7.3 million per year [138].
As bovine trichomoniasis is a global problem, the economic impacts are also very far reaching. It is
estimated that the cost of this disease exceeds $650 million per annum in the US alone (Speer 1999)
and so it is likely to reach into the billions worldwide, particularly as it often goes undiagnosed.
There is a large reduction in the number of calves born and often the adults have to be culled if
they test positive, both of these come at a large financial loss for the farmer. This is particularly
evident for large scale producers, for example, on certain farms in Texas they could lose hundreds
or thousands of infected cows. The income in Texas from cattle, stands at around $10 billion and
is, therefore, the top agricultural commodity [146] [137].
There is also the cost associated with the feed and upkeep of infected animals that will not produce
offspring, particularly for farms that only farm cows, e.g. for beef and milk, and have no other
animals. This could lead to considerable financial losses. The potential loss of thousands of cattle
per year could have a large impact on the economy, particularly in the beef and dairy industry.
The amount of beef eaten in the world is estimated at 129 billion pounds (lb), [147] with countries
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such as the United States and Brazil accounting for around 25 billion lbs and 16 billion lbs per year
respectively. In the US the amount of beef consumed appears to be on the increase, potentially
reaching over 28 billion lbs in the next few years. The lowest it has been over the past 20 years (in
2014) was still over 24 billion lbs so any significant loss of cattle would have a large impact on beef
prices and would affect a large number of farmers. The amount of cows’ milk produced globally is
also very high: over 200 billion litres per annum and the amount of dairy products consumed in
Europe is estimated at 46 billion metric tonnes [148]. In the US the production of milk is increasing
from 160 billion lbs in 1999 to over 210 billion lbs in 2019. A decrease in dairy cow numbers, in
a similar way to beef cows, could have a devastating impact on local economies, particularly in
farming communities.
All figures gathered so far are from developed countries, such as the USA as the incidences rates
of bovine trichomoniasis are not well reported in developing countries. It would seem likely that
this disease is more wide spread in developed countries with large scale farming practises, in part
due to the anthropogenic nature of the spread of this disease. Meaning that if there is one infected
bull, the fact that this bull can be used as a stud for many females means that the disease will be
spread more easily, even with the introduction of artificial insemination.
1.4.3 Diagnosis
The World Organisation for Animal Health has produced the OIE Terrestrial Manual which lists
several ways to identify T. foetus. The samples from cattle are usually collected from the preputial
cavity in bulls, the vagina for heifers or from aborted foetuses [16] [149] [150]. Samples from cats are
faeces or rectal swabs and samples from pigs are nasal swabs. Preputial samples can include brush-
ing, scraping or washing and all techniques are comparable with one another. Three consecutive
weekly tests with a week break after sexual rest gives 95% or higher sensitivity [40]. The simplest
and most widely used technique for identifying T. foetus is by microscopy the sensitivity of which
is predicted to be 38-82% [16] . The parasites can be easily cultured in Diamond media and then
examined using light microscopy [150] [16] . The culture is viable for up to 120 hours and at 37°C
but it is easy to misdiagnose T. foetus if other trichomonads are present [151]. Dufernez (2007)
[151] found 12 non-T. foetus isolates in bull preputial samples which could be mistaken for T. foe-
tus. These included Pentatrichomonas hominis, Pseudotrichomonas species and Tetratrichomonas
species.
There are also molecular methods for diagnosis. Polymerase Chain Reaction (PCR) can be per-
formed, based on ribosomal RNA genes and can detect 1-10 T.foetus parasites per sample [38].
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Real-time PCR is now commonly used [137]. In cattle, T.foetus often does not provoke a strong
immune response. Therefore, there are relatively few serological tests for T.foetus antibodies [16].
There is an enzyme-linked immunosorbent assay (ELISA) based on a T. foetus antigen TF1.17 that
detects vaginal IgA antibodies [152]. Rhyan (1995) [153] evaluated using immunohistochemistry us-
ing formalin fixed aborted foetal tissues. Monoclonal antibodies were used which detected T.foetus
parasites in the sample whilst not labelling other trichomonad species. However, the sensitivity
was very variable .
Diagnosis of infection by T. foetus may be compromised in several ways, including delays in ship-
ping, contamination of samples and false positives. These factors can lead to unnecessary culling
of healthy bulls with financial consequences for the farmer. The only accurate way to test is for
infection is by constant sampling of the herd every two weeks, a procedure that is of relatively low
cost of around $4 per animal [154], although this is not always practical, particularly in very large
herds.
1.5 Pathogenicity
1.5.1 Mechanisms of Pathogenicity in T. vaginalis
There is more information on the mechanisms of pathogenicity in T. vaginalis as it has been
more extensively studied. Some of these mechanisms of pathogenicity may represent reasonable
hypotheses for T. foetus. Important factors for T. vaginalis pathogenesis include: adherence,
hemolysis, phagocytosis, cell-detaching factors, the acquisition of host molecules and virus co-
infection [155] [33].
Adhesion
Cysteine proteases were found to be necessary for adhesion to the host cell surface. Adhesion to
the host cells causes degredation of the host-cell cytoskeleton [156]. During T. vaginalis infections
lipophosphoglycan (LPG) along with fibronectin-binding proteins (FBP), GTP-binding proteins
(GBP) and actinin, amongst others, are upregulated in the presence of the host and are thought
to play key roles in adherence[157] [158]. Highly virulent phenotypes of T. vaginalis were found
to bind more strongly to soy bean protein, than low virulence strains, providing further evidence
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for their role in adherence and virulence. In 2008, it was found that T. vaginalis LPG binds to
the human Galectin-1 and is inhibited by the presence of exogenously added T. vaginalis LPG [?
], supporting a role for LPG in attachment. The exogeneous LPG also prevented binding of T.
vaginalis to epithelial cells [159] [160]. This role for LPG could occur in other trichomonads and
may be a mechanism to induce binding in different hosts.
Different T. vaginalis strains can have very different effects on vaginal cells [67] [161]. T. vaginalis
can also bind to non-cellular structures, suggesting that the binding process is non-specific. There is
a class of adhesion proteins (AP) that are though to be found on the parasite cell surface [162] [163].
They are involved in carbohydrate metabolism and many are found in the hydrogenosome. It is
unclear whether these mediate specific or non-specific binding and what the true binding partners
are. Membrane proteins, [20] serine proteases and cysteine proteases, are homologous some to
aplicomplexan virulence and invasion proteins [164] and may have a role in host-cell degradation
and lysis [20]. The BspA gene family encodes a very large family of leucine-rich-repeat containing
proteins [67] that may mediate host-cell attachment in a similar way to some bacteria. these
leucine-rich repeats are thought to act a recognition motifs for cellular binding. The BspA family
have been found expressed on the bacterial cell and are involved in adhesion and invasion of host
cells [165] and can trigger immune responses. The BspAs found in T. vaginalis contain a similar
structure to those in Bacteroides forsythus, a bacterium which is known to be able to colonise
oral cavities using BspA binding to fibronectin and fibrinogen [166]. Furthermore, bacteria lacking
BspA genes were significantly less pathogenic than those with the genes [167].
Haemolysis and acquisition of host molecules
Beta haemolysin could be used to provide nutrients from the host cell to the parasites, for example
fatty -acids, which T. vaginalis cannot produce itself [33]. In a study by de Carli (1996) [168] T.
foetus was found to not possess haemolytic activity when exposed to a range of erythrocytes or
several blood groups, however, T. vaginalis lysed cells from all of the human blood groups tested
as well as the animal groups. The haemolytic activity was thought to be mediated by the cell
attachment rather than by any secreted proteins or enzymes. When the parasites were pre-treated
with Concanavalin A, the amount of haemolytic activity was reduced, further supporting the cell
attachment hypothesis, potentially via sugars. Furthermore, in another study, when T. vaginalis
cells were separated from blood cells by a permeable membrane no haemolysis occurred [169].
A glycoprotein was also found in T. vaginalis that mediates cell detachment from a monolayer
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(found to be absent in Pentatrichomonas hominis) [155]. This detachment may allow the parasite
to acquire nutrients or access further areas of the host since the monolayer has been breached.
T.vaginalis also implements phagocytosis to acquire host cell nutrients [67]. This phagocytosis is
also thought to potentially reduce the host immune response, leading to the asymptomatic nature
of the disease [67].
Secreted proteins
Supernatant from media that has previously contained T. vaginalis cells has been found to have
cytotoxic capabilities against host cells, suggesting a secreted virulence factor [33]. When the
supernatant is added to a monolayer it can cause host-cell death [33]. T. vaginalis secretes exosomes
that can bind and induce changes in the host cell [33], that may increase adherence, and proteases
that degrade cytokines [67]. Cysteine proteases from T. vaginalis were often found in vaginal
secretions taken from women infected with T. vaginalis and may have roles in cytotoxicity [67].
Certain cysteine proteases, such as Clan CA cysteine proteases, were also found to be produced
in higher amounts in highly virulent strains [170]. When T. vaginalis strains showing low and
high virulence [171] were compared there were several over expressed proteins in the high virulence
strain, including cytoskeletal proteins and proteolytic enzymes. The low virulence strains showed
no morphological changes when exposed to the vaginal epithelial cells (VECs), whereas the high
virulence strains changed from trophozoites to a flattened amoeboid form [171] [172].
Virus co-infection
It has been thought that T. vaginalis can be infected with a double stranded RNA virus, known
as T. vaginalis virus (TVV) and it may have an effect on T. vaginalis virulence, pathogenicity and
drug resistance [173] [174] [175] [176]. It is thought that the prevalence of infected T. vaginalis with
TVV could be as much as 50% [173] [174]. Interestingly, Mycoplasma hominis was also identified in
over 80% of TVV positive isolates tested [174] and they may form an endosymbiotic relationship.
Proteomes were analysed from both infected and non-infected T. vaginalis and 50 proteins were
found to be altered between the two states [173]. In infected T. vaginalis, ribosomal proteins,
isomerases, ABC transporters and adhesion proteins were upregulated, whereas heat shock proteins,
malate dehydrogenase and fimbrin were downregulated [173]. The adhesion proteins, Ap33-1 and
AP51-3 have been implicated in adhesion of T. vaginalis to host cells and their upregulation could
lead to increased infectivity in TVV positive cells. It has also been seen that TVV can lead
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to upregulation of cysteine proteinases [176], key enzymes involved in host cell degradation and
monolayer destruction. Additionally, a surface immunogen, P270, was found to be upregulated in
TVV positive isolates and P270 is thought to aid T. vaginalis in evading the host immune system.
TVV positive isolates are also thought to have increased susceptibility to metronidazole, the usual
trichomonad treatment, however, the mechanism by which this susceptibility increases is unknown
[175] [176].
1.5.2 Mechanisms of Pathogenicity in T. foetus
During infection T. foetus creates close cell contact and can be cytotoxic towards the host cells in
some cases. [38].
In vitro, T. foetus can attach to bovine vaginal cells in addition to MDCKs and CHO cells [38] and
the parasite has been shown to have a high cytotoxicity to Hela cells. It is thought to attach to host
cells via ‘filopodia-like protrusions’ [38] and this adhesion could be a key stage in pathogenicity.
The parasite attaches to the mucosa, such as the gastrointestinal tract or urogenital tract, however,
there is evidence that it can also penetrate the mucosa of foetuses [153] and invade neighbouring
tissues.
Adhesion of cells was found to be enhanced by laminin and inhibited by anti-laminin suggesting
that laminin could be important for cell adhesion. Additionally, T. foetus and T. suis were found
to bind well to porcine mucosa, mediated by lectin-like binding. The presence of sialic acid on the
host cells improved binding [38].
It has also been thought that T. foetus could cause damage to the female urogenital tract by
affecting the usual vaginal flora, such as lactobacillus, thereby, changing the pH and other conditions
[38]. When bovine sperm was incubated alongside T. foetus cells, it was found that the parasite
damaged the sperm and caused agglutination [177], whilst also decreasing sperm motility. The
overall viability of the sperm did not seem to be affected [177].
It has been found that T. foetus can also secrete many different proteases, especially cysteine
proteases, into the media. These proteases can cleave host-cell proteins such as fibronectin and
fibrinogen [38] [177] which could damage the host mucosa. Sialadase was also found to be secreted
and it has been postulated that the cleaved host sialic acid could be a nutrient source for T. foetus
[38]. A similar sialadase has also been found in the related trichomonad T. mobilensis.
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1.5.3 Pathology
Only 100-200 motile cells are required for infection and cows can usually eliminate the parasite after
2 months [178].The bull often shows signs of inflammation for up to 2 weeks before becoming an
asymptomatic carrier. In cattle, it is thought that the first step in colonisation is the attachment
to the mucosal euterovaginal epithelium; likewise in felines, there is attachment to the intestinal
epithelial monolayers. During infection, T. foetus is only found on mucosal surfaces and the main
site of infection in heifers is the cervix. However, the effector mechanisms during infection have
not, as yet, been identified. In males, T. foetus does not localise in the epithelium, rather in the
actual secretions of the epithelial lining [26]. The progress of infection is rapid, with all regions of
the reproductive system being found colonised within 2 weeks [28]. Infection by T. foetus causes
inflammation in uterine tubes and endometrium and T. foetus can, in some cases, cause permanent
sterility [38]. It takes between 2-6 months for a cow uterus to fully recover from an abortion [28]and
the cows can become reinfected at the next breeding session. The parasite cells can adhere directly
with the vaginal mucosal epithelium [179] before occupying the uterus. The T. foetus cells are then
thought to change morphology from trophozoite to pseudocyst form.
1.6 Immunology
1.6.1 Immunity in Cattle
In cattle there is little evidence for acquired immunity. In males, although some parasite specific
immunoglobulins have been identified by some studies in small amounts [5] [180]. In females, T.
foetus specific IgA and IgG responses are recorded [181] [5] in vaginal secretions and urine. The
IgA mediates parasite immobilisation and agglutination, whilst IgG is responsible for complement
recruitment. When bovine immune sera were examined, there was complement-mediated killing
of T. foetus [38]. There are different responses dependent on whether an infection is natural, or
experimental and the parasites have been administered to the cattle.
Immune responses have been describes in cattle following experimental infections [182]. The an-
tibody titre in cattle infected with the Belfast strain of T. foetus [5] increased from 32 before
infection to 512 in heifers and 128 in bulls four months post infection. The heifers showed antibod-
ies in vaginal mucus and became parasite-free after four months. The serum antibody response was
predominantly IgG2, with minor contributions from IgA and IgG1; antibodies in vaginal mucus
were IgG1. No antibodies were seen in the preputial secretions of the bulls. T. foetus does not
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penetrate the preputial epithelium and so its antigen levels may not be high enough to provoke an
immune response.
In another experiment, Corbeil et al. [181] examined the immune response in the female bovine
reproductive tract and compared protective efficacy in animals with genital responses of predomi-
nantly IgG or IgA with a purified surface antigen (TF1.17) of T. foetus. Ten cattle were used as
unvaccinated controls. The other cattle were immunised twice with the TF1.17 antigen and then
either subcutaneous (Group S) or intravaginally (Group S/V) killed T. foetus was administered.
Three weeks after the last immunisation, animals from all groups were challenged with T. foetus
parasites. Samples of vaginal mucus, serum and urine were collected. Very low IgA responses were
seen in vaginal secretions for all groups, however, group S/V had the highest uterine responses.
Both treated groups, S and S/V had members that shows no evidence of T. foetus infection, 35%
and 20% respectively. Both groups also cleared the remaining infection faster than the controls
and there was found to be no statistical difference between clearance rate between the two treated
groups. Serum IgG responses were high in both treated groups, though group S remained higher
throughout the experiment and vaginal IgA was higher in the S/V group.
1.6.2 Potential Mechanisms of Immune Evasion
Tritrichomonas foetus has several ways in which to evade the bovine immune system. It may
colonise the vaginal tract where a relatively low concentration of complement is found, thus pro-
viding protection from the cow’s immune system [38]. The cysteine proteases that it secretes can,
in vivo, cleave IgG1 and IgG2, the main antibodies mediating killing of the parasite. IgA does
not seem to be lysed to the same degree as IgG; however IgA is involved in preventing attachment
rather than mediating killing [38]. There is evidence that the parasite can internalise the anti-
bodies, preventing them from binding effector mediators such as complement or granulocytes [38].
The idea of antigenic variation has also been suggested as in one study there was a variation in
expression of TF190 [38] the surface LPG undergoes epitope variation, however, the major portion
is conserved [177] [183]. Furthermore, if T. foetus sheds its antigens, such as TF1.17, from the
surface, antibodies could bind to these away from the main cell, potentially reducing cell killing
[177].
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1.7 Prevention and Treatment
As T.foetus infections can cause considerable issues to farmers and vets, both financial and in terms
of animal welfare, preventative measures and treatments have been produced.
1.7.1 Prevention-Biosecurity measures
The most successful method for controlling T. foetus infections is considered to be biosecurity
practices and routine testing of animals [139] [5].
Early breeding of heifers
Making heifers become open earlier in the breeding season so they can then be mated with an
infected bull. They would then become temporarily naturally immune to T. foetus and could be
allowed to breed later in the season and could carry the calf to term. This comes with costs,
principally, the amount of cow feed to allow the heifers to enter the breeding season early.
Using virgin bulls
Only breeding using virgin bulls that have never been exposed to T. foetus. The use of younger
bulls also decreases the chances of infection compared to older ones (over the age of four) as they
are naturally more resistant to infection [40]
Culling infected animals
Culling has a large financial impact to the farmer or owner. Culling infected animals will prevent
further spread of the disease. Open heifers and those that have been deemed to be pregnant
but have then not carried to term are likely to be a reservoir of infection and could promote an
infection at the next breeding season. there is also the danger of herds becoming infected again
from neighbouring farms.
Artificial insemination
Using only known uninfected bulls is a way to prevent a whole herd being infected by one infected
male. The rise of artificial insemination (AI) could be seen as a key factor in reducing infection
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rates in developed countries. Most cases of T. foetus infection come from farms still using natural
service rather than AI [5]. The proportions of dairy farms, in North America, using natural service
in 2005 was 40% [5]. However, there have been some cases where AI has not been successful
in preventing the spread of T.foetus. Cases of poor practise have led to increased transmission,
for example, failing to change gloves when manually checking cervico-vaginal mucus from cows or
failing to screen semen for T. foetus contamination [5].
Replacement animals
Any new bulls or heifers brought into the herd should be tested for infection, males brought in
should be virgin bulls or under the age of 4. Any cows that do not become pregnant or carry to
term should be removed from the herd. Dairy cows also have year-round breeding seasons, unlike
those in beef herds. This allows the herd as a whole to promote the spread of T. foetus all year
round, rather than at specific times and can make it more difficult to assess if the pregnancy rate
of the herd is decreasing due to infections.
Monitoring of infection
Should be done prophylactically within herds. Preputial scraping from bulls over the age of 3
should be taken each year before breeding. Samples from aborted foetuses and pyometra should
be taken and examined for T. foetus parasites. If there is a suspicion that heifers in a herd are
infected, cervical mucus samples should be taken, cultured and examined for the parasites.
1.7.2 Treatment
As mentioned previously, imidiazole-ring compounds are no longer used as a T. foetus treatment
and resistance to them is already being seen in parasite populations [184]. Therefore, good biosecu-
rity practises are currently being seen as a more effective way to control disease spread. Historically,
trypaflavine ointment was applied to the penis of the bull [139], however, this required several treat-
ments, was expensive and difficult to apply and is very rarely used now. Dimetridazole given to
bulls orally or intravenously can be used, however, it has been known to cause them to collapse.
Bulls also have to be treated with penicillin too as some bacterial infections can prevent dimetri-
dazole from working [139]. These treatments do not prevent reinfection. For infected animals it is
usually those that are highly genetically valuable that are treated and saved whilst the others are
culled.
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1.7.3 Current T. foetus Vaccines and Vaccine Attempts
Currently there is no approved chemotherapy for T.foetus in the US as the previous treatments
(imidazole ring compounds) for infection have been removed from the market [1]. This is due to
the numerous side effects particularly, those affecting pregnant animals. The only current vaccine
available is Trichguard, a killed vaccine, but it neither cures infected cows nor prevents re-infection.
It does however, reduce the shedding of the parasite by heifers, decrease rates of spontaneous
abortion and as a consequence lead to an increase in calving rates from 60-70% to 80-85% [185].
Trichguard does not appear to reduce bull associated infections nor is it licensed for use in bulls
[23][186].
Fuchs et al. [187] isolated the B1 strain of T. foetus and inactivated the parasites using formalde-
hyde. They then inoculated 74 heifers using a variety of adjuvants. No clinical signs of infection
were seen. IgG increased after the first immunisation in all samples, but IgA remained low until
the challenge with live T. foetus parasites [187]. All animals showed colonisation of the urogential
tract and two of the twelve unvaccinated animals were still infected after 105 days. No animals
became infected in the vaccine groups, apart from one animal when the vaccine was applied with
an oil-adjuvant. The average clearance time was 55 days for the immunised animals and 69 days
for the non-immunised animals [187].
TrichGuard is a commercially available killed whole cell vaccine [150]. Edmonson (2017) [150] tested
the efficacy of Trichguard in an experiment using 40 heifers and another 20 were used as controls,
receiving two sham vaccinations of a saline solution. 60 days after vaccination the heifers were
inoculated with an isolate of T.foetus. Vaccination with Trichguard increased the pregnancy rate
from 70 to 95%; however, this was one study on a small number of cows and it has not been shown
how well the vaccine works long term, i.e. over a number of years [150]. The average clearance
time for control animals was 79.15 days and for vaccinated animals was 63.9 days, a non-significant
reduction. The vaccine appeared to improve conception rates but this is contradicted by other
studies [188] [189]. If a vaccine does not confer long lasting immunity and must be reapplied every
breeding season then it is not practical for large scale farms or cattle drives where there could be
hundreds or thousands of cows to vaccinate every few months.
As there is no vaccine that can prevent re-infection the current modes of control are mainly di-
rected towards prevention rather than cure. Hudson (1993) [1], compared T. foetus vaccines based
on whole cells with those composed of cell membrane fragments. Animals vaccinated with whole
cells had higher clearance rates than cows which were vaccinated with cell membrane fragments.
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Furthermore, cows that were vaccinated twice had higher T. foetus clearance rates than those that
were vaccinated only once. All cases showed an improved response over those in the control group
that had not been vaccinated.
However, cattle have been found to have a limited protection against T.foetus in the form of in-
fection induced acquired immunity. Adhesion of the parasite to the host cells appears to play a
central role in the cytopathic mechanism of host cell damage [190]. Shaia et al. [191] identified
an adhesion molecule Tf190 on the surface of T.foetus. They also studied the humeral responses
of cattle to immunisation with Tf190 and detected a strong systemic response. They found that
immunisation with Tf190 decreased the infection in immunised animals compared with those not
immunised. Furthermore, a parasite-specific antibody was detected in the cervical mucus of the
immunised animals when T.foetus was inoculated into the vagina. Chromatography showed that
different epitopes were expressed in different strains of T.foetus but the Tf190 adhesin complex as
a whole is widespread throughout strains. These differences in expression appear to be based on
the geographic isolates of T.foetus.
When bulls were vaccinated using killed whole cells, a curative effect failed to be demonstrated
[192]. There was a reduction in duration of infection in vaccinated heifers when challenged by bulls
infected with same T. foetus isolate however, no significant practical advantage was seen. One
out of twelve heifers ended up becoming pregnant in the vaccinated group compared to two out of
twelve in the control group.
In another study by Rhyan (1999) [180]; 24 bulls that had history of infection were sampled- T.
foetus was identified in 15 of the bulls using monoclonal antibodies 34.7C4.4 and TF1.15 against
T. foetus surface antigens. Preputal secretions from the bulls were tested and were found to con-
tain specific isotypes and each isotype response was much greater in infected bulls than controls.
Within the samples, IgG1 responses were the highest, IgM and IgA were equal and IgG2 responses
were low. The TF1.15 antigen appears to be widely conserved between T. foetus strains and when
anitbodies were used there appeared to be strong labelling of the myelin shealth by the TF1.15
antigen [180]. The antigens with serological specificity seemed to be on the outer surface of the
parasite and possess polysaccharide and protein components [144]. TF1.15 was shown to be highly
glycosylated with a glycolipid moiety [180].
Clark (1984) [144] conversely, found that injections of killed T. foetus cells could prevent and elim-
inate genital infection in bulls. Their results suggested that bulls can be immunised, 3 of 4 of bulls
vaccinated remained uninfected. This has to be taken with caution as the sample size of 4 bulls
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suggests that at least 25% of bulls would still be infected if this was implemented as a vaccine. It
is likely that the non-infected bulls’ natural immunity played a part. Larger trials using the same
methods would need to be used to give a true outcome. Additionally, genome-wide association
studies (GWAS) could be used to identify whether certain bulls have natural immunity to T. foetus
and whether there are any genetic markers to identify this (Ku 2010, Hart 2015). It may also be
possible to identify gene markers of the most susceptible animals as, as previously stated, certain
breeds of cattle have higher rates of infection than others [26].
Baltzell et al. [193] also looked at numerous studies relating to the use of a whole cell killed vac-
cine. They looked at several parameters, including: the incidence and duration of infection in both
bulls and heifers; the percentage of pregnancies and abortion risk and the overall efficacy of the
vaccine to clear the infection. The Grading of Recommendations, Assessment, Development and
Evaluations (GRADE) quality of evidence in most of the studies was deemed low, in some cases
due to publication bias. There were also issues with small sample sizes and non-randomisation of
the sample animals. The conclusion that had to be drawn from this meta-analysis was that there
was little or no evidence that the killed-whole cell Tritrichomonas foetus reduced infections or risk
to open heifers or bulls.
1.8 Vaccinology
1.8.1 Classical Vaccinology
Classical vaccinology involves the administration of live attenuated or killed cells, cell fractions,
native or recombinant antigens to ellicit an immune response and aquired immunity. For example,
with influenza virus [194] [195], where the vaccines are made from the hemagglutinin (HA) and
neuraminidase (NA). The methods of classical vaccinology have often proved effective, whole cell
vaccines such as the inactivated polio vaccine and live attenuated vaccines like the tuberculosis
BCG vaccine all elicit strong immunity. However, in cases of cell fraction vaccines, finding the
fragments required to promote an immune response can be a slow process as each potential antigen
must be looked at in turn. In addition, to locate genes and determine the effects they have on the
organism using a forward genetics approach mutant phenotypes are typically made, and the effect
it has on the organism is tested. Since the advent of genome sequencing it has been possible to
examine the antigenic repertoire as a whole. As all antigens expressed by a pathogen are encoded
30
in its genome, it follows that it is possible to use the genome sequence to screen possible antigens
for desirable properties in concert with, or in place of, forward genetic approaches [196].
1.8.2 Reverse Vaccinology
Reverse vaccinology involves designing a vaccine from the genome sequence information rather than
having to grow the organisms and use fractions to promote or measure a response [197] and came into
fruition by the advent of whole genome sequencing [198]. The evolution of this field has been greatly
helped by improvements in computing software and bioinformatic analyses. In a reverse vaccinology
approach, potential antigens are first found in silico, i.e. using computational approaches to identify
structural properties in predicted antigens and are then verified using experimental methods. In
many cases this is by screening the putative antigens by way of an assay or protein array to
determine whether they promote an immune response and also by using animal models.
Reverse vaccinology does not just use whole genome sequencing alone but in combination with
transcriptomic and proteomic approaches. Transcriptomic analysis using RNA-Seq can be used to
assist in the identification of proteins from open reading frames (ORFs) and the characterisation
of the expression of potential antigens and vaccine candidates. This can be particularly useful in
finding start and stop sites and splice sites (in the case of eukaryotes). Proteomics can be used
to validate the results from the in silico predictions. In the case of Salmonella typimurium, mass
spectrometry- based proteomics was used as an accompaniment to the in silico predictions, finding
several novel genes and confirming 40% of the ORFS already found [199].
1.8.3 Reverse Vaccinology Examples and Successes
The first vaccine created by a reverse vaccinology approach was that of the MenB vaccine [200]
[201]. This was designed to protect against sepsis and meningitis caused by serogroup B strains
of Neisseria meningitidis (MenB). The whole genome was analysed and proteins that localised
to the cell surface were identified. Over 2000 predicted genes were identified, from which 350
recombinant antigens were created, 28 of which were selected for testing [201]. These were tested
for immunogenicity against a strain collection of Neisseria species so that a ‘universal’ vaccine
could be created, covering as many strains as possible. The final vaccine contained four antigens,
including a heparin binding factor and an outer wall vesicle protein [201]. Using multiple antigens
within a vaccine has been found to be more effective and to confer better protection than just one
antigen [202] [203]. The effectiveness of this vaccine has been estimated at 83% [201].
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Starting with the whole genome of Pseudomonas aeruginosa Bianconi et al. [202] identified 52
potential antigens using bioinformatics approaches. The candidates found were narrowed down
from over 5500 predicted protein sequences and were conserved across strains. A number of outer
membrane proteins and virulence factors were among these. A shortlist of 10 potential antigens was
tested in mice and were found to elicit an immune response, however, the true biological function
of these antigens is unknown.
It is also possible to base antigen design on potential structures found by computational methods
and this was the method adopted when designing an HIV vaccine. A vaccine for the respiratory
syncytial virus (RSV) was based on an epitope-focused design. However, with this method of
vaccine design there can be the problem of naturally occurring epitope variants [200]. Reverse
vaccinology also allows for studies into antigen function and several discoveries were made whilst
using this approach, such as the discovery of the H binding factor, which led to the idea of species
specificity in meningococcus; and the discovery of pili in Gram positive organisms [200]. For the
Helicobacter pylori vaccine, the proteome and also comparative genomics were used [204]. The
3D structure and protein-protein interactions were found and Naz et al. (2015) then screened the
exoproteome and secretome of samples for non-human homologous proteins and epitopes that could
bind B cells and T cells.
To design a Streptococcus agalactiae vaccine [205] eight genomes were used as there are represented
differences between strains. This allowed a much higher number of genes to be screened. A ‘core’
genome was identified that cotained genes found in all strains as well as a ‘dispensable’ genome
containing genes that are only present in one or more of the strains. When these were screened
in silico a large number of cell surface expressed core genes were found. Some of these were then
expressed in E. coli and found to confer some immunity in mice. Several potential immunogenic
genes were also found in the dispensable genome set. There were E.coli [205] antigens found in a
pathogenic strain that did not feature in a non-pathogenic strain. Proteins were also found that
provided protection in mice in recombinant form.
Applications to Parasites
There have been many attempts at producing malaria vaccines, based on various approaches such
as sporozoite-specific antigen subunits, killed whole cells, as well as peptide and toxin based vac-
cines [206]. Whole organism sporozoite vaccines have been used to confer immunity and have been
used to guide the vaccine production process for Plasmodium. Most malaria vaccines only target
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one life stage of the parasite, usually the pre-erythrocyte stage [206]. Duffy (2012) [207] identified a
pre-erythrocytic recombinant vaccine for malaria that does not cause infection but still confers pro-
tection against Plasmodium. Many attempts to ecauate cell-surface proteins as vaccine candidates
found they were poorly immunogenic. Some blood stage vaccines target parasite antigens that are
expressed on the surface of the host red blood cells. However, they are often highly polymorphic
and not conserved across strains [208].
Due to difficulties with classical vaccinology approaches, reverse vaccinology has now also been
applied to malaria vaccine design. This involved looking at the transcriptomes and proteomes of
several different Plasmodium lifestages and identified several potential vaccine targets, including
cell surface proteins [208]. This also had the advantage of identifying which transcripts were stage
specific. The most effective vaccine would be one that targets multiple lifestages and could be
deployed widely. Furthermore, conserved genes and homologs between species, such as reticulocyte
homolog (Rh) proteins, have been found which could be used one day [208].
In the case of human Leishmania, there is still currently no vaccine, one reason being the challenge
of vaccinating against multiple life stages [209]. Initially live attenuated vaccines were used. Second
generation Leishmania vaccines include recombinant vaccines and have been licensed in some coun-
tries [209]. Potential vaccines and candidates could be based on secreted proteins or could include
intracellular proteins like heat-shock proteins, histones, ribosomal proteins or cysteine proteases.
Leishmania cysteine proteases are known to produce a higher IgG response than others intracel-
lular proteins. T. foetus produces cysteine proteases and so if these are successful candidates in
leishmania they also may have potential as T. foetus vaccine candidates.
Leishmania, like Plasmodium, has multiple life stages and the cell surface has been a target for
possible vaccines. Promastigotes have a cell surface covered with glycosylated proteins which is po-
tentially similar to T. foetus cell surface and many GPI anchors. LPG is found on the Leishmania
cell surface and is used to protect the parasite against harsh environmental conditions. LPG is also
found on the T. vaginalis [20] cell surface and is likely also found on T. foetus and could be another
potential target. However, as LPG is formed using phosphodiester bonds and these are an example
of a post translational modification (PTM), they will not been seen in the genome sequence itself.
In order for it to be classified, a likely gene would need to be expressed in a eukaryote, such as
yeast, before being tested for immunogenicity.
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1.8.4 Comparing Classical Vaccinology and Reverse Vaccinology
Both classical vaccinology and reverse vaccinology have been used to produce successful working
vaccines. The main difference between the two is that reverse vaccinology is not hypothesis driven
and is a ‘top down’ approach [198] where as classical vaccinology proceeds from initial hypotheses.
Reverse vaccinology also relies on initial computational methods which predict likely antigens [198].
With reverse vaccinology all antigens encoded by genome even non-immunogenic and from organ-
isms that are cannot be cultured and the most highly conserved antigens can be found, rather than
just 10-20 [210]. Non-structural proteins and non-immunogenic antigens can be found in addition
to those that are not expressed in vitro. It is possible to compare the sequences of all the putative
antigens before moving in vitro. This allows for the identification of homologous antigens in other
species, for example, humans or cattle. The vaccine candidates chosen would need no homology
to the host so that the vaccine would not damage to host itself. Comparing the sequences also
allows for comparisons between the antigens themselves to check for antigenic variability between
strains. However, with reverse vaccinology only protein antigens can be screened and found rather
than glycolipids and polysaccharides which can be identified and used with the classical vaccinology
approach.
1.9 Key T. foetus Vaccine Candidate Criteria
In order to identify vaccine candidates to later test, we used several criteria that our candidates
were to adhere to. These were:
1) Cell surface expressed [211] [212] [213] [214]
2) Antigenically invariant across the population [211] [215]
3) T. foetus specific [216] [217]
4) Immunogenic [218].
As the cell surface is the part of the parasite that comes into contact with the host, many of
these proteins are likely to confer an immune response [213] and, ideally, are required for parasite
survival [217] [219]. Therefore, these are may be good vaccine candidate that will help promote
an immunogenic response. Limiting the vaccine candidates to cell-surface proteins also reduces the
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time and cost associated with finding candidates as they can be predicted computationally [220]. In
order to find cell surface expressed proteins certain motifs were looked for: namely signal peptides,
trans-membrane helices and GPI-anchors, all which suggest cell surface localisation (Figure 1.6).
To promote a strong response to the T. foetus parasites, proteins were examined for trichomonad
specificity. This is important as the vaccine must confer a response to the pathogen and not the
host. We also did not include any putative bacterial proteins or LGTs to further reduce our vaccine
candidate number. When BLAST searches were performed on the T. foetus genes, any genes that
either have no BLAST hit or have a hit to a sequenced trichomonad genome were then examined
in more detail to ascertain whether they fulfill the other criteria. Orthofinder [221] [222] will also
be used to identify similarities between T. foetus and T. vaginalis genes, producing probable gene
families. This allows likely gene function to be identified in cases where there were no BLAST hits.
Samples of T. foetus from different sources (different strains) will be used to make sure the proteins
of interest are antigenically invariant across populations, therefore, a vaccine against one strain will
work against all others rather than different vaccines being needed for different regions.
For the antigens to be successful vaccine candidates they must confer an immunogenic response,
thereby allowing the host to acquire long-lasting immunity.
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Figure 1.6: The stages leading to a vaccine candidate set. Showing all stages from obtaining the
genome sequence to the final candidate set with the different components leading to the completion
of each stage. Where SP refers to signal peptide, TMH refers to transmembrane helix, GPI refers
to Glycosylphosphatidylinositol anchor and KEGG refers to Kyoto Encyclopaedia of Genes and
Genomes.
1.10 Aims of the Thesis
The overall aim of this project was to identify candidates for a bovine trichomoniasis vaccine using a
reverse vaccinology approach, by producing an annotated T. foetus genome sequence and evaluating
all possible antigen genes found within it for their immunogenic potential.
A T. foetus genome has been sequenced on the PacBio platform and then assembled by SMRT
portal [223] [224]. The newly assembled genome was then annotated using gene predictive software
in conjunction with transcriptomic and proteomic data. The resulting genome was 147Mb in size,
with 2,776 contigs and an N50 of 82,179. This appears to be comparable with the T. vaginalis
genome of 160Mb. Additionally, the genome produced has a similar BUSCO [225] [226] score to
that of the T. vaginalis genome, showing completeness.
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As stated previously, potential vaccine candidates were identified from antigen proteins that fulfilled
several criteria, they were:
1) Parasite-specific [216] [217]
2) Cell-surface expressed [211] [212] [213] [214]
3) Naturally immunogenic [218]
4) Consistently expressed
5) Upregulated during host interactions
6) Structurally invariant across the parasite population [211] [215].
To evaluate these criteria we:
1) Identified T. foetus genes containing structural motifs that predict surface expression
2) Validated putative cell-surface expression using cell-surface proteomics and biotin labelling
3) Screened parasite peptide microarrays with infected bovine serum
4) Quantified antigen gene expression using transcriptomic assays in vivo
5) Quantified structural variation in antigen genes sequencing DNA isolated from several different
T. foetus strains and identified SNPs
This project produced validated vaccine candidates as a first step in producing a viable vaccine
against bovine trichomoniasis, facilitating clinical trials into the efficacy of vaccination as an effective
strategy to eradicate the disease.
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Chapter 2
The Genome and Transcriptome of
T. foetus
This chapter describes the assembly and annotation of creation of a Tritrichomonas foetus genome
from PacBio DNA reads. It follows the steps from assembling the reads to the identification of the
open reading frames (ORFs), subsequent annotation of those ORFs and mapping of putative gene
functions. It then compares the genome annotation to those already produced for T. foetus by
Benchimol [227] and Carlton [228] and examines at the merits of each including how the number
of putative genes differs between them. This chapter will also look at which annotated proteins are
predicted by bioinformatic methods to be on the Tritrichomonas foetus cell surface, a key feature
we are looking for in our vaccine candidates. Finally, to improve and enhance the genome annota-
tion, gene expression is examined in this chapter under various developmental and environmental
conditions.
2.1 Introduction
2.1.1 Genome Sequencing
More genomes are being sequenced now than ever before. This is mainly due to falling costs in
sequencing technology, for example $50 for a bacterial genome, and also the availability of in-house
sequencing platforms. According to Moore’s law [229] the cost of genome sequencing will get lower
as time goes on. Many genome technologies have been created in recent years, such as PacBio
sequencing and Nanopore MinION sequencing, each having their own benefits depending on the
composition of the genome itself and conditions in which the DNA has been produced.
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Illumina has long been used as a sequencing platform, producing short reads (up to 250bp) and the
machines are constantly being updated and improved, allowing millions of reads to be produced
quickly and relatively cheaply. In contrast, PacBio sequencing, also known as single molecule
real time sequencing (SMRT), produces long reads (up to 20kb) [224]. These reads are better for
spanning repetitive regions, for example, the large repeats in T. vaginalis genome. This is beneficial
as key genes could be found in these regions and makes it more suitable for the sequencing of this
type of genome compared to Illumina. As the T. foetus genome is likely to have a similar makeup
to T. vaginalis it would be reasonable to assume that it too would have a large number of repetitive
regions.
2.1.2 Gene Prediction Software
Predicting genes in de novo genomes, especially in eukaryotes if they are not closely related to a
model organism, can pose many problems. There may be non-standard codon usage, splice sites and
regulatory signals which would be difficult to identify. Therefore, specialised software would need to
be used and ‘trained’ so that ORFs within a particular genome can be predicted. In order to get the
most accurate results, several programs can be used to obtain a consensus. There are many different
software that employ ab initio techniques, meaning they predict the gene models from the genome
sequences alone [230]. In the absence of any experimental data alongside the genome sequence, these
have been found, to be inaccurate[230]. De novo gene finders include SNAP and AUGUSTUS [231].
Due to the inaccuracies, that appear to be common to de novo gene finders, using other software
that requires experimental data, for example BRAKER which employs transcriptomic data, and
manually curating the resulting ORFs can produce a more accurate consensus.
AUGUSTUS
AUGUSTUS is based on a general Hidden Markov Model (HMM) and submodels and predicts
the most probable distributions for introns and exons [231] in addition to predicting translation
starts and ends. The performance of AUGUSTUS can be improved by integrating BLAST or
sequence alignments. AUGUSTUS also has the advantage of being able to identify alternative
splicing, which is key when annotating an eukaryotic genome. When three de novo gene finders
(AUGUSTUS, SNAP and GLIMMERHMM) were compared using the Toxoplasma gondii genome,
AUGUSTUS was found to have the highest specificity and sensitivity [230] and also appeared to
have the highest accuracy. Additionally, as these gene finders were tested on a eukaryotic protist
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parasite genome, it is reasonable to assume that AUGUSTUS would also have high sensitivity and
accuracy when used to identify genes in the T. foetus genome.
SNAP
Semi-HMM-based Nucleic Acid Parser (SNAP) uses HMMs in a similar way to AUGUSTUS [232].
It is known to be accurate in eukaryotic genomes, such as Drosophilia and C. elegans when trained
and has been found to give fast and accurate gene models even when the training set contains
minimal promoter UTRs [232]. It also models each strand separately and so allows introns on
different strands to overlap each other.
BRAKER
BRAKER [233] uses RNA-seq data to annotate genomes and combines aspects of AUGUSTUS
[231] and Genemark-ET [234]. Both programs are trained by BRAKER before being applied to
the genome [235]. Genemark-ET creates the initial ab initio gene structures and AUGUSTUS
uses those structures to train and then integrates the RNA-Seq data. BRAKER is also interesting
because it integrates RNA-Seq data in the gene models to provide further evidence for likely splice
sites and stop and start codons.
2.1.3 T. foetus Genomes
In 2017, two draft T. foetus sequences were produced [227] [228] and then in 2020, [120] samples
were taken in order to gain an understanding of the prevalence of T. foetus across Europe in cows,
pigs and cats, producing three more genomes from bovine, feline, porcine strains of T. foetus re-
spectively [120]. These genome sequences were all produced using Illumina sequencing and short
DNA reads.
The Benchimol et al. genome [227] was produced using the feline strain ‘K’ as this strain has been
used in several other T. foetus studies [236]. The study was undertaken to develop T. foetus as a
model organism for other trichomonads and parabasalids. Additionally, it was sequenced in order
to allow a comparison between T. foetus and T. vaginalis as they appear to be similar in size and
have similarly large amounts of repetitive regions [227]. It was assembled using AllPaths-LG [237]
to produce 3,730 contigs in 1,573 scaffolds to create an assembly of 68Mb. Allpaths-LG estimated
the total genome size to be 161Mb, which is over twice as large as the actual genome assembly
and more in keeping with Zubakova et al. (2008) [114] predictions and the size of the T. vaginalis
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genome. This suggests that the Benchimol [227] genome assembly is only half the correct size,
possibly due to collapsing large repetitive regions. The percentage of repetitive sequences was es-
timated to be 62%, which is comparable to the T. vaginalis genome. The System for Automated
Bacterial Integrated Annotation (SABIA) [238] was used for gene finding and this identified 7,856
proteins and 17,497 hypotheticals in the Benchimol T. foetus genome assembly [227]. However,
SABIA is designed for bacterial genomes and therefore it is possible that genes or splice sites in
this eukaryotic genome may have been misplaced due to differences in gene structure.
Carlton et al. [239], in a similar way to Benchimol [227], sequenced T. foetus in order to compare
with T. vaginalis. In particular, they wanted to compare conservation of biochemical and metabolic
pathways between the two species. Carlton et al. assembled a T. foetus genome sequence using
Velvet [240] [241], producing 194,695 contigs with an assembly size of 67Mb and N50 of 2,054. This
sequence contained 28,362 ORFs with orthologs in the T. vaginalis genome [228]. This comparison
was particularly important as T. vaginalis is becoming resistant to one of the FDA approved treat-
ment drugs, metronidazole (Mz) and there are now cases of resistance in T. foetus . The KV1 strain
of T. foetus, along with two Mz resistant strains (aerobic resistance only and both aerobic and anaer-
obic resistance) were sequenced. BLASTX of T. foetus ORFs against T. vaginalis showed 28,600
orthologues with 183 SNPs in total in these orthologues. Thirteen of these SNPs were present in
both of the T. foetus resistant lines, suggesting that they may be associated with a gene resistance
phenotype. The results showed that there may be a shared pathway of Mz resistance in both species.
Westrop et al. [242] also compared metabolic profiles of T. foetus and T. vaginalis, particularly
with respect to Mz resistance. Several differences in the metabolic pathways were seen between the
two species and also within the same species depending on whether the strain was Mz resistant. For
example, the T. vaginalis products for glucose metabolism include; glycerol, ethanol and lactate.
In T. foetus they are largely the same, however, T. foetus produces succinate rather than lactate
[242]. In Mz resistant strains of both parasites the metabolism is shifted. In the case of T. vaginalis,
it is shifted to a much higher output of lactate in but in T. foetus it is shifted to a higher output
of ethanol. It was also noted that due to its repetitive regions and predicted large genome size,
the T. foetus genome could likely have undergone massive gene expansion in a similar way to T.
vaginalis. In the case of Dabrowska [16], the genomes produced were mapped to the Benchimol
strain K sequence using Bowtie2 [243] and SNPs were identified using the GATK pipeline [244]. No
estimation of size was stated, nor how many genes found. However, the study by Dabrowska et al.’s
data does provide evidence that the porcine and bovine strains of T. foetus are genetically much
less distinct from one another than they are from the feline strain. Other studies, for example,
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Slapeta et al. (2012) identified differences between cysteine proteases in feline and bovine strains
[88], however, the difference was not as marked. As the assembled Benchimol genome is only 65Mb
in length, especially when it was predicted to be 161Mb, it is highly possible that many genes
and repetitive regions have been missed and, therefore, that the Dabrowska et al. SNP data are
incomplete. The aim of this chapter was to provide a complete genome sequence and improved
assembly compared to the existing genomes, using long read sequencing technology.
2.1.4 The T. vaginalis Genome
As T. vaginalis is the closest, better relative of T. foetus, it is sensible to examine the similarities
between their genomes. Furthermore, comparisons between the two would help to evaluate the
reliability of the T. foetus genome and annotation. In 2007, the T. vaginalis genome sequence
was sequenced [125]. Due to its size (estimated 160Mb) and high percentage of repetitive regions
(approximately 65%) the sequence was highly fragmented, containing 17,290 scaffolds and an N50
of 68,338. This fragmentation and the number of transposable elements present has made key
features of the genome and its true size difficult to determine, as the repetitive nature of some
regions could lead to these being over expanded especially when short DNA sequence reads are
used. It is thought that the high number of repeats is due to a genetic bottleneck in T. vaginalis
history [125]. Sixty-five genes were determined to possess introns. All eukaryotes possess introns
[245] [246] and there can be large ranges of intron density between species. This appears low
compared to many eukaryotes, such as in humans where it has been estimated there are on average
eight introns per gene [245]. However, this comparatively low number is not unheard of in other,
more primitive branches of eukaryotes. Giardia, for example, is predicted to have five spliced genes
[247] and only 6% of Saccharomyces cerevisiae genes are thought to contain introns [247], however,
this still equates to over 2000 genes. Of the protists studied by McGuire et al. (2008) [247],
including P. falciparum, E. histolytica and P. tetraurelia, all possess over 2,800 spliced genes in the
genome, apart from E. histolytica which had 599.
The estimated genome size of 160Mb also differs from the actual reported genome assembly of
176,441,227 bases (176Mb). A core set of 60,000 genes was identified, however, this includes novel
transposable elements and repeat regions and the number of evidence-supported genes is 25,949
[125]. The transcription machinery appears to be more metazoan than protistan, this could be
due to lateral gene transfer (LGT) between eukaryotes and prokaryotes [20]. It is thought that
many of these genes have been obtained from Bacteroidetes-related bacteria [125] which are found
in intestinal flora. The cell membrane is thought to be covered with lipophosphoglycan (LPG) and
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this may be associated with adherence [67]. There are also several potential LGTs that are involved
in sialic-acid synthesis, which has been reported to be present on the T. vaginalis cell surface.
Over 650 BspA proteins were identified in the genome [125] which are known to be cell surface
expressed in bacteria and can mediate cell adherence. Cytolytic effector proteins have also been
putatively identified upon adherence of T. foetus with host cells [248]. It is thought that this may
be in order for the parasite to acquire nutrients such as iron from the host [123].
2.1.5 T. vaginalis Cell-surface Antigens
The creation and publication of the T. vaginalis genome [125] sequence has proved invaluable to
identifying putative cell surface antigens [249]. Due in part to this genome sequence, several cell-
surface adhesin proteins have been identified. This has allowed for many studies into the roles and
regulation of these proteins [249].
The T. vaginalis lipophosphoglycan (TvLPG) is a known virulence factor [20] [250]. These cell-
surface adhesins are a key area being examined for T. vaginalis vaccine candidates. When pregnant
women, both T. vaginalis positive and T. vaginalis negative, were subjected to TvLPG monoclonal
antibodies, produced to conserved regions of the TvLPG [250], there was an immune response in
the infected women. Additionally, all eight strains of T. vaginalis that were tested produced a
response, showing that the immunogenic epitopes are conserved within the populations.
Cadherine-like cell surface proteins (CLP) have also been identified [251] and were found to be
upregulated upon interaction with host cells. One particular CLP was found to be upregulated 2.5
fold in strains of T. vaginalis with high attachment rates and high cytotoxicity [251] and so it is
thought to have major roles in parasite-cell interactions. This CLP is of particular interest as its
induction appears to be mediated by the presence of environmental calcium, rather than iron or
any other commonly known stimulus [252].
2.1.6 Other Trichomonad Genomes
Although T. vaginalis is the most well-studied trichomonad, due to its role in human disease, there
are several other trichomonad species that are more closely related to T. foetus. These include: T.
mobilensis [253] and T. augusta [254]. Unfortunately, genomes have not yet been assembled and
annotated for these or any other trichomonads apart from T. gallinae.
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Using Illumina sequencing, the T. gallinae genome has recently been sequenced [255]. It was found
to have a genome size of 54,799,485 (54Mb) in 11,704 contigs with an N50 of 20,741 and a GC
content of 33.77%. 27,000 genes were found and annotated. This is much smaller than T. foetus
and has a much lower gene count.
2.1.7 Transcriptomes
A transcriptome consists of cDNA sequences for all gene transcripts present at a particular time in
a cell, tissue or organism. Thus, a transcriptome provides a quantitative account of gene expression.
RNA sequencing (‘RNA-Seq’) results are often closely correlated with metabolite results, thus giving
more information about pathways [256] [257]. Transcriptomes are also essential in comprehensive
genome annotation, since mapping of RNA-Seq reads onto the genome reveals the position of
genes that are small or heavily spliced, which might otherwise be difficult to find. However, it
is estimated that only 5% of the genes in a genome are transcribed at any particular time [258].
Therefore, to obtain an accurate gene annotation or estimate of gene expression a wide range of
cellular conditions need to be assayed. In this chapter, multiple transcriptomes for T. foetus are
presented, each representing gene expression in different environmental conditions, and providing
as close to a full repertoire of expressed genes as possible.
Transcriptomes are being increasingly used as a factor in antigen selection and preliminary vaccine
design [259] [260]. For example, the use of transcriptomes, along with other ‘omics’ methods has
been used by Tuju et al. [261] (2017) in a reverse vaccinology attempt for a malaria vaccine. This
allowed quantification of stage specific mRNAs to be identified as assisted with reducing the number
of candidates. Zawawi et al. [260] (2020) used the expression of transcripts to decide which genes
to test for MHC-II binding epitopes when identifying vaccine candidates for whipworm infections
[260]. Transcriptomes have also been used in COVID-19 work, to identify potential T-cell and B-
cell epitopes in the SARS-CoV-2 genome [259]. In this chapter, transcriptomes produced under a
variety of environmental conditions will be used to identify genes that are constitutively expressed
in both T. foetus life stages and to identify and confirm the placement of ORFs in the genome
annotation.
2.1.8 The Pseudocyst
The T. foetus pseudocyst is suggested to be involved in virulence or as an infective stage during
bovine trichomoniasis, and similar cell types are known in other trichomonad species. As stated in
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the general introduction (Section 1.1.3), T. foetus cells can exist in either trophozoite form (pear
shaped) or in a pseudocystic/endoflagellar form [9] [29] [262]. It would appear that the difference in
morphology occurs depending on the environmental conditions, with cells in favourable conditions
displaying trophozoite form and those under less favourable or stressful conditions displaying the
pseudocyst form (Figure 1.4). Given the difference in morphology it would seem likely that a cor-
responding change in gene expression will also occur. This development change is explored through
transcriptomic analysis in this chapter. Cells can be induced to form pseudocysts in various ways;
by decreasing the environmental temperature [29]; the depletion of iron [263] or the addition of
drugs that affect the microtubules of the cell, such as colchicine or nocodazole [262]. Additionally,
it was seen that pseudocyst induction due to the low temperature was reversible, unlike that of the
microtubule affecting drugs. However, there may be many more environmental stress conditions
by which pseudocysts are produced that are currently unknown.
A vaccine for T. foetus would need to be able to target both life stages, particularly if one stage is
key in the pathogenicity of the organism. It is important to try to induce pseudocysts and stress
responses in T. foetus in a variety of environmental conditions if possible as certain conditions may
induce specific responses. In this way it will be possible to see a wide range of potential genes in
the genome.
2.1.9 Sequence Networks
Networks are used to look at sequence similarity, interactions and relationships between genes. They
are a visual way to summarise very large data-sets and can illustrate and highlight key relationships
and sequence superfamilies [264]. Unlike phylogenetic trees they do not require very large multiple
sequence alignments. Sequence networks can be used to look at diversity between species, for
example, in the case of identifying evolutionary relationships between different organisms.
Networks can also show putative homologues and can include non-homologous sequences in analysis
[265]. They can also show trends related to function [264] and can show high levels of similarity
in primary sequence which can identify core genes across species [266] even when secondary or
tertiary structures appear different. Phylogenetic structure can be implied or inferred from a
sequence similarity network and can be used to assist with creating phylogenies [264] [266] [267].
Additionally, the functional data can be used to form or guide experimental hypotheses about the
relationships between genes and gene families. Atkinson (2009) [264] used three groups of proteins
with different structural and functional diversity: G-protein couple receptors (GPCRs), kinases and
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the crotonase family of enzymes, and combined their sequence information with BLAST identity
scores. This information was used to produce networks which showed clear clusters of related
genes and were also in agreement with the known structures and functions of the gene families.
It was also possible to identify very distant relationships between members of the GPCR group.
The networks become more accurate and reliable as the number of entries increases because the
connection between those entries increases. [266][265]. It is also easy to recompute the network if
parameters are changed, for example, BLAST e-values or length of queries.
It is the aim of this project to use these networks to visualise a set of in silico cell surface protein
predictions and to also infer function by using both T. foetus and T. vaginalis genomes. This is in
the hope of identifying a function in the case of genes that currently have no known functions or
homologs and to identify even distantly related genes within and between the two species. These
networks will be able to show gene clusters and gene families that will be used for later steps of the
reverse vaccinology pathway.
2.1.10 Aims and Objectives
The aim of this chapter is to assemble and annotate the T. foetus genome from PacBio sequence
reads and produce an in silico cell surface proteome comprising all genes predicted to encode
cell surface proteins. Reducing the whole genome set to a small cohort that can be validated
proteomically is the first step in the reverse vaccinology process.
1. Using various computer programmes, the genome will be assembled several times using different
parameters to create an optimised assembly.
2. The ORFs will be annotated by computational means and checked by manual curation to create
a gene set.
3. T. foetus transcriptomes, produced under a variety of environmental conditions will be further
used to identify and confirm ORFs.
4. An in silico cell surface proteome will be created by identifying all putative proteins containing
a predicted N-terminal signal peptide and a predicted C-terminal transmembrane domain.
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2.2 Methods
2.2.1 Culture Maintenance
The Belfast strain of T. foetus was grown in Diamond media [268]. The cells were kept at 37 °C
and were passaged during log phase (24-48 hours after passage) when they were at an approximate
density of 5x106 per ml . Unless stated, otherwise all experiments and analyses were performed on
the Belfast strain of T. foetus ATCC strain 3016. The parasites were grown in 15ml tubes, 1 litre
of Diamond media contained: 15g tryptone, 12g yeast extract, 5.5g glucose, 2.5g sodium chloride,
0.5g L-cystine, 0.5g sodium thioglycollate, 1% penicillin/streptomycin (1,000,000 U), 100ml horse
serum and 0.75g agar.
2.2.2 Assembly and Size Estimation of the Tritrichomonas foetus Genome
DNA sequence reads were produced at the Centre for Genomic Research (University of Liverpool)
using the RSII machine; eight SMRT cells produced 249,576 10kb reads [224] [269] [270]. The data
were assembled de novo with SMRTportal using Hierarchicial Genome Assembly Process (HGAP)
2 which is optimised for accuracy. The parameters were changed to see how that affected the
predicted size of the genome so a final value could be established (Table 2.1).
The changed parameters included: max divergence, predicted size and minimum seed read length.
Assemblies were compared according to the total size, number of contigs and N50 value that they
returned. N50 statistic defines assembly quality in terms of contiguity. The N50 is defined as
the minimum contig length needed to cover 50% of the genome. It means half of the genome
sequence is in contigs larger than or equal the N50 contig size. The size estimated by Jellyfish was
specified when assembling the genome using the Hierarchical Genome Assembly Process (HGAP)
[269] within the SMRT Portal server. The genome was assembled several times using the SMRT
Portal server to reach a consensus (ENA study PRJEB41567).
Parameter Value
Expected genome size (MB) 100
Minimum Seed Read Length 8,000
Maximum Divergence (Total) 10
Table 2.1: Parameters used in final T. foetus genome assembly with SMRT Portal
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The genome was annotated using Artemis with the ab initio predictions from SNAP [232] and
BRAKER [233]. The transcriptomic data were used ’train’ the BRAKER annotation and to predict
both genes and splice sites when manually annotating in Artemis. Jellyfish used pre-assembled
reads from the SMRTportal values. Kmer values of: 17,19 and 21 were used in the genome size
prediction. The expected genome size predicted by Jellyfish were then used as the estimated sizes
in the SMRTportal assembler and the assembly was rerun.
SMRT Portal
HGAP process
The reads produced by PacBio are filtered for a minimum length and quality and the adaptors are
removed. The reads are mapped, short to long to produce the preassembly before being assembled
by the celera assembler OLC to form the draft assembly. Finally, the assembly is ‘polished’ meaning
the reads are mapped to a current assembly and errors can be corrected using quiver. HGAP2 is
optimized for quality rather than speed (as in the case of HGAP3).
Canu
Canu is a successor of the celera assembler [271]. Canu, a hierarchical method, uses multiple rounds
of overlapping and alignment before assembly to improve the reads. This is particularly important
for newer sequencers where longer reads are produced with a higher error rate.
2.2.3 Identification of ORFs
In order to find the open reading frames in the assembled genome several different programme were
used. One contig was annotated manually to show both ORFs and splice sites and used as a ‘training
set’ for all further computational programs. In the first instance the program ‘AUGUSTUS’ [231]
was used, however, it was not possible to get the program to work effectively.
An attempt was made to use the companion server [272] to annotate the genome. Companion uses
a reference-based approach to identify genes. It involves orientating the contigs and using Rapid
Annotation Transfer Tool (RATT) [273] to transfer highly conserved sequences from the reference
to the new genome. AUGUSTUS [231] is also used within the server to annotate genes de novo
using the reference genome as a training set. Unfortunately there was no reference genome close
enough to T. foetus to use. The T. vaginalis genome was trialled, however, the genome did not have
a high enough similarity to that of T. foetus and there are many trichomonads more similar but
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without annotated and sequenced genomes. The Gene Locator and Interpolated Markov ModelER
(GLIMMER) online server [274] [275] was also used and 166,143 ORFs were found in the genome.
The GLIMMER server works by using interpolated Markov models (IMMs) to distinguish coding
regions from non-coding regions. However, GLIMMER did not identify splice sites so the high
number of ORFs compared to the manually curated number (see below) could be due to individual
exons being counted as genes.
The programs used for the final computational annotation were BRAKER and SNAP. One large
contig was annotated manually to create a training set. Additionally, BRAKER also used mapped
T. foetus transcriptomes to identify the splice sites. This had the advantage of showing where
many of the splice sites started and ended, whereas SNAP only showed the individual ORFs. The
genome was then annotated in Artemis [276]. The BRAKER and SNAP annotations were used as
a guide to find the reading frames which were then manually curated to check their placement.
2.2.4 Manual Curation
After the computational methods were used to identify the ORFS, they had to be curated by hand
in Artemis to check the start and stop codons and splice sites were in the correct place. This was
to identify correct genes due to the discrepancies between the different computational programs.
In order to identify accurate ORFs; the GC content, frame usage and transcriptomic data were
used. Clear ORFs were marked as were splice sites, using the consensus sequences: 3’ consensus
sequence: CAG—G and 5’ consensus sequence MAG—GTRAGT where M is A or C and R is
A or G [277]. This is the standard splice consensus sequence, it is possible the T. foetus uses
non-standard splicing sequences.
2.2.5 Gene Annotation
Initially, ORF sequences were examined in Blast2Go, using BLASTx to compare each against the
NCBI nr database [278]. This showed which genes had homology with existing, named proteins,
which were conserved hypothetical, ie. they were homologous to existing, unnamed proteins, and
which were unique hypothetical, i.e. they had no homology with other genomes. The predicted
protein sequences of each ORF were also examined using several other programs for structural
features, including InterProScan, KEGG, SignalP and TMHM
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Blast2GO
Blast2GO is a suite of bioinformatics tools within an easy to use graphical user interface [279] [280].
Blast2Go can assign GO terms to sequences even if they are unknown. It is also possible to use a
range of bioinformatic tools such as BLAST and InterProScan within the BLAST2GO software. It
can also produce statistics and and aid in visualisation of results.
InterProScan
InterPro [281] [282] provides information about protein motifs and signatures. It uses a variety of
databases to do this including: PANTHER, prosite and pfam [283] [284] [285]. The use of many
different databases allows a comprehensive result to be determined as each database has different
strengths and criteria and it is due to this that helpful protein annotations can be derived.
KEGG
KEGG [286] [287] allows for the high level functions of genes to be elucidated and the overall
biological systems present in a given organism. It also allows for interpretation of biological function
of genes in a genome and can infer biological pathways. It comprises several categories including
glycans, drugs and diseases [288].
TMHMM
TMHMM [289] [290] predicts transmembrane helices based on a hidden Markov model (HMM), it
has been shown to be able to correctly predict transmembrane helices (TMH) 97-98% of the time
[290]. It is also able to distinguish between soluble proteins and membrane proteins 90% of the
time. It identifies these TMHs by combining hydrophobicity and charge bias analyses [291].
SignalP
SignalP [292] predicts signal peptides. Signal peptides target proteins for translocation across the
cell membrane using an artificial neural network approach [291]. It identifies hydrophobic-α-helical
regions which are a strong indication of signal peptides [291]. Knowing whether a protein has a
signal peptide can also help identify the orientation of a transmembrane helix; if an SP is present,
the N terminus of the TMH has to be on the non-cytoplasmic side.
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PredGPI
PredGPI [293] predicts GPI-anchors. GPI-anchors are a form of lipid anchor for cell surface pro-
teins [294] and GPI-anchored proteins can form a major type of cell surface protein in eukaryotes,
particularly protozoa. PredGPI uses Hidden Markov Models and support vector machine learning
to predict the presence of the anchor and the ω-site, the site of cleavage of the terminal C-terminal
residue- a key post-translational modification in GPI-anchor formation.
Orthofinder
Orthofinder can be used to find homologues between species and can identify putative gene families
[222], forming orthogroups. Identifying this homology can allow us to infer function or classification
of unknown genes by their similarities to known ones, such as between T. foetus and T. vaginalis.
2.2.6 Initial Transcriptome Mapping with Trinity
The initial Trinity assembly was performed to provide a check that the transcripts were mapping
correctly and to identify the top BLAST hits. The assembly was run through Blast2Go to see what
the species distribution was. The top two hits were T. foetus and T. vaginalis. As these were the
top species hits it was reasonable to assume the data was from the expected organism and mapping
correctly. The Illumina reads can be used to assemble both DNA and RNA sequence data.
2.2.7 Environmental Conditions for Transcriptome Creation
After automated genome annotation and manual curation of gene models, many putative ORFs
lacked evidence for transcription, that is, RNA-Seq reads provided zero coverage of those loci. This
could be due to the fact that certain genes are only expressed under certain conditions, other than
those encountered in normal cell culture. In order to maximise the representation of genes in RNA-
Seq data, a range of different environmental conditions were applied to cell culture: high and low
temperature; high and low pH; oxidative stress and nutrient depletion (ENA study PRJEB39462).
pH
The pH of the environment is likely to invoke a stress response. In cattle, the pH of the vagina
ranges from 7.3-7.6 with a median of 7.5 [295]. Therefore, it would seem logical that the optimum
pH for the growth of T. foetus would be around this value. If the pH was increased or decreased
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from this value then growth could be affected and the cells could become stressed and could induce
pseudocyst formation or induce different genes. There are known changes in pH of the cow vagina
depending on pregnancy status [132]. Additionally, the gastrointestinal tract, which T. foetus can
colonise in cats, can also have fluctuations in pH, the severity of which depending on the section of
the tract. Therefore, T. foetus must have adaptations to these changes in conditions.
The pH values of 6 and 8 were chosen as this is outside the average normal range of the growth
environment for T. foetus but is not so extreme as to kill the cells and prevent any growth.
The normal pH for prepared Diamond media is 7.3. The standard Diamond media was used and
the pH altered to the required value. One tube of 15ml was split into three, with 5ml in each
sample containing approximately 6x107 cells per ml. One sample was used for high pH, one for
low pH and one as a control. The pH was measure using vw pH strips and the pH was altered
by the addition of NaOH or HCl. Samples of 5µl were taken at time intervals and the motility,
morphology and mortality of the cells was noted.The resulting pHs of the media were: high pH-
8.5-9, low pH-5.5-6, control pH-7.3. This was repeated three times and RNA was extracted and
sequenced for each sample.
Low temperature
In order to induce pseudocysts, 15ml tubes of cells were placed at 4°C for 4 hours and the proportion
of trophozite and pseudocyst cells were counted every 30 minutes for 2 hours and then every hour
for the following 5 hours. Samples were taken when the proportion of pseudocysts was over 90%
and RNA was extracted and sequenced (Figure 2.8).
High temperature
Cells grown in Diamond media were grown to log phase and split into 3 samples of 5ml. The
temperatures chosen were: 35°C, 42°C and 46°C. Cells were incubated at these temperatures and
samples were taken every 15 minutes for the first 30 minutes and then every 30 minutes for the next
5 hours. The morphology, motility and mortality of the cells was observed over this time (Figures
2.13 and 2.12).
Oxidative stress
It is known that an increase in oxygen can affect the levels of ethanol, CO2 and H2 produced by
the cells [296] and can also affect the growth rate of the cells themselves [297]. There are also
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bacteria, commonly found in the urogentital tract, such as Lactobacillus, that can produce H2O2
[298]. Cows have lower levels of lactobacilli in their urogenital tract than humans, however, there
are other bacteria that produce lactic acid and compete for resources, such as the closely related
genus Pediococcus [298]. In order to induce oxidative stress cells were grown to mid-log phase and
hydrogen peroxide was added.
Initially stock solutions of hydrogen peroxide, 6mM and 10mM were made up in diamond media
from 30% hydrogen peroxide solution.
The H202 was added to 6x10
6 cells to give final concentrations of 300µM and 500µM. The cells
were then grown and samples taken every 30 minutes (Figure 2.9).
Starvation stress
The gastrointestinal or urogenital tracts inhabited by T. foetus contain a wide range of microbial
flora and fauna. The presence of other microorganisms will cause competition for nutrients and
T. foetus will have to either outcompete other organisms or adapt to depleted nutrients, such as
glucose. In order to induce different stress responses due to the depletion or absence of nutrients,
three different types of Diamond media were made up- each lacking a particular component from
the original recipe:
1-Diamond media, without 10% supplemented horse serum
2-Diamond media, without tryptone and L-cystine
3-Dimond media, without glucose
Cells were visualised 24 and 48 hours post media change and a trypan blue assay performed to
calculated percentage cell death. The motility and morphology was also examined.
Colchicine
Cells were grown at 35°C and the proportion of trophozoite and pseudocyst cells were counted every
hour for 7 hours after the initial addition of 1.5mM colchicine (Figure 2.8).
2.2.8 RNA Extraction and Sequencing
Cells were harvested at a density of 1x107 cells by centrifugation at 800 rpm for 5 minutes. The cells
were washed in PBS (Thermofisher) and centrifuged again at the same speed for 5 minutes. RNA
was extracted using the Qiagen RNeasy kits as per the manufacturer’s instructions. To quantify the
amount and concentration of RNA produced, the samples were run out on a 1% agarose gel and then
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analysed with Qubit and nanodrop instruments noting the 260/230 and 260/280 ratios respectively.
The libraries were prepared either by the CGR using poly-A selection or using Serapure beads and
the NEBNext Ultra prep kit.
Serapure beads were prepared using a protocol derived from Rohland (2012) [299]. Libraries were
created using: NEBNext Ultra II Directional RNA Library Prep kit, NEBNext Poly(A) mRNA
Magnetic Isolation Module and NEBNex multiplex oligos for Illumina. The libraries were sequenced
at the CGR using the Illumina HiSeq and Novaseq platforms.
2.2.9 RNA-Seq Analysis Pipeline
Raw RNA reads were trimmed for the presence of Illumina adapters using Cutadapt v1.2.1 [300]
the 3’ end of any reads that matched the Illumina adapter for 3bp or more was trimmed. The reads
were trimmed using Sickle v1.200 [301] using a minimum window quality score of 20. Reads that
were less than 15bp after trimming were removed. The resulting fastq files were uploaded to the
Galaxy server [302] and mapped to the completed genome assembly sequence using the program
Hisat2 [303] [304].
The bam file produced by Hisat2 was sorted and indexed using samtools [305] and used in con-
junction with Artemis to visualise RNA transcripts across the genome. The initial Hisat2 mapping
output bamfile was also run through FeatureCounts[306], again on the Galaxy server, to produce
counts tables. The counts tables were then used as input files in R Studio [307] [308] and the
differential expression analysed using the DeSeq2 package [309]. The Hisat2 program also produced
output files stating how much of the sequence was mapped to the genome (Table A1).
2.2.10 In silico Cell Surface Proteome
Cell surface localisation is the first and principle criterion for plausible vaccine antigens in this
thesis. Therefore, a long-list of vaccine candidate antigens was obtained from the T. foetus gene set
by selecting all genes with a predicted cell-surface protein. These comprised amino acid sequences
with predicted N-terminal signal peptides (SP), either alone (i.e. putative secreted) or in combi-
nation with one transmembrane domain (TMD) (i.e. type-1 transmembrane protein), or multiple
TMDs (i.e. multi-spanning protein) or GPI anchor (i.e. membrane tethered). All of these proteins
are assumed to be located on the plasma membrane because of the SP.
Given the terminal position of SP, TMD and GPI motifs within gene models, and allowing for the
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possibility that some gene models may be incomplete, each predicted cell surface gene sequence was
compared to all T. foetus genes using BLASTP to identify any homologs that might be missing
the key structural features in the annotation. Each gene was also compared to a database of all
T. vaginalis genes using PSI-BLAST to identify homologs in the related parasite. PSI-BLAST was
used as it accounts for protein secondary structure in its comparison, generally making comparison
more sensitive, and thus, more likely to uncover weak similarity between species.
Having obtained a set of all putative T. foetus cell surface proteins and their T. vaginalis homologs,
pairwise PSI-BLAST bit scores were calculated by comparing each entry to a BLAST database of
all proteins. Self-matches were removed, as were , all those with a total amino acid sequence simi-
larity of less than 30%, an e-value more than 1e-20 and where the length of the match was less than
150 amino acids. All other PSI-BLAST bit scores that exceeded these thresholds were extracted
and used to create a sequence network.
Two files were created for use in Cytoscape [310], the input file and attributes file. The input file
contains all sequence names (i.e. nodes in the network) and their pairwise PSI-BLAST bit score
in comparison to other sequences, where a significant match was obtained (i.e. the edge weights in
the network). The bit score was used because it is derived from the PSI-BLAST alignment score
and is normalised relative to the scoring system used. This means the bit scores can be compared
if different BLAST analyses are run. The attributes file contains information about the identity,
origin and structure of each sequence. Nodes in the network were colour-coded by species and by
the presence or absence of SP, TMD and GPI.
The network was manually curated to remove obvious errors or instances irrelevant to the anal-
ysis. For example, clusters derived from transposable elements or clusters in which only a single
representative of many qualified as cell surface expressed by the criteria given above. In the latter
situation, alignments were created to determine whether the SP was likely to be correct or was
more likely to be due to an error in the original genome annotation. Genes were also examined to
for interpro domains that made their annotation consistent with cell surface expression.
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2.3 Results
2.3.1 Genome Assembly
The T. foetus (Strain Belfast) was sequenced on the PacBio RSII machine and initially assembled
using SMRT portal, the proprietary PacBio assembly software, using Hierarchical Genome Assembly
Process 2 (HGAP2) [269] under default conditions. This initial analysis provided a benchmark of
assembly statistics such as contig size and number, and N50. Different parameters were then
changed to see how they affected the overall size of the genome assembly (Figures 2.1, 2.2 and 2.3).
The parameters that were changed were: expected genome size, minimum seed read length and
maximum divergence.
The size of the genome annotation was expected to be around 150-200Mb, based on the prediction
of 177Mb +/- 12 of Zubakova et al. [114] and the size of the T. vaginalis genome (160Mb) [15].
The predicted size using Allpaths-LG 2017 [227] was 161Mb for the T. foetus genome. The final
assembly conditions selected were an expected genome size of 100Mb, a max divergence of 10 and
a minimum seed read length of 8,000. The overall statistics for this optimised genome assembly
were: 147Mb in size with an N50 of 82,179 and 2,776 contigs (ENA study PRJEB41567).
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Figure 2.1: Identifying how the change in SMRT portal parameters affects the predicted genome
size. This graph shows the effect that changing the expected genome size had on the sum of contig
lengths where max divergence was kept at 30% throughout and minimum seed read length was kept
at 8,000. All trials were performed using HGAP2 in the SMRT portal software.
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Figure 2.2: Identifying how the change in SMRT portal parameters affects the predicted genome
size. This graph shows the effect that changing the maximum divergence had on the sum of contig
lengths. Predicted genome size was kept at 100Mb and the minimum seed read length was kept at
8,000. All trials were performed using HGAP2 in the SMRT portal software.
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Figure 2.3: Identifying how the change in SMRT portal parameters affects the predicted genome
size. This graph shows the effect that changing the minimum seed read length had on the sum
of contig lengths. The predicted genome size was kept at 100Mb in all trials and the maximum
divergence was 30% in each All trials were performed using HGAP2 in the SMRT portal software.
2.3.2 Transcriptome Assembly
An initial Trinity assembly was made of a T. foetus transcriptome that had been produced in
September 2016. This was mapped onto the first attempt at genome assembly with SMRT portal
to obtain a rudimentary genome annotation. All large open reading frames (over 200 amino acids)
were selected. The genes were then compared to the NCBI nr database using BLAST2GO to see
whether they appeared to be from the correct organism. The results are shown in Figure 2.4, which
shows that top BLASTn hits come from T. foetus and T. vaginalis (nearly 50,000 and 25,000 hits
respectively), providing further evidence that the genome is for the correct organism.
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Figure 2.4: Species distribution of the Trinity assembly of the T. foetus genome. Data obtained
includes the top 14 species (plus ‘others’) with BLASTn hits from the NCBI nr database with
the highest sequence similarity to the T. foetus transcriptome sequences. The BLAST search was
performed via Blast2Go pro.
2.3.3 Genome Annotation
The training set for automated annotation was created through manual annotation of ORFs and
splice sites consensus sequences, as previously defined [277], in a single 64,4735bp contig; this pro-
duced 251 gene models. Two automated annotation programs that employ different approaches to
ORF and splice site discovery were used: BRAKER [233] and SNAP [232]. Overall, SNAP identi-
fied 134,803 exons over the genome and BRAKER identified 111,040 exons and introns. BRAKER
also predicts splice sites, which were manually added to the annotation. All the exons identified by
the software were manually curated to check that they started and ended in the correct places and
contained the correct number of exons. After manual curation, 84,725 genes had been found.
2.3.4 General Features of the Genome
When tRNAscan [311][312] was run using the genome assembly data, 251 tRNA sequences were
found. 39 contigs were found to contain multiple tRNAs with the largest number in any one contig
being 5. When RNAmmer [313] was run, a total of 101 sequences were found. Of these: 47 were
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Attribute Result
Size (bp) 147,002,103
Number of Contigs 2,776
GC% 32.74
Genic component (%) 58.8
Non-genic component (%) 41.2
Gene density (per kb) 0.576
Protein coding genes (Total) 84,725
Protein coding genes (Spliced) 17,602
Protein coding genes (Non-spliced) 67,123
Mean number of exons 1.26
tRNA genes 251
rRNA genes 101
Table 2.2: General features of T. foetus Genome
8S, 27 were 18S and 27 were 28S. When the number of T. foetus RNA genes were compared to T.
vaginalis, T. vaginalis has a much higher number [314] with 668 rRNAs and 468 tRNAs. This could
mean that some RNA encoding genes have been missed by the program or have been annotated
incorrectly
In many cases, obvious ORFs in the genome sequence had no evidence of gene expression after
mapping of RNA-Seq reads. This suggests that only a minority of genes are expressed at any one
time, and some genes will only be expressed under specific conditions, not found in in vitro cell
culture. In order to increase transcriptomic evidence for annotated gene models, and to discover
more, cell cultures of both trophozoites and pseudocysts were established in various environmental
conditions, RNA-Seq data from cells cultured in high and low temperature, high and low pH,
oxidative stress and (latterly, see Chapter 4) the presence of a host cell monolayer. All of these
transcriptomes were used during manual curation of predicted gene models to produce the final
number of genes.
Initial sequence analysis of the gene models using BLASTx in BLAST2GO against a non-redundant
database found that 12,114 were hypotheticals, homologous to known proteins in the T. foetus
genome that had been produced. Whereas, 42,730 were unique hypotheticals with no homology in
other genomes, suggesting that these could be T. foetus specific and 29,881 had BLAST hits to
known proteins in other genomes .
GhostKOALA
GhostKOALA [288] [315] was used to search and assign KEGG pathways and functional anno-
tations to the annotated genes of the genome (Figure 2.5). 9,803 proteins (11.6%) of the genome
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mapped to 375 pathways. The pathways with very high numbers of proteins linked to them include:
Lysine biosynthesis, acyl-coA biosynthesis and purine metabolism.
The majority of the defined taxonomy belongs to the parabasalids, which is the taxonomic group
T. foetus belongs to (Figure 2.6). Only 18 KEGG modules are fully mapped to T. foetus genes
and include pathways such as: glycolysis, the pentose phosphate pathway, glycogen degradation,
fatty-acid elongation and pyruvate oxidation. Most of the completed pathways found were mem-
bers of carbohydrate metabolism pathways. If modules that have all but one component mapped
the number increases and includes: glycan biosynthesis, Co-enzyme-A biosynthesis and proline
biosynthesis.
Figure 2.5: The functional categories and KEGG pathways identified by GhostKOALA searching of
all annotated ORFs in the T. foetus genome. 9,803 ORFs out of 84,706 were successfully mapped
to 375 pathways. These pathways were clustered into functional categories, the 11 with the most
mapped ORFs are shown here.
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Figure 2.6: The Taxonomic results of a GhostKOALA search of all annotated open reading frames
in the T. foetus genome. The majority of results were undefined with Parabasalids being the second
most common after ‘undefined’.
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Figure 2.7: KEGG metabolism pathways. The mapped KEGG modules of all annotated ORFs in
the T. foetus genome, highlighted in red, produced by GhostKOALA. Modules where at least one
component is represented within the pathway have been highlighted.
2.3.5 Pseudocyst Induction
The proportion of pseudocysts formed over time under each of the environmental conditions, were
calculated. The percentage cell death was also calculated as, in some cases, cell death occurred
very shortly after the stress was applied. This was in order to identify the ideal time to extract the
RNA so the results would show a clear response to the environmental stress without the cells dying
and producing an inaccurate gene expression profile. The low temperature condition produced
the most consistent pseudocyst response and a sample could contain over 75% pseudocysts after
4 hours and nearly 100% pseudocysts after 7 hours (Figure 2.8). Different environmental stresses
induced different proportions of pseudocysts, so the RNA-Seq data was also used to examine if
all pseudocyst samples induced the same gene expression profile or whether the induction method
affected this.
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Figure 2.8: Proportion of T. foetus cells grown in Diamond media that are in pseudocyst form
rather than trophozoite form when a low temperature stress (4°C) or an addition of colchicine
was used. Samples were taken every hour and morphology was identified using light microscopy
techniques [150] [16].
When oxidative stress was used to induce pseudocysts (Figure 2.9), the rate of pseudocyst induction
increased when the concentration of hydrogen peroxide was increased from 300µM to 500µM.
However, when a pH stress was applied, the proportions of pseudocysts formed was very low,
never exceeding 7% of the total sample (Figure 2.10). Looking at the cell death proportions for
the samples, this may be due to the fact that some cells were dying before they could form the
pseudocysts. The death rate for the low pH samples (Figure 2.11) is much higher than the other
samples, and the rate of pseudocysts also increases but only 5% higher than the controls. This
also shows that the T. foetus cells can cope with a pH stress slightly higher than the norm more
successfully than a low pH stress. When pH values that were below 5 and above 9 were used, the
cells immediately died.
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Figure 2.9: Proportion of T. foetus cells grown in Diamond media that are in pseudocyst form
rather than trophozoite form when hydrogen peroxide is added to the media at concentrations of
300µM and 500µM compared to control cells where no hydrogen peroxide has been added. Samples
were taken every 30 minutes. Morphology was identified using light microscopy techniques [150]
[16].
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Figure 2.10: Proportion of T. foetus cells grown in Diamond media that are in pseudocyst form
rather than trophozoite form (controls) when the pH is raised to 8-9 (high pH) or lowered to 5-6
(low pH). Samples were taken initially every 15 minutes for the first 30 minutes (time points 1-
3), every 30 minutes from 30 to 210 minutes (time points 3-7) and subsequently every hour from
210 minutes to 300 minutes (time points 7-9). Morphology was identified using light microscopy
techniques [150] [16].
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Figure 2.11: Proportion of dead T. foetus cells in Diamond media after the pH is raised to 8-9
(high pH) or lowered to 5-6 (low pH) compared to controls in Diamond media with a pH of 7.3
(controls). The pH is changed at time point 0. Samples were taken initially every 15 minutes for
the first 30 minutes (time points 1-3), every 30 minutes from 30 to 210 minutes (time points 3-7)
and subsequently every hour from 210 minutes to 300 minutes (time points 7-9). Cell death was
identified by way of a trypan blue exclusion assay and light microscopy.
When the cells were subjected to high temperature stress the pseudocyst proportions differed again
from all other environmental conditions. For the 46°C sample, the proportion of pseudocysts peaks
and then falls dramatically and at the same time the cell death increases, suggesting that the cells
do not have time to adapt and produce the protective pseudocyst. Whereas, for the 42°C sample,
as the temperature increase is less dramatic the cells have time to adapt and form pseudocysts.
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Figure 2.12: Proportion of T. foetus cells in pseudocyst form, rather than trophozoite form, in
Diamond media after the temperature is raised from 37°C to either 42°C or 46°C. The control
cells were continuously grown at 37°C in Diamond media. Morphology was identified using light
microscopy techniques [150] [16].
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Figure 2.13: Proportion of dead T. foetus cells in media after the temperature is raised from 37°C
to either 42°C or 46°C. The control cells were continuously grown at 37°C in Diamond media. Cell
death was identified by way of a trypan blue exclusion assay and light microscopy.
2.3.6 RNA Seq mapping
All transcriptomes produced were mapped to the genome using Hisat2, there was a wide variation
of read number amongst the samples, ranging from 14 million to 67 million reads, but the overall
alignment rate was over 90% in all cases (Table A1) apart from Colchicine 2. This was removed
from further analysis as it was deemed to have failed in the mapping stage and was an outlier.
2.3.7 Differential Gene Expression
The counts tables produced by Hisat2 and FeatureCounts on the Galaxy Server were used along
with the DeSeq2 package in R in order to identify which genes were significantly preferentially
expressed in each environmental condition relative to the control trophozoites. For all experiments,
control samples are trophozoites grown in Diamond media and incubated at 37°C.
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Low temperature
As previously mentioned, low temperature stress is a well-known mechanism for inducing pseudocyst
formation in T. foetus [262]. The expression of genes within the pseudocysts appears to be more
uniform, with a much smaller variance compared to the control trophozoites (Figure 2.14) and all
the other transcriptome samples (Figure 2.15). This may be because all cells in the low temperature
sample are in their pseudocyst form and have lower metabolic activity, whereas those in the control
are a mixed population comprising predominantly trophozoites but also pseudocysts and can be at
different stages of the cell cycle.
Figure 2.14: PCA plot produced in DESeq2 using principle components 1 and 2. Where untreated
(blue) is the control trophozoite sample and treated (red) is the low temperature induced pseudo-
cysts. Pseudocyst morphology was induced by a temperature decrease to 4°C whilst untreated cells
were kept at 37°C
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Figure 2.15: PCA plot produced in DESeq2 using principle components 1 and 2 for all transcriptome
samples. Where red are the controls, orange are glucose-free samples, light green are high pH,
chartreuse are high temperature (42°C), dark green are high temperature (46°C), turquoise are low
pH, blue are low temperature, dark blue are oxidative stress (300µM), purple are oxidative stress
(500µM), pink are serum-free samples and grey are tryptone-free samples.
There are 1763 genes that are significantly differentially expressed (Figure 2.16) with fold changes
ranging from approximately -10 to 15. The most highly differentially expressed genes that are more
abundant in the low temperature stress samples relative to the control samples (Table A2) appear to
be mainly hypothetical proteins with the exception of two which are coding for N-acetyltransferases.
The downregulated genes in the low temperature samples are more varied, including Myb-like DNA
binding domains, which are involved in transcription. This would be expected to be downregulated
in the low temperature as the metabolic activity of the cells is reduced, leading to a reduction in
gene transcription. Flavodoxin, similarly, is involved in electron transfer so it would be more highly
expressed in the control samples with higher activity and lower in the low temperature pseudocysts.
The similarities in some of the gene numbers could suggest a repetitive region of genes or exons
of a single gene that are currently annotated as separate genes. Upon visualisation of the genome
annotation in Artemis it would seem plausible that TTF74316, TTF74317 and TTF74318 are large
ORFs that are exons of one very large gene of 4,476 bases. Similarly, TTF74053-4 may be very
large exons in a 3,864 base gene.
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Figure 2.16: Volcano plot produced in R using DeSeq2 showing the differentially expressed genes
in the low temperature T. foetus pseudocysts compared to the trophozoites. Those significantly
differentially expressed (p>0.01 and fold change greater than 2) are shown in red
High Temperature Stress
In the high temperature stress sample, upregulated genes included: ATPases, transferases, many
hypotheticals and ABC transporters for both 42°C and 46°C samples (Tables A3 and A4). Whilst
downregulated genes included cysteine proteases and calcium kinases. Some of these may be due
to the stress response however, very few pseudocysts were produced in the 42°C sample so it is
unlikely that the upregulated genes are pseudocyst specific. CAMK family proteins and cysteine
proteases are downregulated at high temperatures, it has been postulated that these proteins are
involved in the virulence of trichomonads [316] and so increasing the temperature may affect key
pathogenicity pathways.
The high temperature stress samples have a higher variance than the controls (Figure 2.15). The
42°C samples have the widest spread, however, both show much wider variance than the other
environmental conditions which may be due to the cells breaking down under the stress, particularly
as there are several differences between the two temperatures.
73
Oxidative Stress
The genes upregulated during oxidative stress appear to have similar functions to those upregulated
in other environmental conditions, which may suggest that these are the general stress response
genes in T. foetus (Tables A5 and A6). When 300µM H2O2 was used, upregulated genes included;
protein phosphatase and CAMK family. This may mean there is increased virulence or a change
in biochemical pathways. CAMK itself is a known stress response protein [317]. There are many
hypothetical proteins up and down regulated in both 300µM and 500µM oxidative stress responses,
these may be T. foetus specific stress response proteins.
There is a smaller variance between the oxidative stress samples than most of the other environ-
mental conditions but a larger variance than that seen in the low temperature experiment (Figure
2.15). Relative to the other environmental samples, the oxidative stress appear to have a smaller
variance than the controls themselves.
pH Stress
As previously mentioned, T. foetus is likely to come under pH stress whilst in the host, particularly
if there are changes to the pregnancy status of the cow. For high pH stress, upregulated genes
included:phosphatase, transferase, and DNA binding domain GNAt family proteins, which are in-
volved in acetylation (Tables A7 and A8).
Downregulated genes include myb-like domains so there is reduction in DNA binding and a decrease
in CAMK family proteins (Tables A7 and A8). It may be that under environmental stress the genes
involved in host-parasite interactions have lower activity.
As the cells die more quickly under low pH stress compared to high pH, the reduction in phos-
phatases may be indicative of the cells reducing their downstream signalling pathways and decreas-
ing metabolic activity, leading to the downregulation of these genes.
The high pH environment samples had a much higher variance than the low pH samples (Figure
2.15). The low pH stress samples had a gene expression profile that was more similar to the control
samples than to the high pH stress samples.
Tryptone-free Media
There appears to be a large variance between parasites cultured in tryptone-free media compared
to the controls (Figure 2.15). This is likely due to the stress response and utilisation of different
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nutrient pathways. However, when compared to the other nutrient depletion samples the variance
between the tryptone-free samples and controls appears smaller than the other nutrient-depletion
samples, particularly glucose, and the controls and, indeed, each other.
The tryptone-free samples have a much smaller variance relative to the controls than the glucose-
free media samples. T. foetus may have the ability to utilise different but similar cellular pathways
to account for the lack of tryptone in the environment or are using another nutrient in the Diamond
media to fulfil a similar purpose. Many genes that are differentially upregulated are skin-secretory
xp-like proteins, which are known to have growth factor activity and are secreted (Table A9).
Although T. foetus does not possess skin itself, it may possess growth factor proteins, the closest
homology in terms of primary structure of which is the skin-secretory xp-like protein. The skin-
secretory-proteins all have similar gene numbers suggesting that these could be repetitive regions
within the genome or are exons of one large gene.
Serum-free Media
The PCA (Figure 2.15) shows that there is a higher variance between the cells grown in serum-free
media and the controls. Again this could be due to stress responses. In a similar way to the
tryptone-free media exposed cells, genes coding for skin secretory proteins have been upregulated
(Table A10). Myb-containing domains were also upregulated suggesting that transcription could
be increased under these conditions.
Glucose-free Media
The samples grown in the glucose-free media have a much larger variance than the controls (figure
2.15). When compared to the other media trials there is still a much larger variance with regards
to cells grown in glucose-free media compared to the others. This suggests that the lack of glucose
in the media promotes a more distinct response within the cells than any of the other conditions.
This response is likely to be due to glucose being a major precursor for many metabolic pathways
within the cells and so its absence will have far reaching effects. There are specific up and down
regulated genes that are not seen in any of the other environmental conditions, such as glycine
dehydrogenase and efflux pumps (Table A11), which are likely to be associated with the change of
metabolism.
Many enzymes in trichomonads have multiple copies, for example enolases in T.vaginalis [316].
During glucose starvation trials for T. vaginalis different paralogues of the same genes were up and
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down regulated [252] [318]. Some paralogues are favoured under certain conditions or may perform
different functions. For example, under glucose reduction stress, six of seven TV hydrogenosomal
malic enzyme paralogues were downregulated and some paralogues of phosphoglycerate mutase
were upregulated [318]. T. foetus paralogues may perform in the same way with some becoming
upregulated in environmental conditions whereas others are downregulated. RNA-Seq and differ-
ential expression analysis will identify those with the highest fold change so the expression of all
paralogues may not identified as significant. Glucose restriction in other organisms, such as malaria,
can also lead to upregulation of virulence genes [318].
2.3.8 Number of Transcribed Genes
For the control samples there were, on average 33,700 genes transcribed which left 50,780 genes
non-transcribed. Averages were taken across the samples for each condition, using the feature
counts tables, to see how many ‘extra’ genes were transcribed in the condition. That is, how many
genes were transcribed on average per condition, that were not transcribed in the original control
samples. Across all conditions, the number of genes that remained non-transcribed ranged from
37,800 to 46,400.
Conditions Extra Genes Transcribed
Low Temperature 1962
High Temperature (42 ° C) 1394
High Temperature (46 ° C) 1994
High pH 1673
Low pH 736
Oxidative stress (300mm) 457
Oxidative stress (500mm) 453
Glucose free 8935
Serum free 9036
Tryptone free 4737
Table 2.3: The number of additional genes found when compared to control trophozoites across a
range of environmental conditions.
There was a much higher number of extra genes found in the samples where a nutrient has been
depleted. This could be due to the cells having to utilise different metabolic and biochemical
pathways in order to survive, therefore turning on a large range of different genes. However, there
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is still a very large number of ORFs that are not expressed, even under these conditions. In
serum-free media, glucose-free media and tryptone-free media there are 45154, 48070 and 48822
not expressed respectively. It may be that they require the presence of the host cells to express
these genes or they need a different environmental condition.
2.3.9 RNA- GhostKOALA Mapping
Figure 2.17: Mapping percentages of significantly upregulated and downregulated T. foetus RNA
transcripts against KEGG pathways. The significantly deferentially expressed genes were identified
using DeSEQ2 and mapping against KEGG pathways was performed using GhostKOALA.
When the significantly differentially upregulated and downregulated genes from each environmental
condition were run through GhostKoala [288] varying percentages of each group were successfully
mapped onto a function. This ranged from over 25% in the case of the down-regulated genes from
the glucose-free environment to less than 10% for the serum-free upregulated genes (Figure 2.17).
The upregulated sets had lower mapping percentages compared to the downregulated sets in all
environmental conditions apart from high temperature stress samples and, overall, the mapping
was low, never exceeding 30%.
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2.3.10 Comparison of T. foetus Genomes
During the course of this project, two more T. foetus genomes have been produced [227] [228]
[16]. These were all Illumina sequence rather than PacBio. Comparisons were made between my T.
foetus genome and those produced by Benchimol [227] and Carlton [239] (Table 2.4). The Benchimol
genome was assembled using Allpaths whereas the Carlton genome was assembled using Velvet, a
de novo assembler designed for short reads [240] [241]. When these genomes were compared, my
assembly had fewer contigs, a higher N50 and was more in keeping with the size of the T. vaginalis
genome, Zubacova’s [114] predictions and the predictions by SMRT Portal and Jellyfish.
BUSCO [226] [319] was used to measure completeness of the genomes and was also compared with
other examples, e.g. Giardia. All the T. foetus genomes have a similar level of completeness and
are comparable with that of T. vaginalis (Figure 2.4).
Genome T. foetus T. vaginalis
Senior Benchimol Carlton Carlton
Isolate/Strain Belfast K KV-1 G3
Data PacBio RSII Illumina Illumina Sanger
Assembly tool HGAP2 Allpaths Velvet Celera
Size (Mb) 147 65 67 160
Contigs 2776 3730 194,695 74351
Protein coding Genes 84,706 25,030 ND 74,351
N50 (bp) 82,179 34,827 2,054 68,338
% GC (Genome) 30.83 - - 32.7
% GC (Coding 32.7 - - 35.5
Spliced genes 17,620 - - 65
Non-spliced genes 67,086 - - 59,616
Gene density (/kb) 0.576 0.385 - 0.464
BUSCO score (Complete) 198 203 217 210
BUSCO score (Missing or Fragmented) 105 100 86 93
BUSCO score (Complete %) 65 67 70 69
tRNAs 251 306 ND 468
rRNAs 101 - ND 668
Table 2.4: Comparison of some of the key features of T. foetus genome assemblies, produced by
Senior, Benchimol and Carlton, and T. vaginalis
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The BUSCO scores could be lower than expected because generic eukaryotes were searched rather
than trichomonads as there is no trichomonad data set. Also, as T. foetus and T. vaginalis are
parasites, they may be using a reduced number of genes. The differences in BUSCO score could
also be due to the differences in assembly methods as there is a large disparity between the numbers
of contigs and N50 which are known to have an impact on the overall score [320] and could be due
to assembly artefacts.
2.3.11 Comparison of T. foetus with T. vaginalis
When the assemblies are compared, there are similarities between my T. foetus and T. vaginalis
genomes. They are a similar size, both being over 140 Mb and appear to have a similar number of
core expressed genes. Some differences in gene number may be due to the differences in assembly
and sequencing method, especially as the T. vaginalis genome was produced ten years earlier than
the T. foetus genome.
The orthofinder [222] results showed a large number, over two thirds of the T. foetus genome, of
shared genes between the two species (Figure 2.18). Benchimol [227] also found high similarity
between species, 72% of ORFs being similar, in terms of sequence, between species. Benchimol also
found a higher number of tRNAs in their assembly, although still a lower number than T. vaginalis
suggesting there is a number of tRNAs not identified in my genome annotation and also that T.
vaginalis has a higher number in general. This could be attributed to, in part, to the larger genome
size. As T. vaginalis is not the most closely related trichomonad to T. foetus it stands to reason
that a large number of these genes are not only conserved between these species but also between
most if not all trichomonads.
2.3.12 In silico Cell Surface Proteome
In order to reduce the 84,725 genes in the genome to set of plausible vaccine antigens, the first of
several filters to exclude unsuitable genes concerned predicted protein structure. Signal P [321] [322]
and TMHMM [290] were used to identify signal peptides and transmembrane domains respectively
in predicted amino acid sequences. The presence of a signal peptide would show that the protein
is probably localised to the plasma membrane and the presence of a TMD would show that it is
embedded in a membrane. Initially, Signal P identified 5,205 proteins with a significant probably
of possessing an SP. Of these, TMHMM identified 1,607 proteins with one TMD, and 621 with two
TMD. When GPIpred was applied, a further 11 proteins were found that contained an SP and GPI
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Figure 2.18: Shared genes between T. vaginalis and T. foetus found by Orthofinder
anchor. Together, this produced a final set of 6,823 genes that are predicted to be expressed on the
cell surface, either as transmembrane or tethered proteins, or secreted outside of the cell
2.3.13 Network
All viral proteins and transposable elements were removed from the final protein list, for example,
integrases and transposases. Where there were large clusters with only one or two SP positive
nodes but many negative nodes, alignments were made and opened in MEGA5 [36] to compare
and see whether the positioning of the SP was sensible and likely to be a real result, rather than
annotation error. The BLAST scores were also checked to see the length and similarities of the
alignments. All families without at least one SP within them were removed, which reduced the sets
to 610 families. After the alignments were checked and those with low similarity were removed.
This left 246 clusters. Overall there were 105 T. foetus specific clusters and 141 clusters with both
TV and TF genes within them. The final network contained 11,259 nodes (Figure 2.19).
All T. foetus specific genes are coloured in blue (Figure 2.19), all T.vaginalis specific genes are
coloured in red and all proteins that contain a signal peptide are highlighted in green (Figure 2.20).
Most peptide array genes belong to ‘hypothetical’ gene clusters however, one belongs to the legume-
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like lectin family proteins, one belongs to the Clan-SC family and nine belong to the largest cluster
that contains the BspA family, CAMK family and leucine-rich repeats. Very few of the top ten
differentially expressed genes from the transcriptome experiments are present within the network,
only 21 out of the top 180 differentially expressed genes.
Figure 2.19: Network showing T. vaginalis (red) and T. foetus (blue) genes produced in Cytoscape.
This network shows the in silico cell surface predictions of T. foetus and their putative gene families
based on PSI-BLAST bit scores.
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Figure 2.20: Network showing T. vaginalis (red) and T. foetus (blue) genes, highlighting those that
posses signal peptides (green) produced in Cytoscape. This network shows the in silico cell surface
predictions of T. foetus and their putative gene families based on PSI-BLAST bit scores.
Key Gene Clusters
There are over 200 cysteine proteases present in the network, mainly in three clusters. Cysteine
proteases are considered to be integral to parasites and their lifestyle [323]. Most parasitic cysteine
proteases are contained within the ‘Clan CA’ family, of which there are 289 in my annotated T.
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foetus genome. As stated in the introduction, cysteine proteases are involved in cytotoxicity and in
T. vaginalis the cysteine proteases are known to degrade IgG, IgM and collagen, thereby protect-
ing itself from the immune system and acquiring nutrients from host cells. Within the D. fragilis
genome, cysteine proteases were the most abundant transcripts found [323] [316]. T. vaginalis has
446 proteases, 202 of which are cysteine proteases and 187 of those which belong to the clan CA
family [125]. The high numbers of these further suggest the importance of the cysteine proteases
to the parasitic lifestyle.
The largest cluster in the network contains: hypotheticals, lecuine rich repeat containing pro-
teins/BspA family proteins and CAMK proteins (Figure 2.21). The BspA family is also thought
to be involved in virulence and pathogencity and is highly expanded in T. vaginalis [316] [125], it
may also be involved in chemotaxis. This family is found amongst many species, both prokaryotic
and eukaryotic, the further implications of this are discussed in the chapter discussion.
CAMKs are associated with intracellular calcium and are involved in signalling cascades and reg-
ulate gene expression, including likely pathogenic pathways [316]. There are 371 of these CAMKs
predicted in the T. vaginalis and 71 in the D. fragilis genome. Within the present genome, 956
genes have greatest identity to a CAMK family protein. The increase in number compared to the
other protists may be due to the multiple hosts and environments that T. foetus inhabits. The
largest cluster also contains a very large number of kinases (over 1000). Kinases are standard house-
keeping genes but, in eukaryotes, they are also linked to pathogenicity [316]. Signal transduction
and vesicle trafficking within trichomonads are regulated by these kinases and by Ras GTPases.
Kinases may be involved in the necessary cytoskeleton remodelling during host-parasite interactions
and during pathogenesis, such as phagocytosis by T. vaginalis. The regulation of vesicle trafficking
also leads to the regulation of virulence factor secretion, such as cysteine proteases.
The second largest cluster in the network contains ankyrin repeat-containing proteins and hypo-
thetical proteins; some ankyrin genes may have host-pathogen responses, such as that in legionella
[324]. This would suggest that the largest gene families in T. foetus are involved in host-parasite
responses and virulence which is plausible as it is an obligate parasite and its host-interactions are
essential for its life-cycle.
There is also a very large ‘NA’ cluster present, this could be a completely T. foetus specific family
although the mechanisms of their action and functions are unknown and there is very little struc-
tural data on the members. The clusters in the network feature a wide range of proteins including:
BspAs, CAMK, Ankyrins, DNA polymerase, Thioredoxin, ATPases and legume like lectins. The
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network contains many housekeeping genes along with many hypotheticals which could be T. foetus
specific gene families. As some do not have any T. vaginalis homologs the genes could belong to
either T. foetus only or more closely related trichomonads that have not yet had their genomes
sequenced. Thioredoxins can be found on the cell surface of some protists and have been linked to
a protective response against oxidative stresses [325] and may play a role in regulating cysteines.
Figure 2.21: Largest Cytoscape cluster (A) highlighted to show: (B) all hypothetical genes, (C)
BspA and Lecuine-rich-repeat containing genes, and (D) CAMK family genes. The products for
all genes were identified by BLAST2Go using a non-redundant database. To form the clusters PSI-
BLAST was used to identify and produce bit scores. Clusters were created in Cytoscape, where T.
foetus genes are blue, T. vaginalis genes are red, signal peptide containing genes are highlighted in
green.
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2.4 Discussion
In this chapter, a T. foetus genome sequence has been assembled and annotated using computational
and manual methods. Genome sequencing has been complemented with a transcriptome derived
from T. foetus cells cultured under diverse environmental conditions, leading to an enhanced genome
annotation and to identification of differentially expressed genes under various stresses. Finally, this
chapter has produced an in silico cell surface proteome of 2,807 genes, containing both conserved
and species-specific genes and gene families, which represents the first step in identifying suitable
antigens for vaccine candidates.
2.4.1 Evaluation of Genome Assembly
The genome was assembled by a variety of methods, including HGAP2 (SMRT portal) and Canu
[271], with Canu predicting a size of genome double that of HGAP2. The size was also predicted
using Jellyfish [326][237] and this was later used in conjunction with HGAP2 to produce the final
genome size. Canu produced a much more fragmented genome with 11,000 more contigs and this
could be due to overexpansion of repetitive regions. Also, previous comparisons that have been
performed between assemblers are in bacteria rather the trichomonds or other eukaryotes [326].
The size of the SMRT Portal assembly seems more inkeeping with the size predicted by Jellyfish
and Zubakova [114] and is a similar size to T. vaginalis. The T. foetus genome is known to be
highly expanded and to contain a large number of duplicated genes [316].
2.4.2 Comparison of T. foetus Genomes
The present PacBio-based genome assembly is twice as large, and contains more genes, than the
other T. foetus genome assemblies that have been created previously. Furthermore, the present
assembly is more consistent with predicted sizes of the genomes from a variety of sources. There
are also differences in N50 and contig numbers between the genomes though it is hard to get a
direct comparison due to differences in assembly and sequencing methods. When the T. foetus
[227] and T. vaginalis genomes were initially compared by Westrop [242], it was shown that 72%
of ORFs were similar between species and 28% were found in T. foetus only. This is similar to the
orthofinder analysis performed in this chapter, which shows that 66% of gene clusters were shared
between species and 34% were found in T. foetus only. The differences in percentages could be
attributed to the fact that the Benchimol genome was much smaller (65Mb opposed to 147Mb) and
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had significantly fewer ORFS (25,000 opposed to 84,700), therefore fewer T. foetus specific genes
may be found.
2.4.3 Comparison of the T. foetus and T. vaginalis Genomes
The T. vaginalis genome is predicted to be larger than the T. foetus genome [20] and the present
assembly conforms to this, being 20Mb smaller than that of T. vaginalis.
T. vaginalis secretes large amounts of cysteine proteases and exosomes, the secretome of T. foetus
would also be interesting to investigate to see if the same repertoire of proteins are secreted between
the two species. Looking at the network of putative cell surface proteins, there is a large cysteine
protease family of genes, each possessing a signal peptide and no transmembrane domain. This
shows that secreted cysteine proteases are also produced by T. foetus and perhaps fulfil the same
functions.
Screening the T. vaginalis genome and proteomic analyses identified many BspA and Pmp family
proteins[20]. BspAs are leucine-rich repeat containing proteins that are found in both prokaryotes
and eukaryotes. Pmps are known to promote binding, making them a potential virulence factor
[167] [327]. As BspAs are found in prokarotes, it is thought that they were introduced to eukaryotic
species via horizontal gene transfer. T. vaginalis is thought to have 911 BspA proteins and 48 Pmp
proteins encoded in its genome [165]. The present T. foetus annotation includes 186 proteins that
are annotated as BspA or leucine rich repeat proteins and 12 Pmp labelled proteins. Although
these numbers are significantly lower than that of the T. vaginalis values, they are consistent with
previous findings. Handrich et al. [327] compared the gene expression of BspAs and Pmps in
trichomonads to general housekeeping genes and found a large expansion of these families in T.
vaginalis. The relative abundance of BspAs and Pmps compared to housekeeping genes was 506
and 80 respectively. Whereas in T. gallinae it was 47 and 6, in T. tenax the abundance was 81 for
BspA and 11 for pmps and in Tritrichomonas batrachorum it was 295 and 2 for relative abundance.
T. foetus was not included in the study.
There is also a large family of rab-GTPases which also appear in the T. foetus genome. These
are involved in controlling intracellular membrane traffic and ensure membrane bound proteins
are located to the correct site [328]. Additionally, these have also been postulated to be involved
in pathogenic processes such as the secretion of virulence factors and cellular motility [316] [329].
There are over 65 Ras and Rab GTPases within the T. vaginalis genome and a similar number
within T. foetus- 49 predicted Ras GTPases and 18 predicted Rab GTPases. The large number of
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CAMK proteins in both genomes also suggests a key role in the parasites lifestyle.
The BspA family of proteins appears to be key in both T. foetus and T. vaginalis [167] and is
likely involved in host-parasite attachment. It is known to be involved in surface adhesion in many
bacteriodes [167]. It is likely that for many parasite-host and virulence proteins in T. vaginalis there
is a T. foetus homologue or protein that performs a similar function. These genes may provide
key vaccine targets for T. foetus, as knocking them out could greatly reduce the virulence and
pathogenicity of the organism. Only 65 genes in the T. vaginalis genome have introns compared
to 18,000 in the T. foetus genome [125]. This may be due to T. foetus colonising many different
environments, such as the urogentital tract and gastrointestinal tracts [30] [330], thereby needing a
higher number of potential proteins. This could also be due to misannotation of either the T. foetus
or T. vaginalis genomes. There is currently no other trichomonad genome that has been sequenced
using PacBio long-read technology and very few trichmonad genomes that have been sequenced by
any technologies. The genes that are found in both T. foetus and T. vaginalis could be conserved
between all trichomonad species, for example: CAMK and rab GTPases.
Additionally, there is a large difference between the genomes in the number of intron containing
genes, with T. vaginalis containing 65 genes and T. foetus containing 17,602. although some protists
are known to have relatively few, many, such as Plasmodium falciparum have thousands, suggesting
that the number found in T. foetus are still inkeeping with the overall intron densities for protists.
2.4.4 Evaluation of Gene Annotations
In the present assembly, 12,106 genes were defined as ‘NA’s and a further 44,953 were annotated as
‘Hypotheticals’. These proteins are not necessarily species-specific, but they are uncharacterized,
perhaps because they have limited taxonomic distribution among parabasalids. Few trichomonad
genomes have been thoroughly sequenced beyond the model T. vaginalis and, therefore, both
sequence and functional databases will not represent much of the core trichomonad gene set, Thus,
while 56,000 genes are found in both T. foetus and T. vaginalis genomes, these have no affinity
beyond trichomonads and no ascribable function.
2.4.5 GhostKOALA Mapping
When the genes were mapped to KEGG pathways using GhostKOALA, many pathways were not
mapped to. Furthermore, of the pathways that were mapped to, many did not have complete
modules,with some only containing one member. Only 18 modules in total were fully mapped
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to and only 11.6% of genes in the genome were successfully mapped to a pathway. This may be
due to a number of reasons: misannotation in the original genome; the parasite could be using a
reduced set a pathways due to its parasitic lifestyle and is gaining some of its required nutrients
and compounds from the host; or, could be due to the fact that the trichomonad genes are too
divergent and so GhostKOALA does not recognise them.
2.4.6 Errors in Genome Annotation
Eukaryotic genes typically consist of multiple exons and introns, which can make correct gene
modelling more challenging [331]. Therefore, automatic gene finders are not always accurate. For
example, when the Mycoplasma genitalium was sequenced [332] the error rate was found to be at
least 8%. Genes with incorrect sequence annotation can be entered into public databases which
leads to further annotation errors down the line with other genomes. In order to try to combat
this inaccuracy, I used two automatic gene finders along with manual curation to minimise obvious
errors. One of these gene finders, BRAKER, also implements RNA-Seq data to identify ORFs and
allows for small genes to be found [331]. Gene finders in general, however, follow a set of assump-
tions which, in some cases may not always be correct or valid [230]. These include:
1) Start and stop codons and splice sites are the same throughout the genome. This is particularly a
problem when annotating a non-standard organism such as T. foetus when the true splice patterns
and codon usage are unknown.
2) No genes in the genome overlap.
3) No genes are nested within other genes.
4) The lengths of the introns and exons are geometrically distributed along the genome. AUGUS-
TUS is known to be an exception for this
5) There are no sequencing errors in the input sequence. PacBio and other long-read technology
are known to have a relatively high error rate.
6) There is no alternative splicing. Many eukaryotic genes use alternative splicing to increase the
number of proteins that can be coded for. If alternative splicing is not taken into account many
genes could be missed. Furthermore, it may not be the highest scoring isoform that is always
predicted by the programs, leading to errors in the gene sequence or functions.
7) The start and stop introns contain no genes.
To attempt to overcome these problems, as previously stated, a range of gene finders were used
along side manual curation with extensive transcriptome analysis to minimise the error rates.
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2.4.7 Network
The network produced contains many expected protist genes including the TLK family and thiore-
doxins. The largest cluster in the network features the BspA family and lycine-rich repeat containing
proteins, both of which are thought to be key virulence factors in T. vaginalis or are involved in
host-parasite interactions. As stated in the results, this cluster also contains a large number of
kinases which are crucial for a wide range of cellular pathways. There were many hypothetical
proteins that did not show homology to any T. vaginalis genes, including several of the peptide
array genes. In the largest gene cluster it would be reasonable to infer that the hypothetical T.
foetus genes display similar functions to the other family proteins, such as kinase activity and it is
likely that the relationships between the different nodes correlate with functional relationships be-
tween genes [264]. Within the T. vaginalis hydrogensome there is the thioredoxin-linked periodoxin
system that removes reactive oxygen species and can convert H202 to H20 [325]. The trichomonad
thioredoxin reductase differs significantly from that found in humans so may be a good drug target
for T. vaginalis. If it is found that the T. foetus thioredoxin is different from the bovine and feline
thioredoxin, which is likely, this too could be a good potential drug target.
2.5 Conclusion
The genome of the Belfast strain of T. foetus has now been sequenced and assembled, producing
84,725 protein coding gene models. From among these, a predicted cell surface proteome has
been identified containing 2,807 genes, which are likely to be expressed on or beyond the plasma
membrane. This gene set can now be validated and tested by immunoproteomic methods to confirm
that they fulfil the original criteria for a good vaccine candidate (Figure 2.22).
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Figure 2.22: Reverse Vaccinology Project Flow Diagram. The sections highlighted are those that
have been completed by Chapter 1, other sections are the subject of following chapters.
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Chapter 3
Proteomic Analysis of T. foetus
3.1 Introduction
This chapter describes proteomic analysis of the T. foetus cell surface in two parts. T. foetus cells
are labelled with biotin and the cell surface proteins are then extracted using a biotin-streptavidin
pulldown. These proteins are analysed using Tandem Mass Tag (TMT) labelled mass spectrometry
and compared to the predicted cell surface proteome described in Chapter 2 to validate the in silico
approach. Both trophozoites and pseudocysts are analysed using mass-spectrometry to identify
differentially expressed proteins between the two developmental stages. In the second part, a peptide
microarray is designed from 50 cell surface proteins identified in Chapter 2, which is then probed
with serum from natural and experimental T. foetus infections, to examine their immunogenicity.
Natural immunogenicity is indicative of good vaccine candidates and will contribute to a short list
of antigens that can go on to further stages of vaccine development [333] [334].
3.1.1 Proteomics
Proteomics is the study of all proteins produced by a particular organism, their diversity and relative
abundance, and is used to complement other ‘omics’ methods, such as genomics and transcriptomics
[335]. Proteomics approaches can be used to identify biomarkers and vaccine candidates, in ad-
dition to providing more information of disease progression [336], aiding drug discovery [335] and
identifying key processes in biochemical pathways [337]. The proteome is much more complex than
the genome and changes in gene expression can be identified by both transcriptomics or proteomics.
The cell proteome can reflect the transcriptome, however, since the amount of protein produced
is not solely controlled by the expression level of a particular gene [242], and since many proteins
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can be modified, for example by post-translational modifications (PTMs) such as glycosylation,
transcriptomes and proteomes can give very different accounts of gene expression. Conventional
techniques for protein purification and analysis are ELISAs, Western blots and chromatography
[335], however, these do not typically have high-throughput capabilities. Mass spectrometry (M/S)
has the ability to handle many samples at the same time and has benefits for a wide range of
organisms, including parasites [338]. In the case of Leishmania, half of predicted genes are hypo-
thetical (similar to the T. foetus genome) [339] which makes purely genomic based approaches for
identifying their function difficult. Proteomics has been used to look at many stages, including the
salivary components of the Leishmania vector, the sand-fly [340], and Leishmania secreted proteins
[338]. Gene expression is regulated at transcription, translation and by PTMs, therefore a variety
of approaches are needed to correctly deduce their roles and functions, this can be particularly
important in host-parasite interactions. Expression proteomics can identify whether protein levels
are up or down-regulated in different life stages or states, such as trophozoites and pseudocysts in
T. foetus and comparisons can be made [338].
3.1.2 Cell Surface Proteomics
The cell surface plays key roles in many different aspects of cellular interactions including in infection
and disease [341] [342] and can be ideal targets for drug therapies or vaccines [341]. Cell-surface
proteomics has been used to investigate many diseases, such as cancers [343]. Labelling the cell
surface and performing a proteomic analysis has been used to identify host-parasite interactions,
drug resistance and possible environmental adaptations [342].
In Trypanosoma brucei, cell-surface proteomics was used to identify stage specific paralogues that
may be involved in cellular remodelling and adaptation to the environment [344]. To identify cell
surface proteins of Giardia [345], cells were labelled with biotin (Section 3.1.8), incubated with
streptavidin and were immunoprecipitated by streptavidin affinity chromatography. 86 peptides
were identified by liquid chromatography and tandem mass tag (TMT) spectrometry, 15 of which
were known Giardia cell surface proteins. Comparisons between the biotinylated proteins of two
strains of Giardia showed 23 highly conserved cell-surface proteins [345]. These conserved proteins
could be good vaccine candidates if they were found to validate all other necessary criteria as they
could elicit an immune response to several if not all, strains.
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3.1.3 Mass Spectrometry
Mass spectrometry measures the mass to charge (m/z) ratio of ions in a sample. Proteins are
digested into peptides which are then fractionated. There are several ways to fractionate these
peptides, such as: protein digestion on 1D SDS page gel, liquid chromatography or buffer exchange
[336]. The mass spectrometer generates multiple ions from the peptide sample under investigation
and separates them according to the specific m/z ratio and records the relative abundance of each
ion type. The relative abundances are compared to a database of known peptides and the identity of
the proteins present in the sample may be inferred computationally. Liquid chromatography mass
spectrometry (LC-MS) and matrix assisted laser desorption ionization-time of flight mass spectrom-
etry (MALDITOF-MS) are the two most widely used methods of M/S [335]. The development of
high throughput M/S has produced far reaching benefits for the areas of immunology and vaccine
design [336]. LC-MS has been used to identify differences in metabolism between species, such as
T. foetus and T. vaginalis [242]. It was also used to compare the proteomes of bovine and feline
T. foetus genotypes [346], which showed highly conserved proteomes between the genotypes, but
with significant differences in the abundance of 25 peptides, particularly cysteine proteases which
are thought to be involved in host-parasite interactions and virulence.
3.1.4 Labelled and Unlabelled Mass Spectrometry
Unlabelled or label-free mass spectrometry involves either counting the peak areas for all of the
peptides found or counting the spectra produced from a sample [347] [348]. The more abundant the
protein, the more peptides that will end up being fragmented. Label-free M/S is less accurate overall
but has greater coverage of the proteome and can identify even very low abundance peptides. It
is also cheaper and does not rely on good labelling efficiencies [348]. Labelled M/S produces more
sequence ions, is usually more accurate and may increase confidence of identifications using the
final database [349] [350]. Examples of labelled M/S included labelling with stable isotope, such as
SILAC and using isobaric tags, for example in TMT labelling.
Labelled Mass Spectrometry-SILAC
Stable Isotopic Labeling with Amino Acids in Cell Culture (SILAC)- cells are grown in culture with
the addition of stable-isotope ’heavy’ forms of amino acids. The peptides produced will be labelled
with heavy or light forms of these amino acids and are then differentiated through M/S [351]. It is
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used predominately to look for changes in cellular pathways and the regulation of PTMs and gene
expression [335] [351].
Labelled Mass Spectrometry-TMT
Tandem Mass Tag Labelling (TMT) involves covalently attaching an isobaric tag, which is a stable
isotopic label to the different peptide samples [352] [353]. This allows the samples to be differ-
entiated during the M/S detection stage. The tags separate under fragmentation and release the
reporter ions. The reporter ions produced are characteristic of each tag and are detected at a
distinct m/z ratio, the intensity of these ions is used as a quantitative measurement [352]. An
advantage of TMT labelling over using stable isotopes is that there is not the limitation of 2-plex
or 3-plex sets of reagents and so many samples can be analysed in one run, thereby reducing time
and cost [352]. It also helps to remove sample preparation variability. However, only one peak
is produced per peptide, which can lead to lower sensitivity if there is a small number of highly
expressed peptides.
3.1.5 Applications of Biotin in Protein Characterisation and Purification
Biotin, also known as vitamin H or vitamin B7, is present in small amounts in all living cells,
where it is a key player in gluconeogenesis and fatty acid metabolism. It is found in low amounts
in many foods, such as oats, molasses and soybeans [354]. In animals there are several biotin-
dependent carboxylases, such as pyruvate-carboxylase and acetyl-co-A-carboxylase-1 [355]. Many
biotin molecules can bind to a protein molecule. It is a small molecule (244.3 Da) and can be
attached to the amine groups of diverse proteins and molecules without altering the biochemistry.
Biotin has the ability to bind to avidin or streptavidin to form a complex (Figure 3.1) and is widely
used in protein purification techniques and identifying protein-protein interactions and PTMs [356].
Biotin can also be modified as needed, such as by the addition of disulphide bridges, extra-long
linkers and many different reactive groups, for example, PEG-4. These can make the biotin more
soluble and easier to cleave from the reactive groups, thereby reducing the need for harsh elution
techniques. There are several reasons why biotin labelling is used so frequently in protein purifi-
cation, including: the ability to purify under extreme conditions due to the strong covalent bond
between biotin and avidin and the high sensitivity and low background noise. Different types of
avidin can be used in experiments depending on the specific needs [356]. In this chapter, I attempted
94
to use these properties of biotin to label T. foetus cell surface proteins prior to identification with
label-free mass spectrometry.
3.1.6 Avidin and Streptavidin
Avidin is thought to be a natural antibiotic found in the egg whites of reptiles and birds and pro-
duces biotin deficiencies in experimental models [355]. It is a tetrameric glycoprotein (67kDa) with
four identical subunits and each subunit can bind to a biotin molecule (Figure 3.2). The binding
occurs by the linking of avidin to tryptophan residues and lysine on the subunit binding site.
There are, however, some disadvantages of using avidin [357], predominantly its non-specific bind-
ing. Avidin is positively charged at neutral pH so may bind to charged cellular proteins and it is a
glycoprotein so may react with lectins. The type of avidin used in an experiment can be modified
depending on the needs, such as lower binding affinities to assist with elution [356].
Streptavidin is an 52.8kDa tetramer and overcomes some of the limitations of the biotin-avidin
method. It is isolated from Streptomyces avidinii. It has less positively charged residues, due to
having a more neutral isoelectric point (avidin’s isoelectric point is closer to 10) therefore will be less
likely to non-specifically bind to positively charged cellular structures. It is also not a glycoprotein
so does not bind to lectins.
3.1.7 Biotin-Streptavidin Interactions for Protein Purification
Biotin-streptavidin binding is one of the strongest known non-covalent molecular interaction be-
tween a protein and a ligand (Figures 3.1 and 3.2) with a Kd value of 1x10-14 (insert Duan 2012
reference). The bond is formed rapidly and is unaffected by environmental extremes, such as
changes in pH and temperature.
However, there are issues with non-specific binding and also the conditions needed to elute the pro-
teins are often harsh which can affect the structure of the proteins that are trying to be captured.
3.1.8 Biotin Labelling and Pulldowns
Biotin labelling of the cell surface or proteins that are expected to localise to the surface has been
widely used. It can be used to enrich samples before mass spectrometry, allowing cell surface anti-
gens to be identified [358]. It can be used to detect proteins that are trafficked to the cell membrane
[359]. Identifying cell surface proteins by mass spectrometry has always proved challenging [342]
[360], particularly plasma membrane proteins. This due to the complexity of cellular membranes
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Figure 3.1: Schematic of the biotin-streptavidin interaction showing biotin (green circles) binding
covalently to the streptavidin (blue tetramer). This is the strongest covalent interaction known in
nature.
and issues with identifying bona fide cell-surface proteins in samples, rather than other intracellular
membrane proteins [360] [361]. It is also possible that some cell surface biomarker proteins can be
lost in the preparation of cells for M/S, as has been the case using multipotent human mesenchymal
stromal cells (hMSCs) [360] . Neihage et al. (2011) [360] labelled the hMSCs with sulfo-NHS-SS-
biotin, harvested the cells and purified them using streptavidin beads, thereby removing unlabelled
cellular proteins and contaminants. The biotinylated proteins were eluted and the elution was run
on a 1D gel before in gel trypsinisation and M/S. They identified 169 cell surface proteins that
contained TMH or GPI anchors [360]. This is an almost identical approach to the one taken in this
Chapter to examine T. foetus cells (Section 3.2.7). Biotinylation with a pull-down has also been
used for parasites, such as Toxoplasma gondii [362]. However, there have been cases where avidin
has bound non-specifically to the target cell wall proteins [363]. It has been thought that avidin
may possess some structural similarity to cell-recognition domains and this non-specific binding
may be indicative of cell-surface integrins [363].
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Figure 3.2: Structure of high affinity biotin binding to a streptavidin tetramer, the strongest covalent
bond known. Each biotin molecule binds to one of the four streptavidin subunits. The four
streptavidin molecules are highlighted with pink circles and numbered 1-4. Obtained from the
Protein Data Bank (PDB) using the ID 1STP with a resolution of 2.6 Angstroms.
3.1.9 Peptide Arrays
Microarrays were originally created as a way to screen large amounts of DNA although [364] today
they can be applied to a wide range of substrates including: peptides, microRNAs and tissues
[365]. Peptide arrays produce a way to rapidly screen hundreds or thousand of peptides for various
criteria such as immunogenicity, binding [305], or enzyme activity in one experiment [366] [367].
Peptide arrays can also be used to identify protein interactions [368], peptide-DNA interactions and
peptide-cell interactions [369]. Microarrays are becoming increasingly widespread as a technique as
the costs associated with the experiments fall.
The peptides are printed as spots in a known configuration onto a chip to which a secondary
antibody conjugated to a reporter enzyme or fluorescent label is added. Once the substrate, for ex-
ample, serum, is applied, and primary antibodies within the serum bind to their cognate peptides,
a colormetric or fluorescent change occurs which can be imaged and quantified using specialist
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software. Peptide arrays have been used for human diseases, such as to identify autoantigens in
cancers [365] and also with regards to parasites, for example, serotyping Toxoplasma gondii [370].
Peptide arrays have also been used in attempts to identify malaria vaccine candidates [371], allowing
information on the process of disease from various endemic regions to be gathered.
3.1.10 Aims and Objectives
The aim of this chapter is to validate the cell-surface location of T. foetus cell surface proteins
predicted in Chapter 2 through mass spectrometry of cell fractions enriched for plasma membrane
through biotin labelling, and through immunogenicity assays after exposure to sera from infected
cattle. The chapter has three objectives:
1. Biotinylate the T. foetus cell surface, extract labelled proteins and identify cell-surface proteins
using mass spectrometry
2. Compare the mass spectrometry profiles of trophozoites and pseudocysts to identify develop-
mental differences in protein expression
3. Analyse the immunogenicity of selected cell surface proteins by screening serum from natural
and experimental infections with a custom peptide microarray
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3.2 Methods
3.2.1 T. foetus Cell Preparations for Label-free Mass Spectrometry
Three samples of Belfast strain T. foetus trophozoites and three samples of Belfast strain T. foetus
pseudocysts all grown in Diamond media were prepared (approximately 1x107 cells per sample).
The samples were lysed using 200ml lysis buffer (1% SDS in 50mM ammonium bicarbonate) and
the lysate was sonnicated three times for 10 seconds each time. The samples were then heated to
90°C on a heat block for 10 minutes and then centrifuged for 10 minutes at 13000rpm. The lysate
was transferred to another tube, dilutions were made and a Bradford assay performed (Section
3.2.4).
3.2.2 Label-free Mass Spectrometry of T. foetus
Label-free mass spectrometry was carried out at the University of Liverpool Centre for Proteomic
Research by Dr Stuart Armstrong. All samples were run into an SDS gel and then the band
cut out and a semi-tryptic digest was performed [372]. Label-free mass spectrometry of the life
stage samples was carried out by Stuart Armstrong using the Q -Exactive mass spectrometer and
Orbitrap mass analyzer. Preferential expression of peptides was analysed by PEAKS 3 [373] [374].
3.2.3 SDS Page Gel Preparation
Unless stated otherwise, 12% SDS Page gels were used in all experiments. To produce two gels,
the stacking gel comprised: 0.65ml Acrylamide, 1.25ml 0.5M Tris pH 6.8, 50µl 10% SDS, 3.025ml
milliQ water, 25µl 10% ammonium persulphate, 2.5µl TEMED. The resolving gel was composed of:
4ml Acrylamide, 2.5ml 1.5M Tris pH 8.8, 50µl 10% SDS, 3.4ml milliQ water, 75µl 10% ammonium
persulphate, 7.5µl TEMED.
3.2.4 Bradford Assay
The following concentrations of Bovine Serum Albumin (BSA) (µl/ml) were made up using milliQ
water: 0,2.5,5,10,15,20 and 25 to produce the Bradford assay standards. A 96-well microplate was
used for the assay. 100µl of the BSA standards were placed in duplicate down the left hand columns
of the plate from lowest concentration to highest and 100µl the samples were placed in duplicate in
the wells alongside the standards (Figure 3.3). 100µl of Bradford assay reagent was added to each
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of the wells and left for 5 minutes at room temperature to incubate. The samples were then read
and the concentrations calculated using a Tecan plate reader and Magellan software [375]. For both
proteomic experiments, the trophozoite and pseudocyst samples were diluted: 1/200 and 1/400 and
measured. The protein concentrations of the biotinylated soluble fractions were also diluted and
measured using a Bradford Assay.
Figure 3.3: Schematic of the Bradford Assay 96-well plate layout showing the standards and blanks
in blue and samples in duplicate in pink. Where blanks are milliQ water only, standard A is
25µl/ml BSA, B is 20 25µl/ml BSA, C is 15µl/ml BSA, D is 10µl/ml BSA, E is 5µl/ml BSA and
F is 2.5µl/ml BSA. All samples are used in duplicate up to a maximum of 40.
3.2.5 Western Blots
The SDS page gels were run at 90 volts (V) for 2 hours. One gel was stained with Coomassie to
show abundance of protein and the other was used in the Western blot.
The gel was washed in water for 5 minutes and then in transfer (Towbin) buffer (10x buffer =
30.3g/L Tris, 144g/L Glycine) for 5 minutes. A PDVF membrane was used and this was soaked in
methanol for 10 minutes prior to use. The Western blot was run for 1 hour at 100V.
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The membrane was washed in double distilled water (ddH20) and then stained with Ponceau S
to check the transfer. The Ponceau S was then washed off and the membrane was covered with
blocking buffer (5% milk protein in TBS) and left to incubate overnight at 4°C.
The membrane was removed from the blocking buffer and washed twice in Tris-buffered saline with
Tween-20 (TBST) for 10 minutes. Streptavidin-HRP was made up in dilution buffer (1% milk
protein in TBS) to a 1/5000 dilution and added to the membrane with rocking for 1 hour. The
membrane was washed in TBST for 5 minutes twice, Tris buffered saline (TBS) for 5 minutes
twice and ddH20 for 5 minutes twice. The membrane was dried and 4ml of Biorad clarity ECL
substrate was added for 5 minutes. Images were taken with varying exposure times using the Biorad
Chemidoc.
3.2.6 SDS Page Gel Staining
The SDS page gels produced were stained using both Coomassie blue (1.5 hours at room temper-
ature with shaking. The excess stain was removing using three washes of 10 minutes of distilled
water) and silver staining using the Pierce Silver Stain Kit from Thermofisher. The membrane
was stained as per the manufacturers instructions with a final developing step of 2 minutes. The
Western blot was stained using Ponceau S. The membrane was left in Ponceau S for approximately
3 minutes until bands were seen. The Ponceau S was then washed off using three washes of 2
minutes of distilled water and the bands were no longer visible before the membrane was incubated
with the blocking buffer.
3.2.7 Biotinylation of T. foetus Cell Surface
Belfast strain T. foetus cells were grown to a density of approximately 1x107 per ml in a 15ml tube.
The cells were washed twice in PBS (Thermofisher) and spun down at 800xg at 4°C and re-suspended
in PBS to give a total volume of cells of approximately 1.5x108 in the 1ml volume. Cells were
incubated with 0.5mg/ml EZ-link-sulfo-NHS biotin on ice for 45 minutes (Thermofisher A39257).
Excess biotin quenched with 50mM Tris pH 7.5 and cells were washed three times with PBS, all
wash steps using the centrifuge were performed at 4°C.
The biotinylation was also later performed using PBS at pH 7 and pH 9 to assess whether the
acidicity of the solution effected the efficacy of the biotinylation.
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3.2.8 Immunofluorescence Assay
100µl of the biotinylated cell solution was used after washing in PBS. The cells were fixed on 0.01%
poly-L-lysin slides with 4% paraformaldehyde for 20 minutes and then the slides were rinsed with
PBS twice. The cells fixed to the slides were blocked with PBS and 10% horse serum for 20 minutes
at room temperature and then rinsed twice with PBS. The slides were incubated with streptavidin-
FITC (1 in 100 dilution) in 10% horse serum in PBS for 1 hour in the dark at room temperature.
The slides were then rinsed twice with PBS. Coverslips were mounted on the slides using Ther-
mofisher prolong gold and 4’,6-diamidino-2phenylindole (DAPI) then imaged on a Nikon Eclipse
Tie fluorescence microscope using the Green Fluorescent Protein-2 (GFP2) and phase contrast
channels.
3.2.9 Creation of Total Cell Extract
The cells were biotinylated as per the biotinylation protocol (Section 3.2.7). Cells were washed
in PBS three times and resuspended in 1ml PBS. The resuspension was centrifuged for 5 minutes
at 5,000xg at 4°C and resuspended in 100µl of ice-cold nuclease buffer (50µg/ml Stapholococcus
nuclease, 2mM CaCl2, 20mM Tris-HCl pH 8.8, before use 1/1000 dilution of E-64 protein inhibitor
was added). 10µl of 3% β-mercaptoethanol was added followed by 10µl DNase/RNase mix (1mg/ml
DNase-1, 0.5mg/ml RNase-A, 50mM MgCl2, 0.5M Tris-HCl pH 7.0). The lysate was mixed with
a 1ml syringe with a brown needle (26G). The lysate was frozen at -80°C and lyophilised before
solublisation in 100µl sample buffer (160mM Tris-HCl, 25% sucrose,6.9% SDS, bromophenol blue).
3.2.10 Streptavidin Pulldown
The supernatant from the solubilised total cell extract (Section 3.2.9) was transferred to a 5ml
tube. 4.5ml TENT-1% (50mM Tris-HCl, 5mM EDTA, 150mM NaCl, 1% Triton X-100) was added.
The streptavidin-agarose beads were equilibriated with two washes in TENT-1%. 50µl per sample
was used initially-then increased to 100µl per sample. The beads were added to the samples and
incubated overnight with rotation at 4°C. The samples were spun down at 1000xg for 1 minute and
both the beads and 1ml of the TENT-1%-cell suspension was transferred into a 1.5ml tube.
Initially the bead step was repeated-another 50µl of streptavidin-agarose beads was added to the
remaining 3.5ml TENT-1%. The samples were incubated for 2 hours with rotation at 4°C, spun
down and the beads and 1.5ml TENT-1% was transferred into a 1.5ml tube.
The beads were washed four times with 1ml TENT-1% and the proteins were eluted by heating at
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95°C for 5 minutes with 100µl sample buffer in the presence of 10mM DTT. The beads were spun
down for 5 minutes at 10,000xg and 10µl of each sample was then loaded onto SDS page gels.
3.2.11 T. foetus Cell Lysis
Initial attempts at proteomic analysis using the label-free mass spectrometry produced only a
small number of peptides from the different T. foetus life stages, and so changes were made to the
protocol. The first stage was to see whether cell lysis was responsible for poor yield. Three lysis
buffers were made and tested on the T. foetus samples.
1. Lysis buffer 1- 50mM Hepes buffer at pH 8.0, 1% SDS, 1xcOmplete Protease Inhibitor Cock-
tail, EDTA (Sigma), 150mM NaCl, 10mM DTT
2. Lysis buffer 2 - 50mM Hepes buffer at pH 8.0, 8M urea, 1xcOmplete Protease Inhibitor
Cocktail, EDTA (Sigma) 150mM NaCl, 10mM DTT
3. RIPA buffer - 50mM Tris, 150mM NaCl, 0.5% DOC, 1% NP-40, 0.1% SDS, pH 8.0 (In this
case Triton-X-100 was used in place of NP-40)
For initial trials one tube (15ml) of T. foetus cells was grown for 24 hours to log phase to an
approximate density of 5x105 per ml. Nine samples of 1ml were then taken and subjected to the
different lysis buffers for different periods of time: 15 minutes, 30 minutes and 1 hour to see which
condition was optimal for cell lysis and protein production. The tubes were spun down at 1000rpm
for 5 minutes at 4°C. The media was removed and the cells were washed twice in PBS, each time
the cells were spun at 1000rpm for 5 minutes. 500µl of lysis buffer was added to each pellet, three
samples were given buffer 1, 3 buffer 2 and 3 RIPA buffer, and the pellet was re-suspended.
The tubes were then vortexed and then left for between 15 and 60 minutes with rotation at room
temperature. Each buffer was left for each time point. The resulting samples were then spun at
1000rpm for 5 minutes and the pellet (insoluble fraction) and the supernatant (soluble fraction)
were stored separately at -80°C.
It was determined that the RIPA buffer, left for 1 hour produced the highest amount of protein
and so this was used for the main experiment. Ten samples, five for trophozoite and five for low
temperature induced pseudocysts were used, 500µl RIPA buffer was used for 1 hour and the sample
concentrations were measured using a Bradford assay.
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3.2.12 TMT-labelled Mass Spectrometry Sample Preparation-Cell Lifestages
Cells were lysed using RIPA buffer and then sonicated. SP3 paramagnetic beads were used [376] as
a clean-up strategy and to bind the proteins so any contaminants could be removed. The proteins
were digested off the beads and then labelled with TMT. The samples were then fragmented by
high pH and then reverse phase (R-P) chromatography [377] to produce 6 fractions. R-P chro-
matography used the hydrophobicity of peptides to get good separation. The samples were then
run on the Orbitrap mass spectrometer.
3.2.13 Label-free Mass Spectrometry of T. foetus Biotinylated Samples
Samples of the eluted biotinylated proteins and the two controls were run into an SDS gel and then
the band cut out and a semi-tryptic digest was performed as stated in Section 3.2.2. Label-free
mass spectrometry was carried out as previously stated at the University of Liverpool Centre for
Proteomic Research by Dr Stuart Armstrong. Preferential expression of peptides was analysed by
PEAKS 3 [373] [374].
3.2.14 Mass Spectrometry Analysis
The mass spectrometry analysis of the peptides was performed using PEAKS [373], MaxQuant[378]
and Perseus [379].
MaxQuant
The MaxQuant [378] analysis was performed using the following parameters: 1) No fractions;
2) Variable modifications of: Oxidisation of Methyonine and acetylation of N-terminus; 3) Fixed
modifications- carbimidomethyl of C; 4) The maximum number of modifications per peptide was
set at 5; 5) The machine used for the M/S was the Orbitrap, using all default parameters with a
4.5ppm tolerance; 6) the digestion method used is Trypsin/P with a maximum number of missed
residues of 2; and 7) The peptides had to be greater than seven amino acids long with a max mass
of 4600Da. All other parameters were set as default.
3.2.15 Peptide Chip Design
To examine the natural immunogenicity of putative T. foetus cell surface antigens, I designed
a customized peptide microarray for screening antibody responses in bovine serum from natural
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and experimental T. foetus infections. The microarray consisted of overlapping peptides from
51 proteins, each containing an N-terminal signal peptide (SP) in combination with a single C-
terminal transmembrane helix (TMH), as well as asparagine (N) and threonine (T) residues that
are predicted to be glycosylated, and all among the most abundant transcripts in trophozoite and
pseudocyst cell culture. The array represented, therefore, the most abundant antigens predicted
to be present on the parasite cell surface. The pipeline implemented to identify these proteins was
similar to the process used in Chapter 2 to identify the cell surface proteome, as is shown in Figure
3.4.
There are 84,706 genes in the T. foetus genome sequence. These genes were translated and any
shorter than 200 amino acids were removed to exclude dubious ORFS and mis-annotations. The
remaining genes were analysed with SignalP 3 [380] and SignalP 5 [381]; 1219 were found to have
a signal peptide. All 84,706 translated ORFs were also run through TMHMM [291] and 2,333
proteins had at least 1 TMH and 1179 had a single helix. Multi-spanning proteins were excluded
because they make poor vaccine targets; the protein is embedded within, rather than projecting
from, the membrane. Finally, the gene sequences were also run through PredGPI [293] to look for
GPI anchors and 102 were found (with 99% reliability). A ‘long list’ of proteins comprising those
with SP and a single TMH at the C-terminus were selected. The C-terminus position is necessary
as the protein has to be pointing outwards from the cell surface, i.e. the N-terminus is outside.
Using the TMHMM scores, only those TMH proteins with at most 10% of their total length inside
the cell were retained; this excluding approximately 60% of TMHs.
These steps reduced the total number of eligible proteins from 1710 to 465, all of which were
predicted to be type-1 transmembrane proteins, localised to the plasma membrane. The peptides
were compared to the NCBI database using BLASTp [278] to detect any obvious homology that
argued against cell surface roles. Any proteins that were obviously intracellular, for example, snare
proteins and nucleoporins were removed based on this BLAST analysis. This reduced the list of
204 proteins.
It was anticipated that some of these proteins would belong to multi-copy gene families. The
inclusion of multiple paralogues of a protein in the array would be inefficient, since they might be
expected to give the same antibody response. To remove this potential source of redundancy, a
BLAST database was created for the 204 proteins and then each was compared to the database
individually using BLASTp. A threshold of e-25 was applied to remove close paralogues. In this
way, no two spots on the array are very similar, so that the maximum structural diversity of protein
can be screened.
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After filtering by these steps, there still remained too many proteins to be accommodated on the
chip, so the decision was made to reduce their number to 50 based on their abundance in cell
culture. Highly expressed transcripts in culture are assumed to indicate highly expressed proteins
in natural infections, and this is assumed to be beneficial for antibody recognition. Transcript
abundance (FPKM) and variability thereof within experiments was determined from three low
temperature and five control transcriptomes generated in Chapter 2. The mean and standard
deviation of FPKM values were used to rank the protein sequences. The top 50 most abundant
and least variable transcripts were then used for the peptide array.
3.2.16 Use of Transcriptomics for Peptide Array Design
Three low temperature and five control transcriptomes (generated in Chapter 1) were also used to
identify peptides for the peptide array. The peptides in the array need to have a high abundance
and have the smallest standard deviation across conditions. i.e. constitutively expressed genes
across both life stages.
First, to trim the reads, Trimmomatic [382] on the Galaxy server [302] was used, using paired reads
and all default settings. The reads were then mapped by Hisat2 [383] to the genome and GTF file.
The resulting Hisat2 bam file was run through stringtie [384] using the unstranded setting. The
isoforms were ordered and renamed and spreadsheet produced with the gene name and FPKM. The
mean and standard deviation was added and the genes were ranked and cross-checked with the in
silico selection. In this way the FPKM numbers from the transcriptomes were used to rank the
genes by abundance and showed which were constitutively expressed across both the trophozoites
and pseudocysts. The top 50 abundant and constitutively expressed genes were then used for the
peptide array (Table 3.1).
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Number Gene ID Product
1 TTF11197 hypothetical protein TRFO 10561
2 TTF35905 hypothetical protein TRFO 02143
3 TTF48034 hypothetical protein TRFO 40837
4 TTF39902 hypothetical protein TRFO 10466
5 TTF11874 hypothetical protein TRFO 05898
6 TTF55982 leucine-rich repeat domain-containing protein
7 TTF53402 hypothetical protein TRFO 12669
8 TTF44625 hypothetical protein TRFO 07982
9 TTF57869 hypothetical protein TRFO 29961
10 TTF19526 hypothetical protein TRFO 18803
11 TTF30114 hypothetical protein TRFO 22128
12 TTF07987 thioredoxin, putative
13 TTF36321 hypothetical protein TRFO 17724
14 TTF31573 hypothetical protein TRFO 02214
15 TTF56587 hypothetical protein TRFO 32199
16 TTF28278 hypothetical protein TRFO 35407
17 TTF07357 hypothetical protein TRFO 34912
18 TTF49921 hypothetical protein TRFO 12246
19 TTF03161 hypothetical protein TRFO 16017
20 TTF23499 Legume-like lectin family protein
21 TTF19157 cation channel sperm-associated protein subunit delta
22 TTF09721 adhesin-like protein
23 TTF00910 hypothetical protein TRFO 06137
24 TTF12012 hypothetical protein TRFO 39497
25 TTF14449 hypothetical protein TRFO 11445
26 TTF09063 hypothetical protein TRFO 39123
27 TTF44685 hypothetical protein TRFO 33209
28 TTF30148 Thioredoxin family protein
29 TTF72966 hypothetical protein TRFO 23368
30 TTF51333 hypothetical protein TRFO 33835
31 TTF41308 hypothetical protein TRFO 20972
32 TTF31692 hypothetical protein TRFO 38466
33 TTF14901 hypothetical protein TRFO 36551
34 TTF13877 hypothetical protein TRFO 19801
35 TTF38179 hypothetical protein TRFO 27265
36 TTF36584 leishmanolysin family protein
37 TTF03361 hypothetical protein TRFO 23519
38 TTF23900 Clan SC, family S28, unassigned serine peptidase
39 TTF73824 hypothetical protein TRFO 11378
40 TTF59933 Legume-like lectin family protein
41 TTF11679 hypothetical protein TRFO 27707
42 TTF75485 hypothetical protein TRFO 20015
43 TTF44949 hypothetical protein TRFO 32080
44 TTF36660 hypothetical protein TRFO 08766
45 TTF13670 hypothetical protein TRFO 19601
46 TTF34783 hypothetical protein TRFO 09395
47 TTF67688 hypothetical protein TRFO 40746
48 TTF16447 hypothetical protein TRFO 30251
49 TTF45090 hypothetical protein TRFO 35948
50 TTF75903 hypothetical protein TRFO 26675
Table 3.1: T. foetus proteins included in the peptide array
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Figure 3.4: Flow diagram of the peptide array design from the full genome of 84,706 ORFs to a set
of 50 proteins. These proteins were over 200 amino acids in length with a signal peptide and one
transmembrane domain, both at the C-terminus of the peptide. They were not close paralogues of
each other nor intracellular proteins.
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3.2.17 Peptide Array
The peptide microarray was manufactured by PEPperPRINT [385]. Each of 50 proteins was split
into peptides 15 amino acids in length with an overlap of 13 amino acids. In total, each array
contains 5,321 peptides printed in duplicate to give 10,642 peptides in total across the chip. Control
peptides allow for correct function to be confirmed in the assay; the hemagglutinin A (HA) control
was YPYDVPDYAG and was used on 116 spots and the polio control was KEVPALTAVETGAT
and used on 114 spots per chip giving a total of 230 control peptides. The peptides were linked and
elongated with neutral GSGSGSG linkers at the C- and N- terminus and translated into overlapping
peptides. The peptides were distributed across three panels on each of six chips (PEPperPRINT
slides array codes: 002492 02 to 002492 07)
Reagents
The four buffers used were:
1) Standard buffer: PBS, pH 7.4, 0.05% Tween-20, filtered
2) Blocking buffer: Standard buffer with the addition of 1% BSA, filtered
3) Staining buffer: Standard buffer with the addition of 10% blocking buffer, filtered
4) Dipping buffer: 1mM Tris, pH 7.4
Conjugate:
Goat anti-bovine IgG (H+L) Cy3 (Jackson ImmunoResearch Laboratories)
Control conjugate (provided by PEPperPRINT): Mouse monoclonal anti-HA (YPYDVPDYAG)
Cy5 Sera from naturally and experimentally infected cows were used for primary antibodies, these
cows had previously been diagnosed as T. foetus positive. Pre-immunization sera from 5 experi-
mentally infected bovines were used as negative controls. Sera collected post immunization from
the same animals (n=5) were used as positive samples. In addition, sera from 10 naturally infected
bovines were used as positive samples. All sera were combined in pools (Table 3.2) and incubated
on a different chip, two replicates of each. The sera samples were provided by Dr Matt Brewer
of the University of Iowa. The sera from the naturally infected animals was opportunistically col-
lected when a naturally positive animal was found. The experimental calves were challenged with a
field strain isolated from a bull in Iowa, USA and serum was collected approximately 30 days post
infection.
1) Pool of pre-immune sera (n=5)
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2) Pool of naturally infected cattle (n=5)
3) Pool of experimentally infected cattle (n=10)
3.2.18 Immunoassay
Each peptide microarray slide was placed into an incubation tray. 1ml of standard buffer (PBS, pH
7.4, 0.05% Tween-20, filtered) was added to the corner of each microarray chamber and incubated
for 15 minutes at room temperature on an orbital shaker (140rpm). The standard buffer was then
aspirated from the corner of the chamber. 1ml of blocking buffer (standard buffer with the addition
of 1% BSA, filtered) was then added to each microarray via the corner of the chamber. A lid was
applied to the tray that included a waterproof seal. The slide was incubated at room temperature
for 45 minutes on an orbital shaker (140rpm). The liquid was then aspirated from the corner of
the array.
One slide was pre-stained with a secondary antibody. Goat anti-bovine IgG (H+L) Cy3 (Jackson
ImmunoResearch Laboratories) was diluted in staining buffer 1:4,500 and 1ml was added to the
microarray. The lid was replaced. The microarray was incubated for 30 minutes at room tem-
perature or an orbital shaker (140rpm) in the dark, after which the liquid was aspirated from the
chamber. The array was washed three times for 1 minute each time with 1ml of standard buffer
on the orbital shaker (140rpm). The slide was removed from the tray and dipped twice in dipping
buffer then dried in a stream of air. The microarray was then analysed in a microarray scanner
(Section 3.2.19). This was in order to acquire a background reading of the ambient levels which
could later be used in a background correction step to obtain the true spot intensities.
Each slide was treated with bovine serum samples, as described in Table 3.2. The negative control
was sera from 5 cattle that had not been exposed to T. foetus (pre-immune). The same 5 cows
were later experimentally infected with T. foetus and sera was collected to use as a positive sample
(post-immune sera) and sera from 10 naturally infected cows was also used as another positive
sample. There were two replicates of each sample which were to later be averaged. The sera was
added to both the new slides that were not incubated in the pre-staining step and also the slide
that was used for the pre-staining step. The new slides must be incubated with the standard buffer
and blocking buffer as per the pre-staining protocol to hydrate and block the slides before use.
To equilibrate the slide, 1ml of staining buffer was added to the microarray and the lid was applied.
The microarray was incubated for 15 minutes at room temperature on an orbital shaker (140rpm).
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The liquid was then aspirated from the corner of the chamber. The microarray was incubated at
2-8°C overnight on an orbital shaker (140rpm). The liquid was then aspirated from the corner of
the chamber. The array was washed three times for 1 minute each time with 1ml of standard buffer
on the orbital shaker (140rpm). Both the secondary antibody goat anti-bovine (1:4500 dilution)
and control antibody anti-HA (1:1000 dilution) were mixed in staining buffer. 1ml was added to
the microarray and covered by the lid. The microarray was incubated for 60 minutes at room
temperature on an orbital shaker (140rpm). The liquid was then aspirated from the corner of the
chamber. The array was washed three times for 1 minute each time with 1ml of standard buffer
on the orbital shaker (140rpm). The slide was removed from the tray and dipped twice in dipping
buffer then dried in a stream of air. The slide was then examined in a microarray scanner (Section
3.2.19).
Chip Chip 1 Chip 2 Chip 3 Chip 4 Chip 5 Chip 6
Array Code 002492 02 002492 03 002492 04 002492 05 002492 06 002492 07
Replicate 1 2 1 2 1 2
Sample
Pool of
pre-
immune
sera from
5
experi-
mentally
infected
Pool of
pre-
immune
sera from
5
experi-
mentally
infected
Pool of
post
immune
sera from
5
experi-
mentally
infected
Pool of
post
immune
sera from
5
experi-
mentally
infected
Pool of
sera from
10
naturally
infected
Pool of
sera from
10
naturally
infected
Sample Codes
Heifers: 70,
3263, 3265,
3266, 3275
Heifers: 70,
3263, 3265,
3266, 3275
Heifers: 70,
3263, 3265,
3266, 3275
Heifers: 70,
3263, 3265,
3266, 3275
Cow1-
Cow10
Cow1-
Cow10
Positive/
Negative
Negative Negative Positive Positive Positive Positive
Table 3.2: List of samples used for the detection of significant epitopes with the peptide array
immunoassay
3.2.19 Peptide Array Imaging and Quantification
An Agilent G2565CA Microarray Scanner (Agilent Technologies, USA) was used at the University
of Liverpool, to record fluorescence emitted by the labelled slides. For both the pre-staining step
and the staining with the secondary antibody, the slides were analysed for red (670nm) and green
(570nm) channels independently with 10µm resolution. Images were saved with 16-bit grayscale
as tiff files (1 image per channel). The tiff images (both red and green) produced were opened in
the PEPSlide Analyzer software (Sicasys Software GmbH, Heidelberg, Germany). The program
overlays both images to allow the user to see both colours simultaneously. The images were rotated
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and filtered for noise to allow the spots to become more visible.
Accurate quantification of fluorescence requires that the image be aligned with a map file containing
the coordinates and identity of each spot. The array map was aligned with the image using the
control spots as a guide. The background correction level ‘global’ was used [386]. This was to
have a global background for the entire array based on the background pixels of all spots in the
array. For each spot in the microarray, the mean and median of its raw, background and foreground
fluorescence values in both the red and green channels were calculated. The data was saved as a
.gpr file which is needed for the limma analysis (Section 3.2.20). 18 files were produced in total as
there were two slides, each with three microarrays and the data quantification was performed three
times.
3.2.20 Peptide Array Analysis
Limma [387] in R [308] was used to create a linear model [388] [389] . This was is order to model
the relationship between the spot intensities of negative and positive samples. The source file used
was from the ‘genepix’ analysis software [389] and a one channel analysis, using only the green
fluorescence channel, was used, meaning, only the green spots were read and used in the analysis
rather than both red and green. The control spots were read by limma but were removed later
in the process and so were not included in the analysis. The analysis was performed three times,
once per microarray map. For background correction the ‘normexp’ method was selected as this is
optimal for using .gpr files. The background correction is used to remove the background intensity,
i.e. the ambient signal, such as from non-specific binding, from the foreground spot intensity [387]
[386]. In this way it prevents negative or zero values which would otherwise affect the linear model.
Normalisation [389] was performed using variance stabilising normalisation (VSN) [390] in the
limma package to transform the data. Peptide filtering was performed to remove the control spots
and the intensity from the duplicate spots were averaged. To fit the linear model, a design matrix
was made to compare the pre-immune sera (negative control) with the naturally and experimentally
infected samples (positive). The standard errors from the log-fold change were normalised using
the empirical Bayes method [391] [392]. This was to reduce differences between replicates due to
technical differences rather than biological ones.
To identify significant immunogenic epitopes an adjusted p-value<0.05 (padj)was used. The false
discovery rate (FDR) was estimated using the Benjamini-Hochberg method (log2fold-change > 2).
The peptides were ranked based on their padj values as well as their fold change (FC), generating a
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list of the upregulated and downregulated peptides. The same data analysis methods were carried
out on the other two microarray maps.
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3.3 Results
3.3.1 Label Free Mass Spectrometry of Lifestages
Both T. foetus trophozoites and low temperature induced pseudocysts were analysed using label-
free mass spectrometry to identify differentially expressed proteins between life-stages. In total 323
proteins were identified using label-free mass spectrometry, that had a fold change over 2 and at
least 2 unique peptides associated with them. In total 316 proteins had higher expression in the
pseudocyst sample relative to the trophozoite sample and 7 had higher expression in the trophozoite
sample relative to the pseudocyst sample (Table 3.3). Two results are domain of unknown function
(DUF) (TTF14018 and TTF29497). Ornithine Transcarbamylase (TTF32993) is found in the
biosynthesis pathway for arginine. The Iron Superoxide Dismutase (TTF58332) may be involved in
the response of T. foetus to environmental oxygen [297] and also may be facilitated by iron, which
is known to be a key element required by T. foetus [263].
Gene ID Product Fold Change
TTF58332 Iron Superoxide Dismutase 5.49
TTF32993 Ornithine Transcarbamylase 2.82
TTF14018 DUF1900-domain-containing Protein 2.21
TTF29497 DUF4980 domain-containing Protein 2.19
TTF26374 WD40 repeat-like Protein 2.16
TTF57322 Hypothetical Protein TRFO 0662 2.06
TTF19653 Cysteine Protease 3 2.02
Table 3.3: Fold change of T. foetustrophozoites relative to pseudocysts from label-free mass spec-
trometry experiments. Pseudocysts were induced by the lowering of the environmental temperature
to 4°C. Samples were run on the Orbitrap mass spectrometer and data was first analysed using
Peaks [373] and then exported to Progensis [374]. Results included had a fold change over 2 and
at least 2 unique peptides associated with each.
Of the top 30 pseudocyst proteins with the highest fold change (Table 3.4) compared to the tropho-
zoites, 8 are hypothetical proteins and one (TTF15093) has a product of ‘NA’ meaning that it does
not have a structural similarity to any protein currently in the NCBI database (Table 3.3). There
are two clan CA proteins (TTF58150 and TTF16060) which would be expected since this is a very
large gene family in the T. foetus genome. There are also two adhesin-like proteins (TTF82447 and
TTF05494) but no clear proteins that would suggest a difference in morphology or metabolism.
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The fact that so few proteins were identified as having higher expression in the control trophozoites
compared to the pseudocyst makes comparisons between the two difficult. There does not seem to
be any clear differences in terms of protein families or functions.
Gene ID Product Fold Change
TTF62432 WH2 Motif Domain Containing Protein 315.81
TTF63297 RNA-binding Protein 60.25
TTF82447 Adhesin-like-protein 60.15
TTF23865 Geranylgeranyl transferase type-2 subunit beta-like 50.42
TTF60517 Hypothetical protein TRFO 29767 43.33
TTF48222 Synaxin-8 41.37
TTF59123 Hydrogenase, Fe-only 32.35
TTF51390 Mitotic apparatus protein 30.04
TTF16060 Clan CA, family C1, cathepsin L-like cysteine peptidase 27.96
TTF47485 Succinyl-CoA ligase [GDP-forming] subunit alpha, mitochondrial 27.57
TTF21656 Co-chaperone GroES 24.40
TTF23767 Hypothetical protein TRFO 17212 23.19
TTF13778 Hypothetical protein TRFO 33979 22.09
TTF62170 Small GTP-binding protein 19.48
TTF36735 dnaK protein 18.23
TTF29274 Hypothetical protein TRFO 21306 18.21
TTF41140 60S acidic ribosomal protein P1 17.26
TTF05494 Adhesin-like protein 16.06
TTF81870 Hypothetical protein TRFO 14461 15.38
TTF08565 Hypothetical protein TRFO 20073 15.20
TTF82812 EF hand family protein 15.12
TTF67499 60S acidic ribosomal protein P1 15.03
TTF58150 Clan CA, family C1, cathepsin L-like cysteine peptidase 14.47
TTF00205 T-complex protein 1 subunit alpha 14.14
TTF00474 Eukaryotic translation initiation factor 2 subunit alpha 14.07
TTF15822 Activator of Hsp90 ATPase, putative 13.87
TTF75555 Hypothetical protein TRFO 37932 13.55
TTF66092 Hypothetical protein TRFO 22858 13.33
TTF15093 -NA- 12.95
TTF11891 HMG box family protein 12.74
Table 3.4: Top 30 T. foetus pseudocyst proteins showing the highest fold change relative to tropho-
zoites from label-free mass spectrometry experiments. Pseudocysts were induced by the lowering of
the environmental temperature to 4°C. Samples were run on the Orbitrap mass spectrometer and
data was first analysed using Peaks [373] and then exported to Progensis [374]. Results included
had a fold change over 2 and at least 2 unique peptides associated with each.
3.3.2 TMT Mass Spectrometry of Lifestages
Due to the low numbers of identified proteins using the label-free approach, another attempt was
made to identify preferentially expressed proteins between the lifestages, using TMT labelled mass
spectrometry.
There are very few differences between trophozoite and pseudocyst peptides, hypothetical proteins
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were commonly found to be expressed in both samples. This is not surprising since there are
12,114 ‘hypothetical’ genes in the genome. There did seem to be more calcium related genes in the
pseudocysts and a limited number of heat shock proteins. However only 138 peptides were found
to have significant differences in expression (proteins significance 20, false discovery rate of 1% and
ratio corresponding to a minimum fold change of 1.5) between all samples which is much lower
than expected (Table B1). There is also a large number of protein kinases found to be upregulated
in both the trophozoite and pseudocyst samples, which are known to be a large T. foetus gene
family, and akyrin containing proteins. Ratios were calculated relative to the trophozoite sample
intensities, this corresponds with fold change. In total 53 proteins had a higher expression in the
pseudocyst than trophozoite and 85 had higher expression in the trophozoite than the pseudocyst.
3.3.3 Cell Surface Biotinylation and Streptavidin-pulldowns
The cell surface of T. foetus trophozoites and pseudocysts were labelled using biotin and then
extracted using a streptavidin pulldown. This was in order to produce a sample of cell surface
expressed proteins only that could then be analysed using mass spectrometry. When imaged, the
biotinylated cells showed clear fluorescence but the non labelled cells did not (Figures 3.5 and 3.6)
showing that the cell-surface labelling was successful. Furthermore, the Western blots also show
that the cells have been biotinylated (Figure 3.7 and 3.8) as bands are present in the biotinylated
lanes. In Figure 3.9 there are no bands in the control lanes but there are bands in all of the
elutions from the streptavidin-pulldowns showing that the samples have been successfully labelled
and biotinylated proteins have been successfully recovered. Figures 3.10 and 3.11 also show that
this pattern on the Western blot is due to biotinylation and not purely protein quantity as the SDS
page gels have both been stained and show clear banding for all samples, confirming there is an
amount of protein present in each.
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Figure 3.5: Biotin Labelling of the T. foetus cell surface.T. foetus trophozoites, both control
(unlabelled- panels A,C and E) and labelled (panels B, D and F) after 30 minutes of labelling
with 0.5mg/ml sulfo-biotin-NHS. After biotinylation the cells were incubated with 1/100 dilu-
tion of 1mg/ml streptavidin-FITC and mounted onto poly-L-lysine coated slides, fixed with 4%
paraformaldehyde and mounted with Prolong gold. Images were taken on a Nikon eclipse Tie mi-
croscope using the Phase contrast (A and B) and GFP2 (C and D) channels. A composite image
was also produced using both channels (E and F) showing that the labelled cells are fluorescing
whereas the control cells are not.
3.3.4 Comparison of Biotinylation of Trophozoites and Cysts
There did not seem to be any marked differences between the trophozoite and pseudocyst western
blot results (Figure 3.7, 3.8, 3.9)and both life stages showed fluorescence. When elutions from
all three trials were compared, there were again clear bands on the biotinylated samples and not
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Figure 3.6: Biotin labelled and unlabelled T. foetus cells. Images were taken on a Nikon eclipse Tie
microscope using the Phase contrast and GFP2 channels. A composite image was also produced
using both channels. The composite images from Figure 3.5 (E and F) were corrected for sharpness
and contrast in ImageJ.
on the control (Figure 3.9) but there was also clear banding on the SDS page gel labelled by both
Coomassie (Figure 3.10) and Silver staining (Figure 3.11) and showing that there was protein loaded
on all samples. When samples were not biotinylated there were no bands seen on the Western blots.
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Figure 3.7: A: Coomassie stain of biotinylated T. foetus samples.
B: Western blot of biotinylated T. foetus samples.
For both trophozoites (trophs) and pseudocysts(cysts) approximately 1x108 cells were used each
time. Samples were labelled using EZ-link-NHS-biotin for 45 minutes at 4°C. They were then
subjected to a nuclear protein exclusion protocol and a streptavidin pulldown was performed using
streptavidin-agarose beads. The proteins were eluted off the beads by boiling in 100µl sample buffer
in the presence of DTT for 5 minutes. The elution was stored and the beads were eluted from again
using the same process. This gave two samples of 100µl of elution (elution 1 and elution 2) for each
condition, both trophozoites and pseudocysts. 10µl of sample was then run on a 12% SDS page gel
and a Coomassie stain and a Western blot was performed. For the Western blot, the membrane
was imaged on the Chemidoc with an exposure time of 54 seconds.
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Figure 3.8: Western blot of biotinylated T. foetus trophozoites and pseudocysts. Both trophozoites
(trophs) and pseudocysts(cysts) were used and approximately 1x108̂ cells were used each time.
Samples were labelled using EZ-link-NHS-biotin for 45 minutes at 4°C. They were then subjected to
a nuclear protein exclusion protocol and a streptavidin pulldown was performed using streptavidin-
agarose beads. The proteins were eluted off the beads by boiling in 100µl sample buffer in the
presence of DTT for 5 minutes. The elution was stored, and the beads were then eluted from again
using the same process. This was repeated again to give 3 samples of 100µl of elutions (elution 1,
elution 2 and elution 3) for each condition, both trophozoites and cysts. 10µl of sample was then
run on a 12% SDS page gel and a western blot was performed. For the western blot, the membrane
was imaged on the chemidoc with an exposure time of 10 seconds.
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Figure 3.9: Western blot of three biotinylation trials of T. foetus trophozoites and pseudocysts.
For each sample the cells were centrifuged and the nuclear fraction was removed. Lane labelled
‘Trial’ contain the samples in which the cells have been biotinylated and the proteins ‘pulled down’
by way of a streptavidin pulldown using streptavidin agarose beads. The lanes labelled ‘control’
contain unlabelled T. foetus cells that were processed in the same way as the labelled samples.
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Figure 3.10: SDS page gel of three biotinylation trials of T. foetus trophozoites and pseudocysts.
A Coomassie stain was used to show the protein bands. For each sample the cells were centrifuged
and the nuclear fraction was removed. Lanes labelled ‘Trial’ contain the samples in which the cells
have been biotinylated and the proteins ‘pulled down’ by way of a streptavidin pulldown using
streptavidin agarose beads. The lanes labelled ‘control’ contain unlabelled T. foetus cells that were
processed in the same way as the labelled samples.
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Figure 3.11: SDS page gel of three biotinylation trials of T. foetus trophozoites and pseudocysts.
A silver stain was used to show the protein bands. For each sample the cells were centrifuged and
the nuclear fraction was removed. Lanes labelled ‘Trial’ contain the samples in which the cells
have been biotinylated and the proteins ‘pulled down’ by way of a streptavidin pulldown using
streptavidin agarose beads. The lanes labelled ‘control’ contain unlabelled T. foetus cells that were
processed in the same way as the labelled samples.
3.3.5 Label-free Mass Spectrometry of Biotinylated Proteins
When the T. foetus cells were biotinylated, three trials were performed for each lifestage and both
trial 2 and trial 3 had multiple elutions for each lifestage. All elutions along with unlabelled control
samples were analysed using label-free mass spectrometry. This was to identify which proteins
appear to be found on the cell surface and also to identify the similarities and differences between
the lifestages. Across all samples and life stages 295 unique proteins were identified containing at
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least 2 unique peptides (p>0.05). The number of proteins found in non-labelled trophozoite control
was 7 and the number found in the non-labelled pseudocystcontrol was 5. For analysis, results for
the multiple elutions for each trial were combined. Between the different biotinylated experimental
trials there was a wide range in the number of unique proteins identified. In trial 1, 27 proteins were
identified in the trophozoite sample and 29 in the pseudocyst sample. In trial 2, 276 proteins were
identified in the trophozoite and 285 in the pseudocyst and in trial 3, 113 proteins were identified
in the trophozoite sample and 135 in the pseudocyst. This does make comparing the expression
between lifestages and the controls more difficult as the samples are so variable.
25 proteins were found in all three of the biotinylated trophozoite samples and all 25 were also
found in at least two of the three biotinylated pseudocyst trials. 24 proteins were found in all three
pseudocyst trials and, again, all were found in the trophozoite trials.
When comparing how many proteins appeared to be lifestage specific, in total, there were 12
proteins that were found in at least 1 trophozoite trial but in none of the pseudocyst trials (Table
3.5) and there were 21 proteins found in at least 1 pseudocyst trial but in none of the trophozoite
trials (Table 3.6). Of those found in the trophozoite sample, V-ATPases (TTF81703) are known
to be found in the plasma membrane [393] and the C2 [394] domain (TTF10759) is known to show
selectivity for the cell membrane. However, many are proteins that confer generic functions within
the cell or metabolism, such as 14-3-3 protein (TTF12165) [395] and NAD-dependent malic enzyme
(TTF55649).
Protein ID Product
TTF19128 hypothetical protein TRFO 32317
TTF12165 14-3-3 protein
TTF55649 NAD-dependent malic enzyme
TTF48506 hypothetical protein TRFO 11810
TTF57088 RNA-binding protein
TTF10759 putative C2 domain containing protein
TTF14285 UTP–glucose-1-phosphate uridylyltransferase family protein
TTF81703 V-type ATPase 116kDa subunit family protein
TTF16698 Carbamate kinase
TTF41230 RHO1-GTP-binding protein-rho subfamily of ras-like proteins
TTF27729 RNA-binding protein
TTF33240 glycyl-tRNA synthetase
Table 3.5: Biotinylated proteins found in Trophozoites and not Pseudocysts using label-free mass
spectrometry. All proteins were found in at least 1 of the 3 trophozoite biotin trials but not in any
of the pseudocyst trials nor either of the control samples. Samples were run on an Orbitrap mass
spectrometer and results were analysed in Peaks [373].
Within the pseudocyst specific proteins, there are six hypothetical proteins and several enzymes,
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such as tRNA ligase (TTF76542 and TTF59061) and oleate hydratase (TTF54486). Very few of
the proteins seem to be specific to the T. foetus cell surface. However, there is an adhesin precursor
(TTF65538) and a variable surface antigen like protein (TTF42565) which are highly likely to be
cell surface expressed.
Protein ID Product
TTF65538 adhesin AP65-1 precursor
TTF42565 Immuno-dominant variable surface antigen-like
TTF29274 hypothetical protein TRFO 21306
TTF61869 hypothetical protein TRFO 08502
TTF84159 long chain base biosynthesis protein 2a
TTF01232 DUF1846 domain-containing protein
TTF17659 Glucokinase 1
TTF44117 rubrerythrin family protein
TTF76542 serine–tRNA ligase
TTF81851 Dynamin central region family protein
TTF43479 beta subunit of citrate lyase
TTF00183 chaperonin containing TCP1 beta subunit
TTF16218 T-complex protein 1 subunit beta
TTF54486 oleate hydratase
TTF12141 hypothetical protein TRFO 21694
TTF12142 hypothetical protein TRFO 21694
TTF78733 hypothetical protein TRFO 27310
TTF70512 aldehyde dehydrogenase family protein
TTF32993 ornithine transcarbamylase
TTF59061 valine-tRNA ligase
TTF41913 hypothetical protein TRFO 42469
Table 3.6: Biotinylated Proteins Found in pseudocysts and not trophozoites using TMT mass
spectrometry. All proteins were found in at least 1 of the 3 pseudocyst biotin trials but not in any
of the trophozoite trials nor either of the control samples. Samples were run on an Orbitrap mass
spectrometer and results were analysed in Peaks [373].
When all trials for each lifestage were combined, 70 proteins were found to be more abundant in the
pseudocyst (fold change >2) (Table B3) 43 proteins were found to be more abundant in the tropho-
zoite samples (Table B2). In the trophozoite samples, the majority (23), of proteins are ribosomal.
This does not appear to be similar to the results of the label-free (Table 3.3) or TMT-labelled
results (Table B1) there are also 4 hypothetical proteins (TTF56658), TTF08567, TTF27101 and
TTF01106). There are also few clear cell-surface proteins apart from the C2 domain containing
protein (TTF41309) and immuno-dominant variable surface antigen-like (TTF4080). This provides
evidence that the labelling has not been specific to the cell surface. In the pseudocyst induced sam-
ples there is a much wider range of proteins than in the trophozoite preferentially upregulated
samples. There is a thioredoxin protein (TTF22695), V-type subunit (TTF28277) and C2 domain
containing protein (TTF10766) which suggest the cell surface has been labelled. However, the pres-
ence of several enzymes, such as catalase (TTF23521) and glutamate decarboxylase (TTF06177)
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suggest other areas of the cell, such as the cytoplasm, have also been labelled.
When the abundance, in terms of peak area of both lifestages was compared, the top 50 abundant
proteins were identified (Table B4). The most highly abundant protein was a thioredoxin precursor
(TTF81436) followed by an adhesin precursor (TTF65227). There are tubulin, enolases and actin
related proteins showing high levels of abundance. Tubulin, thioredoxin and enolases have all
been found to be associated with the cell surface or organisms in varying capacities [396]. There
are, again, many proteins that would not be expected to be associated with the cell membrane:
ribosomal proteins, indole-3-pyruvate decarboxylase and ligases, showing that the cell labelling with
biotin has not been specific to the cell surface.
3.3.6 Comparison of Cell Surface Predictions and Proteomics
Several of the proteins found in the biotin pulldown analysis were also found in the predicted
cell surface proteome. Thioredoxin peroxidases were presentin the in silico network in Chapter
1, particularly in the largest cluster, and as stated, may have roles in protective responses [325].
Thioredoxins are also known to be found on the cell surface of trichomonads [325] providing evidence
that the correct area of the cells have been labelled. Tubulin is involved in the formation of the
cell membrane and so would be expected to be localised to the cell-surface, however, they would
be expected to face inwards and would not be expected to be labelled. Profilins have be linked
to membrane traffiking and signalling pathways between the cell membrane and cell cytoskeleton
[397]. However, overall, there see to be a large number of general proteins found in the cell-
surface biotinylated proteome that match general genes found in the transcriptome, for example,
acetyltransferases and ABC transporters suggesting that is a more general proteome rather than a
cell-surface enriched one.
3.3.7 Immunogenicity assays
The immunogenicity analysis consisted of three assays. Six microarray chips were each incubated
with one of three sera, with two replicates of each serum, either pre-experimental infection (negative
controls), post-experimental infection or post-natural infection (positives).
The images obtained the PEPslide Analyzer demonstrated a low background signal values with
very weak interaction between the conjugate and the epitope, suggesting there is no interaction
between the conjugate and the peptides.
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The two replicates of each assay were combined to produce an average fluorescent response for each
peptide spot. Distinct patterns can be seen between the positive and negative samples. The pre-
immune sera showed high fluorescence at random positions and no fluorescence at others (Figure
3.12). The post-immune experimentally infected samples produced higher fluorescence than the
negative control and naturally infected samples (Figure 3.13). The naturally infected samples
had lower fluorescence than experimentally infected animals and in some cases the raw values for
peptides were similar to those of the negative controls (Figure 3.14).
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Figure 3.12: Spot intensities from T. foetus peptide microarray incubated with pre-infection sera
from experimentally infected cattle (negative controls). The images were obtained from the PEP-
slide Analyzer. Each spot corresponds with a peptide. Two replicates were performed.
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Figure 3.13: Spot intensities from T. foetus peptide microarray incubated with post-infection sera
from experimentally infected cattle (positive samples) The images were obtained from the PEPslide
Analyzer. Each spot corresponds with a peptide. Two replicates were performed.
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Figure 3.14: Spot intensities from T. foetus peptide microarray incubated with post-immune sera
from naturally infected cattle (positive samples) The images were obtained from the PEPslide
Analyzer. Each spot corresponds with a peptide. Two replicates were performed.
The raw intensity values were analysed using limma in R. When the pre-immune (negative control)
and post-immune experimental sera signal intensities were compared, the analysis identified 1532
epitopes (padj <0.05 and LogFC>2) that has significantly high fluorescence in the post-immune
experimentally infected sample. Likewise, when the intensities for the negative control and naturally
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infected animal samples were compared 791 epitopes were identified (padj <0.05 and LogFC>2).
There were fewer peptides identified in the naturally infected sera than the experimentally infected
sera, 1532 and 791 peptides were identified in experimentally and naturally infected sera respectively
compared to the pre-infection sample.
Proteins were identified that induced a strong immune response from the post-infection sera. The
number of significant immunogenic epitopes for all 51 proteins in the microarray, and the top twenty
proteins by epitope number are listed for both natural and experimental infections, in Table 3.7.
Among proteins that are highly responsive to both natural and experimental post-immune serum,
TF11197 was the protein with most immunogenic epitopes (167), followed by TTF53402 (163) and
TTF00910 (151).
Protein ID
Experimental Infection
No. of Epitopes
Protein ID
Natural Infection
No. of Epitopes
TTF00910 99 TTF00910 52
TTF03161 44 TTF03161 14
TTF09063 48 TTF09063 25
- - TTF09721 20
TTF11197 88 TTF11197 79
TTF12012 75 - -
TTF13670 38 TTF13670 24
TTF13877 52 TTF13877 25
TTF14901 84 TTF14901 62
TTF16447 31 TTF16447 16
TTF19157 35 TTF19157 30
TTF34783 27 TTF34783 26
TTF38179 85 - -
TTF44625 36 - -
TTF44949 47 TTF44949 37
- - TTF49921 28
TTF53402 105 TTF53402 58
TTF55982 35 - -
TTF56587 43 TTF56587 13
- - TTF59933 20
- - TTF67688 26
TTF72966 63 TTF72966 62
TTF73824 59 TTF73824 32
TTF75485 46 - -
- - TTF75903 14
Table 3.7: The protein IDs and number of significant epitopes of the proteins with the largest 20
numbers of expressed epitopes for the experimentally infected cows and naturally infected cows
Of the top 20 proteins by epitope number, 15 were identified in both the experimental and natural
infection assays (Table 3.7. In some cases the number of epitopes was similar for sera from both
naturally infected and experimentally infected cattle, such as TTF34783 and TTF72966, however
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in many others, such as TTF53402 and there were very large differences with 105 compared to
58. Overall, there was a positive correlation between the number of significant epitopes in proteins
recognised by serum from naturally infected cows compared to experimentally infected cows (Figure
3.15) with an R2 of 0.5784. Therefore, those proteins that had a large number of significant
immunogenic epitopes recognised by in the experimentally infected samples also tended to have
larger numbers in the naturally infected samples, although there are several outliers. These were
significantly higher than the pre-infection sera.
Figure 3.15: Correlation of the number of significant immunogenic epitopes in peptide array proteins
using serum from experimentally infected and naturally infected cattle. Significance was calculated
using padj <0.05 and LogFC>2. Graph was produced using ggplot2 in R and a linear regression
line was added with an adjusted R2 value of 0.5784.
While the same proteins appear to contain the most immunogenic epitopes detected by both types
of infected serum, this does not guarantee that these proteins elicit a dominant response, since no
account has been taken of the magnitude of the response. The fold change in fluorescence intensity
of each peptide, relative to negative controls, was used to estimate the abundance magnitude of
the antibody. When the fold changes in fluorescence for each peptide probes with sera from exper-
imentally and naturally infected cattle were compared, there was no obvious correlation (Figure
3.16). This shows that a strongly immunogenic epitope, detected by antibodies from experimentally
infected animals does not necessarily mean the same epitope will have a high level of antibody in
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sera from naturally infected animals and vice versa.
Figure 3.16: Comparison of the fold changes of significantly immunogenic epitopes expressed in
the peptide array. Fold change was calculated using limma in R, comparing the spot intensities of
the post-infection sera samples to the negative controls. The fold changes of epitopes found to be
expressed in both post-infection trials were then compared. Graph was produced using ggplot2 in
R and a linear regression line was added with an adjusted R2 value of 0.0005263
When the fold change of the epitopes recognised by antibodies were compared and the adjusted P
value (Padj) calculated ,the results were markedly different between the epitopes expressed from
the experimentally infected samples (Figure 3.17) and those from the naturally infected samples
(Figure 3.18). The epitopes with the highest fold change were ranked, as were those with the lowest
Padj value. The 200 epitopes with the highest combined score, i.e. high fold change and low Padj
were used for the correlation as these showed the most significant and high intensity expression.
The epitopes from the experimentally infected sera showed a much weaker correlation than those
from the naturally infected sera samples, with adjusted R2 values of 0.01022 and 0.5421 respectively.
There is a number of epitopes from the experimentally infected samples that have a log fold change
over 4.5 but a Padj over 0.002 meaning they are more likely to have occurred by chance, however,
the vast majority of the epitopes have a Padj under 0.02. For the naturally infected samples,
there is a stronger correlation between the log fold change and Padj, however, the spread of Padj
values is much wider, with the majority falling between 0.002 and 0.007. This shows that whilst
the correlation between values is lower for the epitopes from experimentally infected samples, the
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significance is higher. Furthermore, the fold change values for the epitopes from experimentally
infected sera are higher than the naturally infected sera, with the vast majority ranging from 4 to
7.5 compared to under 5.
Figure 3.17: Correlation of the log fold change and adjusted P value of epitopes from the peptide
array expressed using sera from experimentally infected cattle. The epitopes with the highest fold
change were ranked, as were those with the lowest Padj value. The 200 epitopes with the highest
combined score, i.e. high fold change and low Padj were used for the correlation. Graph was
produced using ggplot2 in R and a linear regression line was added with an adjusted R2 value of
0.01022
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Figure 3.18: Correlation of the log fold change and adjusted P value of epitopes from the peptide
array expressed using sera from naturally infected cattle. The epitopes with the highest fold change
were ranked, as were those with the lowest Padj value. The 200 epitopes with the highest combined
score, i.e. high fold change and low Padj were used for the correlation. Graph was produced using
ggplot2 in R and a linear regression line was added with an adjusted R2 value of 0.5421
The maximum intensity of each protein was calculated using the significant epitope from each
protein which had the highest fold change relative to the negative control. This was then corelated
against the number of significantly responsive epitopes found in the protein overall. This was
performed for both the experimental sera and the natural sera (Figures 3.19 and 3.20). Overall, for
both sera types there was a positive correlation between the log fold change of the most reported
epitope in a protein and the number of significant epitopes in the protein. There were 9 proteins
for the experimental sera samples that had over 50 significant epitopes and a maximum intensity
of over 4.5 times that of the negative control (Figure 3.19 and Table 3.8), whereas, there were
5 proteins for the natural sera that fulfilled the same criteria (Figure 3.20 and Table 3.9). All
5 proteins identified in the naturally infected sample were also identified in the experimentally
infected sera: TTF00910, TTF11197, TTF14901, TTF53402 and TTF72966.
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Protein ID No. of Significant Epitopes Maximum Intensity
TTF38179 85 7.17
TTF12012 75 7.07
TTF73824 59 6.68
TTF11197 88 6.55
TTF72966 63 6.34
TTF00910 99 6.09
TTF13877 52 5.91
TTF14901 84 5.33
TTF53402 105 5.06
Table 3.8: The protein IDs, number of significant epitopes and maximum intensity of those epitopes
from Figure 3.19. Proteins were included if their maximum intensity/log fold change was higher
than 4.5 and the protein possessed over 50 significant epitopes. Maximum intensity was calculated
using the epitope with the highest log fold change in the protein relative to the negative control
when sera from experimentally infected animals was used.
Figure 3.19: The Correlation of the number of significant epitopes per protein in the microarray
and the maximum intensity of the protein. Maximum intensity was calculated using the highest
log fold change of an epitope in the protein relative to the negative controls. For this experiment,
sera from experimentally infected cattle were used. The IDs of those proteins that had a maxi-
mum intensity/log fold change over 4.5 and contained over 50 significant epitopes were added. A
regression line has also been added. There was a positive correlation between the values, with an
R2 value of 0.4068 and Pearson correlation coefficient of 0.6378 (95% confidence).
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Protein ID No. of Significant Epitopes Maximum Intensity
TTF00910 52 5.99
TTF11197 79 5.74
TTF14901 62 5.23
TTF53402 58 5.06
TTF72966 62 4.84
Table 3.9: The protein IDs, number of significant epitopes and maximum intensity of those epitopes
from Figure 3.20. Proteins were included if their maximum intensity/log fold change was higher
than 4.5 and the protein possessed over 50 significant epitopes. Maximum intensity was calculated
using the epitope with the highest log fold change in the protein relative to the negative control
when sera from naturally infected animals was used.
Figure 3.20: The Correlation of the number of significant epitopes per protein in the microarray and
the maximum intensity of the protein. Maximum intensity was calculated using the highest log fold
change of an epitope in the protein relative to the negative controls. For this experiment, sera from
naturally infected cattle were used. The IDs of those proteins that had a maximum intensity/log
fold change over 4.5 and contained over 50 significant epitopes were added. A regression line has
also been added. There was a weak positive correlation between the values, with an R2 value of
0.1576 and Pearson correlation coefficient of 0.397 (95% confidence).
3.3.8 Comparison of Peptide Array Results and in silico Predictions
When compared to the network in Chapter 1, TTF11197 and TTF00910 were both found in the
same cluster, along with TTF72966 which was also a peptide strongly recognised by antibodies in
both the experimentally infected and naturally infected samples (Figure 3.21). All three proteins
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were found to have a high number of significant epitopes: 88, 99 and 63 for TTF11197, TTF00910
and TTF72966 respectively in the experimental sera sample and 79, 52 and 62 in the natural sera
sample, and a high fold change relative to the negative control, over 4.5 times in all cases (Tables
3.8 and 3.9). The cluster itself contains 25 genes, all of which are T. foetus specific and contained
four other proteins that contained signal peptides. This family of genes itself contains T. foetus
specific proteins only, at least three of which are immunogenic.
TTF53402, which had 263 immunogenic peptides was part of a triplet family which contained an-
other T. foetus specific gene and a T. vaginalis specific protein and TTF44949 was a member of
a doublet, the other member of which was a T. vaginalis gene. The only protein that was highly
immunogenic, with over 30 peptides in both naturally and experimentally infected samples and
found in the largest cluster was TTF73824. Of the proteins found only in the post-immune experi-
mentally challenged serum, two of them are found in the large cluster: TTF44685 and TTF45090.
TTF23499 is found as a double and TTF23900 is found in the Clan-SC cluster.
There are 11 of the top 20 expressed epitope peptides found in the network when the experimen-
tally (Figure 3.22) infected sera was used compared to 13 when the naturally infected sera was used
suggesting there were more single copy genes that had immunogenic epitopes to the experimentally
infected cattle sera.
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Figure 3.21: Network showing T. vaginalis (red) and T. foetus (blue) genes produced in Cytoscape.
All members that contain a signal peptide are highlighted in green. Additionally, peptides found in
the peptide array are highlighted as large green squares. Highly immunogenic peptides identified in
the peptide arrays when both sera types were used: experimentally infected and naturally infected
animals are highlighted using a box. These are TTF11197, TTF00910 and TTF72966 found all
found in the same cluster; TTF53402 found as a triplet, TTF73824 found in the largest cluster and
TTF44949 found in a doublet. All of these proteins had high numbers of significant immunogenic
epitopes and were found in both infected sera samples.
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Figure 3.22: Network showing T. vaginalis (red) and T. foetus (blue) genes produced in Cytoscape.
All members that contain a signal peptide are highlighted in green. Additionally all of the proteins
with the 20 highest epitope numbers of expression that are also present in the network, and show
significant immunogenicity when sera from naturally or experimentally infected animals is used are
highlighted. Those that are found in the top 20 of both the experimentally and naturally infected
samples are highlighted as green squares, those found only in the experimental sera samples were
highlighted in pink and those in natural sera grey.
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3.4 Discussion
In this chapter, the cell-surface of both T. foetus life-stages were labelled using biotin and extracted
by way of a biotin-streptavidin pulldown. Proteomic analysis was performed by TMT mass spec-
trometry (Figure 3.23). Additionally, proteins from the in silico cell surface proteome described
in Chapter 1 were analysed for their immunogenicity using a peptide microarray, probed with sera
from experimentally and naturally infected cows. This has identified numerous parasite antigens
that elicit consistently strong antibody titres, a feature that indirectly corroborates their predicted
cell-surface localisation, and is a key feature of a good vaccine candidate.
Figure 3.23: Reverse Vaccinology Project Flow Diagram. The sections highlighted are those that
have been completed over the course of this chapter and those that are pale are to be completed in
subsequent chapters.
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3.4.1 Cell Surface Proteins
The aim of this chapter was to find immunogenic peptides that could be used as vaccine candidates,
however this pipeline excludes glycolipids, which could be vaccine candidates [398] [399]. The
peptides themselves may also be subjected to PTMs which could affect their structure or function.
The pipeline used to select the peptides themselves also removes any peptides that do not have a
TMH, meaning any that are purely secreted will not feature on the array. These secreted proteins
may have an key role in virulence, as is the case for some T. vaginalis secreted proteins such as
β-amylases [400].
In the case of a rabies vaccine [401], attempts were made to create a DNA vaccine using a rabies
glycoprotein and four constructs were made using the rabis-virus glycoprotein ectodomain. One
containing the signal peptide sequence and transmembrane domain, one containing the SP but no
TMH, one containing a TMH but no SP and one containing neither the SP or TMH. When a prime-
boost strategy was performed, the mice primed with the construct with both the SP and TMH
produced the highest antibody titres when challenged, followed by mice primed using the construct
with a TMH but no SP [401]. These results show that priming with the rabies construct containing
the full glycoprotein and TMH provides the best protective response, showing the importance of
the TMH being present in the immunogenic peptide. Furthermore, both SP and TMH have been
found to have high epitope densities [402] relative to sequence length and can show strong MHC
binding, further showing their importance in epitope selection and vaccine design.
There are some issues with using signal peptides as a key factor in choosing the peptides. The
translated proteins may not have the correct start codon or may use non-standard SPs. If the
original annotation is not correct then the TMH could be missidentified as a GPI anchor or signal
peptide, however, choosing proteins that contain both SP and TMH with clear sequences would
help to minimise this.
3.4.2 Proteomic Differences Between Trophozites and Pseudocysts
No strong key differences were seen between the trophozoite and pseudocyst samples, both biotiny-
lated and non-biotinylated. No clear distinctions were seen in the IFAs, banding patterns of the
Western blots or in the proteomic analysis. This is potentially an issue of inducing the pseudocysts
themselves as the most successful way we have found to induce them is by subjecting the T. foetus
cells to low temperatures (4°C). Keeping all reagents and preparation stages at this temperature
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can prove difficult and the optimal temperature for biotinylation of the cells is 4°C. This means
that both cell samples are subjected to temperature changes which can cause morphology changes
and therefore mixed populations rather than pure trophozoites or pseudocysts, thereby skewing the
results.
Very few proteins were seen that would have been expected to be in high abundance in any cell,
such as tubulin or cysteine proteases. There was also very little similarity with the stage specific
transcriptome results, such as the heat shock proteins. There were many ribosomal proteins, along
with many enzymes, which suggests it was not only the cell surface that was labelled. There were
thioredoxin proteins and elongation factors found in relatively large numbers in the biotinylated
trials which were not seen in the top 10 up or down regulated transcriptomes for any of the different
environmental conditions. It may be that the proteomics methods were not sensitive enough to pick
up many of the proteins, but it would still be expected than some, such as the myb-like binding
domains or N-acetyl-transferases would be seen in some number, particularly if more than just the
cell surface was labelled.
Between the TMT labelled and the label-free proteomics experiments there were few similarities
between the responses. This may be in part tat the label-free experiments were only using one
replicate per life stage rather than three in the labelled experiment and the fact that there were a
significantly smaller number of proteins seen, for example only 7 significant proteins found in the
label-free sample. This makes comparisons between the two more difficult. For the low numbers
of proteins that are seen, the only proteins that are found in both experiments are hypothetical
proteins and ribosomal proteins.
In regards to the biotin proteomic results, there was only one sample with a significant number
of peptides and so there was no replication due to the other two samples not being high enough
quality or having a large number of peptides. Due to this the samples were pooled and then the
lifestages compared. It was possible to obtain abundance values for the two lifestages generally,
however, a large number of proteins from each sample were only found in one of the three trials,
reducing the overall reliability.
3.4.3 Peptide Array
Overall, 1532 and 791 peptides were identified using experimentally and naturally infected sera
respectively compared to the pre-infected (negative control) sample. Of the top 20 proteins that
had the highest number of significantly immunogenic epitopes, 15 were shared in both infected
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trials. There were lower spot intensities using sera from naturally infected animals overall when
compared to the experimentally infected animals. This may be due to lack of stimulation in the
naturally infected animals, or the challenge itself may have been lower, ie. fewer parasites and so
the immune response may have been lower. The response itself may have been short -term rather
than long lasting. Furthermore, The strength of binding between the antibody and some peptides
may have been low [403] even if they are immunogenic. This may have been due to the duration
of the infection or there may be conformational epitopes that are not present in the microarray.
This may be due to the timing post infection of the samples being taken as different antibodies
may be expressed at different stages or, as the naturally infected animals were infected prior to the
experimentally infected animals the immune response may be lower and so key epitopes may not
be expressed in the same way. Other explanations might be that the experiments were done on
calves, whereas the natural infections came from adults, leading to difference in immune response.
Also, the natural infections may have had lower parasitaemia than experimental infections, causing
the lower intensity responses.
Other veterinary vaccines have also been using peptides as antigens [404], for example against foot
and mouth disease (FMDV) and canine parvovirus [404]. Peptide vaccines have also been used in
attempts to combat Porcine circovirus type 2 (PCV2) [405] and it was demonstrated that, when
liposomes were used as adjuvants, the peptides could stimulate both humoral and cellular immune
responses [405].
Of the proteins identified in the peptide array, TTF11197, TTF00910 and TTF72966 appear to be
interesting as they show significantly high responses when probed with both natural and experi-
mental sera and they are found within one T. foetus specific gene family (Figure 3.21). They all
contain a signal peptide and transmembrane domain and other members of the same gene family
also contain these signal peptides. TTF73824 is found in the largest cluster, that contains the BspA
family and cysteine proteases, genes that are known to be involved in host parasite interactions. All
proteins generate strong B-cell immunological responses, however, a B-cell response alone does not
always necessarily confer full protective immunity [406] and so testing for T memory cell responses
would also be crucial.
3.4.4 Future work
In terms of future work using these same approaches, further peptide arrays could be performed.
These could involve proteins from several different strains and could identify if there are differences
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in immunogenic proteins across the species. Arrays could also be performed using sera from animals
of a different sex, i.e. bulls, as T. foetus affects the genders differently and so different peptides may
be immunogenic. The arrays could be performed using sera from different time points to provide an
insight into the progression of the disease over time and if different antigens are expressed and how
long antibody responses last for. These arrays could also be used to identify targets for diagnostic
assays as there seem to be reliable markers for infection and could potentially show not only if the
animal is infected, but also how far along the disease is in its progression. The experiment could
also be repeated on animals of different ages to identify cow lifestage specific immune responses.
The epitopes examined in these experiments were B-cell epitopes, and so looking also at T- cell
epitopes to examine the cell-mediated responses would also be a next step. Furthermore, future
work could involve labelling different strains of T. foetus as there may be differences in cell surface
composition, e.g. adhesins, as some strains appear to be more cytotoxic than others and have
higher levels of adherence. This could also be applied to strains that infect cats and may be a
potential diagnostic strategy for feline infections.
3.4.5 Conclusion
This chapter has examined the immunogenicity of 50 putative cell surface antigens discovered in
Chapter 1 and identified a cohort eliciting consistently strong immune responses in vivo. Some of
these antigens belong to parasite-specific gene families that may represent important features of the
T. foetus cell surface architecture. The task now, before reaching a final selection of the best vaccine
candidates, is to examine the expression of these antigens in an in vitro disease model (Chapter
4) and the natural polymorphism in their protein structures (Chapter 5). Although these antigens
may be strong immunogens, only when they are proven to be robustly expressed and structurally
invariant can they be considered reliable candidates for vaccination.
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Chapter 4
Transcriptomic Analysis of
Parasite Gene Expression in a
Host Co-culture Infection Model
This chapter describes a model of T. foetus infection in the form of parasite culture on a host cell
monolayer. Growth of five strains of T. foetus (Belfast, KV-1, BP-4, UT and DK2) and one strain
of T. mobilensis in the presence of an MDCK (canine kidney) monolayer is measured, and the rates
of adhesion and cytotoxicity among the different Tritrichomonas strains is compared. Thereafter, it
also describes a transcriptomic analysis of parasite gene expression (strain DK2) during MDCK co-
culture. Gene expression profiles of parasites in various degrees of association with the monolayer
are compared to axenic parasite cultures to identify those gene transcripts that are significantly
more abundant during host cell interaction, and which therefore may be considered important for
infection in vivo.
4.1 Introduction
The interactions between T. foetus, and indeed any parasite, and its host are crucial to its pathogenic-
ity and the clinical signs it produces. If the proteins used in the T. foetus vaccine are expressed
predominately in the presence of the host, targeting these has the potential to greatly reduce the
virulence of the parasite. Successful vaccines target abundant antigens that are reliably expressed at
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the host-pathogen interface. Discovering these for T. foetus requires an analysis of gene expression
using a relevant model of the infection interface.
4.1.1 Cell Monolayers
Monolayers are tissues that are one-cell thick. They make up many components of multicellular
organisms [407], such as the intestinal epithelia, and fulfil roles in development and protection [407].
Monolayers can also have different physiological characteristics to single cells, for example, Harris et
al. (2012) [407] determined that monolayers have twice the elasticity of single cells. They also have
the addition of cell-cell interaction components, such as tight junctions and adherent junctions [408]
which would also be found in vivo. Therefore, when considering parasite gene expression, and so
modelling all of these aspects is likely to give more accurate results than working with single cells.
The benefit of monolayers is that they consists of living cells and so can mimic the responses of an
organism. Furthermore, interactions between parasites and host cells often occurs on monolayers
in vivo, such as in T. vaginalis infections of the urogenital tract.
Monolayers have long been used as a way to model host-parasite interactions in vitro. For example,
human corneal monolayers have been used to model Streptococcus aureus keratitis in humans [409]
and biofilms have been used to model periodontal disease [410]. In the case of intestinal epithelial
monolayers, both luminal and basal sides can be examined and screened [408] if a membrane or
scaffold is used. Monolayers have also been used to further the understanding of Cryptosporidium
[411] and T. vaginalis [412]. They have allowed for host-parasite interactions to be modelled in
mice. They have been used in numerous binding and cytotoxicity studies [413] [414], for example
in the binding of feline T. foetus to IPEC-J2 (porcine) intestinal epithelial cells to determine their
pathogenic effect [413].
4.1.2 Host-trichomonad Cellular Interactions
The mechanisms of host-trichomonad interactions for T. foetus or T. vaginalis are poorly under-
stood. It has been postulated that T. vaginalis adheres to the host cells via adhesin proteins [67],
however, the exact identity of these is still unknown. Proteomic analyses have identified secreted
proteins, in addition to cell surface associated proteins that may play a role in the interactions [67].
When T. vaginalis adheres to the host cells, there is typically a developmental change from their
trophozoite form to pseudocysts [67]. As stated in Chapter 1, there are three classes of molecules
that have been postulated to be involved in host-cell adhesion in T. vaginalis: Lipophosphoglycan
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(LPG), metabolic proteins and membrane proteins [67].
LPG is a surface glycan of the T. vaginalis glycocalyx [67]; surface carbohydrates such as galac-
tose are involved in the parasite virulence as binding studies show that more virulent T. vaginalis
phenotypes bind to agglutanin more than less virulent strains. This shows that differences in phe-
notype can greatly impact T. vaginalis virulence. Currently, the structure of LPG is not resolved
but contains many poly-N-acetyllactosamine repeats that may be important [415] [416].
Metabolic proteins-adhesion proteins have been identified that are involved in carbohydrate metabolism
and are often found in the hydrogenosome, such as AP65, AP33, AP51 and AP120 [162]. However,
these same proteins have also been reportedly found on the cell surface [163] [162], meaning they
may have duel functions as both metabolic proteins and adhesins. Furthermore, some of these
proteins, AP51 and AP65, have also been shown to bind non-specifically, such as to haem groups
[417] and, as yet, no specific binding partners have been found [67].
T. foetus is known to adhere to monolayers and it was thought that this adherence may also lead
to cytotoxicity [38]. As stated in Chapter 1, laminin and fibronectin may mediate this host-cell
adhesion. Both T. suis and T. foetus were found to adhere to mucus, mediated by lectin binding
[111] [38]. Extracellular proteases, capable of cleaving fibronectin, are also thought to be involved
in the host-parasite interactions and pathogenesis and may damage host cell integrity [38].
Membrane proteins-of the proteins identified in the T. vaginalis genome, serine and cysteine pro-
teases were implicated in pathogenesis [67] due to their similarity to virulence-associated proteins
from Leishmania, and they may have roles in degrading the host cells cytoskeleton or extracellular
matrix. Immunodominant variable surface antigens were also identified which may be involved in
the attachment of the T. vaginalis parasites to the host epithelia [67]. Furthermore, BspAs were
identified, which have also been thought to be involved in virulence [67] [167] [327].
4.1.3 Host-cell Adhesion and Cytotoxicity in Trichomonads
It is known that infection by trichomonads can cause a range of clinical signs. Numerous studies
have documented that trichomonads, particularly T. foetus and T. vaginalis, can adhere to host
cells and can display cytotoxic activity [69] [78] [112] [38] [155] [33]. Tolbert et al. (2014) [413]
examined the pathogenic effect of T. foetus parasites, acquired from cats, on intestinal epithelial
cells and looked at the effect of adhesion on the pathogenicity of T. foetus cells. They used an
in vitro monolayer co-culture system and demonstrated that direct contact of T. foetus and host
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cells triggered apoptosis of the epithelial cells. These effects were also shown to be largely due to
secretion of T. foetus cysteine peptidases, which also promoted cellular binding [413].
Tolbert et al. (2013) [418] also aimed to establish a model of feline T. foetus adhesion to intestinal
epithelial cells. They demonstrated that viable T. foetus cells can adhere to monolayers and this
adhesion is not reliant on the integrity of the T. foetus cytoskeleton. They also compared the
cell binding properties of Pentatrichomonas hominis, another intestinal trichomonad of cats, and
determined that T. foetus could adhere in far greater numbers, nearly four times greater in some
cases [418].
Singh et al. (1999) [414] studied the cytopathic effects of T. foetus on bovine vaginal epithelial
cells (BVECs) and determined what the role of lipophosphoglycan (LPG) in the adhesion of the
parasites. They showed that direct contact of T. foetus to the epithelial cells was cytotoxic, the
effect being dependent on the number and density of T. foetus cells. To investigate the role of
LPG, they developed a binding assay. The BVECs were cultured in 24-well plates and allowed to
become confluent before the T. foetus cells were added. In some wells LPG was added in varying
concentrations before the addition of the T. foetus cells. The higher the concentration of LPG
added prior to infection, the lower the binding of the parasites, suggesting that there is competition
for binding sites and showing possible receptor-binding ligands on the cell surface [414].
When HeLa, human epithelial (HEp-2), normal baboon testicular (NBT), and monkey kidney
(Vero) cells were exposed to T. vaginalis parasites, there was damage to all monolayers [419]. T.
foetus (strain KV-1) was also found to damage the same monolayers, however, T. tenax was found
to not induce any cytotoxicity [24]. The actual mechanisms of damage by these trichomonads has
been debated for many years [420], however, what is known is that the trichomonads aggregate and
it appeared to be the physical attachment of these ‘clumps’ that caused the damage. Kreiger et
al. (1985) [420] stated that it is only this physical attachment that causes cell damage, rather than
anything being secreted by the parasites themselves.
In contrast, Amin et al. (2012) [421] found that when cell-free filtrates of T. gallinae were added
to a cell monolayer, the monolayer cells had reduced viability. Furthermore, if the same monolayer
cells (QT35-Quail Fibroblasts and LMH-chicken liver) were freshly seeded into a new flask and the
cell-free filtrate was added, the cells were unable to form confluent monolayers [421]. This indicates
that trichomonad secretory products do cause monolayer cell damage, and this is not purely the
result of the attachment process [140].
The identity of these secreted factors promoting pathogenesis is not completely understood. The
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cysteine protease CP30 has been identified as a virulence factor in T. foetus [68] [140]. In 2017
Gould et al. [68] showed that CP30 could act as a mediator in the adhesion and cytotoxicity
of feline strain T. foetus to monolayers. When CP30 was inhibited, the adhesion capabilities
and cytotoxicity of T. foetus was decreased. Furthermore, expression of CP30 was found in all
feline T. foetus strains tested [29]. Singh et al. (2004) [140] showed that when this protease
was inhibited using the inhibitors Nα-p-tosyl-L-lysine chloromethyl ketone (TLCK) and L-trans-
epoxysuccinylleucylamide-(4-guanido)-butane (E-64) the adherence of bovine T. foetus parasite to
bovine vaginal epithelial cells (BVECS) was reduced. However, the same purified cysteine proteases
in T. vaginalis did not show the same damage to the BVECS, showing some species specificity.
The precise genotype of interacting cells seems to affect the pathology observed. Pindak et al. (1986)
[422] investigated the effects of T. vaginalis on various cell strains to identify those most suitable
for cell cytotoxicity experiments. It was seen that, when the T. vaginalis cells were inoculated
into the cell cultures, only 103 parasites were needed to disrupt the monolayers of HeLa (human),
HEp-2 (human) and RK-12 (rabbit kidney). With other cell types, Veros, CHO (chinese hamster
ovary) and McCoy (mouse) were tested, 10-100 fold higher levels of T. vaginalis were needed to
induce the same amounts of damage [422]. Furthermore, when the T. vaginalis cells adhered to all
of the monolayers, lesions were visible, showing the monolayers have been damaged.
4.1.4 Pathological Differences Between Trichomonad Strains and Species
While host cell types appear to be affected to varying extents by parasite binding, different tri-
chomonads are known to display interspecific and strain variation in the damage they inflict when
placed in the presence of cell monolayers [419]. This damage can depend on the strain and species of
trichomonad itself, or the type of monolayer. In a study by Alderete et al. (1984) [419], T. vaginalis
cased twice the damage to HeLa cell monolayers than T. foetus and T. tenax did not cause any
obvious damage [419]. In terms of the monolayers, when T. vaginalis was added to several different
cell types, clear differences in cytotoxicity were seen [419].
When T. gallinae was added to a flask of chicken liver cells and also a flask of fibroblasts, damage
to both host cell types was seen, and the cells could not form a cohesive monolayer [421]. Whereas,
when Tetratrichomonas gallinarum was used, it did not show any visible effect to either cell type.
However, the cell filtrates of both trichomonad species were shown to have an effect on the viability
of the monolayer cells, suggesting that something secreted was having an impact [421]. This dam-
age occurred both when filtrate was taken from axenic trichomonas culture and infected culture,
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ie. the trichomonads had been co-cultured with host cells, and there was less damage when filtrate
from T. gallinarum was used.
Different phenotypes and subpopulations of T. vaginalis were found to have different effects on
host cell cytotoxicity [423]. Those T. vaginalis cells that did not possess a particular cell surface
glycoprotein (MAR) were found to be cytotoxic to HeLa cell monolayers, culminating in their to-
tal disruption [423]. Cells that were positive for the glycoprotein had significantly lower levels of
cytotoxicity and if the phenotype was altered from positive to negative, the rates of cell monolayer
destruction increased accordingly [423]. Significant differences were also seen in surface charge be-
tween different strains of T. vaginalis and T. foetus [424], although the overall mean charge between
the two species did not differ. It was found that those strains with the most negative charges were
also the most cytotoxic to a mouse monolayer [424].
A proteomic comparison was performed between long-term lab grown and freshly isolated T. vagi-
nalis strains to identify if there was a difference in virulence and, if so, which proteins were up-
regulated in the virulent strain. This analysis identified 29 protein spots that were differentially
expressed between the two [171]. Of those 29, 19 were overexpressed in the freshly isolated, more
virulent, strain. These included cytoskeletal proteins in addition to metabolic proteins, such as
malate dehydrogenase and aldolase [171]. Additionally, it was found that, in the presence of vagi-
nal epithelial cells, the more virulent T. vaginalis strain could switch between trophozoite and
pseudocyst forms [171] more quickly than the long-term lab grown strain.
Da Rocha-Azevedo et al. (2005) [425] compared five clonal subpopulations of T. foetus strain K
to characterise their cytotoxicity towards epithelial cells. The different subpopulations ablated the
monolayers at different rates, ranging from 25-55% although the rates of adhesion and levels of
protease activity between them were all similar [425]. The subpopulation that had the highest
cytotoxic effects also had high protease activity and those with lower cytotoxic effects had lower
activity [425].
Different strains of T. vaginalis were also compared to determine whether the length of time grown
in a laboratory setting affects their virulence and pathogenicity and which genes and enzymes are
upregulated in more pathogenic strains. When two strains of T. vaginalis, one a fresh isolate and
one long-term lab cultured, were, again, grown in both iron rich and iron depleted media [170]
there were clear differences between the strains in terms of growth rate and enzyme activity. The
fresh isolate produced four times the enzyme activity (ecto-ATPase) when grown in the iron-rich
media than the long-term cultured isolate. In the iron depleted media the fresh isolate again had a
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significantly higher enzyme activity, showing clear differences between the strains. These differences
could be mirrored in the T. foetus stains used within this chapter as one has been grown long term
in culture, whereas others are lower passage isolates that have not been cultured long-term within
my lab.
As the Belfast strain, which has been used in all prior experiments in this thesis, has been grown in
culture for several years, we wanted to identify if there were any changes in terms of cell adhesion
or cell damage when compared to other strains. Furthermore, we wanted to examine whether there
were significant differences in host-parasite interactions when comparing the new isolates to each
other. Additionally, we wanted to find genes that were expressed in the presence of the host cells
in all strains as these could be good vaccine candidates.
4.1.5 Aims and Objectives
The aim of this chapter was to produce RNA-Seq data for T. foetus parasites in the presence of a
host cell monolayer, in this case Madine-Darby Canine Kidney cells (MDCKs) and to identify the
differentially expressed genes. In order to achieve this we aimed to:
1) Test several strains of T. foetus and T. mobilensis for cytotoxicity against an MDCK monolayer
2) Test several strains of T. foetus and T. mobilensis for adherence to an MDCK monolayer
3) Produce transcriptomes from T. foetus cells in the presence of an MDCK monolayer
4) Identify differentially expressed genes between T. foetus cells grown axenically and T. foetus
that had been incubated in the presence of an MDCK monolayer.
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4.2 Methods
4.2.1 MDCK cell culture
Madine-Darby Canine Kidney (MDCK) epithelial cells were grown in DMEM with 10% foetal
bovine serum (FBS) and 1% Penicillin/Streptomycin at 37°C with 5% C02. This cell type was
chosen because it has been previously used to examine trichomonad-host cell interactions [426] [29].
4.2.2 T. foetus Strain and Cell Culture
Multiple strains of T. foetus, along with a related parasite, T. mobilensis were used in the MDCK
cell monolayer experiments. This was to identify whether all strains and species showed the same
cell adherence and cytotoxicity, particularly as the Belfast strain had been grown in a laboratory
setting for many passages and this may have affected the virulence. In total, four other T. foetus
strains were used along with T. mobilensis:
1) T. foetus KV-1 strain-naturally infected from Czechoslovakia (1962) ATCC 30924
2) T. foetus BP-4 preputial washings from Beltsville Maryland (1956) ATCC 3003
3) T. foetus UT Preputial washings from Beltsville Maryland (1967) ATCC 30232
4) T. foetus DK-2 Preputial washings from Davis California (1967) ATCC 30231
5) T. mobilensis USA-M776 Bolivian squirrel monkey (1984) ATCC 50116
Cells were initially grown in ATCC entamoeba medium before being passaged into Diamond media.
All cells were incubated at 35°C.
4.2.3 T. foetus Growth Curves
The five strains of T. foetus: Belfast, KV-1, BP-4, UT and DK-2 and T. mobilensis were each
grown in 15ml tubes of Diamond media. 1ml of cells from these 15ml growth tubes, at 24 hours
post passage, was spun down at 1000rpm for 5 minutes. The pellet produced was resuspended in
fresh Diamond media to give a cell count of approximately 1x106 cells for each strain. 200µl of this
cell suspension was added to a 15ml falcon tube containing fresh Diamond media. 10µl samples
were taken at different intervals: 30 minutes, 1 hour, 2 hours, 6 hours, 12 hours, 24 hours and 48
hours. Growth curves were then created for each strain.
Growth curves were also produced when the T. foetus cells were cultured in DMEM in the presence
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of MDCK cells. Briefly, 1ml of cells from 15ml growth tubes was spun down at 1000rpm for 5
minutes. The pellet was resuspended in fresh media to give a cell count of approximately 1x105
cells. 200µl of each cell suspension was added to a well in a 46 well plate, already containing 80%
confluent MDCK cells. The plate was incubated at 35°C and 10µl samples were taken at different
time intervals stated previously for the initial growth curves.
4.2.4 MDCK Cell Binding Assays
MDCK cells were grown to confluency to approximately 2x106 cells in a T25 flask. T. foetus cells
were grown in Diamond media to approximately 5x106 cells.
The T. foetus cells were spun down 1000rpm for 5 minutes and washed in PBS. They were then
added at a ratio of 10:1 T.foetus:MDCK cells. Initially the cells were incubated with the parasites
from 30 minutes to 48 hours and samples were taken at different time points: 30 minutes, 1 hour, 2
hours, 6 hours, 12 hours, 24 hours and 48 hours. The media was removed and cells washed gently
five times with PBS. The T25 flask was then imaged under an inverted light microscope. The
percentage of MDCK cells with at least one T. foetus cell attached was calculated.
4.2.5 MDCK Cell Cytotoxicity Assays
In the same way as the binding assay, T. foetus cells were added at a ratio of 10:1. The media was
removed and saved and 100µl trypsin-EDTA was added.
After 2 minutes, when the cells were released and the old media was added to neutralise the trypsin.
100µl of the sample was taken and added to 100µl trypan blue. This was then placed in a haemo-
cytometer so cell counts could be taken and dead cells could be identified. Any cells that had been
stained with the trypan blue were assumed to be dead. The haemocytometer was then imaged
using an inverted light microscope.
4.2.6 Effect of Cell Number on Cell Binding and Cytotoxicity
In order to determine how much of an impact the initial cell number has on the numbers of cells
binding, two different concentrations of cells were added to a 6-well plate, with each well containing
an MDCK cell monolayer.
200µl of approximately 1x105 cells were added to wells (1-3 across).
20µl of approximately 1x105 cells were added to wells (4-6 across).
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The supernatant was removed and the cells washed with PBS as previously stated. The number of
MDCK cells with at least one T. foetus cell attached per field of view were counted.
4.2.7 The Effect of Cell Growth Stages on MDCK Cytotoxicity and Cell
Death
In all other experiments, the cells were taken 24 hours after passage, (the middle of the log growth
phase). Trials were done using cells 12 hours after passage (early log phase) to see if and/or how
this affected the MDCK cell death and adhesion. This was to see whether cells that are in earlier
stages of growth possess any differences in pathogenicity than later growth stage cells. The trial
was set up as stated previously in the cell cytotoxicity assays with T. foetus cells from early-log
growth phase added to three wells of a 6-well plate containing a confluent MDCK monolayer and
mid-log growth phase T. foetus cells added to the remaining three. Another plate was used as cell
death controls, containing confluent MDCK cell monolayers that had been originally passaged on
the same day as the experimental samples.
The Effect of Cell Growth Stages on MDCK Cytotoxicity-sub 2 hours
To further identify whether there are differences in early infection rather than later infection and
to find the optimum points for harvesting cells for transcriptomics, and to determine whether early
growth phase T. foetus cells show greater cell adhesion and cytotoxicity assays were performed
using both, 24 hour and 12 hour post-passage T. foetus cells at 15 minute time points up to 2
hours. The time points were: 15 minutes (post addition of T. foetus cells), 30 minutes, 45 minutes,
1 hour, 1 hour 15 minutes, 1 hour 30 minutes, 1 hour 45 minutes and 2 hours.
4.2.8 The Effect of Trichomonad Passage Number on MDCK Cell Death
The aim was to see if the passage number of the trichomonad cells had an effect on the cell death
rate of the MDCKs, i.e. if they became more or less damaging the longer they have been allowed
to multiply and have been passaged. When trichomonads are kept in cell culture for long periods
of time and several passages, their phenotypes can be changed, leading to reduced cell cytotoxicity
or attachment. The use of early passages to was to diminish this effect as far as possible so that
effects seen were due to strain differences rather than lab culture conditions. To test, early passage
numbers (passage 1-3 of ‘new strains’ and passage 10 of Belfast) were used in adherence and trypan
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blue exclusion assays (Table 4.1). The results were then compared to ‘late’ passage samples (passage
15 or above for all strains).
Strain ‘Early’ Passage Number ‘Late’ Passage Number
Belfast 10 35
BP4 1 15
UT 1 18
KV1 2 15
T.mobilensis 3 19
DK2 1 20
Table 4.1: Passage number of trichomonads used in MDCK cytotoxicity experiments. Both ‘Early’
(passage 10 and below) and ‘Late’ (over passage 15) passages of the trichomonads were added to a
confluent MDCK monolayer for up to 48 hours. A trypan blue assay was performed to test for cell
death.
4.2.9 Supernatant Effect on Cell Death
In order to test whether it is the attachment of the trichomonads physically that is damaging the
MDCK cell monolayer or whether it is something being secreted by the trichomonads, trials were set
up using supernatant only to test for cell damage. Supernatant from one well of a 6-well plate that
had contained trichomonads and an MDCK monolayer was removed and added to a well contain-
ing an MDCK monolayer only. These MDCKs had never been in contact with any trichomonads.
‘Early’ and ‘Late’ supernatant was used for the trials. In each case ‘early’ supernatant refers to
supernatant from the well where trichomonad cells have be in contact with the MDCK monolayer
for 1 hour and ‘late’ refers to the supernatant from a well were the trichomonas cells have been in
contact with an MDCK monolayer for 24 hours.
Four different trials were performed:
1)‘Early’ supernatant added to MDCKs for 1 hour.
2)‘Early’ supernatant added to MDCKs for 24 hours.
3)‘Late’ supernatant added to MDCKs for 1 hour.
4)‘Late’ supernatant added to MDCKs for 24 hours.
Initial cell counts from the 15ml growth tubes were taken. 1ml from each was taken, spun down at
1200rpm for 5 minutes and resuspended to give 4x104 cells.
200µl of this suspension of trichomonad cells was added to the MDCK wells initially. The plate was
incubated at 35°C. After the specified time, either 1 hour or 24 hours, the media was aspirated and
spun down at 1200rpm to remove the trichomonads. 200µl of supernatant was removed from the
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new MDCK well before the cell suspension or control suspensions were added. The supernatant
from the trichomonad infected well, was then added to fresh MDCK cells for the specified time (1
hour or 24 hours).
After this time 100µl of the media was added to 100µl trypan blue. 10µl was then imaged using an
inverted microscope (10x magnification) and percentage cell death was calculated. The early and
late supernatant samples were compared, as was the 1 hour and 24 hour time points. There were
two controls used which were:
1) PBS only added to the MDCK wells
2) Diamond media only added to the MDCK wells.
4.2.10 Cell Detachment
The aim was to see how many trichomonad cells can reasonably be expected to detached from the
cell monolayer and thus determine how many cells need to be added initially to get the optimal
number for successful RNA extractions.
200µl of approximately 1x105 cells were added to wells (1-3 across).
20µl of approximately 1x105 cells were added to wells (4-6 across).
The media was then aspirated. 200µl of trypsin-EDTA was added to each well and the plate was
left for 3 minutes at 35°C. When cells appeared to be rounded and detaching (visualised under 10x
magnification using an inverted microscope) 200µl of DMEM, containing 10% FBS, was added to
neutralise the trypsin-EDTA.
10µl was taken from the neutralised solution and imaged using an inverted microscope. The pro-
cedure was also repeated using cells that had been washed five time with PBS to see how many
‘attached’ cells would remain within the flask. This was to gauge how many cells there were likely
to be for starting material for the RNA extractions.
4.2.11 Separation of cells
In order to get the optimal T. foetus transcriptomes, a pure T. foetus after the co-incubation with
MDCK cells would be ideal. In order to achieve this, a way had to be devised to separate both cell
types. After co-incubation of trichomonads and MDCK, the monolayer was washed five times with
PBS, trypsin-EDTA was added for 30 seconds. This allowed the trichomonads to detach from the
MDCKs whilst minimising the number of MDCKs detaching from the flask.
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4.2.12 RNA extraction
Initially, both the Belfast and DK2 strains were selected for the experiment; the former because
it has been used in all other proteomics trials, the latter because it gave the highest percentage
of cell damage and, therefore, may be the most ‘pathogenic’. Given that the dynamics of gene
expression when parasites initially contact host epithelia are not know, three different time points
were chosen for sampling (30 minutes, 1 hour and 24 hours), in order to accommodate distinct
effects at different times post contact.
Three technical replicates and three biological replicates were taken for each time point and each
strain. For each time point three flasks were set up and the RNA extracted. This was then repeated
three separate times to increase replication. Due to time and reagent constraints it was decided
that samples would only be taken from DK2 cells as these produced a stronger cytotoxic response
(Figures 4.4 and 4.8). For the transcriptomic DK2 controls, cells were grown in a T25 cell culture
flask for 24 hours and then all cells were harvested and the RNA was extracted as stated in Chapter
2.
4.2.13 RNA preparation and sequencing
Due to issues of quality with certain samples (Table 4.2), not all library preparations could be
produced using poly-A selection, as was the case in Chapter 1, hence, the lower quality samples
were processed using the ‘Zymo’ (Zymo Research) isolation kit. This kit was able to process lower
levels of RNA and convert the RNA to cDNA before a universal depletion to produce the libraries.
All RNA samples were sequenced on the Illumina Novaseq. The reads produced (ENA Study
PRJB39464) were processed in the same way as Chapter 1 using Cutadapt v1.2.1 [300] and Sickle
v1.200 [301]. The resulting fastq files were uploaded to the Galaxy server [302] and mapped to the
completed Belfast genome assembly sequence using the program Hisat2 [303] [304].
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Sample Number Experiment Library Preparation
1 Trophozoite Trypsin Wash (30 min) 1 Poly-A Selection
2 Trophozoite Trypsin Wash (30 min) 2 Poly-A Selection
3 Trophozoite Trypsin Wash (30 min) 3 Poly-A Selection
4 Pseudocyst Trypsin Wash (30 min) 1 Zymo-kit
5 Pseudocyst Trypsin Wash (30 min) 2 Zymo-kit
6 Pseudocyst Trypsin Wash (30 min) 3 Zymo-kit
7 Trophozoite Trypsin Wash (1 hour) 1 Poly-A Selection
8 Trophozoite Trypsin Wash (1 hour) 2 Poly-A Selection
9 Trophozoite Trypsin Wash (1 hour) 3 Zymo-kit
10 Pseudocyst Trypsin Wash (1 hour) 1 Zymo-kit
11 Pseudocyst Trypsin Wash (1 hour) 2 Zymo-kit
12 Pseudocyst Trypsin Wash (1 hour) 3 Poly-A Selection
13 Trophozoite Trypsin Wash (24 hours) 1 Zymo-kit
14 Trophozoite Trypsin Wash (24 hours) 2 Zymo-kit
15 Trophozoite Trypsin Wash (24 hours) 3 Zymo-kit
16 Pseudocyst Trypsin Wash (24 hours) 1 Zymo-kit
17 Pseudocyst Trypsin Wash (24 hours) 2 Zymo-kit
18 Pseudocyst Trypsin Wash (24 hours) 3 Zymo-kit
19 Trophozoite PBS Wash (1 hour) Zymo-kit
20 Trophozoite PBS Wash (24 hours) Poly-A Selection
21 Pseudocyst PBS Wash (24 hours Poly-A Selection
22 MDCK cells only Zymo-kit
23 DK2 Control 1 Zymo-kit
24 DK2 Control 2 Zymo-kit
25 DK2 Control 3 Poly-A Selection
26 DK2 Supernatant 1 Poly-A Selection
27 DK2 Supernatant 2 Poly-A Selection
28 DK2 Supernatant 3 Poly-A Selection
Table 4.2: The methods of library preparation for host-monolayer RNA-Seq samples. Where some
samples had lower quality, the ‘Zymo’ kit was used rather than Poly-A selection.
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4.3 Results
4.3.1 Trichomonad cell growth
When cells were grown in Diamond media they were passaged at mid log phase and samples were
taken at 1h, 2h, 6h, 12h, 24h, 48h and 72h and cell counts made. All strains show the same shaped
curve, with the cell numbers increasing from the initial passage, peaking at 48 hours and dropping
off post 48 hours (Figure 4.1). This may be due to a lack of space and nutrients and a build-up of
toxic waste products. The Belfast strain had the highest total cell count of all the strains, reaching
over 350x104 cells per ml, potentially due to the fact that it had been grown in cell culture for many
passages and was well adapted. All samples showed a lag phase up to 6 hours, with T. mobilensis
having a lag phase of 12 hours. At their peak three samples: Belfast, T. mobilensis and UT had a
density of over 300x104.
When the T. foetus cells were grown with MDCK cells a similar growth pattern was seen with
all strains reaching a peak before decreasing (Figure 4.2). However, the peak of the cell numbers
for all strains was at 24 hours rather than 48 hours and the decrease in cell numbers occurs more
slowly. It may be due to the increase in nutrients available from the monolayer. Furthermore, the
peak number of cells when grown in the T25 flask in the presence of a monolayer was lower for all
samples than the T. foetus grown alone, with peak numbers reaching between 75 and 125x104 cells
per ml compared to over 250x104 cells.
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Figure 4.1: Growth Curves of five strains of T. foetus: Belfast, BP-4 DK-2, KV-1 and UT and T.
mobilensis (TM) over 72 hours. All cells were grown in 15ml tubes of Diamond media at 37°C. Cell
numbers were calculated using a haemocytometer.
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Figure 4.2: Growth Curves of five strains of T. foetus: Belfast, BP-4 DK-2, KV-1 and UT and
T. mobilensis (TM) over 48 hours. All cells were grown in T25 cell culture flasks of DMEM
containing a confluent cell monolayer of MDCK cells at 37°C. Cell numbers were calculated using
a haemocytometer.
4.3.2 Binding assays
As time went on the number of T. foetus cells bound to the MDCK monolayer increased (Figure
4.3). This was particularly marked over the first six hours, with the DK2 strains showing much
higher adhesion, with over 50 cells bound per field of veiw, than all other strains. This reached 250
cells bound per field of view after 48 hours for the DK2 strain, with the T. mobilensis strain being
the next highest with over 150 cells bound. All other strains had less than 100 cells bound at 48
hours.
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Figure 4.3: Cell adhesion of five strains of T. foetus: Belfast, BP-4 DK-2, KV-1 and UT and T.
mobilensis to a confluent MDCK monolayer over 48 hours. Cells were counted as bound if at least
one parasite cell attached to it after five PBS wash steps.
4.3.3 Cytotoxicity Assays
As time increased the proportion of dead MDCKs cells from the sample of supernatant increased.
The most dramatic increase was in the first hour (Figure 4.4) but the percentage cell death increased
after this point up to 24 hours, albeit more slowly. The DK2 strain appeared to be the most
damaging or cytotoxic when compared to the other strains, with the highest percentage cell death
reaching over 70%. The UT strain also reached a high percentage cell death at over 65%. The
Belfast strain, conversely, had a relatively low cytotoxic or destructive capability as the death rate
did not reach 20%, even at 24 hours post addition to the monolayer
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Figure 4.4: Cell death of MDCK cells when five strains of T. foetus trophozoites: Belfast, BP-4
DK-2, KV-1 and UT and T. mobilensis were added for up to 48 hours. Parasite trophozoites in
log growth phase were added to a confluent monolayer of MDCK cells. Cell death was determined
by way of a trypan blue exclusion assay.
4.3.4 The Effect of Cell Growth Stages on MDCK Cell Death
T. foetus cells from axenic culture, were taken at different points in their growth cycles; 12 hours
and 24 hours after passaging, corresponding with the beginning and middle of log phase respectively.
This was in order to determine whether the T. foetus cells have different phenotypes with regards
to adhesion and cytotoxicity depending on their growth phase. The percentage cell death of the
MDCK cells were measured for 2 hours, with samples being taken every 15 minutes. For the early
log phase samples (12 hours post original passage) the percentage cell death increased from 0 to 2
hours in all strains (Figure 4.5). The same is also true of the strains 24 hours post passage (Figure
4.6) and in both cases it was, again, the strain DK2 that seems to produce the most marked effect
in terms of cell death, increasing to 50% in the 12 hour samples and to 45% in the 24 hour samples.
Cell death induced by the Belfast strain was very low in both trials, never reaching more than 15%
and in some cases was lower than the control samples of MDCKs with no trichomonads suggesting
there is very little, if any, destructive capability. Overall, the growth phase of the T. foetus cells
did not have an effect on the cytotoxicity of MDCKs.
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Figure 4.5: Cell death of MDCK cells when five strains of T. foetus: Belfast, BP-4 DK-2, KV-1
and UT and T. mobilensis were added for up to 2 hours with samples taken every 15 minutes. The
T. foetus cells had been growing for 12 hours post passage which corresponds with the beginning
of log phase growth. Cell death was determined using a trypan blue exclusion assay.
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Figure 4.6: Cell death of MDCK cells when five strains of T. foetus: Belfast, BP-4 DK-2, KV-1
and UT and T. mobilensis were added for up to 2 hours with samples taken every 15 minutes. The
T. foetus cells had been growing for 24 hours post passage which corresponds with the middle of
log phase growth. Cell death was determined using a trypan blue exclusion assay.
4.3.5 Effect of Trichomonad Passage Number on MDCK Cell Death
‘Early’ passage number T. foetus cells (passage 10 or less) were also used to examine cytotoxicity
and cell damage towards MDCK cells. This was to determine whether the effects seen between
strains were due purely to biological differences or whether their length of time in culture also has
an effect. The early passage T. foetus cells did not appear to have a different effect than using
older passages (Figure 4.4). The cell death percentages were comparable with the higher passages
(Figure 4.7) as four of the six strains (DK-2, BP-4, UT and T. mobilensis) still reached over 40%
cell death, whilst the other two strains, KV-1 and Belfast induced less than 20% cell death. The
same strains, DK-2 and UT were the most cytotoxic and damaging, as was seen in the original
experiment with the late passages. Overall, the passage number did not have an effect on the
cytotoxicity of the different T. foetus strains towards MDCK cells.
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Figure 4.7: Cell death of a confluent monolayer of MDCK cells when five strains of T. foetus:
Belfast, BP-4 DK-2, KV-1 and UT and T. mobilensis were added for up to 48h. All T. foetus
strains were early passage numbers, P10 or below. Cell death was determined using a trypan blue
exclusion assay.
4.3.6 Secretome
Initially supernatant from growing trichomonads was added to a confluent MDCK monolayer to
see if there was any effect and whether it was likely that there are secretions from the parasite
causing the cell monolayer damage (Figure 4.8). This showed that there was still damage to cells
occurring, even without the presence of the physical trichomonad cell bodies. The percentage cell
death also followed the same pattern as the initial trichomonad cytotoxicity experiments (Figures
4.4, 4.5 and 4.6) with DK2 showing a far higher effect on the MDCK mortality, with a cell death of
over 70% at 24 hours. Similarly, the Belfast strain shows the lowest cell death induction compared
to the other strains, never reaching 20%.
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Figure 4.8: Cell death of MDCK Monolayers when T. foetus supernatant was added. T. foetus cells
were grown in diamond media to mid-log phase. The cells were spun down and removed, leaving
the supernatant containing any cellular secretions. This supernatant was then added to a confluent
MDCK monolayer and the percentage cell death calculated using a trypan blue exclusion assay.
When supernatant from trichomonads that had been growing for 1 hour were added to an MDCK
monolayer for 1 hour (Figure 4.9), the UT and DK-2 strains showed the highest levels of cell death,
reaching 60%. BP-4 and T. mobilensis also have a high level of cell death at 50% and KV-1 and
Belfast strains are lower at 30% and 20% respectively. This mirrors the results seen in the other
cytotoxicity experiments.
The rates of cell death for each strain were compared between the whole cell sample and super-
natant sample by way of a paired t-test, there was no significant difference seen for any of the
strains.
When supernatant from trichomonads that had been growing for 1 hour were added to an MDCK
monolayer for 24 hours the results are largely the same as leaving the supernatant for 1 hour (Figure
4.9), with DK2 and UT showing high levels of cell death (60%) and Belfast showing lower levels
(20%). However, the level of cell death when the KV-1 strain is added to the monolayer is much
higher at 24 hours than at 1 hour, reaching 50% rather than 30%.
When supernatant from trichomonads that had been growing for 24 hours were added to an MDCK
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monolayer for 1 hour the results were similar, in that strain DK2 had the highest death percent-
age(Figure 4.10). In this case it was even higher than the ‘early’ supernatant at 80% cell death
verses 60%. Belfast and the controls also showed higher death rates than in the ‘early’ supernatant
trials and, interestingly, KV-1 was much lower at only 20% cell death rate compared to all other
trials when the death rate ranged between 30-60% and was higher than the controls.
When supernatant from trichomonads that had been growing for 24 hours were added to an MDCK
monolayer for 24 hours (Figure 4.10) the results, again, were broadly the same. With DK2 showing
the highest rates of cell death (80%), whereas the Belfast strain induced relatively low levels (40%)
comparatively. The KV-1 strain appeared to need longer periods of time to induce cell damage as,
when the supernatant was added to the MDCK cells for 24 hours, the death rate was 50% or over
in both cases. However, when the supernatant was added for only one hour, the cell death rates
were much lower, at 20% and 30%.
As in almost all cases, apart from the 24 hour KV-1 sample added to a monolayer for 1 hour, the
percentage cell death was always higher in cases where trichomonad supernatant was used opposed
to the controls. This directly contradicts Krieger et al. (1985) findings as they stated that it was
direct contact alone that damaged the CHO cell monolayers, rather than anything that is being
secreted by the trichomonad. However, these results are in keeping with the findings of Amin et
al. (2012) [421] as they found evidence of secreted proteins, such as cysteine peptidases, that could
damage the monolayer without direct cell-cell contact.
169
Figure 4.9: MDCK cell death when trichomonad supernatant is added for 1 hour. The supernatant
had been extracted from four strains of T. foetus: Belfast, BP-4, DK-2, KV1 and UT and T.
mobilensis. Two controls were also used consisting of 1) PBS and 2) Diamond media only. The
supernatant was obtained from trichomonads that had been growing in the presence of an MDCK
monolayer for one hour, this supernatant was then added to a fresh MDCK monolayer for 1 hour
(1-1) or 24 hours (1-24) respectively.
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Figure 4.10: MDCK cell death when trichomonad supernatant is added for 1 hour. The supernatant
had been extracted from four strains of T. foetus: Belfast, BP-4, DK-2, KV1 and UT and T.
mobilensis. Two controls were also used consisting of 1) PBS and 2) Diamond media only. The
supernatant was obtained from trichomonads that had been growing in the presence of an MDCK
monolayer for 24 hours, this supernatant was then added to a fresh MDCK monolayer for 1 hour
(24-1) or 24 hours (24-24) respectively.
4.3.7 Cell Detachment
To see how many trichomonad cells were needed to be added initially to the monolayer in order
to obtain successful RNA extractions. Trypsin was added to the MDCK-trichomonad co-culture
and the number of T foetus cells that detached after three minutes was measured (‘unwashed’
samples) (Table4.3). This was also repeated for monolayers that had been washed using PBS prior
to trypsinisation (‘washed’ samples) in order to obtain only those T. foetus cells that had been
physically attached to the monolayer. Overall the number of cells retrieved after the monolayer
had been washed was 3-10 times fewer than the unwashed samples.
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Strain Cell counts (unwashed) Cell counts (washed)
Belfast 14x104 1x104
BP4 9.5x104 1x104
UT 12.5x104 3.5x104
KV1 26x104 7.5x104
T.mob 19.5x104 9.5x104
DK2 21.5x104 3x104
Table 4.3: Cell counts per well of ‘unwashed’ and ‘washed’ cells from one well of a 46 well plate.
4.3.8 Cell Washes
During the course of collecting the samples for transcriptomics all stages were collected: the super-
natant from the adhesion assay, the PBS wash and the trypsin wash. At each stage the numbers of
cells collected decreased dramatically (Figure 4.11). Between the initial number of cells added to
the flask and the number recovered in the trypsin wash fraction there is a 100-fold decrease in cell
number, from over 625 x104 initially to 6-7x104. In order to obtain reliable RNA-Seq data a larger
number of cells would be required, this led to the move from 6-well plates to T25 cell culture flasks
in order to maximise the number of cells in the trypsin wash. The trypsin was stage was deemed
most important for the transcriptomic experiments as this fraction included the trichomonad cells
that had been physically attached to the monolayer and so would likely be expressing host-parasite
attachment specific genes.
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Figure 4.11: Numbers of T. foetus Belfast and DK2 cells initally added to the MDCK monolayer in
a 6-well plate and per each cell wash fraction: supernatant removed from the well, 1st wash (PBS)
and 2nd wash (trypsin)
4.3.9 RNA Isolation and Preparation
Due to the lack of integrity in some of the RNA samples, leading to them being processed using a
different library preparation kit, there appeared to be a very large batch effect with the different
preparation methods driving 94% of the variance. Corrections were made in DESeq2 for batch
effect but the difference in variance was too high to remove the effect completely.
When all T. foetus DK2 samples were compared to identify the effect, if any, that the change in
library preparation had on the results a clear batch effect was seen between those produced using
the ‘Zymo’ kit rather than by poly-A selection (Figure 4.12). There was a variance of 94% when the
first principle component is used. Due to this large batch effect the ‘Zymo’ samples were removed
from the future analyses so only the poly-A selected samples were used. It was decided that the
‘Zymo’ samples should be removed as these came from the RNA samples with the lowest integrity
and quality. Consequently, this low quality led to low numbers of reads being produced and low
mapping percentages to the T. foetus genome (Table C1).
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Figure 4.12: PCA plot produced in R with the DeSeq2 using principle components 1 and 2 showing
the variance between samples. All samples are from T. foetus strain DK2 monolayer experiments
where the DK2 cells were placed on an MDCK cell monolayer for varying lengths of time and the
different washes were obtained. RNA was extracted from the samples and was processed either
using poly-A selection or using a ‘Zymo’ kit. The samples treated using poly-A selection are red
and those treated using the the ‘Zymo’ kit are blue.
There were also differences between the number of reads obtained for each sample and the mapping
percentage to the produced and annotated T. foetus genome (Table C1). The number of reads
ranged from 4,146,360 for the trophozoite trypsin wash to 51,657,211 for a DK2 only control, over
a ten fold change difference.
4.3.10 Alignment Rates-Mapping Percentages
The mapping of the RNA-Seq reads to the T. foetus genome also varied hugely, from 0.04% to
95.9% (Table C1). The low value of mapping from the MDCK sample is to be expected, as MDCK
cells are completely different to T. foetus cells. However, the mapping of the other samples, the
controls and the washes, were expected to have a much higher mapping percentage in general.
The low percentages in some samples and not others, for example the range of 8.03% to 95.90%
amongst the 1 hour trophozoite trypsin washes, suggests that either too few T. foetus cells were
obtained or that the samples were contaminated with the MDCK host cells, this seems consistent,
particularly amongst many of the trypsin washes. Additionally, it also seems that those samples
with the lowest alignment rates are the ‘Zymo’ prepared samples rather than the poly-A selected
samples. These samples had a lower RNA integrity before library preparation which may also
explain the lower alignment rates.
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4.3.11 Zymo Samples Removed
Due to the clear batch effect between library preparation methods, it was decided that the ‘Zymo’
produced samples were to be removed and analyses performed only on the poly-A selection samples.
The poly-A selection samples were chosen as all other RNA-Seq analyses had been performed on
samples with this library preparation method. Furthermore, the ‘Zymo’ produced samples came
from lower quality RNA and showed low alignment rates to the genome and so very few gene
were likely to be identified. When all ‘Zymo’ produced samples were removed, the analyses were
rerun and the samples showed clear differences between them, although the variance of principle
component 1 had been reduced to 50%. The samples cluster according to wash step, with the PBS
samples appearing to be the most far removed from the other samples (Figure 4.13). The trypsin
samples cluster together according to time points: 30 minutes and 1 hour.
Figure 4.13: PCA plot produced in R with the DeSeq2 using principle components 1 and 2 showing
the variance between samples. All samples are from T. foetus strain DK2 monolayer experiments
where the DK2 cells were placed on an MDCK cell monolayer for varying lengths of time and the
different washes were obtained. RNA was extracted from the samples and was processed either usin
poly-A selection or using a ‘Zymo’ kit. All samples processed using the ‘Zymo’ kit were removed
and the remaining samples were compared. The control sample is in red, trypsin wash samples are
pink (30 minute samples) and blue (1 hour samples), PBS are yellow and supernatant are green.
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After removing the ‘Zymo’ samples it becomes much easier to see the differences between the
different wash stages with clear similarities in the expression profiles, for example, the PBS washes
look very similar to one another, with the same genes more highly expressed, but different to the
supernatant samples. The Trypsin 1 hour samples produce one cluster, as do the PBS, supernatant
and 30 minute trypsin samples. However, removing all of the ‘Zymo’ samples led to a lack of
replication in some instances, for example, there is now only one DK2 control. The trypsin samples
for pseuodcyst and trophozoites also had to be combined so that there were three samples to
compare. As shown in Figure 4.13, all the trypsin samples are similar regardless of which life stage
they were originally from. Furthermore, as the samples were all incubated at 37°C it is highly
likely that the low temperature induced pseudocysts would have reverted back to their trophozoite
form quickly,sometimes within 10 minutes, therefore, all samples would essentially have come from
trophozoites.
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4.3.12 Comparison of DK2 and Belfast Negative Control Samples
Due to there only being one DK2 control that was processed using poly-A selection, we considered
using the previously produced Belfast controls instead. The five Belfast controls and the single
DK2 control were compared using DeSeq2 to identify if there were significant strain differences.
There appear to be large differences in variance (77%) using principle component 1 (Figure 4.14)
between the Belfast and DK2 controls, whereas between Belfast samples themselves there is a much
lower variance of 19%.
Figure 4.14: PCA plot produced in R with the DeSeq2 using principle components 1 and 2 showing
the variance between samples. Samples are comparing control T. foetus trophozoites of strains
Belfast and DK2. Cells were grown in Diamond media to log growth phase and then RNA was
extracted.
Furthermore, when looking at the table of significantly differentially expressed genes (Table 4.4)
from the RNA-Seq results there are 2,376 differentially expressed genes, with a fold change above
2 and a -log10 p value >0.01. There are 1221 significantly upregulated genes and 1155 significantly
downregulated genes. The fold changes range from -14 to 15. As there were many significant
differences between the two strains, the Belfast and DK2 controls were used to identify differentially
expressed gene separately.
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Comparison
No. Differentially
Expressed Genes
No. Upregulated
Genes
No. Downregulated
Genes
Fold Change
Range
DK2 Control vs
Belfast Control
2,376 1,221 1,155 -14 to15
Trypsin Samples vs
DK2 Control
5,353 2,625 2,728 -13 to 14.5
PBS Samples vs
DK2 Control
5,038 2,625 2,728 -14 to 15
Supernatant Samples vs
DK2 Control
6,266 3,659 2,607 15.7 to 11
Table 4.4: Number of significantly differentially expressed genes between transcriptome compar-
isons. The number of differentially expressed genes and whether these genes were up or down
regulated were identified using DESeq2 in R. Genes were classed as significantly differentially ex-
pressed if -log10 pvalue>0.01 and fold change greater than 2. The range of fold changes from the
most upregulated and downregulated genes per comparison are also shown.
4.3.13 Comparison of Trypsin Samples to DK2 Control
The DK2 controls were compared to the DK2 trypsin samples. These were the cells that had been
attached to the MDCK monolayer and had not been removed when the supernatant was aspirated
or when the monolayer was washed with PBS.
The results of the PCA plot using the DK2 control shows a large variance between the control and
the trypsin samples, with a smaller variance between the trypsin time-point samples themselves
(Figure4.13).
Regarding the number of significantly differentially expressed genes (Table 4.4) there is a larger
range of fold changes, from -13 to 14.5. There are 5,353 significantly differentially expressed genes
with 2,625 upregulated and 2,728 downregulated.
There are differences in the upregulated genes with CAMK protein kinases being upregulated and
Iron-only hydrogenase subunits (Table C2). There are also no adenylate and guanylate cyclase
catalytic domain containing proteins being upregulated, this suggests that this is a difference be-
tween the T. foetus strains rather than due to the experimental differences. The downregulated
proteins have some similarities to those from the Belfast control samples with DnaJ, cysteine pro-
teases and sialidase genes all being downregulated. However, there are differences: again there
are no adenylate and guanylate cyclase catalytic domain containing proteins, CLN3 proteins or
hydroxyglutaryl-CoA dehydratases.
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4.3.14 Other Sample Comparisons to DK2 Control
Comparison of PBS wash sample to DK2 control
The PBS samples show an even greater variance between themselves and the DK2 control than the
trypsin samples. They also show a large variance compared to the trypsin and supernatant samples
(4.13).
In total there were 5,038 differentially expressed genes with 2,961 upregulated and 2,077 down-
regulated (Table 4.4). The fold changes are again, large, reaching -14 to 15 (Figure 4.4). CAMK
proteins and hypotheticals were again, highly preferentially expressed in the PBS samples, with fold
changes over 12 from the control. Iron-only hydrogenase was upregulated as was dihydropyrimidase
(Table C3).
Comparison of Supernatant Samples to controls
The DK2 control and supernatant sample have a smaller variance than the other wash samples.
There is also a small variance between the different replicates in the sample itself (Figure 4.13).
There are 6,266 differentially expressed genes, 3,659 upregulated in the DK2 supernatant samples
and 2,607 downregulated (Table 4.4). The maximum fold change for upregulated genes is larger
than the downregulated genes, 15.7 compared to 11.
The upregulated genes include CAMK kinases and serine proteases, similar to the other DK2 control
comparisons. 5 of the top 10 downregulated are hypotheticals, similar to the DK2 trypsin wash
(Table C4).
4.3.15 Comparison of Control and Experimental Samples in DK2
Between the two washes and supernatant samples, there were several gene products that were pref-
erentially expressed relative to the control DK2 sample. Along with hypothetical genes, tubulin was
preferentially expressed in each experimental condition relative to the DK2 controls, showing that
cell cytoskelton proteins are upregulated in the presence of host cells. Protein binding proteins and
transmembrane transporters were also upregulated in all experimental conditions as were catalytic
activity related proteins. CMGC family protein kinases and CAMK genes are also upregulated
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in all environmental conditions. CAMK genes are known virulence factors in T. vaginalis so it is
likely they play a similar role in T. foetus.
Figure 4.15: Venn diagram showing the number of preferentially expressed genes in the DK2 trypsin,
PBS washes and supernatant samples relative to the DK2 control. For the wash and supernatant
samples, DK2 cells were co-cultured with an MDCK monolayer and the parasites were then removed
in the different wash steps. RNA was extracted and sequenced and differential expressed was
identified using DeSEq2.
Over 1000 genes were preferentially expressed across all samples relative to the DK2 controls (Fig-
ure 4.15) with 353-433 genes preferentially expressed in two of the experimental sample conditions.
Overall there were more genes that featured in two or more conditions than only one. The su-
pernatant samples had the most genes that were specifically upregulated compared to the other
samples, potentially because these were not cells that had necessarily been in contact with the
monolayer and so had not expressed some host specific genes.
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Immunodominant variable surface antigen like proteins were found upregulated in the trypsin and
PBS samples (7 genes and 9 genes respectively) rather than the supernatant samples. As no im-
munodominant variable surface antigen like proteins were found in the supernatant or control this
suggests that they require actual attachment to a host cell to increase expression. Adenylate and
guanylate cyclase catalytic domain containing protein was also downregulated in all samples, this
is involved in the conversion of GTP to GMP [427] and so a reduction in the expression of these
proteins may also lead to a reduction in metabolic activity, potentially as the parasites are obtaining
nutrients from the host cell monolayer.
4.3.16 Comparison of Differentially Expressed Genes and Peptide Array
Proteins
When the 50 proteins used in the peptide array in Chapter 3 were compared with the differentially
expressed DK2 genes from each wash, 19 proteins were found differentially expressed in at least one
of the samples. Eleven proteins were preferentially expressed in the experimental samples relative
to the DK2 controls and 7 were preferentially expressed in the DK2 controls.
Three proteins: TTF57869, TTF09721 and TTF36584 were found in the upregulated trypsin wash
samples suggesting that they are upregulated by coming into contact with host cells. TTF09721
was also found to have the top 20 highest number of immunogenic epitopes for the natural infected
samples. Five proteins (TTF14901, TTF38179, TTF347783, TTF16447 and TTF45090) were found
in both washes and the supernatant, suggesting that the presence of host cells increases their
expression. Of those five, three (TTF14901, TTF38179 and TTF34783) were found in the top 20
proteins for the number of expressed epitopes. Two (TTF11874 and TTF75903) were found in both
the PBS and trypsin samples, again suggesting that some form of contact with the host cells leads
to an increase in expression.
Of those peptide array proteins that are downregulated, four are found in the supernatant only
(TTF36321, TTF35905, TTF12012 and TTF41308), two were found in all washes and supernatant
(TTF14449 and TTF44685) and one was found in the trypsin wash only (TTF11197) meaning that
the presence of host cells reduces their expression. This would mean that they are less likely vaccine
candidates as they are not naturally expressed in the presence of the host.
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4.4 Discussion
In this chapter cell assays were performed on five strains of T. foetus: Belfast, DK2, BP4, KV1
and UT and one strain of T. mobilensis to discover whether different strains had different cytotoxic
and adhesion properties. One strain, DK2, was used in subsequent experiments to obtain RNA
from cells that had been grown in the prescence of an MDCK monolayer. T. foetus cells from the
supernatant, PBS wash and trypsin wash from the co-culture had RNA extracted and sequenced
and preferentially expressed transcripts between the stages and between the co-culture and DK2
cells only were obtained. The preferentially expressed genes from T. foetus/MDCK co-cultures
were cross-checked with the peptide array results from Chapter 3 to create a list of genes which
could be tested for structural invariance in Chapter 5.
4.4.1 Limitations of Cell assays
To identify dead cells during the comparison of T. foetus strains experiments, trypan blue exclusion
assays were used. However, the samples were only taken from supernatant so dying cells in the
monolayer were not counted and pieces of cell debris could have been from the T. foetus cells rather
than the MDCKs. To account for this only whole dead cells were counted rather than debris. MDCK
cell detachment was a key measure of monolayer destruction and so the supernatant would be the
best sample to measure of this.
One other limitation is that trypsin-EDTA was required to detach the T. foetus cells from the
MDCKs. This could potentially mean that the differential gene expression could be due to the
presence of trypsin rather than the presence of the host cell. However, the fact that the same genes
also appear to be preferentially expressed in the supernatant and PBS cell fractions, suggests it is
caused by the presence of the host cells rather than the presence of the trypsin-EDTA.
4.4.2 Monolayer Cell Death
There has been debate on whether trichomonad infection causes damage to the host cells by attach-
ing to them [420] [421] or whether it is due to something that the parasites are secreting, such as
proteases [414]. The results show (Figures 4.4, 4.7 and 4.8) that the presence of the trichomonads
causes damage.
There seem to be three potential reasons for the increase in death rate of the MDCKs when T.
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foetus cells are added to them.
1) The T. foetus cells are producing secretions that are cytotoxic to the MDCKs
2) The T. foetus cells are using up all the nutrients in the media, causing the MDCKs to be nutrient
deficient leading to cell death.
3) The T. foetus cells are producing waste products which are toxic to the MDCKs.
Due to the fact that the increase in cell death of MDCKs occurs within 2 hours and the rate of
cell death is different between strains, it is more likely the T. foetus cells are producing enzymes
and other secretions that are cytotoxic. If the cell death was due to a lack of nutrients or build-up
of waste products, the cells death would increase at a later time point, such as 24 hours, as is the
case in the control samples. Furthermore, the death rate would be consistent between strains as
the same number of starting cells were used.
The damage to the MDCK monolayers when the Belfast strain T. foetus cells were added was lower
compared to all the other strains. This may be due to the fact that it has been grown in culture for
many years and passaged numerous times, and the results are similar to those reported by De Jesus
et al. (2009) [170] who identified that fresh clinical isolates of T. vaginalis were more cytotoxic and
damaging to cell monolayers than those grown in culture for long periods. The fresh isolates used
by De Jesus et al. also had higher enzyme activity than the cultured strains [170].
Curvo et al. (2008) [171] compared strains of T. vaginalis with differences in virulence and looked
for proteomic differences between them. Of the genes that were found to have increased expression
in the more virulent phenotype several were also found upregulated in the more destructive DK2
strain of T. foetus compared to the Belfast strain in my transcriptome experiments. Seven Clan
CA family proteins were found to have increased expression in the DK2 strain. Clan CA proteins
were also found to have increased expression in the more virulent T. vaginalis strain [171]. Haloacid
dehalogenase-like hydrolase family protein and cathepsin like cysteine protease were also found to
be preferentially expressed in both the virulent T. vaginalis strain and DK2 [171] suggesting they
are involved with increases in virulence or cell damage.
De Miguel et al. (2010) [161] also compared fresh T. vaginalis strains to those grown in long-term
lab culture to identify potential virulence associated proteins. Of the proteins they identified as
preferentially expressed in the more virulent strain, two categories were also found preferentially
expressed in the DK2 strain: serine-threonine protein phosphatase of which 17 genes were upreg-
ulated and adenylate and guanylate cyclase catalytic domain containing protein, of which 16 were
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upregulated in the DK2 control. Of the proteins identified in the less virulent T. vaginalis strain
[161], two categories were also found preferentially expressed in the less cytotoxic Belfast controls:
ABC transporters of which 13 genes were upregulated and auxin efflux carrier proteins, of which 4
were upregulated in the Belfast samples.
4.4.3 Differentially Expressed Genes in the Presence of a Host Cell
Monolayer
When the differentially expressed genes from the controls were compared to the different wash
samples, there were more similarities between the washes than between the washes and controls. In
all experimental wash samples for example, cytoskeleton related genes and CAMK proteins-known
virulence factors, were upregulated. This was also the case when the Belfast controls were used
rather tha th DK2 control, suggesting that these genes are not strain specific and are upregulated in
the presence of the host monolayer. There are gene that are upregulated in all of the experimental
samples but not the controls, such as ankyrin repeats, adhesin-like proteins and CAMK proteins,
suggesting that these are preferentially expressed in the presence of host cells, even if the parasites
do not have direct contact with the monolayer. Key gene families that were upregulated included:
CAMK and cysteine proteases, Ser-Thr kinases and leucine-rich repeat containing proteins.
However, due to the issue with producing the samples, there is only one control replicate with
which to compare the different environmental samples so results may not be fully representative.
The results do, however, seem in agreement with past literature as several of these genes have been
associated with virulence and pathogenicity in trichomonads [67] [418], particularly the CAMK
genes.
CAMK and Cysteine Proteases
CAMK and cysteine proteases are known virulence factors in a variety of organisms [428], having
roles in autophagy, adhesion and penetration of host tissues. In Entamoeba histolytica they are
known to degrade the extracellular matrix and it has been postulated that they can degrade IgA
[428] in addition to invasion and parasite encystation. In trypanosomes, they are known to be
virlence factors and have roles in evading the host immune system and iron aquisition [428].
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Ser/Thr Kinases
Ser/Thr protein kinases are signalling proteins in eukaryotes [429] and can modulate signal trans-
duction pathways. They were found to be preferentially expressed in T. foetus in the presence of
a host cell monolayer and so may have roles in virulence or pathogenicity as, in other organisms,
they possess these functions. They are also known virulence factors in bacteria [430] [429] where
they have roles in environmental sensing and evading the host defences.
In Yesinia species Ser-Thr kinases have been found to affect the host cytoskeleton, particularly
disrupting actin [429] and in Shigella they have been found to downregulate the host immune sys-
tem. In Streptococcus pyogenes Ser/Thr protein kinases have been found to be required to induce
disease in a mouse model [430] and can activate virulence genes. Additionally, they were found to
be involved in regulation of metabolism, cell division and penicillin tolerance [430]. In Toxoplasma
they have been implicated in host invasion [431]. It is therefore possible that similar functions could
be performed by trichomonad Ser-Thr kinases, explaining why they are preferentially expressed in
the presence of the host cells.
Leucine-rich Repeats
As stated in previous chapters, the BspA family are leucine-rich repeat containing proteins. Leucine-
rich repeats are involved in recognition of cell surface motifs [166]. BsPA proteins are known to
be involved in adherance to host cells [167] and pathogenicity [165] [33] and so the increase in
preferential expression in the presence of the host are in keeping with this.
4.4.4 Comparison of Differentially Expressed Genes to Cell Surface Pre-
dictions
Of those proteins that feature in the network, CAMK and leucine rich repeat containing proteins
also appear in the preferentially expressed genes when the parasites are in contact with a host
monolayer as do immunodominant variable surface antigens. All three groups have been associated
with trichomond-host interactions [67] [68] particularly the cysteine proteases. These have been
suggested as vaccine candidates previously for T. vaginalis [68]. Additionally the immunogenic
proteins from the peptide array have been found, in some instances, to also be preferentially ex-
pressed in the presence of the host cells, such as TTF14901 and TTF38179. There were also a large
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number of hypotheticals preferentially expressed across the different washes: 971 across the trypsin
washes, 1,203 across the PBS washes and 1,296 across the supernatant samples. As these appear
to only be present in T. foetus, these again would make interesting potential vaccine candidates if
they follow the other criteria.
To create the list of candidate genes for Chapter 5, the top 20 proteins, with the highest numbers of
epitopes and maximum intensity, that were found in the peptide array of Chapter 3 were selected.
These proteins had high number of epitopes and maximum intensities in the presence of both the
experimentally infected and naturally infected sera. Additionally, the genes that were found to be
upregulated in all of the trypsin, PBS and supernatant samples were examined. These were then
cross-checked with the data from Chapter 1 to identify which of these genes also possesses one
transmembrane helix. This produced the final list of 77 genes that are going to be examined for
SNPs and differences within them between the different T. foetus species (Table 4.5).
Protein ID Product
TTF00910 hypothetical protein TRFO 06137
TTF01152 hypothetical protein TRFO 30327
TTF01161 hypothetical protein TRFO 36810
TTF02039 hypothetical protein TRFO 30849
TTF02745 hypothetical protein TRFO 08363
TTF03161 hypothetical protein TRFO 16017
TTF03169 hypothetical protein TRFO 16005
TTF04635 hypothetical protein TRFO 32884
TTF05043 —NA—
TTF05727 hypothetical protein TRFO 04170
TTF05864 hypothetical protein TRFO 16898
TTF08006 hypothetical protein TRFO 19408
TTF08916 hypothetical protein TRFO 04830
TTF09063 hypothetical protein TRFO 39123
TTF09721 adhesin-like protein
TTF11197 hypothetical protein TRFO 10561
TTF12012 hypothetical protein TRFO 39497
TTF13670 hypothetical protein TRFO 19601
TTF13877 hypothetical protein TRFO 19801
TTF14449 hypothetical protein TRFO 11445
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TTF14901 hypothetical protein TRFO 36551
TTF16365 cation channel sperm-associated protein subunit beta-like
TTF16447 hypothetical protein TRFO 30251
TTF18002 hypothetical protein TRFO 42877
TTF19171 PKD domain-containing protein
TTF20128 LPXTG-motif cell wall anchor domain protein
TTF21569 DUF2804 domain-containing protein
TTF21670 ankyrin repeat protein
TTF23071 hypothetical protein TRFO 15320
TTF25642 T9SS C-terminal target domain-containing protein
TTF28036 hypothetical protein TRFO 12081
TTF28414 hypothetical protein TRFO 36741
TTF29007 hypothetical protein TRFO 03744
TTF31219 hypothetical protein TRFO 20571
TTF33095 hypothetical protein TRFO 42895
TTF33122 Mannosyl-oligosaccharide 1,2-alpha-mannosidase MNS2
TTF33823 hypothetical protein TRFO 22464
TTF33905 hypothetical protein TRFO 09572
TTF34783 hypothetical protein TRFO 09395
TTF37306 hypothetical protein TRFO 41775
TTF38179 hypothetical protein TRFO 27265
TTF40724 hypothetical protein TRFO 38622
TTF43413 two component sensor and regulator histidine kinase bacteria
TTF43627 hypothetical protein TRFO 32949
TTF44528 adhesin-like protein
TTF44600 conserved domain protein
TTF44685 hypothetical protein TRFO 33209
TTF44949 hypothetical protein TRFO 32080
TTF45042 adhesin-like protein
TTF45771 hypothetical protein TRFO 26599
TTF46221 tyrosine kinase, putative
TTF47476 hypothetical protein TRFO 08795
TTF48521 hypothetical protein TRFO 11786
TTF49933 hypothetical protein TRFO 12226
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TTF50636 Lecithin:cholesterol acyltransferase family protein
TTF53402 hypothetical protein TRFO 12669
TTF56587 hypothetical protein TRFO 32199
TTF62174 hypothetical protein TRFO 11993
TTF62376 hypothetical protein TRFO 43242
TTF63395 hypothetical protein TRFO 33646
TTF63680 adhesin-like protein
TTF67401 hypothetical protein TRFO 35350
TTF70906 hypothetical protein TRFO 12915
TTF70954 hypothetical protein TRFO 11878
TTF71197 putative outer membrane protein pmp20 precursor
TTF72511 hypothetical protein TRFO 29759
TTF72966 hypothetical protein TRFO 23368
TTF73221 hypothetical protein TRFO 39563
TTF73824 hypothetical protein TRFO 11378
TTF74586 hypothetical protein TRFO 16588
TTF74797 hypothetical protein TRFO 03869
TTF75601 adhesin-like protein
TTF79943 hypothetical protein TRFO 14199
TTF80312 hypothetical protein TRFO 42647
TTF82375 Synaptobrevin family protein
TTF83271 hypothetical protein TRFO 31294
Table 4.5: Shortlist of genes to be tested for structural invariance in Chapter 5. These proteins
either feature in the Chapter 3 peptide array where they showed high maximum intensity and large
numbers of significantly immunogenic epitopes; or they were found preferentially expressed in the
co-culture transcriptome samples and possessed a transmembrane domain
4.4.5 Future Work
Future work could involve looking at the transcriptome of the MDCK cells, both axenic and after
T. foetus strains are added, to identify which genes are preferentially expressed due to the host-
parasite interactions. This could provide a more targeted approach to identifying potential vaccine
candidates. The other T. foetus strains could be examined and gene expression could be compared
to the Belfast strain to identify other strain specific preferentially expressed genes. This may also
allow further comparisons between the expression of certain genes and the virulence and cytotoxicity
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of the strain, in a similar way to T. vaginalis. The different strains could also be tested for
differentially expressed genes in the presence of a host cell monolayer to identify whether the genes
seen in the DK2 and Belfast strains are representative of all strains. This could also be tested using
T. mobilensis and T. vaginalis to identify if genes identified are related to virulence in several
trichomonad species or just T. foetus. If the same genes were found to be related to cell adhesion
and cytotoxicity in all of the trichomonad strains tested then there could be a potential for a more
generic trichomonad vaccine.
4.4.6 Conclusion
In this chapter, five different strains of T. foetus along with T. mobilensis were co-cultured with a
monolayer of MDCK cells and differences in their adherence and cytotoxic properties were observed.
The transcriptomes of the DK2 strain, which appeared to be the most destructive, were produced
for several washes in the presence of the MDCK monolayer. These transcriptomes from T. foetus
cells, following co-culture were compared to both a DK2 control and Belfast controls and genes
that were preferentially expressed in the presence of the monolayer, identified. These genes were
compared to the peptide array proteins in Chapter 3 and Network proteins in Chapter 2 to identify
key gene families that appeared to be associated with virulence and pathogenicity. A subset of 77
genes has been found which fulfils all of these criteria. The next stage is to identify which genes
in T. foetus are structurally invariant between the populations, whcih is the aim of chapter 6, and
then to cross check these with the peptide array, cysteine peptidases and variable surface antigens
to produce a short list of potential vaccine candidates (Figure 4.16).
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Figure 4.16: Reverse Vaccinology Project Flow Diagram. The sections highlighted are those that
have been completed over the course of this chapter and previous chapters and those that are pale
are to be completed in subsequent chapters.
190
Chapter 5
Population Genetics of T. foetus
and T. mobilensis
5.1 Introduction
When creating a vaccine and identifying vaccine candidates, one of the key requirements is that it
must protect against all strains of the pathogen.
In some parasites, such as Theileria [432], there are strain differences that have lead to issues in
vaccine design and production. The vaccine produced against this parasite uses a cocktail from three
isolates in order to cover more genetic diversity [432]. In a similar way, a T. foetus or trichomonad
vaccine may need multiple genetic variants from the strains in one cocktail to produce the most
effective vaccine. However, the T. foetus strains used in my analysis are not from Africa or Asia so
there is relatively little geographic genetic diversity, the strains are from North America, Ireland and
Czechoslovakia. The Theileria vaccine itself is also non-standardised [433] meaning that between
different batches of the vaccine there can be slightly diffrent components. In Theileria, p67 [434]
was used to inoculate cattle. However, only 70% of them were immune when later challenged with
a buffalo strain of Theileria. The buffalo strain is 95% identical to the cattle strain, however, it
does contain a peptide insert.
Amzati et al. (2019)[435] identified multiple polymorphisms in the Theileria genes Tp1 and Tp2,
genes that were potential vaccine candidates. Six variants were found in Tp1 and 9 in Tp2 caused
by 10 and 11 different alleles respectively [435]. The diversity appeared to depend on the geographic
location of the Theileria isolates tested, i.e. isolated from lowland or highland areas. A trivalent
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vaccine is used for Theileria to attempt to combat this, commonly seen, geographic diversity. If
diversity is seen between T. foetus strains from different continents in the candidate genes, a bivalent
or trivalent vaccine may be needed to account for the polymorphisms and diversity.
A bovine trichomoniasis vaccine needs to work against all T. foetus strains circulating in nature; if
the vaccine candidate is significantly different between strains then the vaccine might be unsuccessful
in certain populations or multiple vaccines would need to be created. Furthermore, if the vaccine
candidate is highly polymorphic, it is possible that it could evolve or mutate further, potentially
making the vaccine less effective over time.
Thus, we must select a candidate antigen that confers immunity against all strains of T. foetus.
In this chapter, I employ genome re-sequencing of T. foetus strains to quantify single nucleotide
polymorphisms (SNPs) across the ‘short-listed’ loci to identify those genes that are most conserved
among different T. foetus strains and trichomonad species.
5.1.1 SNPs and Indels
There are many variables that can alter the sequence of a genome: large scale variants such as
transposons, tandem repeats and duplication events and small scale variants such as SNPs and
indels.
Single nucleotide polymorphisms (SNPs) are a change to a single nucleotide base in a genetic
sequence [436]. They comprise 80% of known genetic polymorphisms [437] and can affect the
likelihood of acquiring certain diseases, along with affecting the likelihood of recovery [437]. They
are also commonly used for genetic tests as they can serve as biomarkers [437]. Additionally, it
has been found that SNPs that occur in introns and those that appear to be silent, i.e, changing
a nucleotide which does not change the amino acid, can also affect the function of genes [437].
Insertion deletion variants (indels) add or remove one or more nucleotides from a sequence [436].
They can have impacts in coding and non-coding regions (Figure 5.1).
SNPs can also be used for genotyping and diagnostics [438] for instance, single locus genotyping has
been used to identify different species of Plasmodium in samples, even when they show multiplicity
[439]. The SNP panels produced can help in identifying which Plasmodium species are in the
sample, even when low amounts of DNA are present. 24 SNP markers have been used to identify
Plasmodium falciparum from patients and laboratory samples [440]. SNP biomarkers and single
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locus genotyping have been used to identify speciation in Rickettsia in ticks [441]. This same
procedure could be applied to different trichomonad species to determine if they are the same
species, such as in the case of T. foetus and T. suis and could allow for more accurate phylogenetic
reconstruction.
Figure 5.1: Example of SNPS and an indel in a genetic sequence. Sequence 2 contains two SNPs
and one indel relative to reference sequence 1, highlighted in green and red respectively.
5.1.2 Synonymous and Non-synonymous Mutations
Amino acids show redundancy, meaning that different codons can code for the same amino acid,
this leads to the rise of synonymous and non-synonymous mutations.
Synonymous mutations are mutations that do not change the amino acid coded for, for example,
a change from CGA to CGG will encode arginine [442], therefore they are also known as silent
mutations.
Non-synonymous mutations are mutations that do produce an amino acid change and are also
known as substitution mutations. There are two types of non-synonymous mutations, missense
and nonsense mutations. Missense mutations occur when one amino acid is changed to another,
for example TGC to TGG would change the amino acid from cysteine to tryptophan. A nonsense
mutation changes the amino acid to a stop codon, for example, changing TGC to TGA would
change the cysteine to a stop codon.
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Nucleotide Substitution-dN/dS ratios
Synonymous substitution has been shown to have very little effect on the organisms ability to
survive [443]. The substitutions have been found to be more rapidly appearing in pseudogenes
[443]. Synonymous differences are known as dS and non-synonymous differences are dN. dN is
usually smaller than dS and a dN/dS ratio can be calculated. This ratio estimates how much non-
synonymous evolution (non-neutral) has occurred compared to synonymous selection (neutral). If
the dN/dS is 1, a gene or site is evolving neutrally. If the dN/dS ratio is <1, this suggests that
non-synonymous mutations in a gene or site are selected against (purifying selection). Finally if
the dN/dS ratio is >1, this indicates that the non-synonymous changes are being favoured (positive
selection), and the gene is changing more quickly.
5.1.3 Population Genetics
Population genetics is the study of biological populations and the changes in genetic composition
that occur within and between them [444]. It also aims to explain molecular evolution seen between
populations in addition to their genetic variation [445].
As Tibayrenc et al. (1995) [446] mentions, there are well known issues in classifying different
species within microorganisms. Population genetics assists in finding subdivisions within larger
populations that may otherwise be missed. It can also be used to evaluate how genetic diversity
affects diversity in a practical setting, e.g. drug resistance. T. cruzi, for example, was found to
have two major lineages, each divided into subpopulations. The different subpopulations and their
genetic distances had marked effects on several properties, such as parasitaemia in mice, growth
rate in culture and infectivity [446].
Barry et al. (2009) [447] used 10 potential Plasmodium falciparium candidate antigens from three
stages: pre-erythrocytic, merozoite and gametocyte. It was found that the merozoite antigens had
high levels of diversity and this diversity was spread globally, whereas the diversity of the non-
merozoite antigens was due to physical barriers and different geographic locations. There were high
levels of diversity in countries with high levels of malaria transmission, such as those in sub-Saharan
Africa, and lower levels in the Americas where transmission is known to be low.
The five strains of T. foetus will be sequenced using Illumina sequencing. Each strain originates
either from a different location or a different time point of collection. Strain KV-1 originates
from Czechoslovakia in 1962, strains BP-4 and UT from Beltsville, Maryland in 1956 and 1967
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respectively. Strain DK-2 originates from Davis California in 1967 and the Belfast strain, that has
been used as a reference, is from Belfast in 1938. As the strains of T. foetus are from different
geographic locations, such as Maryland and Czechoslovakia, it would be interesting to see whether
differences in genes is location specific. Furthermore, if a vaccine is created, it must be conserved
in all strains across all continents. For example, the vaccine for P. falciparum mentioned by
Barry et al., [447] seems to be based on low prevalence haplotypes from one subgroup, rather
than representing several global populations of the parasite. They also identified between 3 and
6 subgroups within the antigens. Haplotypes within the subgroups were similar and able to elicit
antibody responses, whereas haplotypes between different subgroups were not similar and could
not elicit the same responses. Furthermore, as the samples were collected decades apart in some
instances, it would be interesting to identify if the year of collection affects the gene expression
and mutations. Using samples from several locations and time points will maximise the potential
variation seen so that vaccine candidates will be present across these strains. This would aim to
create consistent responses by the vaccine candidates, regardless of where the original infection
has been found. However, all strains used are laboratory strains that have been in lab culture for
decades. The length of time the isolate has been in lab culture may also provide interesting results.
Huyse et al. (2005) [448] stated that the environment within the host changes quickly, which leads
to more rapid speciation in parasites. There are also differences between each separate parasite
population and there can be different speciation pressures within these subpopulations [448]. As the
T. foetus strains are, again, from different areas, they may have had different selection pressures.
This could be particularly marked if a comparison was made between feline and bovine strains.
Additionally, parasites tend to have short generation times and fragmented populations [448]. Low
host specificity and host switching can also affect phylogenetic timelines, for instance switching
between cat and cow hosts in T. foetus or different bird species for T. gallinae. There is a large
amount of diversity in natural infections which will affect the number of SNPs present between the
strains and species. Comparing the five T. foetus strains and the T. mobilensis strain could give a
good indication of how much natural variation there is within and between species that need to be
taken into account when choosing the vaccine candidates.
Tajimas D
Tajimas D is a comparison for neutrality used in population genetics. It compares the average
number of pairwise differences with the number of segregating sites [449] [450].
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The equation Tajima’s D is:
D =
θ̂T − θ̂W√
V̂ (θ̂T − θ̂W)
Where θ̂T is the number of pairwise differences or π, V is the variance and θ̂W is the number of
segregating sites.
When Tajima’s D is negative, positive selection is occurring, if the population is not undergoing
changes such as migration or expansion. In this case there are more segregating sites than pairwise
differences [449]. When the Tajima’s D value is positive, balancing selection is occurring and there
are more pairwise differences than segregating sites.
Bottlenecks can have large effects on the Tajima’s D value, as the population expands and recovers
the Tajima’s D value drops sharply before eventually increasing [449]. This is due to the increase in
population leading to a high rate in new mutations [451]. By looking at the Tajima’s D value across
the T. foetus genomes it may be possible to determine whether there has been a recent expansion
of bottleneck in the populations history.
5.1.4 Variants in Trichomonads
As described in Chapter 4, different strains of T. foetus have different cytotoxic and adherence
effects [414] [418], and in some cases these have been traced to individual genetic variants.
Paulish-Miller et al. (2014) [452] identified resistance in T. vaginalis to metronidazole has been
associated with SNPs in two nitroreductase genes: ntr4Tv and ntr6Tv. It was also suggested that
these SNPs could be used as diagnostic tests to identify whether a T. vaginalis strain in an infection
will be metronidazole resistant. It is possible that there are similar SNPs within T. foetus strains
that confer the same resistance, possibly explaining the increase in antibiotic resistance seen in the
species.
Bradic et al. (2017) [228] sequenced 100 isolates of T. vaginalis and identified 72 SNPs related
to metronidazole resistance, predominantly in genes that were deemed ‘hypothetical’ and were
generally enriched in genes showing gene ontology to drug detoxification. SNPs were also identified
that showed convergent evolution between T. vaginalis and T. foetus. They also identified SNPs
for genes that currently have no function.
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5.1.5 Aims and Objectives
This chapter aims to identify the SNPs within the genomes of five strains of T. foetus. These will
then be compared to the list of possible vaccine candidates from Chapter 4 to identify which of
these genes are most conserved across all strains. There are four objectives.
1) The genomes of five T. foetus strains and one T. mobilensis strain will be sequenced using
Illumina sequencing.
2) Map the newly created genomes to the reference PacBio Belfast genome
3) Call the SNPs found between each strain and the reference genome
4) Calculate the population parameters and statistics for each gene, such as Tajima’s D and dN/dS
ratio.
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5.2 Methods
5.2.1 Trichomonad Strains Used
Multiple strains of T. foetus, along with related parasite, T. mobilensis were used. This was to
identify how many SNPs are seen between each strain and the reference T. foetus genome and
whether there are similarities between the different strains and species. In total, five T. foetus
strains were used along with T. mobilensis:
1) T. foetus KV-1 strain-naturally infected from Czechoslovakia (1962) ATCC 30924
2) T. foetus BP-4 preputial washings from Beltsville Maryland (1956) ATCC 3003
3) T. foetus UT Preputial washings from Beltsville Maryland (1967) ATCC 30232
4) T. foetus DK-2 Preputial washings from Davis California (1967) ATCC 30231
5)T. foetus Belfast strain, Belfast, Ireland (1938) ATCC 30166
6) T. mobilensis USA-M776 Bolivian squirrel monkey (1984) ATCC 50116
In the same way as Chapter 4, cells were initially grown in ATCC entamoeba medium before being
passaged into Diamond media. All cells were incubated at 35°C.
5.2.2 DNA Extraction
DNA was extracted from all six strains using the Qiagen ‘All Prep DNA/RNA mini Kit’ as per
the manufacturers instructions. 100µl was of eluted DNA was produced The amount of DNA
and the 260/280 and 260/230 ratios were all calculated using the nanodrop and concentration was
calculated using Qubit.
Strain Concentration (ng/µl) 260/280 260/230 Total DNA amount (µg in 100µl)
Belfast 191.8 2.11 0.71 19.18
KV-1 86.9 1.92 0.36 8.69
DK-2 166.9 1.97 0.93 16.69
BP-4 117.5 2.06 0.54 11.75
UT 155.5 1.90 0.34 15.55
Mobilensis 134.6 1.95 0.34 13.46
Table 5.1: DNA preparation statistics for one T. mobilensis and five T. foetus strains. DNA was
extracted using the Qiagen ‘All Prep DNA/RNA mini kit’, the 260/280 and 230/280 ratios were
calculated using the nanodrop and concentration was calculated using Qubit.
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5.2.3 DNA Sequencing
Sequencing was performed by the CGR at the University of Liverpool using Novaseq SP 2x150bp.
One lane on Illumina Novaseq using SP chemistry (paired-end 2x150bp sequencing), generated an
estimated 325 million clusters per lane (ENA study PRJEB39463).
5.2.4 Sequence Read Processing
The raw fastq files were trimmed using using cutadapt version 1.2.1 [300] to remove Illumina adaptor
sequences. Option -o 3 was used so that the 3’ ends of any reads that match the adaptor sequence
for 3bp or more are trimmed.
The reads were trimmed using Sickle version 1.200 [301] with a minimum window quality score of
20. Reads that were shorter than 15bp after trimming were removed. If only 1 read pair passed
this filter it is included in the R0 file.
5.2.5 Variant Calling
The Genome Analysis Toolkit (GATK) was used to discover variants between the genomes and
to mark the SNPs [453] [454]. The pipeline was used according the GATK best practices. First,
fastQC [455] was used to assess the quality of the sequence files, both R1 and R2. The reads
were mapped to my T. foetus annotated genome using genome using BWA (version 0.7.17 r1188)
[305] [456] which created a SAMfile using samtools (version 1.9) [305]. The resultant SAM file was
converted to a BAM file also using samtools [305].
Picard [457] was used for pre-processing of the BAM files before they were passed to the GATK
pipline [453]. The steps used were: AddorReplaceReadGroups, CleanSam, FixMateInformation,
MarkDuplicates, IndelRealligner, CallableLoci and Haplotype caller.
AddorReplaceReadGroups assigns a unique identifier to each BAM file. This means that identified
SNPs can be assigned to a specific BAM file or sample.
CleanSam cleans the provided BAM file, sets MAPQ to 0 for unmapped reads and performs soft-
clipping beyond the end of the reference alignment.
‘FixMateInformation’ ensures that all mate-pair information is matching between both pairs.
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Duplicates were marked using ‘MarkDuplicates’.The duplicates come from where the same piece of
DNA has been sampled more than once. This can cause errors with finding true variants. BWA
can sometimes ‘clip’ the end of sequence when it has mapped, therefore some fragments, i.e. those
mapped to the reverse strand, can be identified by 3’ instead of 5’. These duplicates can cause
overrepresentation in the sequence quality, therefore, they must be marked and removed from the
samples.
‘IndelRealligner’ was used to reduce the number of mismatched bases between the BAM file se-
quence and the reference genome sequence. It finds the best alternate consensus sequence caused
by the the indels.
‘CallableLoci’ determines which loci can be called and the Haplotype Caller was used to iden-
tify SNPs and indels within the BAM files and were called separately for each sample. Variants
from each sample were joined using the Haplotype Caller and then saved in a variant call format
(VCF) file. The VCF file contains information, such variant position and quality. The GVCF files
of all samples were merged together.
5.2.6 Filtering of SNPS
Just the SNPs were selected using ‘selectvariants’. Those that passed or failed the quality criteria
were tagged using ‘variantfiltration’. Any that lack the PASS annotation were filtered out by
‘selectvariants’. The SNPS were then filtered to genotypes using ‘vcftools’. This produced a list of
all contigs and whether the SNPs possess:
1) homozygous reference i.e two copies of reference allele (0/0).
2) heterozygous for reference genome i.e. one allele is the same as the reference genome and another
is different (0/1).
3)homozygous for non-reference allele i.e. two copies that are not the same as the reference genome
(1/1).
The gene list was processed through a perl pipeline to extract the SNPS and a file was created with
all the SNPs in each gene, their position, the nucleotide change and whether it is a synonymous or
non-synonymous mutation.
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5.2.7 Per Gene Population Statistics
Genome statistics were calculated using popgenome [458] [459]. This programme was used as it
can handle whole genome data. The SNPs that were identified in introns and untranslated regions
were filtered out, as were genes that did not contain SNPs. A list was produced of all the SNPs
present in the exons from the T. foetus strains. Popgenome was used to calculate statistics: the
nucleotide diversity and Tajima’s D values for each protein-coding gene based on the SNPs.
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5.3 Results
5.3.1 Trichomonad DNA Reads
DNA from six trichomonad strains were sequenced by the University of Liverpool CGR. After
trimming there was a range of 108-156 million trimmed reads produced for the different samples
(Table 5.2).
Strain No. Raw Reads No. Trimmed reads
Belfast 113,680,106 113,309,480
KV-1 116,656,664 116,288,048
DK-2 114,995,714 114,636,161
BP-4 157,339,356 156,774,360
UT 123,295,706 122,859,639
T. mobilensis 108,896,432 108,342,358
Table 5.2: Numbers of raw and trimmed reads of Illumina sequenced DNA of multiple trichomonad
strains
5.3.2 Genomic Variation
SNPs were found in 2,543 contigs in the genome when all samples were included: all five T. foetus
strains and T. mobilensis. In the T. foetus samples only there were 102,986 SNPs found over 2,461
contigs. When the number of SNPs per kb was calculated there was a range of 0-72 SNPs per
kb across the genome (Figure 5.2). 60,094 kbs along the genome contained no SNPs, with 26,264
containing 1 and 11,043 containing 2. As the number of SNPs per kb increased, the frequency of
kbs containing that number decreased. Only one kb contained 72 SNPs. There were also three
other kbs that contained 50 or more SNPs.
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Figure 5.2: The frequency of SNP number per kb of the T. foetus genome. Five strains of T. foetus
were used in the analysis and there is a range from 0 to 72 SNPs per kb with the majority of kbs
along the genome possessing 0 SNPS. A trendline was also added.
Strain Heterozygous SNPs Homozygous SNPS
Belfast 9,009 1,440
DK-2 15,576 24,930
UT 23,037 52,328
BP-4 8,806 1,435
KV-1 22,826 52,441
T. mobilensis 787,776 33,928
Table 5.3: The number of homozygous and heterozygous SNPs found in different strains of T. foetus
and T. mobliensis when compared to the reference T. foetus Belfast strain genome annotation.
Between all of the trichomonad samples there are very large differences in the number of SNPs
found (Table 5.3). For instance, T. mobilensis was found to possess 787,776 heterozygous SNPs,
meaning one copy was the same as the genome reference and one copy was different and 33,928
homozygous SNPs where both copies possessed a different nucleotide to the reference. This is over
30 times higher than any of the T. foetus samples.
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Within the T. foetus samples, there was, again, a large range of SNP number, with the Belfast and
BP-4 strains having 1,440 and 1,435 homozygous SNPs respectively and the UT and KV-1 strains
having over 52,000 homozygous SNPs. The number of SNPs were relative to the original Belfast
strain reference genome, produced by PacBio sequencing.
5.3.3 SNPs in Gene List
When all the trichomonad strains were used in the SNP analysis, five T. foetus and one T. mo-
bilensis, in total 2,023 SNPs were identified in the antigen shortlist (77 genes). There were 1,126
non-synonymous mutations and 897 synonymous mutations found. There was a large range of SNP
number between the different genes, with 2 SNPs identified in TTF14449 and 265 SNPs identified
in TTF45042 (Table D1). Every gene contained at least one SNP and there were only two genes
that did not contain any non-synonymous mutations, TTF00576 and TTF08916.
When only the T. foetus strains are compared with the reference genome, the number of SNPs
identified per gene are significantly lower, with the highest number being 35 in TTF04635. In total
there were 174 SNPs found; 133 non-synonymous and 41 synonymous (Table D1). There are 23
genes that do not contain any SNPs.
Across the shortlist there was a range in dN/dS ratio with 31 of the T. foetus only genes having a
ratio of 1 or 0 and one gene (TTF75601) having a ratio of 8.
5.3.4 Whole Genome Statistics
Across the 21,053 genes of the T. foetus samples that contained SNPS, the Tajima’s D values were
spread from -2 to 3. There were 18,888 genes that were identified as having a positive Taijima’s
D value and 2,161 that had a negative value. Those with a value of 0 had been filtered out of the
analysis in a previous step due to not possessing any SNPs.
As 21,000 genes from the strains out of a total of 84,000 genes in the T. foetus genome contained
SNPs, one quarter of the genome appears to be under selection pressures.
There is a weak positive correlation between the Tajima’s D values and nucleotide diversity (Figure
5.3). The overall majority (66,600) of genes in the strain genomes have a nucleotide diversity of 0 as
they have been filtered out due to not possessing SNPs and 13,396 genes have a nucleotide diversity
between 0 and 1. However, four genes (TTF25397, TTF03299, TTF33699 and TTF77035) have a
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nucleotide diversity of over 40 in terms of mutated sites. Overall, the majority of genes (75%) in
the T. foetus genome appear to have a nucleotide diversity of 0 and 90% have one changed site or
less.
Figure 5.3: Tajima’s D value compared to log10 nucleotide diversity, in terms of number of changes,
of genes containing SNPs between the T. foetus samples and the reference T. foetus genome. SNPs
between only the different T. foetus strains and the reference genome were taken into account.
Both the Tajima’s D value and nucleotide diversity were calculated using Popgenome [458][459] in
R.
5.3.5 Gene Shortlist
The genes in the shortlist were given a score according to certain criteria. The total number of
SNPs, both synonymous and non-synonymous; the fold change was the expression of each gene in
the presence of a cell monolayer relative to controls grown in Diamond media and peptide immuno-
genicity is a measure of all of the immunogenic epitopes seen in both the natural and experimental
infections as identified by the peptide array. The scores for each criterion were calculated and added
together. The genes were ranked based on their total score and the top 8 were selected (Table 5.4).
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Gene ID Product Total no. of SNPs Gene Expression FC
Total No.
Immunogenic
peptides
TTF53402
hypothetical protein
TRFO 12669
0 1.88 163
TTF00910
hypothetical protein
TRFO 06137
0 1.85 151
TTF05727
hypothetical protein
TRFO 04170
0 10.31 0
TTF73824
hypothetical protein
TRFO 29759
1 1.39 91
TTF72511
hypothetical protein
TRFO 29759
5 5.59 90
TTF08916
hypothetical protein
TRFO 04830
0 8.81 0
TTF48521
hypothetical protein
TRFO 11786
0 7.13 0
Table 5.4: Vaccine candidate gene shortlist. All genes fulfil the vaccine candidate criteria from
previous chapters including the presence of a transmembrane domain. They contain few or no non-
synonymous or synonymous mutations in any T. foetus strain examined relative to the T. foetus
reference genome. They are also preferentially expressed in the presence of a cell monolayer relative
to controls and for those that were used in the peptide array, they have a high combined total of
immunogenic peptides from both experimental and natural infections.
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Figure 5.4: 3D plots, shown from different angles, (A, B and C), created in R showing the SNP
number, immunogenicity and fold change of the vaccine candidate shortlist. The total number of
SNPs includes both synonymous and non-synonymous mutations, the fold change was the expression
of each gene in the presence of a cell monolayer relative to controls grown in Diamond media. The
peptide immunogenicity is a measure of all of the immunogenic epitopes seen in both the natural
and experimental infections as identified by the peptide array. The 8 points highlighted in red are
those in the final gene shortlist as, when all genes were ranked according to all three criteria, these
had the highest final score and were therefore, most suitable for taking forward for further testing.
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5.4 Discussion
This chapter aimed to identify the SNPs in five T. foetus strains relative to the assembled and
annotated Belfast strain genome and to see whether SNPs were present in the list of possible vac-
cine candidates from Chapter 4. Overall, the short list of 77 candidates has been reduced to 8 well
conserved antigen genes (Table 5.4).
Commonly, SNPs can produce issues for designing vaccines, for example, the Plasmodium falci-
parum circumsporozoite protein (PfCSP) [460] is a well studied, potential vaccine candidate for
malaria. However, genetic polymorphisms, such as SNPs could be an issue regarding the efficacy of
the vaccine. In Myanmar, 51 full length genes were amplified from blood samples from 51 patients
and polymorphic diversity was analysed. Polymorphic diversity was also analysed from other, pub-
licly available PfCSP genes as a comparison [460]. Low genetic diversity was seen in the global
population but there were geographic differences. The central repeat region of the Myanmar PfCSP
was found to be highly polymorphic, whereas the N and C-terminal repeat regions were conserved.
The differentiation between geographic isolates showed evidence of recombination which would need
to be taken into account for a vaccine.
Saralamba et al. (2018) [461] also analysed blood samples from 89 Malaria patients from vari-
ous Asian countries in addition to 58 previously published Plasmodium falciparum sequences from
Africa. There was clear clustering of isolates by geographic origin with high genetic differentiation
between the Asian and African countries [461]. They also identified fewer genetic repeats in the
Asian samples but these also showed higher nucleotide diversity [461].
5.4.1 Whole Genome SNPs
Across the whole genome, there were more genes with a positive (18,888) Tadjima’s D value than
negative (2,161) suggesting a potential lack of rare alleles or the genes are undergoing balancing
selection. Additionally, the nucleotide diversity, in terms of mutated sites, across 90% of the genome
was either 0 or less than 1 suggesting that the majority of genes are not undergoing mutations or
strong selection pressures.
All strains used were laboratory strains, not natural infections, and had been obtained from North
America and Europe. In order to identify whether a vaccine cocktail would be required, it would
be beneficial to analyse SNPs from T. foetus strains found in different continents, such as Africa
or Asia.
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5.4.2 SNP Number Between Strains
There was a much larger number of heterozygous SNPs found in the T. mobilensis sample compared
to the T. foetus samples. This is due to the fact that T. mobilensis is less genetically similar to the
reference genome which was created from the Belfast T. foetus strain. The re-sequenced Belfast
strain has a low number of homozygous SNPs compared to T. mobilensis and the other T. foetus
strains, apart from strain BP-4. This low number, 1,440 is to be expected as the original reference
genome was created from the Belfast strain. It is, therefore, surprising that BP-4 also has a similar
number of homozygous SNPs, 1,435 and an even lower number of heterozygous SNPs (8,806)
compared to the Belfast 9,009 (Table 5.3). In Giardia [462] there were over 100,000 SNPs found so
this number seems inkeeping if low.
The SNPs seen between the original PacBio reference and the Illumina re-sequenced Belfast sample
may be due to the differences in genome sequencing, especially as it is known that PacBio sequencing
can have a relatively high error rate [224]. Additionally several years had passed between the original
sequencing and the re-sequencing and so changes to the Belfast strain could have occurred in the
lab.
There do not appear to be clear similarities in number from strains from the same geographic areas,
for instance, the two T. foetus strains that were isolated in Beltsville, Maryland (BP-4 and UT)
have very different SNP numbers. There were 8,806 heterozygous SNPs identified for BP-4 and
23,037 for UT and 1,435 homozygous SNPs identified for BP-4 and 52,328 for UT (Table5.3). The
number of SNPs between all of the American samples seems highly variable. There may be a large
amount of variation between strains, in a similar way to malaria in Africa.
However, when the number of SNPs between the feline strain of T. foetus and the bovine and
porcine strains were compared, only 68 SNP heterozygous variants were found between the bovine
and porcine samples [120], much lower than any comparison seen in my analysis (Table 5.3). When
the feline strain was compared to the bovine and porcine strains, 65,569 and 65,615 SNPs were
identified respectively [120]. This suggests that the different geographic regions and time points
when the samples were collected appear to have a large effect on the genetic distinctness of the
strains.
All the T. foetus strains used in these experiments were laboratory strains, first isolated over 50
years ago. The adaption of these strains to lab culture and freeze-thawing of samples could have
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lead to a change in genetic diversity, such as bottle-necking or an overall general loss of diversity.
Comparing the findings here to freshly isolated strains may further genetic differences.
5.4.3 Shortlist of Vaccine Candidates
The genes chosen as the vaccine candidate shortlist have no or very few synonymous or non-
synonymous mutations between themselves and the reference genome, suggesting that these genes
are not subjected to high selection pressures and do not commonly mutate. In this way, they
are more likely to be structurally invariant. Additionally, they fulfil the criteria of the previous
chapters of containing a transmembrane helix. They are also all preferentially expressed in the
presence of a host monolayer. For those that were present in the peptide array, all show a high
number of immunogenic epitopes. Furthermore, TTF08916 has no non-synonymous mutations
when T. mobilensis is used in the analysis, so there may be the possibility of a cross species vaccine
candidate.
As many of these genes do not contain either synonymous or non-synonymous SNP mutations they
were filtered out at an earlier stage. Due to the lack of mutations, their Taijima’s D value, nucleotide
diversity and the dN/dS ratio will be 1. These genes have been found to contain transmembrane
motifs, are have increased expression in the presence of the host and appear to be structurally
invariant across the populations.
Genes were looked at using Phyre, InterProScan [281] [282] and BlastP [278]. Looking at the amino
acid composition, all vaccine candidate genes have more serine (S), threonine (T) and asparagine
(N) residues than would be expected on average. Serine, threonine and asparagine are routinely sites
for glycosylation [463] so it is highly likely that the genes are heavily glycosylated and decorated
with sugars. This is usually indicative of cell-cell interactions [464].
1) TTF53402 is 1560 amino acids in length and has a combined serine, threonin and asparagine
(S+T+N) value of 21.7%. It also was found to have an interpro [281] [282] match to a bacterial
invasin protein (IPR008964) and has a homolog in T. vaginalis (XP 001329076.1). There was also
a Phyre match to a sugar binding protein (confidence 99%, coverage 9%). This suggests that this
gene is a glycoprotein but not a member of any recognised family.
2) TTF00910 is 1764 amino acids in length and has an S+T+N of 25.1%. InterProScan showed no
domains, however, Phyre [465] shows a match to a viral glycoprotein (confidence 86.8%, coverage
3%).
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3) TTF05727 is 236 amino acids in length and has an S+T+N of 19.9%. like TTF53402 it has
a homolog in T. vaginalis (XP 001302612.1), however, like TTF00910 InterProScan showed no
domains. There is also a Phyre match to a member of e2f family of transcription factors (100%
confidence, 73% coverage).
4) TTF73824 is 943 amino acids in length and has an S+T+N of 25.3%. No homologs or domains
were identified but there was a Phyre match to an alginate lyase (confidence 87%, coverage 54%).
This may be a similar enzyme which is involved in the breakdown of host proteins.
5) TTF38179 is 1068 amino acids in length and an S+T+N of 25.5% and contains a PT-domain
found in bacteria and phytophthora and may fulfil a similar function.
6) TTF72511 is 153 amino acids in length and an S+T+N of 26.1% and contains no homologs or
domains.
7) TTF08916 is 153 amino acids in length and an S+T+N of 19.0%. It has a homolog in T. vaginalis
(XP 001314982.1)but no matches with InterProScan. Like TTF05727 it has a Phyre match to an
e2f family of transcription factors (100% confidence, 89% coverage).
8) TTF48521 is 529 amino acids in length and an S+T+N of 25.5% and like TTF08916, TTF53402
and TTF05727 it has a homolog in T. vaginalis (XP 001320645.1). Though there were no InterPro
domains, Phyre matched to an alginate lyase, in a similar way to TTF73824 (96.8% confidence,
23% coverage).
The genes in the shortlist suggest that they have some capacity for cell-cell interactions, namely
in their high serine, threonine and asparagine content and the likelihood that they are highly
glycosylated. As three have homologs in T. vaginalis, they appear conserved, another advantage
for a vaccine candidate.
5.4.4 Conclusion
In this chapter, SNPs between the five T. foetus strains and one T. mobilensis strain have been
identified. These SNPs, both synonymous and non-synonymous, have been crosschecked with the
vaccine candidate gene list produced in Chapter 4 in order to identify which, if any, candidates are
structurally invariant across populations (Figure 5.5). Eight genes were identified from the shortlist
of 77 genes that possessed few, if any SNPS, were upregulated in the presence of the host and many
showed strong immunogenic responses in the peptide array. These genes can then be tested to see
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if it is possible to express them in other organisms, such as yeast and preliminary clinical trials
could be performed.
Figure 5.5: Flow diagram showing the reduction of genes from the T. foetus genome from the
initial annotation (87,000 genes) to a final set of 8 genes. The genes were tested for their structure,
presence of transmembrane helices, immunogenicity and upregulation in the presence of the host.
They also appear to be structurally invariant across the populations tested.
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Chapter 6
General Discussion
This thesis describes the identification of vaccine candidate antigens against the bovine parasite
Tritrichomonas foetus. Starting from the assembly and annotation of the T. foetus genome to
identifying a small subset of putative cell surface antigens as potential vaccine candidates.
The T. foetus genome was assembled using a variety of methods to produce a final genome size of
147Mb. Open reading frames were identified and manually curated. This yielded a gene set of 84,756
genes. A network was produced containing the entire predicted T. foetus cell surface predicted
proteome, showing gene families from T. foetus and T. vaginalis. The proteins included had key
features that would make them likely to be cell-surface expressed. Fifty proteins were selected from
the network. These proteins were used in a peptide array to test the immunogenicity of the epitopes
of the peptides produced. This produced a list of peptides with the highest number of immunogenic
epitopes and high maximum intensity which could be highly credible vaccine candidates.
Several strains of T. foetus and T. mobilensis were grown in co-culture with a confluent MDCK
monolayer and transcriptomes were produced. This was to identify genes that were expressed in
the presence of the host cells. The genes that were found to be preferentially expressed in the
presence of the host cells were cross-checked with the peptide array proteins to produce a list
of 77 candidate antigens. These candidate antigens were examined for SNPs to see if they were
structurally invariant. The genes were then cross-checked, comparing the number of immunogenic
epitopes, transcriptomic fold change in the presence of a host monolayer and number of SNPs
relative to the reference genome. The genes were ranked for each of these attributes and the total
scores across the three criteria were calculated. In total, the 8 genes with the highest scores were
selected.
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6.1 Future Steps in Vaccine Development
As stated by Rappuoli et al. (2016) [197] and Dalsass et al. (2019) [466] one of the next steps in
determining the most successful vaccine candidates is the expression of the proteins. The proteins
from the genes in the shortlist could be expressed in vitro either in Escherichia.coli or a yeast such as
S. cerevisiae. This is particularly important as the proteins need to be expressed with the correct
post-translational modifications (PTMs), such as glycosylation. The cell-surface localisation of
these proteins also has to be confirmed experimentally and B and T cell epitopes could be predicted
bioinformatically [197]. Furthermore, trials could be performed using either individual proteins, or
a cocktail of proteins, first in mice and then in cattle to test for their protective effect in challenge
experiments. A range of adjuvants would also have to be trialled and tested to see which gives the
highest immunological effect [197] [466] and so can go forward to preliminary clinical trials.
6.1.1 SNPs between strains
It would be interesting to know whether there is an increase in SNPs between strains of T. foetus
that infect different hosts, such as comparisons between feline, bovine and porcine strains. All
strains examined in this thesis were originally isolated from infected cattle and show a large range
in SNP number, so there is likely to be even greater differences between strains from different host
species. Furthermore, if some of the 8 vaccine candidates identified were also found to not possess
SNPs in the feline isolated strains, there may be potential for a vaccine that can protect multiple
host species, although there are known to be large numbers of SNPs between the feline and bovine
T. foetus strain [467]. However, if vaccine candidates can be identified between five T. foetus strains
and T. mobilensis, a related but distinct species, it is likely that genes containing no SNPs between
the different T. foetus genotypes can be found.
Additionally, as two genes within the 77 candidate antigen shortlist were found that did not possess
any SNPs when all five T. foetus and the T. mobilensis samples were compared with the reference,
it may be possible to find genes from other trichomonad species that are conserved, such as T.
gallinae or T. vaginalis. This may lead to a trichomonad vaccine.
6.1.2 Recombinant expression
One of the key criteria for a vaccine candidate is its ability to be expressed recombinantly so that it
can be produced in large quantities. Producing a recombinant vaccine protein involves transfecting
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cells with the gene of interest inserted into a vector. A protein can then be produced by the host
cell and this can be harvested, purified and used.
Both prokaryotic and eukaryotic expression systems are widely used [468].
Bacterial expression systems are useful because they are relatively cheap, easily scalable and easy
to mass produce proteins [468]. Zhang et al. (2020) [469] [470], for example, used E. coli to
express proteins against Toxoplasma and T. vaginalis. However, there can be issue when expressing
mammalian proteins and they can form inclusion bodies and also do not have the ability to add
post translational modifications (PTMs), such as glycosylation [468]. E. coli and other bacteria
can also produce low yields and inclusion bodies [471].
Yeast can express eukaryotic proteins and also has the advantage of being able to express secreted
proteins as well as intracellular proteins [468]. It can also produce both O-linked and N-linked
glycosylation, both of which are found in T. foetus [414]. The yeast Pichia pastoris has been found
to have advantages over S. cerevisiae [471]. S. cerevisiae contains sugars, for example, mannose
[472] that can affect glycosylation and so these sugars need to be removed before the recombinant
protein is produced. S. cerevisiae can also hyper-glycosylate the protein by adding hundreds of
mannose residues. K. phaffii or Pichia pastoris comparatively, adds fewer residues, which can
somewhat overcome the problem.
Glycosylation and glycosylation profiles are important for several reasons. Certain antibodies can
recognise glycosylation [473] and can also be blocked by glycosylation in high levels [474] and can
prevent the protease action of antigens [474]. Key proteins involved in antigen recognition, such as
the Major Histocompatibility Complex (MHC) are glycosylated [474] and the patterns of which can
also affect MHC uptake. MHCs can present glycopeptides and this may affect T-cell recognition.
Mammalian cell culture systems also allow for glycosylation but do not have the potential drawback
of over-glycosylation of proteins, however, it is much more expensive [468]. Additionally, different
mammalian cell lines have different glycosylation effects, e.g CHO or HEK cells [475] so this has
to be taken into account when choosing cell lines. CHO cells, for example, do not express certain
glycosylation enzymes (Gal α-2,6 ST, and α-3/4 fucosyltransferase) which, in human cells at least, is
required for certain glycostructures and human-glycoproteins. Additionally, when glycans produced
by both CHO and HEK cell lines were compared, HEK cells had more complicated glycosylation
profiles [475]. Specific yields from mammalian cells lines can be very low and expensive to produce
[471].
Pichia pastoris was also deemed as more useful than E. coli and S. cerevisiae by Morton et al.
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[476] (2000). When rabbit liver carboxylesterase was expressed in E. coli, Pichia pastoris and S.
cerevisiae different amounts of enzymatic activity were seen in the recombinant proteins. Very little
enzymatic activity was identified in the recombinant protein produced by E. coli and little by S.
cerevisiae, however, active protein was produced using Pichia pastoris.
As T. foetus appears to use both O-linked and N-linked glycosylation [414], either the yeast or
mammalian cell culture systems would appear to be the best method for protein expression. The
vaccine candidate gene would need to be able to be expressed in some form so that it could be mass
produced and used in clinical trials
6.1.3 Serum Lysis Assays
In order to test for the protective effect of the candidates and whether antibodies or complement
have been produced, several methods have been developed. Serum from animals post infection is
extracted and added to T. foetus cells to see whether they induce killing of the parasites. Zhang
et al. [469] [470] collected antisera from both rats and mice that had been injected with Freund’s
adjuvant and recombinant proteins, either TvAP33 for the T. vaginalis experiments or TgTH for
the Toxoplasma experiments. This antisera was then used in later expression and localisation ex-
periments.
Meulenbroek et al. (2014) [477] used non-quantitative haemolytic assays to assess the lysis capa-
bilities of serum from patients on bromelain-treated red blood cells (RBCs). Fluorescently labelled
cells were used in combination with FACS for spectrophotometric detection of lysate, for example,
haemoglobin in the case of red blood cells. Whereas, Stasilojc et al. (2020) [478] used calcein
release to measure serum complement activity and Costabile et al. (2010) [479] used a CD50 assay
to measure the complement response induced. This CD50 assay tested the capability of serum from
sheep to lyse sheep red blood cells that are coated with haemolysin. A similar assay could be used
to show how strongly this pathway is induced in cattle that have been infected with T. foetus.
Weerts et al. (2019) [480] used a bacteriocidal shigella assay to measure the antibody killing ability
and activating complement response in serum from rabbits, i.e. where there is attachment and lysis
of the bacteria (or parasite) by the antibodies found in the serum. This also has the advantage that
it can be performed in 96-well plates so it has high throughput abilities and could also be used to
quantify antibody titres.
Another way of measuring antibody production and damage in the sera is using the Sabin-Feldman
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dye test. Dando et al. (2001) used this method [481] to identify whether antibodies were present
in sera of clinical patients against Toxoplasma. If antibodies are present, they prevent methylene
blue from entering the Toxoplasma cells. If cells do stain blue, however, there are no antibodies.
This provides an easy to quantify result. One of these methods, or a combination of methods could
be used to identify whether infected cattle have produced functional antibodies against T. foetus
infection.
6.1.4 Expression localisation
It has been shown that the vaccine candidate genes all possess a transmembrane helix that suggests
that the protein is located on the cell surface based on its primary and secondary structures.
However, the cell-surface localisation of the proteins would need to also be confirmed experimentally.
Zhang et al. (2020) [469] used cell-surface localisation for both Toxoplasma [469] and T. vaginalis
[470]. Toxoplasma cells were fixed on slides, washed using rat antiserum, PBS and then goat anti-rat
IgG antibody with Cy3 labelling. This was in order to fluorescently label the proteins of interest.
DAPI was added to identify the nucleus, and cells were examined using fluorescence microscopy.
Meissner et al. (2011) [482] similarly used fluorescent tags and microscopy to determine cell-surface
localisation. They used GFP tags with C. elegans then fluorescently imaged the cells to identify
localisation of body wall muscle (sarcomeric) genes.
Molecular sensors can now also be used [483] by way of the co-localisation of fluorescent markers,
however this is low throughput. Fitzgerald et al. (2020) [483] have developed a SNAP-tag substrate
that can be conjugated to the protein of interest and the trafficking of said protein can be detected
using flow cytometry. This allows for quantitative tracking of the protein localisation. The SNAP-
switch is a localisation sensor. When the SNAP-switch interacts with the SNAP-tag a quencher
molecule is transferred to the SNAP-tag and a Cy3 fluorophore becomes permanently attached to
the protein of interest. The fluorescence can then be measured and tracked [483].
Cell surface localisation can also be determined biochemically. Besingi et al. (2015) [484] used
susceptibility to extracellular protease digestion as a way of identifying if a protein of interest is
on the cell surface. An intracellular reporter protein is attached (in bacteria) that is undigested if
the membrane remains intact but is digested when cells are lysed. The intracellular reporter will
have access to the extracellular protease if the protein it is attached to is on the cell surface but, if
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it remains within the cell, the protein will not be digested. These techniques could provide further
evidence that the 8 T. foetus candidate antigens are indeed cell-surface expressed.
6.1.5 Challenge Models
Challenge experiments are needed to show that the vaccine candidates confer protection against
the pathogen or disease. Mice or cows are given the vaccine and then challenged by infection with
the parasite to see if there is a reduction in severity or length of the infection or no infection at all.
In experiments performed by Zhang et al. (2020) [470] on the T. vaginalis adhesion protein, 80
Balb/c mice were used. They were split into four groups of 20 mice and were injected with the T.
vaginalis putative recombinant adhesion protein TvAP33 with an adjuvant. They were vaccinated
3 times with the protein on day 0,14 and 28. On day 38 the mice were challenged using 1x107 T.
vaginalis parasites any mice that showed clinical signs in the following month were euthanised. The
survival rate of the mice was significantly higher when the protein was used than in the controls,
with 100% survival 20 days after the challenge. In order to identify whether immunity is long
lasting when T. foetus antigens are used, further challenge experiments would be needed, at least
a month, two months and six months. this would show whether there is immune memory and the
initial results seen are not only the immediate vaccine response. Current T. foetus vaccine attempts
provide only short term immunity and so multiple vaccinations and boosters are needed which is
not practical in large herds.
Zhang et al. (2020) [469] also performed a similar experiment with Toxoplasma. Mice were again
immunised 3 times and challenged 10 days after last inoculation. The survival rate was measured-
after 30 days post challenge, the brains of all mice were removed and analysed to identify the number
and size of Toxoplasma cysts present. It would seem that a similar experiment could be performed
using T. foetus proteins once they have been shown to be recombinantly expressed. Ideally the
vaccine candidates would induce CD4+ T cells as these play a key role in B cell proliferation and
switching [197]. CD4+ effector activity is also commonly needed against parasite infections [197].
The antigens could be trialled both individually and in combination to identify which has the most
protective effect against T. foetus.
Challenge experiments are also commonly performed in cattle as there are clear physical differences
between mice and cattle, these would prove to be a more accurate experimental model for a T.
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foetus vaccine. Edrington et al. (2013) [485], for example, used a challenge model of Salmonella
in the lymph nodes of cattle. Calves were vaccinated with a commercially available Salmonella
vaccine and then challenged with Salmonella after 14 days. The Salmonella was recovered from
the lymph nodes of fewer vaccinated calves than controls and a modest vaccine effect was identified.
Albanese et al. (2018) [486] used a similar method with chickens. They used chickens to test a
Coccoidia vaccine with readings were taken 7 days post challenge to evaluate acquired protection.
In this case the challenge experiment showed that the vaccine was successful.
Cooper et al. (2018) [487] used human challenge models for evaluating malaria vaccine candidates,
they were also able to test multiple strains. Multiple testing in this way facilitates pre-clinical
development and can allow for faster clinical trials, particularly as multi-strain vaccines can be
more relevant for immunity. Challenge experiments using candidates found in multiple strains of
T. foetus could lead to faster and more relevant clinical trials in cattle.
6.1.6 Mouse and cattle trials
Matuschewski et al. (2012) [488] tested their vaccine for malaria using murine infection models.
All vaccines require clinical trials before they can be licensed. Mouse models allow for larger scale
pre-clinical experiments than using cattle would allow due to their small size and relatively low
cost comparatively to cows. In malaria, a vaccine candidate that was thought to be successful in
phase II trials, SPf66, was later found out to not have a significant protective effect in phase III
trials [488]. As there was no mouse model for this candidate it led to great difficulties to make
improvements to the vaccine design.
After experiments in mice are performed, there would also need to be experiments performed in
cattle, as these are the species the vaccine is designed for and because there are clear physiological
differences between mice and cows. They may have different immune responses or susceptibilities
that are not shown through mouse trials alone.
When Buddle et al. (2013) [489] were testing an oral TB-BCG vaccine against M. bovis they
identified parameters that affect vaccine efficacy in the cattle tested. These included: age of the
cow, as calves less than 1 month had the best efficacy, dose, pre-exposure to M. bovis and the strain
of BCG used. Similar criteria would have to be taken into consideration for a T. foetus vaccine and
trials, particularly the age of the cattle and strain of T. foetus. Duration of infection and timing
of booster vaccinations would also need to be considered. As mentioned in the introduction, older
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bulls are usually more affected by T. foetus than younger bulls [25]. It has also been shown in
this thesis that different strains of T. foetus have different levels of cytotoxicity and so may show
different effects in trials or challenge experiments.
When Farooq et al. (2019) [490] were testing a vaccine for haemorrhagic septicaemia, they had to
test whether it was safe in multiple types of cattle. This is also relevant for a T. foetus vaccine
as there are many breeds of cows and they can be affected differently by T. foetus. As mentioned
in the introduction certain species and breeds of cow are more likely to retain T. foetus infection
than others [26]. For example, Bos taurus are more likely to retain infection than Bos indicus,
particularly the Angus, Simmental and Charolais breeds [26]. Testing the vaccine candidate in
multiple breed and species of cattle could lead to clearer picture of how effective the vaccine is,
particularly as natural infections could show greater variation than laboratory infections.
6.2 Conclusion
In this thesis, a T. foetus genome has been sequenced and assembled, and annotated using diverse
transcriptomic evidence. The basis for the selection of candidate antigens depended on a set of
assumptions set out in the general introduction. Assumptions such as these are necessary, par-
ticularly when the identity of proteins is unknown and there are many thousands to reduce the
diversity to a manageable list of candidates. These assumptions are based on rational criteria but
may not always be accurate, meaning that some potentially useful antigens are ignored. From
a total number of 84,706 protein-coding genes, 2,807 were identified to be cell surface expressed
and parasite specific using in silico methods. Of these, 77 genes were identified from proteomic
and transcriptomic assays to be both preferentially expressed in the presence of host cells and also
among the most immunogenic antigens in natural and experimental infections. Population genetic
approaches were used to examine the predicted antigens for structural variation amongst parasite
strains. Finally, 8 antigens have been identified as the most likely T. foetus vaccine candidates
because they have highly conserved protein structures across the parasite population. These can-
didates are now available to move to the next stages in the reverse vaccinology pipeline, such as
recombinant expression and challenge experiments, and may provide a way towards eradicating
bovine trichomoniasis in livestock across the globe.
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[4] C. Yao and L. S. Köster, “Caprine prion gene polymorphisms are associated with decreased
incidence of classical scrapie in goat herds in the United Kingdom,” Veterinary Research,
vol. 42, 2011.
[5] R. H. BonDurant, “Venereal Diseases of Cattle: Natural History, Diagnosis, and the Role
of Vaccines in their Control,” Veterinary Clinics of North America: Food Animal Practice,
vol. 21, no. 2, pp. 383–408, 2005.
[6] K. C. Ribeiro, L. H. Monteiro-Leal, and M. Benchimol, “Contributions of the Axostyle and
Flagella to Closed Mitosis in the Protists Tritrichomonas foetus and Trichomonas vaginalis,”
The Journal of Eukaryotic Microbiology, vol. 47, no. 5, pp. 481–492, 2000.
[7] M. Benchimol and F. Engelke, “Hydrogenosome behavior during the cell cycle in Tritri-
chomonas foetus,” Biology of the Cell, vol. 95, no. 5, pp. 283–293, 2003.
[8] R. F. Madeiro Da Costa and M. Benchimol, “The effect of drugs on cell structure of Tritri-
chomonas foetus,” Parasitology Research, vol. 92, no. 2, pp. 159–170, 2004.
[9] A. Pereira-Neves, C. M. Campero, A. Mart́ınez, and M. Benchimol, “Identification of Tritri-
chomonas foetus pseudocysts in fresh preputial secretion samples from bulls,” Veterinary
Parasitology, vol. 175, no. 1-2, pp. 1–8, 2011.
[10] W. Amos, A. Grimstone, L. Rothschild, and R. Allen, “Structure, protein composition and
birefringence of the costa: a motile flagellar root fibre in the flagellate Trichomonas,” Journal
221
of Cell Science, vol. 35, no. 1, 1979.
[11] W. E. Sledge, A. D. Larson, and L. T. Hart, “Costae of Tritrichomonas foetus: Purification
and chemical composition,” Science, vol. 199, no. 4325, pp. 186–188, 1978.
[12] M. Rosa, I; de Souza, W; Benchimol, “High-resolution scanning electron microscopy of the
cytoskeleton of Tritrichomonas foetus,” Journal of Structural Biology, vol. 183, no. 3, pp. 412–
418, 2013.
[13] Kstate, “Animal Parasitology https://www.k-state.edu/parasitology/625tutorials/Protozoa10.html
(Accessed 19.5.20).”
[14] Cornell, “Tritrichomonas foetus: What shelters need to know – Gimme Shel-
ter https://blogs.cornell.edu/cornellsheltermedicine/2014/07/01/tritrichomonas-foetus-
illu/comment-page-1/ (Accessed 10.5.20).”
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Veloso, D. B. Petrópolis, E. Cupolillo, and G. B. Domont, “Cysteine peptidase expression in
trichomonas vaginalis isolates D isplaying High- And low-virulence phenotypes,” Journal of
Proteome Research, vol. 8, no. 3, pp. 1555–1564, 2009.
[171] P. Cuervo, E. Cupolillo, C. Britto, L. J. González, F. C. e Silva-Filho, L. C. Lopes, G. B.
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senböck, “First evidence of previously undescribed trichomonad species in the intestine of
pigs?,” Veterinary Parasitology, vol. 185, no. 2-4, pp. 86–90, 2012.
[254] V. Hampl, A. Pavlicek, and J. Flegr, “Construction and bootstrap analysis of DNA
fingerprinting-based phylogenetic trees with a freeware program FreeTree: Application to
trichomonad parasites,” International Journal of Systematic and Evolutionary Microbiology,
no. 51, pp. 731–5, 2001.
[255] A. Fahad Alrefaei, R. Low, N. Hall, R. Jardim, A. D. Avila, R. Gerhold, S. John, S. Steinbiss,
A. A. Cunningham, B. Lawson, D. Bell, and K. Tyler, “Multilocus Analysis Resolves the
European Finch Epidemic Strain of Trichomonas gallinae and Suggests Introgression from
Divergent Trichomonads,” Genome Biology and Evolution, vol. 11, no. 8, pp. 2391–2402,
2019.
[256] N. T. Reem, H. Y. Chen, M. Hur, X. Zhao, E. S. Wurtele, X. Li, L. Li, and O. Zabotina,
“Comprehensive transcriptome analyses correlated with untargeted metabolome reveal dif-
ferentially expressed pathways in response to cell wall alterations,” Plant Molecular Biology,
vol. 96, no. 4-5, pp. 509–529, 2018.
[257] H. Tan, J. Zhang, X. Qi, X. Shi, J. Zhou, X. Wang, and X. Xiang, “Correlation analysis
of the transcriptome and metabolome reveals the regulatory network for lipid synthesis in
developing Brassica napus embryos,” Plant Molecular Biology, vol. 99, no. 1-2, pp. 31–44,
2019.
[258] M. C. Frith, M. Pheasant, and J. S. Mattick, “The amazing complexity of the human tran-
scriptome,” European Journal of Human Genetics, vol. 13, no. 8, pp. 894–897, 2005.
[259] S. K. Kushwaha, V. Kesarwani, S. Choudhury, S. Gandhi, and S. Sharma, “SARS-CoV-2
transcriptome analysis and molecular cataloguing of immunodominant epitopes for multi-
epitope based vaccine design,” bioRxiv, p. 2020.05.14.097170, 2020.
[260] A. Zawawi, R. Forman, H. Smith, I. Mair, M. Jibril, M. H. Albaqshi, A. Brass, J. P. Derrick,
and K. J. Else, “In silico design of a T-cell epitope vaccine candidate for parasitic helminth
infection,” PLOS Pathogens, vol. 16, no. 3, 2020.
242
[261] J. Tuju, G. Kamuyu, L. M. Murungi, and F. H. A. Osier, “Vaccine candidate discovery for
the next generation of malaria vaccines,” Immunology, vol. 152, pp. 195–206, 2017.
[262] R. Furtado, M. Da Costa, and M. Benchimol, “The effect of drugs on cell structure of Tritri-
chomonas foetus,” Parasitology Today, no. 92, pp. 159–170, 2004.
[263] C. Castro, R. Figueiredo, S. Menna-Barreto, N. De, S. Fernandes, L. Saboia-Vahia, G. Dias-
Lopes, C. Britto, P. Cuervo, J. Batista, and D. Jesus, “Iron-modulated pseudocyst formation
in Tritrichomonas foetus,” Parasitology, vol. 143, no. 8, 2017.
[264] H. J. Atkinson, J. H. Morris, T. E. Ferrin, and P. C. Babbitt, “Using Sequence Similarity
Networks for Visualization of Relationships Across Diverse Protein Superfamilies,” PLoS
ONE, vol. 4, no. 2, p. 4345, 2009.
[265] T. Frickey and A. Lupas, “CLANS: a Java application for visualizing protein families based
on pairwise similarity,” Bioinformatics Applications Note, vol. 20, no. 18, pp. 3702–3704,
2004.
[266] S. Cheng, S. Karkar, E. Bapteste, N. Yee, P. Falkowski, and D. Bhattacharya, “Sequence
similarity network reveals the imprints of major diversification events in the evolution of
microbial life,” Frontiers in Ecology and Evolution, vol. 2, p. 72, 2014.
[267] D. Beaudet, Y. Terrat, S. Bastien Halary, I. Enrique De La Providencia, and M. Hijri, “Mi-
tochondrial Genome Rearrangements in Glomus Species Triggered by Homologous Recombi-
nation between Distinct mtDNA Haplotypes,” Genome Biology and Evolution, vol. 5, no. 9,
2013.
[268] Hardy-Diagnostics, “Modified Diamonds Medium - for Trichomonas
https://catalog.hardydiagnostics.com/cp prod/Content/hugo/ModDiamondsMed.htm
(Accessed 10.6.20).”
[269] Pacific Biosciences, “HGAP in SMRT Analysis http://github.com/PacificBiosciences/Bioinformatics-
Training/wiki/HGAP-in-SMRT-Analysis (Accessed 22.02.2018),” 2017.
[270] Pacific Biosciences, “De Novo Assembly - Pacific Biosciences http://www.pacb.com/products-
and-services/analytical-software/smrt-analysis/analysis-applications/de-novo-assembly/
(Accessed 03.08.2017),” 2017.
[271] S. Koren, B. P. Walenz, K. Berlin, J. R. Miller, N. H. Bergman, and A. M. Phillippy, “Canu:
Scalable and accurate long-read assembly via adaptive κ-mer weighting and repeat separa-
tion,” Genome Research, vol. 27, no. 5, pp. 722–736, 2017.
[272] S. Steinbiss, F. Silva-Franco, B. Brunk, B. Foth, C. Hertz-Fowler, M. Berriman, and T. D.
Otto, “Companion: a web server for annotation and analysis of parasite genomes,” Nucleic
Acids Research, vol. 44, 2016.
243
[273] T. D. Otto, G. P. Dillon, W. S. Degrave, and M. Berriman, “RATT: Rapid Annotation
Transfer Tool,” Nucleic Acids Research, vol. 39, no. 9, 2011.
[274] A. L. Delcher, D. Harmon, S. Kasif, O. White, and S. L. Salzberg, “Improved microbial gene
identification with GLIMMER,” Tech. Rep. 23, 1999.
[275] A. L. Delcher, K. A. Bratke, E. C. Powers, and S. L. Salzberg, “Identifying bacterial genes
and endosymbiont DNA with Glimmer,” Bioinformatics, vol. 23, no. 6, pp. 673–679, 2007.
[276] K. Rutherford, J. Parkhill, J. Crook, T. Horsnell, P. Rice, M.-A. Ele Rajandream, and B. Bar-
rell, “Artemis: sequence visualization and annotation,” Bioinformatics Applications, vol. 16,
no. 10, pp. 944–945, 2000.
[277] Splice, “RNA info: Splice site consensus https://science.umd.edu/labs/mount/RNAinfo/consensus.html
(Accessed 10.6.20).”
[278] NCBI, “RefSeq non-redundant proteins https://www.ncbi.nlm.nih.gov/refseq/about/nonredundantproteins/
(Accessed 10.6.20).”
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Mottram, and S. Mü ller, “The Amitochondriate Eukaryote Trichomonas vaginalis Contains
a Divergent Thioredoxin-linked Peroxiredoxin Antioxidant System,” Journal of Biological
Chemistry, vol. 279, no. 7, pp. 5249–56, 2004.
[326] K. Judge, M. Hunt, S. Reuter, A. Tracey, M. A. Quail, J. Parkhill, and S. J. Peacock,
“Comparison of bacterial genome assembly software for MinION data and their applicability
to medical microbiology,” Microbial Genomics, vol. 2, no. 9, 2016.
[327] M. R. Handrich, S. G. Garg, E. W. Sommerville, R. P. Hirt, and S. B. Gould, “Character-
ization of the BspA and Pmp protein family of trichomonads,” Parasites Vectors, vol. 12,
p. 406, 2019.
[328] Y. Zhen and H. Stenmark, “Cellular functions of Rab GTPases at a glance,” Journal of Cell
Science, vol. 128, no. 17, pp. 3171–3176, 2015.
[329] D. E. Bosch and D. P. Siderovski, “Entamoeba histolytica RacC selectively engages p21-
activated kinase effectors,” Biochemistry, vol. 54, no. 2, pp. 404–412, 2015.
[330] V. Morin-Adeline, K. Mueller, A. Conesa, and J. Slapeta, “Comparative RNA-seq analy-
sis of the Tritrichomonas foetus PIG30/1 isolate from pigs reveals close association with
Tritrichomonas foetus BP-4 isolate ’bovine genotype’,” Veterinary Parasitology, vol. 212,
pp. 111–117, 2015.
[331] S. L. Salzberg, “Next-generation genome annotation: We still struggle to get it right,” 2019.
[332] S. E. Brenner, “Errors in genome annotation,” Trends in Genetics, vol. 15, no. 4, pp. 132–133,
1999.
[333] Lia and E. M. De Jesus, Ribeiro, “Human Immune Responses to Schistosoma mansoni Vaccine
248
Candidate Antigens,” Infection and Immunity, vol. 68, no. 5, pp. 2797–2803, 2000.
[334] N. Khalaf Alharbi, I. Qasim, A. Almasoud, H. A. Aljami, M. W. Alenazi, A. Alhafufi, O. S.
Aldibasi, A. M. Hashem, S. Kasem, R. Albrahim, M. Aldubaib, A. Almansour, N. J. Tem-
perton, A. Kupke, S. Becker, A. Abu-obaidah, A. Alkarar, I.-K. Yoon, E. Azhar, T. Lambe,
F. Bayoumi, A. Aldowerij, O. H. Ibrahim, S. C. Gilbert, and H. H. Balkhy, “Humoral immuno-
genicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary
Camels,” Scientific Reports, vol. 9, pp. 1–11, 2019.
[335] B. Aslam, M. Basit, M. Atif Nisar, M. Khurshid, and M. H. Rasool, “Proteomics: Technologies
and Their Applications,” Journal of Chromatographic Science, vol. 55, no. 2, pp. 182–196,
2017.
[336] S. A. Hayes, S. Clarke, N. Pavlakis, and V. M. Howell, “The role of proteomics in the age of
immunotherapies,” Mammalian Genome, vol. 29, no. 11, pp. 757–769, 2018.
[337] K. Novakova, O. Sedo, and Z. Zdrahal, “Mass Spectrometry Characterization of Plant Phos-
phoproteins,” Current Protein & Peptide Science, vol. 12, no. 2, pp. 112–125, 2011.
[338] S. Sundar and B. Singh, “Understanding Leishmania parasites through proteomics and im-
plications for the clinic,” Expert Review Proteomics, vol. 15, no. 5, pp. 371–390, 2018.
[339] P. J. Myler and K. D. Stuart, “Recent developments from the Leishmania genome project,”
Current Opinion in Microbiology, vol. 3, no. 4, pp. 412–416, 2000.
[340] B. Ockenfels, E. Michael, and M. A. Mcdowell, “Meta-analysis of the Effects of Insect Vector
Saliva on Host Immune Responses and Infection of Vector-Transmitted Pathogens: A Focus
on Leishmaniasis,” PLoS Negl Trop Dis, vol. 8, no. 10, p. 3197, 2014.
[341] P.-R. Karhemo, S. Ravela, M. Laakso, I. Ritamo, O. Tatti, S. Mäkinen, S. Goodison, U.-H.
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.1 Chapter 2 Appendix
Transcriptome Condition No. of Reads Overall Alignment Rate (%)
Control 1 67634690 96.04
Control 2 15521536 97.22
Control 3 14386258 97.12
Control 4 14490527 97.39
Control 5 18342427 97.38
Colchicine 1 53132714 93.16
Colchicine 2 39965884 5.29
Colchicine 3 23430572 61.03
Low Temperature 1 67107494 91.86
Low Temperature 2 54584264 91.94
Low Temperature 3 58026576 90.35
High Temperature (42°C) 1 17228591 97.36
High Temperature (42°C) 2 15035565 97.45
High Temperature (42°C) 3 16267485 96.52
High Temperature (46°C) 1 14733629 96.45
High Temperature (46°C) 2 17161827 96.89
High Temperature (46°C) 3 13449004 96.60
High pH 1 17422478 96.29
High pH 2 16157854 93.04
Low pH 1 19597891 97.46
Low pH 2 15681152 92.47
Low pH 3 13862147 95.64
Oxidative Stress (500) 1 23622541 96.76
Oxidative Stress (500) 2 13969196 70.64
Oxidative Stress (300) 1 21351760 96.97
Oxidative Stress (300) 2 20516795 92.32
Glucose-free media 1 36099598 94.94
Glucose-free media 2 32593301 95.72
Glucose-free media 3 30682198 94.84
Tryptone-free media 1 16999365 90.33
Tryptone-free media 2 37760351 95.49
Serum-free media 1 31774637 95.13
Serum-free media 2 36355202 95.66
Serum-free media 3 36948206 96.03
Table A1: Mapping statistics for T. foetus transcriptomes.The initial sequences were sequenced
using Hiseq at the Liverpool CGR and statistics calculated using the HiSat2 package on the Galaxy
Server. Where numbers ‘1, 2 and 3’ refer to replicates.
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Low Temperature Upregulated
Gene ID Fold change Gene Product
TTF74316 14.34 Hypothetical
TTF74318 12.56 Hypothetical
TTF74053 12.45 Hypothetical
TTF74317 11.88 Hypothetical
TTF74052 11.83 Hypothetical
TTF74054 11.65 Hypothetical
TTF40717 10.93 N-acetyltransferase
TTF42099 10.63 N-acetyltransferase
TTF44477 10.55 Hypothetical
TTF09898 10.16 Hypothetical
Low Temperature Downregulated
Gene ID Fold change Gene Product
TTF81834 -9.10 Transposable element t3 transposase
TTF24549 -7.79 Myb-like DNA-binding domain containing protein
TTF38890 -7.50 Hypothetical
TTF33346 -7.36 Flavodoxin-like fold family protein
TTF33132 -7.35 Transposable element t3 transposase
TTF06492 -7.15 Hypothetical
TTF55653 -7.05 Hypothetical
TTF12964 -6.90 NA
TTF33007 -6.87 Hypothetical
TTF59816 -6.84 NA
Table A2: Differential expression of low temperature induced pseudocysts relative to the control
Trophozoites, for both up and downregulated genes the top 10 with the highest fold change are
shown.
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High Temperature 42°C Upregulated
Gene ID Fold change Gene Product
TTF08541 5.43 Calcium Translocating P-type ATPase
TTF23546 5.25 Hypothetical
TTF72038 5.23 Hypothetical
TTF81061 5.07 NA
TTF20278 4.99 NA
TTF23324 4.95 GNAT family N-acetyltransferase
TTF36525 4.83 ABC transporter ATP-binding domain
TTF01010 4.80 Helicase carboxy terminal domain
TTF70954 4.63 Hypothetical
TTF39485 4.53 Hypothetical
High Temperature 42°C Downregulated
Gene ID Fold change Gene Product
TTF54491 -29.65 Glycosyl hydrolase
TTF33467 -28.33 CAMK family protein
TTF35720 -22.35 Hypothetical
TTF54196 -25.23 Skin secretory protein xp2-like
TTF81834 -24.70 Transposable element
TTF00196 -24.55 NA
TTF67826 -24.29 NA
TTF23815 -13.46 Cysteine protease
TTF23813 -14.43 Cysteine protease
TTF54492 -12.52 Glycosyl hydrolase
Table A3: Differential expression of High Temperature (42°C) exposed T. foetus cells compared to
control trophozoites, for both up and downregulated genes the top 10 with the highest fold change
are shown.
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High Temperature 46°C Upregulated
Gene ID Fold change Gene Product
TTF74570 6.02 Hypothetical
TTF57624 5.92 ABC Transporter
TTF08569 5.90 Phosphoglycerol transferase
TTF06433 5.81 Hypothetical
TTF46339 5.56 Hypothetical
TTF22177 5.63 Hypothetical
TTF23557 5.54 Myb-like DNA-binding domain containing protein
TTF11466 5.54 Major Facilitator superfamily transporter
TTF44911 5.41 Histone-lycine N-methyl transferase
TTF07238 4.04 Hypothetical
High Temperature 46°C Downregulated
Gene ID Fold change Gene Product
TTF23815 -14.91 Cysteine protease
TTF54491 -14.05 Glycosyl hydrolase
TTF33467 -13.10 CAMK family protein
TTF32002 -12.74 Myb-like DNA-binding domain containing protein
TTF23818 -12.12 Cysteine protease
TTF54492 -11.73 Glycosyl hydrolase
TTF54493 -11.73 Hypothetical
TTF23815 -11.43 Cysteine protease
TTF81875 -11.01 Cytoplasmic heat shock protein
TTF15376 -10.94 SH3 domain containing protein
Table A4: Differential expression of High Temperature (46°C) exposed T. foetus cells compared to
control trophozoites, for both up and downregulated genes the top 10 with the highest fold change
are shown.
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Oxidative stress 300mM Upregulated
Gene ID Fold change Gene Product
TTF67650 7.01 HECT E5 ubiquitin ligase
TTF26415 6.75 Hypothetical
TTF82770 6.63 CAMK family protein
TTF30026 6.55 Protein phosphotase
TTF10206 6.52 Keratinocyte proline-rich protein like
TTF58873 6.46 Myb-like DNA-binding domain containing protein
TTF37785 6.43 Hypothetical
TTF51385 6.41 Hypothetical
TTF55240 6.41 Major facilitatory superfamily
TTF82201 6.38 Hypothetical
Oxidative Stress 300mM Downregulated
Gene ID Fold change Gene Product
TTF54196 -7.18 Skin secretory protein xp2-like
TTF54204 -6.92 NA
TTF17855 -6.67 NA
TTF42969 -5.54 Acetylhydrolase
TTF36815 -5.51 NA
TTF51460 -5.17 NA
TTF16293 -5.06 Hypothetical
TTF32590 -4.88 Hypothetical
TTF54061 -4.77 TCCD-inducible-PARP-like domain
TTF71281 -4.65 Hypothetical
Table A5: Differential expression of T foetus cells exposed to oxidative stress of 300mM hydrogen
peroxide compared to control trophozoites, for both up and downregulated genes the top 10 with
the highest fold change are shown.
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Oxidative stress 500mM Upregulated
Gene ID Fold change Gene Product
TTF32010 8.59 Hypothetical
TTF09943 7.92 Dyenin heavy chai family protein
TTF43762 7.33 Hypothetical
TTF14719 7.18 Hypothetical
TTF39941 7.18 Hypothetical
TTF62578 7.08 Hypothetical
TTF32900 7.06 Hypothetical
TTF10038 7.03 E3 ubiquitin protein
TTF38527 7.01 Hypothetical
TTF46338 6.93 Hypothetical
Oxidative Stress 500mM Downregulated
Gene ID Fold change Gene Product
TTF54196 -8.36 Skin secretory protein xp2-like
TTF43713 -7.36 Adenine-specific methyltransferase
TTF51074 -7.35 Hypothetical
TTF67629 -7.35 Hypothetical
TTF60423 -7.27 Adenine-specific methyltransferase
TTF02258 -7.24 Hypothetical
TTF49034 -7.17 Integrase core domain containing protein
TTF09544 -7.08 Hypothetical
TTF75062 -6.96 DNA polmerase type B
TTF26956 -6.72 Histone lysine N-methyltransferase
Table A6: Differential expression of T. foetus cells exposed to oxidative stress of 500 mM hydrogen
peroxide compared to control trophozoites, for both up and downregulated genes the top 10 with
the highest fold change are shown.
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High pH Upregulated
Gene ID Fold change Gene Product
TTF37964 7.99 NA
TTF53975 7.69 Hypothetical
TTF62758 7.55 Hypothetical
TTF31470 7.54 Histidine acid phosphatase
TTF44346 7.44 GNAt family N-acetyltransferase
TTF22638 7.25 Hypothetical
TTF84400 7.20 Hypothetical
TTF37965 7.18 Exportin 1
TTF25039 7.18 Major facilitator superfamily transporter
TTF37669 7.08 Hypothetical
High pH Downregulated
Gene ID Fold change Gene Product
TTF39285 -12.56 Hypothetical
TTF54196 -12.19 Skin secretory protein xp2-like
TTF38866 -11.60 N-acetyltransferase
TTF18006 -11.50 Myb-like DNA-binding domain containing protein
TTF74883 -11.45 Myb-like DNA-binding domain containing protein
TTF79591 -11.17 CAMK family protein
TTF79485 -10.44 Myb-like DNA-binding domain containing protein
TTF37949 -10.21 NA
TTF65543 -10.17 Hypothetical
TTF29000 -10.14 Myb-like DNA-binding domain containing protein
Table A7: Differential expression of T. foetus cells exposed to high pH stress compared to control
trophozoites, for both up and downregulated genes the top 10 with the highest fold change are
shown.
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Low pH Upregulated
Gene ID Fold change Gene Product
TTF48041 5.95 Kerotinyte proline-rich repeat
TTF45031 5.45 NA
TTF63369 5.15 NA
TTF11808 4.97 Hypothetical
TTF25260 4.95 NA
TTF24809 4.89 Hypothetical
TTF13772 4.81 NA
TTF05255 4.80 Leucine-rich-repeat
TTF09507 4.76 Hypothetical
TTF19547 4.68 Hypothetical
Low pH Downregulated
Gene ID Fold change Gene Product
TTF54198 -9.92 Skin secretory protein xp2-like
TTF26270 -6.62 NLI-Interaction factor-like phosphatase
TTF62269 -6.15 NA
TTF59396 -6.00 NA
TTF54198 -5.88 Skin secretory protein xp2-like
TTF65164 -5.84 Hypothetical
TTF76380 -5.76 Hypothetical
TTF73685 -5.55 Ser/Thr Protein phosphatase
TTF54200 -5.32 Skin secretory protein
TTF14152 -5.13 Protein phophatase
Table A8: Differential expression of T. foetus cells exposed to low pH stress, compared to control
trophozoites, for both up and downregulated genes the top 10 with the highest fold change are
shown.
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Tryptone free Upregulated
Gene ID Fold change Gene Product
TTF54196 14.87 Skin secretory protein xp2-like
TTF54200 11.04 Skin secretory protein xp2-like
TTF82335 10.39 Hypothetical
TTF54198 9.18 Skin secretory protein xp2-like
TTF29736 9.04 NA
TTF54204 8.33 NA
TTF54203 7.97 Skin secretory protein xp2-like
TTF10811 7.58 NA
TTF33899 7.38 Cation efflux protein
TTF67560 7.10 NA
Tryptone free Downregulated
Gene ID Fold change Gene Product
TTF03367 -10.52 RND transporter protein
TTF17133 -10.44 Ras-family protein
TTF65665 -10.23 NA
TTF03369 -10.18 Hypothetical
TTF31558 -10.09 Neimann-pick C1-like domain containing protein
TTF65674 -10.00 Hypothetical
TTF03368 -9.59 Hypothetical
TTF81870 -9.50 Hypothetical
TTF41168 -9.45 Rhodanese-like domain
TTF80844 -9.14 Hypothetical
Table A9: Differential expression of T. foetus cells grown in media with no tryptone added compared
to control trophozoites grown in standard Diamond media, for both up and downregulated genes
the top 10 with the highest fold change are shown.
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Serum free Upregulated
Gene ID Fold change Gene Product
TTF54196 13.06 Skin secretory protein xp2-like
TTF10811 10.84 NA
TTF54200 9.76 Skin secretory protein xp2-like
TTF82335 9.10 Hypothetical
TTF61610 8.57 NA
TTF27394 8.46 ABC transporter
TTF14418 8.35 Hypothetical
TTF58441 8.13 Myb-like DNA-binding domain containing protein
TTF49081 8.05 Hypothetical
TTF79613 7.98 Myb-like DNA-binding domain containing protein
Serum free Downregulated
Gene ID Fold change Gene Product
TTF48543 -7.12 Ras related protein
TTF52850 -6.15 DNA polymerase
TTF34502 -5.43 Comm domain containing protein
TTF62451 -5.43 Hypothetical
TTF78238 -5.36 uDENN domain containing protein
TTF03377 -5.33 Phosphotidylinositol phosphodiesterase
TTF28511 -5.27 NA
TTF66345 -5.18 NA
TTF69058 -5.13 Major facillitator superfamily transporter
TTF28773 -5.11 Hypothetical
Table A10: Differential expression of T. foetus cells in media with no serum added compared to
control trophozoites grown in standard Diamond media, for both up and downregulated genes the
top 10 with the highest fold change are shown.
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Glucose free Upregulated
Gene ID Fold change Gene Product
TTF54196 15.53 Skin secretory protein xp2-like
TTF10811 14.61 Sperm motility kinase
TTF54200 14.42 Aminotransferase
TTF82335 14.04 Glycine dehydrogenase
TTF61610 12.87 Aminomethyl transferring glycine dehydrogenase
TTF27394 12.81 Hypothetical
TTF14418 12.75 Aminomethyl transferring glycine dehydrogenase
TTF58441 12.29 Hypothetical
TTF49081 12.24 Myb-like DNA-binding domain containing protein
TTF79613 12.10 Glycine clevage system t protein
Glucose free Downregulated
Gene ID Fold change Gene Product
TTF31558 -10.56 Niemann pick c-like protein 1
TTF03367 -9.37 RND family protein
TTF17133 -9.00 Ras family protein
TTF03368 -8.99 Hypothetical
TTF19166 -8.58 Serine-protease inhibitor family protein
TTF53714 -8.43 Acetyltransferase family protein
TTF62567 -8.19 PQ loop repeat family
TTF62049 -8.17 PQ loop repeat family
TTF80844 -7.60 Hypothetical
TTF62568 -7.56 Hypothetical
Table A11: Differential expression of T. foetus cells in media with no serum added compared to
control trophozoites grown in standard Diamond media, for both up and downregulated genes the
top 10 with the highest fold change are shown.
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Accession Trophozoite Pseudocyst Description
TTF30249 1 2.54 glycosyl hydrolase
TTF48473 1 2.22 60S ribosomal protein L18a
TTF37123 1 2.17 40S ribosomal protein S3a
TTF00247 1 2.08 40S ribosomal protein S15a
TTF21423 1 2.08 40S ribosomal protein S15a
TTF00248 1 2.08 40S ribosomal protein S15a
TTF10548 1 2.08 40S ribosomal protein S15a
TTF00249 1 2.08 40S ribosomal protein S15a
TTF00246 1 2.08 40S ribosomal protein S15a
TTF05687 1 2.06 Coatomer subunit beta
TTF37642 1 1.99 hypothetical protein TRFO 20197
TTF05663 1 1.97 archaeal ribosomal protein S17P
TTF43167 1 1.95 hypothetical protein TRFO 16532
TTF00060 1 1.94 ribosomal protein L27e
TTF51775 1 1.94 ribosomal protein L27e
TTF01798 1 1.91 cAMP-dependent protein kinase type I-alpha
TTF32301 1 1.9 hypothetical protein TRFO 23773
TTF23412 1 1.9 putative C2 domain containing protein
TTF47374 1 1.88 ribosomal protein S3
TTF79711 1 1.88 ribosomal protein S3
TTF79900 1 1.88 ribosomal protein S3
TTF79814 1 1.88 ribosomal protein S3
TTF45174 1 1.88 ribosomal protein S3
TTF20455 1 1.88 kelch-like protein 24
TTF28444 1 1.86 40S ribosomal protein S3a
TTF05650 1 1.86 40S ribosomal protein S3a
TTF37554 1 1.79 ABC transporter E family member 2
TTF23491 1 1.79 ABC transporter E family member 2
TTF01496 1 1.76 clathrin heavy chain
TTF32482 1 1.72 signal recognition particle subunit SRP72-like
TTF00547 1 1.71 hypothetical protein TRFO 18052
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TTF78075 1 1.71 hypothetical protein TRFO 37894
TTF74267 1 1.69 AMP-binding enzyme family protein
TTF62595 1 1.69 hypothetical protein TRFO 05477
TTF68935 1 1.64 oxidoreductase
TTF73129 1 1.63 GTP-binding protein SAR1A
TTF01232 1 1.59 DUF1846 domain-containing protein
TTF00552 1 1.59 ankyrin repeat protein
TTF70519 1 1.58 Rho family GTpase
TTF48213 1 1.58 ribosomal protein L21e
TTF16749 1 1.58 ribosomal protein L21e
TTF07112 1 1.58 60S ribosomal protein L21
TTF04577 1 1.58 60S ribosomal protein L21
TTF66543 1 1.58 cysteine desulfurase
TTF21484 1 1.57 coatomer subunit gamma
TTF14082 1 1.56 Elongation factor 2
TTF74567 1 1.56 Phosphoglucomutase phosphomannomutase
TTF30640 1 1.55 Glycogen debranching enzyme
TTF45115 1 1.55 elongator complex protein 1
TTF26436 1 1.54 sugar nucleotide epimerase
TTF35736 1 1.51 60S ribosomal protein L9
TTF01791 1 1.5 Copine family protein
TTF28341 1 1.5 hypothetical protein
TTF41143 1 0.67 hypothetical protein TRFO 12516
TTF52086 1 0.65 kinetoplast-associated protein
TTF37126 1 0.65 charged multivesicular body protein 3
TTF37125 1 0.65 predicted protein
TTF39902 1 0.65 hypothetical protein TRFO 10466
TTF42678 1 0.65 endoplasmic reticulum-Golgi intermediate compartment
TTF65056 1 0.64 hypothetical protein TRFO 35633
TTF31986 1 0.64 hypothetical protein TRFO 26034
TTF73657 1 0.64 Centrin-3
TTF44549 1 0.63 MBL fold metallo-hydrolase
TTF24016 1 0.63 histidine acid phosphatase
TTF07839 1 0.63 hypothetical protein TRFO 23646
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TTF20851 1 0.62 Clan SC
TTF63668 1 0.62 hypothetical protein TRFO 03267
TTF23702 1 0.62 14-3-3 protein
TTF04579 1 0.62 Transmembrane amino acid transporter protein
TTF45738 1 0.62 hypothetical protein TRFO 42261
TTF54599 1 0.61 hypothetical protein TRFO 13511
TTF43209 1 0.61 hypothetical protein TRFO 39443
TTF22383 1 0.61 hypothetical protein TRFO 30043
TTF35926 1 0.59 histidine acid phosphatase
TTF58541 1 0.59 hypothetical protein TRFO 00866
TTF08565 1 0.59 hypothetical protein TRFO 20073
TTF58329 1 0.59 Prefoldin subunit 1
TTF50578 1 0.59 vacuolar proton translocating ATPase
TTF74681 1 0.59 inner centromere protein
TTF45739 1 0.59 hypothetical protein
TTF60517 1 0.58 hypothetical protein TRFO 29767
TTF68546 1 0.58 C2 domain containing protein
TTF39353 1 0.58 NAD synthetase
TTF83994 1 0.58 hypothetical protein TRFO 08132
TTF22382 1 0.58 histidine acid phosphatase
TTF40175 1 0.57 Laminin A family protein
TTF58150 1 0.56 Clan CA
TTF58433 1 0.56 Clan CA
TTF15102 1 0.56 hypothetical protein TRFO 34808
TTF54148 1 0.56 hypothetical protein TRFO 38207
TTF00659 1 0.56 Inositol polyphosphate kinase family protein
TTF42565 1 0.55 Immuno-dominant variable surface antigen-like
TTF70906 1 0.55 hypothetical protein TRFO 12915
TTF67248 1 0.55 coiled-coil domain-containing protein
TTF17368 1 0.55 hypothetical protein TRFO 07600
TTF21472 1 0.55 hypothetical protein TRFO 31205
TTF81703 1 0.54 V-type ATPase 116kDa subunit family protein
TTF53390 1 0.54 predicted protein
TTF62573 1 0.54 hypothetical protein TRFO 05497
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TTF36533 1 0.53 Uncharacterised protein
TTF58505 1 0.53 hypothetical protein TRFO 00819
TTF10766 1 0.52 C2 domain containing protein
TTF42563 1 0.52 Immuno-dominant variable surface antigen-like
TTF43593 1 0.51 Clan MH
TTF41233 1 0.51 cathepsin O-like
TTF39115 1 0.51 cell division control protein 31
TTF11319 1 0.51 hypothetical protein TRFO 23477
TTF61143 1 0.5 hypothetical protein TRFO 19729
TTF44089 1 0.5 hypothetical protein TRFO 01273
TTF40594 1 0.48 hydrogenosomal membrane protein 31 precursor
TTF25098 1 0.48 papain family cysteine protease domain containing protein
TTF54808 1 0.48 CAMK family protein kinase
TTF25320 1 0.47 hypothetical protein TRFO 20099
TTF15373 1 0.47 hypothetical protein
TTF59087 1 0.47 hypothetical protein TRFO 05193
TTF54959 1 0.47 hypothetical protein TRFO 14709
TTF43481 1 0.47 hypothetical protein TRFO 10329
TTF01106 1 0.46 hypothetical protein TRFO 08327
TTF55788 1 0.46 hypothetical protein TRFO 17592
TTF81917 1 0.46 ATPase
TTF63245 1 0.46 Clan SB
TTF21701 1 0.45 hypothetical protein TRFO 40634
TTF62655 1 0.45 putative centrin
TTF68155 1 0.45 hypothetical protein TRFO 40979
TTF56506 1 0.44 major antigen-like isoform X1
TTF11427 1 0.43 hypothetical protein TRFO 06752
TTF12145 1 0.43 proliferating cell nuclear antigen
TTF08567 1 0.42 hypothetical protein TRFO 20073
TTF00657 1 0.42 hypothetical protein TRFO 01490
TTF15093 1 0.42 —NA—
TTF12585 1 0.41 hypothetical protein TRFO 38671
TTF13971 1 0.4 kinetoplast-associated protein
TTF67500 1 0.39 Clan SC
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TTF36554 1 0.36 major facilitator superfamily transporter
TTF80961 1 0.36 syntaxin-related protein
TTF81042 1 0.31 putative folate-biopterin transporter 2
TTF81043 1 0.31 leishmanolysin family protein
Table B1: Ratio of intensities of TMT labelled pseudocysts relative to trophozoites. When the
ratio is higher than 1 in the pseudocyst sample, there is significantly higher intensity of the protein.
Where the ratio is less than 1, there is significantly higher intensity of the protein in the trophozoite
sample.
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Protein ID Product Fold Change
TTF01106 hypothetical protein TRFO 08327 36.43962745
TTF44954 60s ribosomal protein l23a 24.64628994
TTF56658 hypothetical protein TRFO 31205 21.66641155
TTF32797 ATP-dependent RNA helicase eIF4A 16.29165891
TTF08567 hypothetical protein TRFO 20073 11.66314474
TTF01817 40S ribosomal protein S2 11.55148153
TTF23865 geranylgeranyl transferase type-2 subunit beta-like 10.90461661
TTF21701 hypothetical protein TRFO 40634 9.520755849
TTF35844 ribosomal protein L32 putative 7.915135316
TTF09389 60S ribosomal protein L37a 7.617905076
TTF13481 Histone H4 6.471337116
TTF20135 ribosomal protein L27e 6.119031455
TTF49479 ribosomal protein S13p S18e 5.348171121
TTF41309 C2 domain containing protein 5.236961108
TTF32892 ribosomal protein L24e 5.103441195
TTF53391 40S ribosomal protein S13 4.650094756
TTF78555 ribosomal protein L35Ae 4.567931793
TTF04577 60S ribosomal protein L21 4.393391297
TTF83969 60S ribosomal protein L23 3.930978844
TTF55912 ribosomal protein L13e 3.881543321
TTF00609 60S ribosomal protein L37 3.801548523
TTF80890 alpha tubulin 3.621496719
TTF49944 40S ribosomal protein S16 3.600275778
TTF59123 Hydrogenase Fe-only 3.365426696
TTF41687 RNA-binding protein 3.356894016
TTF26810 C2 domain containing protein 3.296468656
TTF44008 AMP-binding enzyme family protein 3.018174385
TTF15811 60S ribosomal protein L14 2.928534836
TTF20747 ribosomal protein S14 2.869292992
TTF81253 ribosomal protein L7Ae 2.777875702
TTF20525 ribosomal protein L14 2.591067847
TTF03379 RAC GTPase putative 2.546520935
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TTF79182 Tudor domain containing protein 2.53090186
TTF30587 F420-0–gamma-glutamyl ligase 2.492632666
TTF01496 clathrin heavy chain 2.473896323
TTF81691 78 kDa glucose-regulated protein 2.40220795
TTF39123 40S ribosomal protein S7 2.397611797
TTF37123 40S ribosomal protein S3a 2.361080861
TTF07843 beta tubulin 2.231087242
TTF50642 40S ribosomal protein S4 X isoform 2.230788366
TTF02180 40S ribosomal protein S8 2.224038174
TTF41702 Immuno-dominant variable surface antigen-like 2.212639449
TTF40080 40S ribosomal protein S9-1 2.060041442
Table B2: Fold change of biotinylated T. foetus biotinylated trophozoites relative to low tempera-
ture induced pseudocysts . All elutions and all experimental trials for each life stage were combined
then compared. The samples had all been run on the Orbitrap mass spectrometer using label free
m/s and the results were analysed in Peaks [373]. All differentially abundant proteins had a fold
change >2 a P< 0.05.
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Protein ID Product Fold Change
TTF21425 alanyl-tRNA synthetase 74.44341287
TTF21911 6-phosphogluconate dehydrogenase 43.52033493
TTF02041 Glucokinase 1 29.43518205
TTF24249 OsmC family peroxiredoxin 25.74577122
TTF64999 NADP-specific glutamate dehydrogenase 23.22239141
TTF10541 Rubrerythrin family protein 16.6191032
TTF40382 WD40 domain containing protein 16.40132548
TTF11427 hypothetical protein TRFO 06752 14.9687056
TTF22398 hydrogenase assembly factor 14.22965026
TTF06177 glutamate decarboxylase 13.25025351
TTF44855 hypothetical protein TRFO 30443 9.578736602
TTF33068 protein disulfide-isomerase domain 8.988597843
TTF15804 T-complex protein 1 subunit eta 8.062109075
TTF10766 C2 domain containing protein 7.452111345
TTF28277 V-type proton ATPase subunit H 7.279193768
TTF81588 thioredoxin peroxidase 6.233543893
TTF20914 hypothetical protein TRFO 06622 6.005153428
TTF26427 pyruvate ferredoxin flavodoxin oxidoreductase 5.801389649
TTF36147 sugar O-acetyltransferase 5.658459359
TTF01062 hydrogenosomal membrane protein 31 precursor 5.441286178
TTF39122 Glucokinase 1 5.073289902
TTF23521 Catalase 5.061837325
TTF30749 L-fucose isomerase 4.944426989
TTF23491 ABC transporter E family member 2 4.646384663
TTF47666 myo-inositol-1-phosphate synthase-like protein 4.635849802
TTF66999 elongation factor 1-beta 4.468929758
TTF26391 Transaldolase 4.439203402
TTF29022 Rab8 family GTPase 4.364227719
TTF82156 30S ribosomal protein S19e 4.334407888
TTF22695 Thioredoxin family protein 4.167570561
TTF81884 vacuolar protein sorting-associated protein 35 4.056338948
TTF37447 actin putative 3.916002153
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TTF35950 MBL fold metallo-hydrolase 3.910664481
TTF55099 glycylpeptide N-tetradecanoyltransferase 1 3.828385724
TTF79971 BTB POZ domain containing protein 3.756098544
TTF65227 adhesin AP65-1 precursor 3.687693138
TTF00205 T-complex protein 1 subunit alpha 3.60655547
TTF61619 Glucosamine-6-phosphate deaminase 3.547086707
TTF55377 Aldose 1-epimerase 3.502384256
TTF82220 galactose mutarotase 3.502384256
TTF40594 hydrogenosomal membrane protein 31 precursor 3.439136548
TTF07837 putative Arp2 3 3.416055378
TTF81436 thioredoxin peroxidase 3.366773783
TTF51797 cytosolic malate dehydrogenase 1 3.316542701
TTF30959 V-type proton ATPase subunit E 3.265933769
TTF24218 Dynamin central region family protein 3.261656228
TTF36731 hypothetical protein TRFO 08672 3.234768945
TTF62416 ribose-phosphate pyrophosphokinase putative 3.186811392
TTF08207 TPR Domain containing protein 3.092873245
TTF73388 Actin-related protein 2 3 complex subunit 3 3.020048743
TTF77415 AMP-binding enzyme family protein 2.959804154
TTF08733 Glucosamine-6-phosphate deaminase 2.734008587
TTF22965 Malate dehydrogenase 2.723376697
TTF44549 MBL fold metallo-hydrolase 2.722754715
TTF31424 chaperonin GroEL 2.717108135
TTF64548 sarcoplasmic-endoplasmic reticulum calcium ATPase 2.696320314
TTF32664 F-actin capping protein alpha subunit 2.581813293
TTF20133 isoleucine–tRNA ligase cytoplasmic 2.559204573
TTF11891 HMG box family protein 2.549922783
TTF70519 Rho family GTpase 2.501171814
TTF31287 hypothetical protein TRFO 32279 2.276728765
TTF84547 Dynamin central region family protein 2.237542395
TTF16414 NADP-dependent alcohol dehydrogenase 2.229437347
TTF76816 T-complex protein 1 subunit gamma 2.224989247
TTF58511 lysine–tRNA ligase isoform X2 2.211240873
TTF78798 diphosphate–fructose-6-phosphate 1-phosphotransferase 2.166745694
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TTF65307 Serine threonine-protein phosphatase PP-X isozyme 2 2.122385234
TTF71959 Glucose-6-phosphate isomerase 2.114417852
TTF70031 Ras-related protein Rab-15 2.088045028
TTF33037 tRNA binding domain containing protein 2.045065078
Table B3: Fold change of biotinylated T. foetus low temperature induced pseudocysts relative to
biotinylated trophozoites. All elutions and all experimental trials for each life stage were combined
then compared. The samples had all been run on the Orbitrap mass spectrometer using label free
and the results were analysed in Peaks [373]. All differentially abundant proteins had a fold change
>2 and p< 0.05.
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Protein ID Product Abundance
TTF81436 thioredoxin peroxidase 414868400
TTF65227 adhesin AP65-1 precursor 136023209
TTF51797 cytosolic malate dehydrogenase 1 93423020
TTF11042 actin 82719800
TTF14082 Elongation factor 2 71402020
TTF07843 beta tubulin 69469862
TTF25397 succinate-CoA ligase 44354215
TTF12365 enolase family protein 42847814
TTF44549 MBL fold metallo-hydrolase 38260418
TTF06996 pyruvate:ferredoxin (flavodoxin) oxidoreductase 36933454
TTF81425 Phosphoglycerate kinase 36657695
TTF22965 Malate dehydrogenase 29752200
TTF01814 glyceraldehyde-3-phosphate dehydrogenase 26562274
TTF11905 longation factor 1 alpha 24162330
TTF40594 hydrogenosomal membrane protein 31 precursor 23964945
TTF35950 MBL fold metallo-hydrolase 23064900
TTF35490 heat shock protein 90 20919399
TTF78902 cytoplasmic heat shock protein 70 16924214
TTF26427 pyruvate ferredoxin flavodoxin oxidoreductase 16796331
TTF23112 phosphoglyceromutase 15772091
TTF16414 NADP-dependent alcohol dehydrogenase 15430510
TTF79469 phosphoenolpyruvate carboxykinase 14829839
TTF39915 V-type proton ATPase catalytic subunit A 12537500
TTF18666 actin-like protein 9431274
TTF69995 butanol dehydrogenase 9192480
TTF02727 fructose-1 6-bisphosphate aldolase class II 8456640
TTF16721 40S ribosomal protein S5 8181100
TTF74904 cofilin tropomyosin-type actin-binding protein 8047959
TTF08500 Acetyl-CoA hydrolase 7302390
TTF23613 luminal-binding protein 7104653
TTF34557 thioredoxin-disulfide reductase 7074890
TTF74567 Phosphoglucomutase phosphomannomutase α-β-α domain I family protein 6766330
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TTF15197 cytoplasmic heat shock protein 70 6663890
TTF79473 indole-3-pyruvate decarboxylase 6431555
TTF50464 Triosephosphate isomerase cytosolic 6277090
TTF08733 Glucosamine-6-phosphate deaminase 6174930
TTF80890 alpha tubulin 6050140
TTF26092 pyruvate:ferredoxin (flavodoxin) oxidoreductase 5986110
TTF01457 Rpl16ap 5772530
TTF79814 ribosomal protein S3 5663865
TTF55806 60S ribosomal protein L11 5519965
TTF16219 ribosomal protein 5496910
TTF32204 succinyl-CoA ligase [GDP-forming] subunit alpha mitochondrial 5439207
TTF02180 40S ribosomal protein S8 5388335
TTF78798 diphosphate–fructose-6-phosphate 1-phosphotransferase 5342870
TTF04501 actin bundling protein 5313160
TTF50642 40S ribosomal protein S4 X isoform 5273002
TTF08633 adenylyl cyclase-associated protein 1-like 5226086
TTF53150 glucose-6-phosphate 1-dehydrogenase family protein 5194351
TTF36328 Actin-like protein 3 5175300
Table B4: The top 50 most highly abundant proteins identified using TMT mass spectrometry
of biotinylated T. foetus trophozoites and pseudocysts. Pseudocysts were induced by the lowering
of the environmental temperature to 4°C. All elutions, all experimental trials and life stages were
combined to give a total peak area (abundance) for all identified proteins.The samples had all been
run on the Orbitrap mass spectrometer using label free m/s and the results were analysed in Peaks
[373]
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Sample Experiment No. of Reads
Alignment
Rate (%)
Preparation
Method
1 Trophozoite Trypsin Wash (30 min) 1 4146360 87.13 Poly-A Selection
2 Trophozoite Trypsin Wash (30 min) 2 7349902 90.64 Poly-A Selection
3 Trophozoite Trypsin Wash (30 min) 3 4788146 93.47 Poly-A Selection
4 Pseudocyst Trypsin Wash (30 min) 1 23525942 0.53 Zymo-kit
5 Pseudocyst Trypsin Wash (30 min) 2 23885184 1.64 Zymo-kit
6 Pseudocyst Trypsin Wash (30 min) 3 28682918 3.36 Zymo-kit
7 Trophozoite Trypsin Wash (1 hour) 1 30250978 95.90 Poly-A Selection
8 Trophozoite Trypsin Wash (1 hour) 2 33638458 95.42 Poly-A Selection
9 Trophozoite Trypsin Wash (1 hour) 3 38894232 8.03 Zymo-kit
10 Pseudocyst Trypsin Wash (1 hour) 1 35507766 7.59 Zymo-kit
11 Pseudocyst Trypsin Wash (1 hour) 2 33849182 1.26 Zymo-kit
12 Pseudocyst Trypsin Wash (1 hour) 3 28381338 95.83 Poly-A Selection
13 Trophozoite Trypsin Wash (24 hours) 1 14634181 8.99 Zymo-kit
14 Trophozoite Trypsin Wash (24 hours) 2 22552918 9.04 Zymo-kit
15 Trophozoite Trypsin Wash (24 hours) 3 51201848 10.29 Zymo-kit
16 Pseudocyst Trypsin Wash (24 hours) 1 30086208 7.13 Zymo-kit
17 Pseudocyst Trypsin Wash (24 hours) 2 37850319 8.36 Zymo-kit
18 Pseudocyst Trypsin Wash (24 hours) 3 32535957 7.15 Zymo-kit
19 Trophozoite PBS Wash (1 hour) 23207498 39.16 Zymo-kit
20 Trophozoite PBS Wash (24 hours) 25562814 92.90 Poly-A Selection
21 Pseudocyst PBS Wash (24 hours 22905766 85.31 Poly-A Selection
22 MDCK cells 36795633 0.04 Zymo-kit
23 DK2 Control 1 21229824 58.08 Zymo-kit
24 DK2 Control 2 51657211 61.60 Zymo-kit
25 DK2 Control 3 31988385 95.66 Poly-A Selection
26 DK2 Supernatant 1 17683526 95.45 Poly-A Selection
27 DK2 Supernatant 2 25688412 95.30 Poly-A Selection
28 DK2 Supernatant 3 26781840 95.16 Poly-A Selection
Table C1: The number of reads produced from RNA-Seq data from T. foetus DK2 cells in the
presence of an MDCK monolayer and Mapping percentage of the reads against the reference T.
foetus genome. Samples included several wash steps and controls of cells only of the DK2 strain of
T. foetus. All RNA samples were produced using the Qiagen RNeasy kit and were sequenced on
the Illumina Novaseq. The library preparation was performed either using poly-A selection or a
‘zymo’ kit. Mapping of the reads to the assembled and annotated T. foetus genome was performed
using Hisat2 on the Galaxy Server.
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Trypsin Upregulated Using DK2 Controls
Gene ID Fold change Gene Product
TTF10220 14.46 Flavodoxin-like fold family protein
TTF83273 14.17 Hypothetical
TTF84480 13.21 β-galactosidase
TTF60835 12.79 CAMK protein kinase
TTF43440 12.72 Iron only hydrogenase large subunit C-terminal containing protein
TTF31570 12.63 Hypothetical
TTF81526 12.54 6-phosphoglucolactonase
TTF41322 12.27 ABC-transporter protein
TTF81248 12.08 CAMK protein kinase
TTF83248 11.96 CAMK protein kinasel
Trypsin Downregulated Using DK2 Controls
Gene ID Fold change Gene Product
TTF81579 -12.79 DnaJ containg protein
TTF45476 -11.96 Potassium-sodium hyperpolarisation activated gated channel
TTF34734 -11.91 Cysteine protease
TTF34777 -11.29 Cysteine protease
TTF64110 -11.25 Cysteine protease
TTF03418 -10.72 40S ribosomal protein S11
TTF74559 -10.45 Sialidase-like protein
TTF51463 -10.42 Myb-like DNA-binding domain containing protein
TTF70500 -9.89 Serine-threonine protein kinase 2
TTF48862 -9.89 Hypothetical
Table C2: Differential expression of T. foetus DK2 cells after their addition to an MDCK monolayer.
The cells were removed from the monolayer using a trypsin wash and RNA extracted. The top 10
preferentially up and down regulated genes are relative to T. foetus DK2 controls are shown.
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PBS Upregulated with DK2 Controls
Gene ID Fold change Gene Product
TTF83273 15.11 Hypothetical
TTF25670 14.58 Dihydropyrimidase
TTF84480 13.85 β-galactosidase
TTF43440 13.28 Iron-only hydrogenase large subunit C terminal domain containing protein
TTF60835 13.18 CAMK family protein
TTF80312 13.09 Hypothetical
TTF69994 13.07 Hypothetical
TTF81526 12.59 6-phosphogluconolactase
TTF81248 12.56 CAMK family protein
TTF23280 12.45 NA
PBS Downregulated with DK2 Controls
Gene ID Fold change Gene Product
TTF45476 -14.09 Potassium-sodium hyperpolarisation activated gated channel
TTF60658 -12.67 Pyrroline-5-carboxylate reductase
TTF48862 -11.94 Hypothetical
TTF42967 -11.50 Acetlyhydrolase
TTF74496 -10.83 Zinc finger protein
TTF42134 -10.78 SEl 1 protein
TTF42966 -10.69 Acetlyhydrolase
TTF46664 -9.75 Poxvirus D5 protein
TTF13115 -9.69 Clan CA family cysteine peptidase
TTF23726 9.37 NA
Table C3: Differential expression of T. foetus DK2 cells after their addition to an MDCK monolayer.
The cells were removed from the monolayer using a PBS wash prior to the trypsin was and RNA
extracted. The top 10 preferentially up and down regulated genes, relative to T. foetus DK2 controls
are shown.
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Supernatant Upregulated Using DK2 Controls
Gene ID Fold change Gene Product
TTF60835 15.73 CAMK family protein kinase
TTF80312 15.32 Hypothetical
TTF84480 14.93 β-galactosidase
TTF43440 14.03 Iron only hydrogenase large subunit C-terminal containing protein
TTF19166 13.60 Bowman birk serine protease inhibitor family protein
TTF25670 13.59 Dihydropyrimidinase
TTF83273 13.50 Hypothetical
TTF40347 13.37 Small-GTP binding protein
TTF31013 12.73 Clan SB family serine peptidase
TTF83251 12.72 Myb-like DNA-binding domain containing protein
Supernatant Downregulated Using DK2 Controls
Gene ID Fold change Gene Product
TTF45476 -11.04 Potassium-sodium hyperpolarisation activated gated channel
TTF48862 -10.42 Hypothetical
TTF75464 -10.16 Cysteine protease
TTF64908 -9.89 Ser-Thr protein phosphatase
TTF41202 -9.57 Hypothetical
TTF44561 -9.49 Dnak protein
TTF31045 -9.46 Hypothetical
TTF07998 -9.24 Hypothetical
TTF36147 -9.21 Sugar O-acetyltransferase
TTF74467 -9.16 Hypothetical
Table C4: Differential expression of T. foetus DK2 cells after their addition to an MDCK monolayer.
The supernatant from the experiment was removed from the monolayer and RNA extracted. The
top 10 preferentially up and down regulated genes relative to T. foetus DK2 controls are shown.
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Gene All Trichomonads T. foetus strains only
Non-synonymous Synonymous Total Non-synonymous Synonymous Total
TTF00576 0 3 3 0 0 0
TTF00910 2 4 6 0 0 0
TTF01152 3 0 3 0 0 0
TTF01161 2 3 5 0 0 0
TTF02039 9 9 18 0 0 0
TTF02745 12 4 16 2 0 2
TTF03161 9 4 13 0 0 0
TTF03169 10 7 17 2 0 2
TTF04635 56 21 77 27 8 35
TTF05043 5 8 13 0 0 0
TTF05727 2 4 6 0 0 0
TTF05864 18 5 23 2 0 2
TTF08006 7 7 14 1 0 1
TTF08916 0 4 4 0 0 0
TTF09063 8 22 30 1 0 1
TTF09721 3 6 9 0 2 2
TTF11197 79 42 121 2 1 3
TTF12012 11 5 16 0 0 0
TTF13670 11 14 25 0 0 0
TTF13877 26 22 48 1 0 1
TTF14449 1 1 2 1 0 1
TTF14901 22 31 53 1 4 5
TTF16365 18 21 39 4 0 4
TTF16447 8 3 11 0 0 0
TTF18002 14 12 26 0 1 1
TTF19171 12 12 24 10 8 18
TTF20128 7 4 11 0 0 0
TTF21569 5 6 11 0 1 1
TTF21670 7 5 12 1 0 1
TTF23071 32 20 52 6 0 6
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TTF25642 7 9 16 2 0 2
TTF28036 22 21 43 1 0 1
TTF28414 8 4 12 0 0 0
TTF29007 5 9 14 0 1 1
TTF31219 4 3 7 2 2 4
TTF33095 4 4 8 0 0 0
TTF33122 11 3 14 0 0 0
TTF33823 3 3 6 1 0 1
TTF33905 3 3 6 1 0 1
TTF34783 14 8 22 5 0 5
TTF37306 11 2 13 2 0 2
TTF38179 16 23 39 3 2 5
TTF40724 15 20 35 1 0 1
TTF43413 12 28 40 3 0 3
TTF43627 12 7 19 1 0 1
TTF44528 43 25 68 2 0 2
TTF44600 10 17 27 5 1 6
TTF44685 11 8 19 2 0 2
TTF44949 6 11 17 2 0 2
TTF45042 201 64 265 5 3 8
TTF45771 7 4 11 2 0 2
TTF46221 39 19 58 1 0 1
TTF47476 5 9 14 0 0 0
TTF48521 4 5 9 0 0 0
TTF49933 16 11 27 2 0 2
TTF50636 6 10 16 0 0 0
TTF53402 6 21 27 0 0 0
TTF56587 6 8 14 3 0 3
TTF62174 33 11 44 1 0 1
TTF62376 1 3 4 0 0 0
TTF63395 27 8 35 3 0 3
TTF63680 6 15 21 1 1 2
TTF67401 2 4 6 0 1 1
TTF70906 6 13 19 1 0 1
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TTF70954 4 8 12 2 1 3
TTF71197 34 52 86 5 0 5
TTF72511 5 2 7 0 0 0
TTF72966 26 20 46 5 0 5
TTF73221 27 25 52 4 2 6
TTF73824 11 27 38 0 1 1
TTF74586 17 7 24 0 0 0
TTF74797 2 2 4 0 0 0
TTF75601 48 43 91 8 1 9
TTF79943 14 18 32 1 0 1
TTF80312 2 1 3 2 1 3
TTF82375 2 1 3 1 0 1
TTF83271 1 12 13 0 1 1
Table D1: Number of SNPs identified in shortlist produced in Chapter 4. The numbers were
identified when five T. foetus and one T. mobilensis strain were compared to the reference T.
foetus genome (‘All trichomonads’) and when only the five T. foetus strains were compared to
the reference (‘T. foetus only’). For each gene the number of non-synonymous and synonymous
mutations are given.
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